data_1gjx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gjx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.812 0.339 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 5.9 t -149.36 161.99 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.492 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -134.38 106.88 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.429 HD12 ' CG1' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -51.87 -176.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.264 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.427 ' CD ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 mttp -164.62 142.78 6.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.78 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 67.8 t -49.17 138.38 14.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 53.2 Cg_endo -72.7 -167.05 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.356 2.037 . . . . 0.0 112.92 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.67 69.13 3.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.976 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.441 ' HB ' ' CG2' ' A' ' 40' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HA ' ' CB ' ' A' ' 67' ' ' SER . 1.3 pt-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.883 0.373 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 8.1 p-10 44.73 69.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 66' ' ' ILE . 20.0 m -125.97 124.91 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.32 122.97 20.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.706 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 3.6 mt -62.12 164.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.577 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.461 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -126.53 -13.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.845 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 36' ' ' ILE . . . -153.14 144.66 23.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.351 . . . . 0.0 111.372 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.445 ' HA ' HG21 ' A' ' 36' ' ' ILE . 13.4 p -145.13 122.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.218 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 2.5 pt-20 -140.09 47.72 1.8 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 m -144.71 123.37 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.266 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -128.42 18.62 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 95.0 t 65.4 112.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.36 -21.28 5.75 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.499 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -81.41 147.59 29.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.3 m -71.81 155.9 39.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.477 ' CD1' ' CG2' ' A' ' 51' ' ' VAL . 1.7 pp -144.19 144.28 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.214 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.72 -179.06 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.03 48.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.3 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 p30 163.65 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.523 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' CB ' ' A' ' 49' ' ' ALA . 8.1 p-10 -155.29 115.47 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -50.66 117.29 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.153 0.501 . . . . 0.0 111.488 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.428 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 13.8 mt -87.58 -43.6 11.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.009 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.475 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -158.06 -180.0 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.314 0.578 . . . . 0.0 111.86 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.432 ' CG2' HG12 ' A' ' 19' ' ' ILE . 99.9 m -140.05 117.49 11.42 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.455 ' CD2' HG22 ' A' ' 66' ' ' ILE . 5.9 mp -111.61 171.83 7.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.023 0.44 . . . . 0.0 112.187 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 40' ' ' THR . 49.4 tt0 -172.06 157.91 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.643 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.441 ' CG2' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.55 -89.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.904 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.26 21.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.71 -43.44 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.07 169.54 19.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.6 p -108.5 115.93 31.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.493 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -101.1 -175.82 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.161 0.505 . . . . 0.0 111.534 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -172.92 170.43 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.241 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.429 ' CG1' HD12 ' A' ' 5' ' ' LEU . 97.3 t -126.35 124.51 24.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.813 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -88.71 27.03 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.975 2.45 . . . . 0.0 112.702 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.405 ' CB ' ' OD1' ' A' ' 33' ' ' ASP . . . 59.67 150.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.304 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -149.35 70.62 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.476 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -178.33 -178.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.494 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.28 67.79 1.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.818 0.342 . . . . 0.0 111.838 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.48 -134.84 1.75 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.115 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 76' ' ' GLU . 88.5 t -126.23 144.4 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.61 0.243 . . . . 0.0 111.183 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 95.2 t -76.56 145.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.152 0.501 . . . . 0.0 111.303 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.423 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -115.49 -46.92 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.556 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.63 175.3 5.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.498 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.6 p -165.37 119.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.573 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -132.36 66.41 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.587 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -172.82 156.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.694 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -170.97 -159.93 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.737 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.07 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.54 -15.72 3.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.57 163.77 12.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.044 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.08 148.62 24.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.475 HG21 ' N ' ' A' ' 67' ' ' SER . 1.3 tp -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.477 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.475 ' N ' HG21 ' A' ' 66' ' ' ILE . 6.9 m -142.97 138.32 30.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 111.272 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.463 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 95.0 mt-10 -39.57 115.66 0.54 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.427 ' HA3' ' CD ' ' A' ' 6' ' ' LYS . . . 70.17 74.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.221 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -137.64 31.64 2.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.447 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 4' ' ' GLU . 13.7 tp 49.06 95.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.982 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 0.8 OUTLIER -95.2 -74.86 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.654 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.482 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 19.7 m -125.05 136.93 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 111.787 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 61.9 t -104.96 141.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.097 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 33.1 m -127.62 171.47 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.244 0.545 . . . . 0.0 112.362 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 54' ' ' VAL . 1.8 tm-20 -84.49 -39.37 18.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.293 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.246 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.438 ' CD2' ' HD2' ' A' ' 56' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.916 0.389 . . . . 0.0 111.074 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 30.7 t -136.3 159.3 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -134.67 108.61 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.999 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.435 ' CD2' HG12 ' A' ' 47' ' ' VAL . 2.9 tp -63.39 161.07 14.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.454 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 139.52 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.767 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.447 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 96.9 t -42.12 141.21 1.42 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.139 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.447 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 61.1 Cg_endo -75.37 -169.36 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.436 2.091 . . . . 0.0 113.102 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 45' ' ' MET . 5.2 t0 -83.95 94.56 8.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 38' ' ' LEU . 1.1 pp . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.076 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.02 0.438 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 6.5 p-10 46.01 94.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.434 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' CG2' HG12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -137.82 166.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -97.87 133.1 42.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.658 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 8.6 mt -74.76 163.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.896 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.468 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -131.04 -8.75 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.736 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -151.09 150.18 30.39 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 80.0 t -142.03 120.39 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.844 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -146.41 59.48 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.981 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.432 ' CG2' HG22 ' A' ' 58' ' ' VAL . 2.0 m -140.01 115.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.432 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 1.6 t30 -93.99 12.23 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.44 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 24' ' ' ASN . 5.4 p 43.04 63.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.487 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.09 45.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.476 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -136.71 173.25 11.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.996 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.6 m -79.17 132.91 36.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.761 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.435 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -127.5 150.33 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.31 178.82 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 4.0 t -87.96 47.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.61 70.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.546 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.51 100.42 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.483 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -42.98 115.22 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.197 0.523 . . . . 0.0 111.774 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 23.6 mt -87.16 -50.16 6.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.914 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.494 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -149.41 -178.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 111.73 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.429 ' N ' ' HB2' ' A' ' 20' ' ' ALA . 3.5 m -131.96 130.69 41.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.669 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.463 ' CD1' ' CG1' ' A' ' 18' ' ' ILE . 1.9 mm? -116.04 165.15 13.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.799 0.333 . . . . 0.0 110.826 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 40' ' ' THR . 48.9 tt0 -178.21 164.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.447 ' N ' ' CG ' ' A' ' 39' ' ' GLU . 3.5 p -121.28 -59.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.684 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.3 t0 -172.68 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -109.64 -36.8 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.033 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.74 141.38 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -126.9 130.14 49.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.829 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.43 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -117.25 -164.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.287 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -179.66 172.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 34' ' ' THR . 78.8 t -121.15 116.8 30.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.81 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.4 Cg_endo -86.63 18.56 1.55 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.993 2.462 . . . . 0.0 112.7 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 56.1 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.875 0.369 . . . . 0.0 111.551 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -110.6 70.69 0.72 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.446 ' CB ' HG23 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.35 -172.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.116 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.59 63.77 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.661 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.53 -124.38 0.74 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.243 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 77.1 t -139.96 138.17 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.473 0.178 . . . . 0.0 111.165 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 58.2 t -75.04 145.02 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.114 0.483 . . . . 0.0 111.476 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HD2' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -115.54 -44.24 2.98 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.497 178.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 17.8 mt-10 -115.06 174.24 6.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.606 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 HG22 ' CG2' ' A' ' 23' ' ' VAL . 15.0 p -160.86 122.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.363 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -134.19 74.62 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.749 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.439 HG21 ' N ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -173.58 148.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.491 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.439 ' N ' HG21 ' A' ' 60' ' ' VAL . 6.5 mttt -143.85 -166.26 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.984 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG21 ' CG2' ' A' ' 21' ' ' VAL . 59.6 t -106.71 86.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.09 18.99 4.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.85 171.71 7.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.794 0.33 . . . . 0.0 110.662 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.97 123.35 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.413 HG23 ' CG2' ' A' ' 16' ' ' VAL . 1.1 tp -122.44 167.17 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.408 ' N ' HG21 ' A' ' 66' ' ' ILE . 82.4 p -151.28 141.13 21.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 26.0 mt-10 -42.9 95.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.204 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.37 61.46 0.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.393 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.31 20.18 23.65 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.472 ' CD1' ' CB ' ' A' ' 4' ' ' GLU . 11.2 tp 49.92 50.01 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.796 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 4.3 mt -48.07 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.256 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.458 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 17.6 m -117.0 141.07 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.148 0.499 . . . . 0.0 112.029 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 91.5 t -113.6 131.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 27.8 m -121.95 169.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.425 ' N ' ' HE2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -78.61 -36.46 44.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.607 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.176 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.894 0.378 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 6.5 t -148.92 161.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.951 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 69.0 mt-10 -133.39 115.29 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.198 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.439 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -73.45 160.8 31.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -147.34 150.09 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 111.405 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 84.0 t -46.05 140.43 4.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.432 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.459 ' CD ' ' CD2' ' A' ' 38' ' ' LEU . 74.1 Cg_endo -76.38 -166.17 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.592 2.195 . . . . 0.0 112.614 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 45' ' ' MET . 16.5 t70 -94.47 88.74 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.054 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.445 HG12 ' CG2' ' A' ' 16' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.98 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.973 0.416 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 44.89 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.445 ' CG2' HG12 ' A' ' 10' ' ' ILE . 34.6 m -143.72 115.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.569 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 128.21 35.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.556 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.466 ' CG1' ' CD1' ' A' ' 38' ' ' LEU . 4.2 mt -65.39 164.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.461 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -126.93 -35.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.275 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -118.59 148.11 43.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HA ' HG21 ' A' ' 36' ' ' ILE . 7.8 p -134.9 119.22 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.991 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -146.3 40.09 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.432 ' CG2' HG22 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -133.72 117.82 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -132.6 12.25 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.377 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 90.0 t 62.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.35 . . . . 0.0 111.085 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.08 -21.54 13.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.779 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.42 139.41 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 111.107 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.2 m -74.76 102.29 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.448 ' CD1' HG22 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -87.16 153.91 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.38 -174.36 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.841 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 8.9 t -89.94 42.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.395 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER 163.7 72.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.591 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -148.78 115.16 5.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.78 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.58 115.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.527 . . . . 0.0 111.45 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.403 ' O ' HG21 ' A' ' 36' ' ' ILE . 98.3 mt -88.98 -40.97 12.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.541 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.6 OUTLIER -159.31 -177.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.441 ' N ' ' HB2' ' A' ' 20' ' ' ALA . 23.2 m -136.04 133.17 37.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.811 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.466 ' CD1' ' CG1' ' A' ' 18' ' ' ILE . 1.8 mm? -116.11 150.59 37.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.864 0.364 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 40' ' ' THR . 41.7 tt0 -159.91 163.18 34.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.428 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -133.03 -82.92 0.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.656 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 40' ' ' THR . 12.0 p-10 -143.79 -43.48 0.27 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 42.63 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.65 133.64 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.193 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 p -129.4 118.48 22.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.431 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -117.29 -167.95 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.572 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -177.23 167.62 2.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.13 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.434 ' CG1' HD12 ' A' ' 5' ' ' LEU . 57.8 t -121.85 111.8 32.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.409 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 58.9 Cg_endo -89.64 33.35 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.115 2.544 . . . . 0.0 112.401 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 56.57 163.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.96 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -157.76 44.83 0.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.097 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -173.45 163.37 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.96 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.7 87.92 2.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.19 -139.68 2.7 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.939 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.11 136.58 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 59.5 t -72.87 143.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.105 0.478 . . . . 0.0 111.397 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -112.51 -47.69 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.338 178.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.7 mm-40 -112.18 173.38 6.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 HG22 ' CG2' ' A' ' 23' ' ' VAL . 7.6 p -163.14 120.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.306 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.7 mttm -132.05 64.09 1.6 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.533 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.436 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -173.05 151.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.672 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.99 175.52 2.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.658 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.22 68.34 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.43 55.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.893 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 10.7 p-10 -173.15 132.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -76.28 119.76 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.437 HG21 ' CG1' ' A' ' 7' ' ' VAL . 1.7 tp -104.6 172.74 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.8 m -144.13 137.66 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 72.4 mt-10 -40.48 130.52 2.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.0 61.73 3.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.037 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.27 129.05 5.44 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.131 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -53.06 94.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 110.584 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 1.3 mt -92.45 -78.83 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.476 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 19.6 m -126.77 137.6 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.0 111.873 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 85.3 t -108.77 136.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.782 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -126.06 167.52 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.212 0.529 . . . . 0.0 112.32 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . 3.7 tt0 -71.59 -38.87 70.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.612 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.441 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 121.311 0.577 . . . . 0.0 112.169 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.909 0.385 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 3.3 t -142.91 162.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.882 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 2.0 mt-10 -130.86 91.08 3.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.494 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -48.41 155.18 0.54 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.784 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.435 ' CD ' ' HA3' ' A' ' 69' ' ' GLY . 10.9 mttm -147.06 150.18 34.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 111.492 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 91.1 t -50.13 140.75 16.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.628 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.447 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 37.8 Cg_endo -68.73 -166.66 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.285 1.99 . . . . 0.0 112.88 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -99.22 69.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.432 ' HB ' ' CG2' ' A' ' 40' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 4.8 mt-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.171 0.51 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.412 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 1.5 p30 169.82 66.75 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.459 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.48 ' CG1' ' CG2' ' A' ' 40' ' ' THR . 1.0 OUTLIER -120.0 137.74 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.556 -179.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.86 131.88 37.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.972 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 11.5 mt -67.64 162.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -125.95 -16.42 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.706 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' A' ' 36' ' ' ILE . . . -145.7 150.36 36.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 13.5 p -138.78 129.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -150.23 44.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.59 124.16 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -135.55 10.32 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.46 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 87.7 t 64.51 118.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.081 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.94 -23.29 8.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.54 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -71.73 165.7 23.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.2 m -100.44 108.87 20.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.436 HG12 ' CG1' ' A' ' 75' ' ' VAL . 1.1 pt -93.55 138.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.36 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.14 39.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 168.29 68.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -145.03 123.25 12.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.88 116.12 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.279 0.561 . . . . 0.0 111.278 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.412 ' CD1' ' HG ' ' A' ' 5' ' ' LEU . 49.1 mt -88.33 -43.0 11.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.417 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.466 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -153.94 -178.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.516 179.013 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.448 ' CG2' ' CD1' ' A' ' 19' ' ' ILE . 44.6 m -144.9 123.42 12.43 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.471 ' CD2' ' CG2' ' A' ' 66' ' ' ILE . 1.2 mp -116.24 -179.37 3.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.437 ' HG3' ' CG2' ' A' ' 44' ' ' THR . 5.8 tm-20 -174.87 160.04 2.82 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.48 ' CG2' ' CG1' ' A' ' 16' ' ' VAL . 5.5 p -116.54 -61.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 20.7 m-20 -151.0 -43.28 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -141.4 25.43 2.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.12 98.69 2.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.19 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.437 ' CG2' ' HG3' ' A' ' 39' ' ' GLU . 17.8 p -93.51 116.26 28.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.62 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -105.83 -176.32 3.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.076 0.465 . . . . 0.0 111.482 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -168.3 167.12 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.342 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.403 HG13 ' CD1' ' A' ' 5' ' ' LEU . 96.4 t -123.0 115.24 29.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.17 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -90.86 35.81 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.047 2.498 . . . . 0.0 112.137 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 59.72 175.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.448 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 15.7 tt0 -162.85 43.31 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.548 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 176.23 167.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.12 89.35 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.24 -156.95 8.87 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.006 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' GLU . 81.6 t -113.93 146.28 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.53 0.205 . . . . 0.0 111.246 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 67.6 t -81.3 144.93 9.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.293 0.568 . . . . 0.0 111.348 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.435 ' CA ' ' HE2' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -112.7 -51.27 2.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.193 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.3 mt-10 -106.2 172.92 6.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.672 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 7.4 p -166.2 126.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.626 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -147.5 74.22 1.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.437 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -171.3 150.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -160.42 -163.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.904 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.7 93.32 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.107 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.38 33.86 0.8 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.622 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 12.3 p-10 -129.34 140.96 51.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' CD ' ' HB2' ' A' ' 15' ' ' ASN . 6.8 mttt -73.22 130.47 40.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.471 ' CG2' ' CD2' ' A' ' 38' ' ' LEU . 1.1 tp -130.86 170.75 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.453 ' N ' HG21 ' A' ' 66' ' ' ILE . 8.7 m -147.62 135.99 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mp0 -41.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.435 ' HA3' ' CD ' ' A' ' 6' ' ' LYS . . . 107.53 62.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.378 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.04 23.03 8.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 3.2 tp 45.76 57.22 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.029 0.443 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 2.9 mt -49.35 -80.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 21.3 m -124.94 157.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.415 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 78.4 t -118.46 131.32 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.284 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 16.8 m -118.36 165.57 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' VAL . 4.5 tp10 -72.4 -38.84 68.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.032 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 121.151 0.5 . . . . 0.0 111.893 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.42 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 1.5 mt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.906 0.384 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 8.4 t -161.63 159.58 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 2.0 mp0 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.361 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 49' ' ' ALA . 1.2 mt -59.2 164.82 2.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.748 0.309 . . . . 0.0 110.676 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HD3' ' HA3' ' A' ' 69' ' ' GLY . 20.3 mttt -143.81 172.41 12.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.58 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.461 ' CG2' HG22 ' A' ' 66' ' ' ILE . 23.7 t -72.83 140.04 80.72 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.032 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 19.4 Cg_endo -63.32 -166.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 112.86 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' A' ' 10' ' ' ILE . 24.5 t70 -93.19 -13.35 28.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.463 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.449 ' CD1' ' O ' ' A' ' 9' ' ' ASP . 1.5 pp . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 11.8 mt-10 . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.885 0.374 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.434 ' N ' ' HB3' ' A' ' 67' ' ' SER . 8.0 p-10 44.33 95.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.507 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 66' ' ' ILE . 27.1 m -152.49 141.06 14.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.66 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -82.02 130.32 35.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.56 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 22.0 mt -62.56 164.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.469 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -128.18 -12.47 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.294 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -146.96 158.25 43.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.002 0.429 . . . . 0.0 111.61 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 7.4 p -148.66 123.87 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.078 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -149.07 44.45 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.429 ' CG2' HG22 ' A' ' 58' ' ' VAL . 2.5 m -135.22 120.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -128.95 10.97 6.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.401 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG12 ' CA ' ' A' ' 56' ' ' LYS . 84.6 t 58.84 112.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.2 -15.32 5.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.833 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.97 142.52 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 127.84 33.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.481 ' CD1' ' CG2' ' A' ' 51' ' ' VAL . 1.1 pp -108.54 154.7 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.02 179.53 5.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.1 t -85.66 48.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.351 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 164.11 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.59 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -156.74 99.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.768 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -45.49 117.5 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.147 0.498 . . . . 0.0 111.822 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 36' ' ' ILE . 20.5 mt -92.79 -42.5 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.389 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.475 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 1.2 pp -148.77 -175.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.057 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.446 ' CG2' ' CD1' ' A' ' 19' ' ' ILE . 32.4 m -149.24 124.55 10.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.449 ' CA ' HG22 ' A' ' 19' ' ' ILE . 2.4 mp -113.2 167.18 10.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' N ' HG23 ' A' ' 10' ' ' ILE . 70.3 tt0 -161.91 164.15 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.692 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.432 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 6.2 p -121.93 -57.54 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -175.33 -37.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -116.59 -19.3 10.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.622 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.14 148.42 49.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.628 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -131.2 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.439 ' HG3' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -121.06 -173.51 2.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.223 0.535 . . . . 0.0 111.675 -179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -168.76 159.35 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.044 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.416 ' CG1' HD23 ' A' ' 5' ' ' LEU . 54.6 t -123.08 126.67 25.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.356 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 86.5 Cg_endo -89.58 34.13 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.882 2.388 . . . . 0.0 112.325 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 5' ' ' LEU . . . 81.64 -51.25 0.26 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' C ' ' CG2' ' A' ' 51' ' ' VAL . 5.0 tp10 55.03 56.16 6.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -174.16 -169.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.21 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -156.42 65.9 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.84 -139.7 2.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.129 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.04 135.56 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.386 0.136 . . . . 0.0 110.642 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 58.3 t -71.93 144.37 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.293 0.568 . . . . 0.0 111.636 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' CA ' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.54 -47.05 2.74 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.265 178.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -110.28 172.53 6.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.429 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.429 HG22 ' CG2' ' A' ' 23' ' ' VAL . 7.2 p -164.81 128.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.873 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -146.06 75.81 1.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.642 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -172.5 155.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.491 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.43 -160.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.774 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.427 HG21 ' CG1' ' A' ' 21' ' ' VAL . 61.3 t -110.13 76.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.216 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.52 41.23 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.811 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 16.7 p-10 -128.73 138.63 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.924 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -72.05 110.71 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.792 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.461 HG22 ' CG2' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -137.99 168.83 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -152.85 162.7 40.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 111.283 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -42.19 107.4 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.488 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 6' ' ' LYS . . . 98.91 70.41 0.96 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.783 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.95 21.35 4.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.373 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 1.7 tp 43.52 57.54 3.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.113 0.482 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.444 HD13 ' CA ' ' A' ' 7' ' ' VAL . 3.7 mt -49.95 -73.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.096 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.427 ' CG1' ' HA ' ' A' ' 58' ' ' VAL . 18.1 m -135.45 145.23 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 92.4 t -104.97 136.74 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 1.2 m -126.69 167.54 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.0 112.295 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -101.1 46.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' HA ' ' C ' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--N 1.335 -0.058 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 2.7 t -142.86 161.62 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -136.51 117.59 14.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.401 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.432 ' CD2' HD13 ' A' ' 35' ' ' LEU . 1.6 tp -68.65 160.81 29.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -143.75 144.42 31.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 111.415 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.442 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 86.8 t -41.19 140.58 1.16 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.035 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 61.0 Cg_endo -75.32 -168.04 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.24 1.96 . . . . 0.0 113.076 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 45' ' ' MET . 0.1 OUTLIER -98.65 83.78 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.952 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.441 ' CG2' HD22 ' A' ' 38' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.895 0.378 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.418 ' CA ' ' O ' ' A' ' 66' ' ' ILE . 5.5 p-10 43.75 78.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.405 HG21 HG23 ' A' ' 66' ' ' ILE . 25.1 m -122.26 -178.02 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.433 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -106.59 118.45 36.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.915 0.388 . . . . 0.0 111.401 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 19.5 mt -55.21 165.29 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.475 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -136.5 2.99 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.508 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.32 152.21 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.297 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.427 ' HA ' HG21 ' A' ' 36' ' ' ILE . 81.2 t -137.26 120.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.759 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -148.42 60.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.926 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG2' HG22 ' A' ' 58' ' ' VAL . 2.4 m -142.1 113.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -120.94 96.25 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 63.3 t -40.21 116.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.56 15.13 7.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.66 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.91 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 m -70.25 146.29 50.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.466 ' CD1' ' O ' ' A' ' 52' ' ' ALA . 2.8 pt -136.69 154.81 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.51 -174.88 3.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 t -91.94 47.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 p30 172.68 67.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.058 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.99 108.58 3.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.564 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -46.95 119.12 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.092 0.472 . . . . 0.0 111.874 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.432 HD13 ' CD2' ' A' ' 5' ' ' LEU . 21.5 mt -94.52 -39.39 10.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.877 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.452 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -161.11 -177.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.349 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.44 ' CG2' HG12 ' A' ' 19' ' ' ILE . 70.5 m -142.53 109.11 5.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.743 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.441 HD22 ' CG2' ' A' ' 10' ' ' ILE . 1.8 tp -95.02 155.93 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.679 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' CB ' HG22 ' A' ' 19' ' ' ILE . 33.6 tt0 -166.31 144.63 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.655 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.44 ' CG2' ' HB ' ' A' ' 10' ' ' ILE . 3.4 p -104.99 -59.46 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.425 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.7 p30 -174.63 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.34 35.75 4.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 177.25 131.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.252 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.434 HG23 ' CG ' ' A' ' 39' ' ' GLU . 73.6 p -119.21 116.33 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.406 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -123.7 128.02 49.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.253 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.0 OUTLIER -113.23 174.47 5.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.757 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' CG2' HD12 ' A' ' 36' ' ' ILE . 76.9 t -120.59 116.3 31.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 85.2 Cg_endo -87.37 37.27 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.94 2.427 . . . . 0.0 112.359 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 46.83 93.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.856 0.36 . . . . 0.0 111.11 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -93.38 63.03 3.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.426 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 1.0 OUTLIER 163.43 148.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.333 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -96.35 -168.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.368 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.449 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 102.14 -146.52 16.98 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.839 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.95 135.4 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.538 0.209 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 56' ' ' LYS . 61.5 t -68.22 147.05 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.69 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.67 -50.75 2.4 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.277 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.81 166.32 13.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.409 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 23' ' ' VAL . 5.4 p -152.17 138.56 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.318 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' N ' HG21 ' A' ' 58' ' ' VAL . 6.9 mmtt -140.65 59.35 1.55 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.306 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.433 ' CG2' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -157.47 143.58 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -146.61 -174.2 4.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.76 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.5 t -98.04 92.73 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.45 35.57 1.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.628 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 19.6 p-10 -119.13 172.89 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.958 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.54 123.06 40.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.434 HG13 ' CG2' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -129.16 161.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.161 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.9 p -135.42 127.28 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.421 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.435 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 42.5 mt-10 -40.91 115.02 0.53 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 88.17 64.65 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.011 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.78 -165.83 11.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.024 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 4' ' ' GLU . 8.5 tp -104.49 89.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.969 0.414 . . . . 0.0 110.372 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 2.1 mt -87.35 -80.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.944 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 17.4 m -122.41 135.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.064 0.459 . . . . 0.0 111.891 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 41.4 t -103.78 144.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.338 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG2' ' HB ' ' A' ' 3' ' ' VAL . 10.9 m -129.07 165.41 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.122 0.487 . . . . 0.0 112.008 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 6.3 tt0 -83.73 -26.49 29.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.58 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.075 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.832 0.348 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.444 ' HB ' ' CG2' ' A' ' 75' ' ' VAL . 19.8 t -139.27 146.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 1.3 mp0 -124.34 100.63 6.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.435 HD13 ' CD1' ' A' ' 35' ' ' LEU . 44.1 mt -63.88 131.24 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.72 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.2 mtmt -130.29 55.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.483 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 38.2 t 58.75 147.04 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.442 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' CD ' ' CD2' ' A' ' 38' ' ' LEU . 98.8 Cg_endo -94.29 -178.39 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.756 2.304 . . . . 0.0 112.453 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 45' ' ' MET . 0.4 OUTLIER -64.2 173.69 1.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.012 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 38' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.754 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.175 0.512 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.468 ' N ' ' CB ' ' A' ' 67' ' ' SER . 3.6 p30 44.15 94.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.453 HG21 ' CB ' ' A' ' 67' ' ' SER . 0.1 OUTLIER -142.64 -176.08 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.372 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -112.06 138.68 48.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 28.8 mt -73.45 161.91 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.471 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -134.62 -7.02 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.929 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -152.85 155.26 36.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.44 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 61.5 t -147.57 126.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.313 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -153.3 32.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.98 123.46 68.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -135.0 9.76 3.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.492 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.42 HG22 ' CG1' ' A' ' 58' ' ' VAL . 87.3 t 63.4 131.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.85 -22.51 18.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.371 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.51 139.03 30.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.7 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -68.16 162.22 25.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.437 HG12 ' CG1' ' A' ' 75' ' ' VAL . 1.2 pp -143.73 130.19 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.15 -174.43 4.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.935 0.398 . . . . 0.0 111.008 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 t -90.32 41.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 168.05 67.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -141.78 116.62 9.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.867 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -59.65 115.32 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.435 ' CD1' HD13 ' A' ' 5' ' ' LEU . 16.6 mt -90.37 -41.95 11.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.406 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.48 ' CD1' ' CD2' ' A' ' 38' ' ' LEU . 1.3 pp -150.43 -175.97 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.884 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.432 ' N ' ' HB2' ' A' ' 20' ' ' ALA . 3.7 m -133.3 152.59 51.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.491 ' CD2' ' CD ' ' A' ' 8' ' ' PRO . 2.4 mm? -134.45 166.8 22.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 40' ' ' THR . 76.0 tt0 -174.4 164.07 3.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.401 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.466 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 13.5 p -120.71 -72.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.892 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.466 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.9 m-20 -159.72 25.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.731 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm 176.24 -43.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.65 128.76 45.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 p -116.71 115.81 26.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.44 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -104.07 -165.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 5.7 p30 -175.69 167.34 3.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' THR . 74.0 t -112.03 104.15 55.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 70.3 Cg_endo -89.35 42.11 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.118 2.545 . . . . 0.0 111.886 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.7 177.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 23.1 pt-20 -163.19 38.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.442 ' CB ' ' HB1' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 175.74 168.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 29' ' ' ILE . . . -112.27 93.15 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.961 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.35 -140.15 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.259 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.08 145.24 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 0.0 111.065 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 63.2 t -75.16 145.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 0.0 111.397 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.413 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -115.13 -47.59 2.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.466 178.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.92 167.2 10.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.644 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 12.4 p -162.87 124.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.93 80.93 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.433 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.32 151.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -149.56 -173.87 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.97 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.427 HG21 ' CG2' ' A' ' 21' ' ' VAL . 46.3 t -101.31 77.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.7 41.49 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' OD1' ' CD1' ' A' ' 18' ' ' ILE . 3.9 p30 -132.8 164.04 27.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.418 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -88.76 105.0 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.18 0.514 . . . . 0.0 110.705 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.443 HG21 ' CG2' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -132.89 164.61 34.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.369 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.468 ' CB ' ' N ' ' A' ' 15' ' ' ASN . 54.3 p -167.2 168.32 13.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -45.72 91.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.196 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 124.34 57.56 0.18 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.76 9.02 6.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.928 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 4.2 tp 47.25 46.86 16.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.679 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.454 HD13 ' CG2' ' A' ' 7' ' ' VAL . 9.1 mt -43.26 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 58' ' ' VAL . 18.5 m -135.36 147.25 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.51 . . . . 0.0 111.99 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 98.5 t -109.84 140.72 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.705 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 3' ' ' VAL . 16.4 m -123.16 161.91 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.127 0.489 . . . . 0.0 112.303 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -68.58 -42.28 78.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.016 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.97 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.938 0.399 . . . . 0.0 110.788 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 6.2 t -125.51 162.76 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.451 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 11.2 mt-10 -125.48 90.32 3.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.428 ' CB ' HG21 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -51.84 152.16 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.572 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -140.12 151.54 45.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.205 0.526 . . . . 0.0 111.626 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 85.2 t -47.11 143.13 4.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.88 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 43.5 Cg_endo -70.78 -167.47 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.149 1.9 . . . . 0.0 112.738 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 76.86 2.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.562 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.464 ' HB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.683 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' CA ' ' HA ' ' A' ' 67' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.047 0.451 . . . . 0.0 110.65 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -179.34 57.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.437 HG22 ' CD2' ' A' ' 38' ' ' LEU . 17.1 m -106.38 -175.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.173 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.18 130.6 52.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 5.6 mt -66.15 161.15 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.956 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.456 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -126.6 -37.98 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -118.08 166.18 12.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.0 p -159.38 116.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -135.64 61.4 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.415 ' CG2' HG21 ' A' ' 58' ' ' VAL . 5.8 m -145.18 118.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.69 23.17 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' CG2' HG13 ' A' ' 58' ' ' VAL . 71.8 t 66.73 -86.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.991 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.7 62.03 0.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.946 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -129.94 171.03 13.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.709 0.29 . . . . 0.0 110.761 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 m -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.903 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.4 HD12 HG22 ' A' ' 75' ' ' VAL . 1.1 pt -132.21 153.2 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 0.0 111.344 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.91 174.06 11.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 3.1 t -78.51 54.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 3.6 p30 162.09 70.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.83 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -153.81 124.39 7.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.78 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.53 117.38 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.277 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 19.1 mt -90.42 -40.78 11.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.849 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -157.68 -161.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.862 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.453 ' N ' HG12 ' A' ' 36' ' ' ILE . 93.1 m -157.7 51.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.329 0.585 . . . . 0.0 109.846 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.437 ' CD2' HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -41.83 163.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.859 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 40' ' ' THR . 70.1 tt0 -172.76 154.42 2.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.464 ' CG2' ' HB ' ' A' ' 10' ' ' ILE . 50.2 p -102.01 -82.87 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' N ' ' OG1' ' A' ' 40' ' ' THR . 16.7 t70 -150.96 21.41 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -179.98 -41.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.03 105.58 17.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.234 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -91.74 115.07 27.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -95.43 138.9 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.478 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 3.7 m-20 -119.89 144.41 47.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.955 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 8' ' ' PRO . 76.5 t -122.09 112.8 31.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 83.6 Cg_endo -88.4 35.41 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.963 2.442 . . . . 0.0 112.331 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 54.23 168.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.035 0.445 . . . . 0.0 111.176 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -165.65 67.88 0.12 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.484 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.445 HG22 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -173.87 176.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.237 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.67 79.01 1.69 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.627 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 77' ' ' ALA . . . -167.99 -140.66 2.97 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.308 -1.425 . . . . 0.0 113.857 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -130.94 139.09 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.83 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 57.7 t -79.53 146.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.408 0.623 . . . . 0.0 111.527 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.424 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -118.59 -44.45 2.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.045 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -109.88 158.0 18.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.453 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.437 HG13 ' CG2' ' A' ' 25' ' ' VAL . 7.7 p -151.44 119.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -131.07 68.89 1.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.683 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.437 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -172.46 154.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.643 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -169.11 170.69 8.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.591 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.427 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 54.1 t -82.03 88.42 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.28 46.88 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.72 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 19.0 p-10 -139.46 176.53 8.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.772 0.32 . . . . 0.0 111.042 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 7.8 tttt -104.07 156.09 18.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.669 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -140.76 172.56 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 7.2 p -147.13 48.39 1.13 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.433 ' CG ' HD13 ' A' ' 10' ' ' ILE . 36.4 mt-10 39.95 55.21 2.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 138.0 69.97 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.442 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.93 29.07 6.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.553 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.9 tp 48.09 56.67 7.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 0.0 110.571 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 3.3 mt -45.98 -82.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.457 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 27.3 m -122.0 160.15 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.17 0.51 . . . . 0.0 111.875 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 76.3 t -128.93 120.58 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.907 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 29.7 m -112.09 156.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -31.08 72.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.656 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' N ' ' HA2' ' A' ' 53' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.061 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.89 0.376 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.437 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 7.9 t -141.84 152.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.426 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 7.3 mt-10 -128.37 100.79 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.376 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.442 HD23 ' CG1' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -60.93 157.56 15.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.069 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' CD ' ' HA3' ' A' ' 69' ' ' GLY . 8.5 mttp -142.13 145.07 33.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.314 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.458 ' CG1' HG21 ' A' ' 66' ' ' ILE . 95.9 t -48.23 141.24 8.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.04 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 38.0 Cg_endo -68.72 -166.08 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.2 1.934 . . . . 0.0 112.24 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -92.59 -13.04 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.645 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 9' ' ' ASP . 1.2 pp . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.924 0.392 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 44.03 95.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 66' ' ' ILE . 30.9 m -146.54 137.12 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.92 126.22 29.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.522 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 3.7 mt -55.72 165.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -140.75 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.066 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.436 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -177.95 146.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 111.099 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HA ' HG21 ' A' ' 36' ' ' ILE . 13.4 p -137.81 124.39 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.981 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mm-40 -148.82 39.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.426 ' CG2' HG22 ' A' ' 58' ' ' VAL . 3.0 m -120.07 112.77 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.357 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -122.84 97.6 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 23.5 m -39.05 111.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.921 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.93 21.17 4.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.67 143.11 50.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -69.83 127.08 31.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.453 HD12 ' CG1' ' A' ' 75' ' ' VAL . 2.6 pt -108.09 169.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -178.58 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 t -94.34 33.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 176.23 62.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.93 108.34 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -48.76 116.23 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.187 0.518 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.429 ' CD1' ' CD1' ' A' ' 5' ' ' LEU . 70.2 mt -94.63 -44.29 7.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.788 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.496 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -149.93 -173.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.433 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.439 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 47.5 m -149.12 107.67 3.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.486 ' CD2' ' CD1' ' A' ' 36' ' ' ILE . 2.7 mm? -92.19 151.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' CB ' HG22 ' A' ' 19' ' ' ILE . 78.2 tt0 -155.51 150.1 26.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.892 0.377 . . . . 0.0 110.991 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 3.0 p -112.06 -61.39 1.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.988 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 15.3 t0 -168.53 -41.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 37.77 3.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.51 118.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -113.04 119.95 39.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.43 ' HG3' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.03 153.56 21.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.4 p30 -133.12 143.91 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.572 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.442 ' CG1' HD23 ' A' ' 5' ' ' LEU . 93.8 t -105.87 108.09 60.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 71.0 Cg_endo -88.07 37.74 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.043 2.495 . . . . 0.0 112.469 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 44.66 95.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 111.338 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 4.2 mt-10 -87.39 53.66 2.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.441 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 1.2 p 161.85 141.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -83.14 -162.26 0.59 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.79 -145.17 15.93 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.089 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 76' ' ' GLU . 45.7 t -145.44 138.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.401 0.143 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.446 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 60.0 t -76.25 146.98 8.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.316 0.579 . . . . 0.0 111.796 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -119.71 -47.87 2.4 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.122 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -109.54 172.4 6.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.652 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 7.6 p -164.39 137.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.27 67.96 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.402 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -169.59 152.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.639 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -171.81 -167.24 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.521 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.87 90.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.45 -19.94 0.71 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.892 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 2.3 p-10 -98.59 167.25 10.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.095 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.54 134.61 44.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.458 HG21 ' CG1' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -127.92 162.83 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.054 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -145.87 144.63 30.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -41.08 106.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' HA3' ' CD ' ' A' ' 6' ' ' LYS . . . 94.26 70.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.608 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.35 21.13 3.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.416 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.431 HD12 ' CG2' ' A' ' 74' ' ' VAL . 5.5 tp 47.58 59.67 3.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.429 HD13 ' CA ' ' A' ' 7' ' ' VAL . 3.6 mt -52.35 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 58' ' ' VAL . 20.8 m -129.83 148.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 111.597 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 79.3 t -115.1 134.25 58.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.453 ' CG1' HD12 ' A' ' 29' ' ' ILE . 32.0 m -121.84 177.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.155 0.502 . . . . 0.0 112.205 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' VAL . 1.5 tt0 -82.81 -33.53 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.268 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.442 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.879 0.371 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.485 ' CG2' ' CG1' ' A' ' 51' ' ' VAL . 3.6 t -144.31 161.27 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.471 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 63.5 mt-10 -129.87 100.06 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.552 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.428 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -57.75 164.09 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.023 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' CD ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -154.18 155.61 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.273 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 96.5 t -53.76 140.74 48.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HG3' HD21 ' A' ' 38' ' ' LEU . 70.5 Cg_endo -73.69 -168.44 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.65 2.233 . . . . 0.0 113.03 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.434 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.4 OUTLIER -82.9 92.94 7.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.79 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.426 HG12 ' CG2' ' A' ' 16' ' ' VAL . 1.3 pp . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.042 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 2.8 mp0 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.025 0.441 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 169.32 73.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.437 ' CG2' HG23 ' A' ' 66' ' ' ILE . 4.0 m -134.88 130.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.366 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.68 140.76 49.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.475 ' CG1' ' CD1' ' A' ' 38' ' ' LEU . 5.8 mt -74.9 161.33 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.709 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -124.35 -38.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.794 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.95 170.8 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.735 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.474 ' HA ' HG21 ' A' ' 36' ' ' ILE . 10.6 p -159.93 124.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.313 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 39.1 mt-10 -158.64 90.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 22' ' ' GLU . 2.6 m -163.95 113.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.361 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.5 m120 -114.7 96.23 5.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.506 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.408 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 2.3 m -42.68 92.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.546 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 136.31 -15.73 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.588 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.28 169.92 16.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.84 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 m -96.36 103.16 15.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.06 158.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.45 -176.79 4.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.941 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -90.21 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.316 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 172.08 73.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.783 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -150.25 107.84 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.614 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -48.76 118.6 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 111.417 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.407 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 81.8 mt -92.55 -39.5 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.08 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.474 HG21 ' HA ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -161.81 -178.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.626 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 76.3 m -142.08 56.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.669 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.475 ' CD1' ' CG1' ' A' ' 18' ' ' ILE . 3.2 mm? -41.45 166.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 40' ' ' THR . 67.1 tt0 -168.52 153.89 6.53 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.306 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 29.9 p -100.04 -72.65 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.707 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.1 p-10 -160.22 26.99 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.601 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.04 -42.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.875 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.85 124.26 43.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.044 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.9 p -107.5 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.054 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.434 ' HG3' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -97.5 133.09 42.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 2.9 p30 -118.3 144.31 45.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.229 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 34' ' ' THR . 92.4 t -113.34 116.58 46.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.417 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 78.4 Cg_endo -87.42 27.8 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.964 2.443 . . . . 0.0 112.619 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 59.28 151.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 111.297 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.42 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 9.4 tp10 -145.98 70.9 1.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.485 ' CG1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 176.81 153.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.038 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.87 77.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.77 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.98 -130.84 1.23 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.179 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 61.8 t -137.18 138.77 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.45 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 70.4 t -78.6 146.59 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.519 . . . . 0.0 111.291 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.429 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -116.6 -47.08 2.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.589 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.05 175.04 5.58 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.82 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.419 HG22 ' CG2' ' A' ' 23' ' ' VAL . 7.5 p -163.39 126.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.525 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.1 mttt -136.87 69.01 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' CG2' ' N ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -171.78 159.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.723 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.437 ' N ' ' CG2' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -171.89 -172.89 1.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.523 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.61 79.19 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.272 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.13 44.21 0.07 OUTLIER Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.701 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 7.7 p-10 -148.01 147.01 29.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.88 0.371 . . . . 0.0 111.108 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 137.18 40.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.437 HG23 ' CG2' ' A' ' 16' ' ' VAL . 1.1 tp -131.27 172.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.441 ' CB ' ' HB3' ' A' ' 14' ' ' GLU . 7.1 p -152.2 142.78 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.203 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 76.9 mt-10 -44.74 97.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.201 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.8 62.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -114.26 22.03 14.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.357 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 13.9 tp 48.15 53.58 11.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.977 0.418 . . . . 0.0 110.686 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.436 HD13 ' CG2' ' A' ' 7' ' ' VAL . 3.7 mt -48.11 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.044 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.428 ' CG2' ' HB2' ' A' ' 5' ' ' LEU . 22.8 m -123.05 159.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.559 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 27.9 t -127.75 132.52 68.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.934 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 33.2 m -119.38 -179.64 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -93.2 -37.19 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.514 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.153 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.342 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.862 0.363 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 13.7 t -134.69 160.27 41.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 31.0 mp0 -133.01 103.98 6.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.552 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.434 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -60.9 159.05 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.651 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.433 ' CD ' ' HA3' ' A' ' 69' ' ' GLY . 15.5 mttt -148.72 145.04 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 72.3 t -47.91 140.45 8.66 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.998 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' CD2' ' A' ' 38' ' ' LEU . 71.8 Cg_endo -76.94 -169.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.677 2.252 . . . . 0.0 112.89 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.44 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -81.85 84.45 6.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.791 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.44 HD12 ' CG1' ' A' ' 16' ' ' VAL . 1.1 pp . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 25.7 mp0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.993 0.425 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 7.0 p-10 45.38 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' CG1' HD12 ' A' ' 10' ' ' ILE . 35.3 m -136.18 -175.67 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.355 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.33 120.34 38.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.824 0.345 . . . . 0.0 111.369 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 27.2 mt -68.18 159.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.449 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -126.19 -15.81 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.51 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.0 150.47 32.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 p -140.21 124.19 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -132.09 34.69 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 m -132.93 115.21 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.405 ' O ' HG11 ' A' ' 25' ' ' VAL . 16.1 t30 -114.75 14.91 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER 62.24 118.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.15 23.39 32.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.45 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.82 148.03 30.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 m -69.47 136.17 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.462 HG13 ' N ' ' A' ' 53' ' ' GLY . 2.9 pt -126.86 160.33 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.363 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.19 -176.21 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.9 t -91.55 41.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.247 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 167.14 71.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.489 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.5 p30 -145.58 120.32 9.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.974 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -54.55 117.06 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 47.5 mt -92.62 -36.33 13.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.876 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 ' CD1' ' HB ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -159.11 -176.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.266 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 84.9 m -144.56 45.79 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.502 0.667 . . . . 0.0 109.447 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.456 ' CD2' ' HD2' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -39.69 165.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.362 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 40' ' ' THR . 76.6 tt0 -174.63 164.55 3.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.086 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.438 ' N ' ' CG ' ' A' ' 39' ' ' GLU . 6.6 p -120.35 -158.38 0.75 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.38 -22.96 66.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 54.81 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.78 113.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.434 ' HA ' ' CB ' ' A' ' 39' ' ' GLU . 2.1 p -98.9 141.81 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.189 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.44 ' HG3' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -143.34 131.38 21.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.059 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.39 173.59 7.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 36' ' ' ILE . 94.4 t -143.72 116.78 5.85 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 65.1 Cg_endo -90.92 36.83 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.203 2.602 . . . . 0.0 112.087 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 57.88 160.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 3.5 mt-10 -139.33 35.53 2.07 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.424 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER 165.25 153.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.417 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -85.49 -165.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.069 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.462 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 111.46 -157.24 15.08 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.715 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.73 134.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 58.2 t -68.35 145.39 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.245 0.545 . . . . 0.0 111.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.428 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.24 -44.56 2.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.251 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 19.6 mm-40 -111.86 174.66 5.77 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.636 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.4 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 12.5 p -173.83 137.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.508 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -153.12 51.01 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.107 0.479 . . . . 0.0 110.231 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.435 ' CG1' HG12 ' A' ' 72' ' ' ILE . 28.3 m -155.15 164.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.155 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -170.72 145.78 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -55.99 86.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . 122.91 62.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.512 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 2.0 p30 -153.34 178.58 9.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -94.83 112.92 24.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.445 HG21 ' CG2' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -125.99 165.48 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.443 ' N ' HG21 ' A' ' 66' ' ' ILE . 4.5 p -147.53 141.11 25.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.96 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.46 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 28.7 mt-10 -43.08 109.14 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA3' ' CD ' ' A' ' 6' ' ' LYS . . . 83.83 70.43 1.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.24 10.83 9.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.716 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp 60.51 48.48 7.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.423 0.63 . . . . 0.0 109.964 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.455 HD13 ' CG2' ' A' ' 7' ' ' VAL . 56.0 mt -46.84 -83.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.725 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 5' ' ' LEU . 29.3 m -118.38 159.13 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 0.0 111.616 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 75' ' ' VAL . 90.7 t -131.4 141.1 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.91 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 24.4 m -121.87 -178.51 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.242 0.544 . . . . 0.0 112.4 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.42 ' HG3' ' CE ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -95.56 -27.35 15.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.498 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.704 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.882 0.373 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 13.8 t -134.8 150.21 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.711 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -119.46 104.01 9.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.221 179.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.73 161.09 30.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.007 0.432 . . . . 0.0 111.264 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.81 159.7 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 87.1 t -50.0 140.06 16.7 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.475 ' CD ' ' CD2' ' A' ' 38' ' ' LEU . 60.9 Cg_endo -73.79 -168.17 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.578 2.185 . . . . 0.0 113.052 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -89.87 86.89 6.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.745 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.46 HG12 ' CG2' ' A' ' 16' ' ' VAL . 1.2 pp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.436 ' CA ' ' HB3' ' A' ' 67' ' ' SER . 6.2 mt-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 4.2 p30 162.64 76.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.434 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.46 ' CG2' HG12 ' A' ' 10' ' ' ILE . 32.6 m -138.83 133.6 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.547 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -76.06 137.05 39.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.047 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.471 ' CG1' ' CD1' ' A' ' 38' ' ' LEU . 7.9 mt -72.16 161.18 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.026 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.18 -20.98 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.825 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' A' ' 36' ' ' ILE . . . -140.07 158.52 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 111.423 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 62' ' ' VAL . 97.1 t -145.92 127.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.9 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -149.92 77.11 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -160.66 141.62 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.224 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -137.58 18.42 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.256 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 ' CG2' HG13 ' A' ' 58' ' ' VAL . 73.8 t 65.92 -82.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 58.84 2.48 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -128.4 166.73 18.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.743 0.306 . . . . 0.0 110.821 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.5 m -90.52 125.49 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.798 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.434 ' CD1' HG22 ' A' ' 51' ' ' VAL . 1.1 pt -120.35 143.24 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.06 -171.78 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.218 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 t -90.0 44.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.62 73.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -152.69 98.82 2.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -45.12 116.4 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.183 0.516 . . . . 0.0 111.611 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' O ' HG21 ' A' ' 36' ' ' ILE . 26.4 mt -91.09 -41.68 10.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.067 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.459 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -154.88 -178.39 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.455 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.476 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 96.4 m -144.39 57.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.475 ' CD2' ' CD ' ' A' ' 8' ' ' PRO . 2.1 mm? -39.16 162.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.322 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.446 ' CB ' HG22 ' A' ' 19' ' ' ILE . 65.3 tt0 -175.41 156.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.786 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.417 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -123.71 -83.79 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.585 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.6 OUTLIER -144.56 -42.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.29 42.93 3.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 176.21 136.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.304 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -129.48 120.77 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.569 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.43 ' HG3' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -108.58 156.17 19.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -179.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 9.0 p-10 -141.43 144.82 34.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.458 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 34' ' ' THR . 93.9 t -117.29 118.34 35.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 87.7 Cg_endo -90.02 30.13 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.015 2.477 . . . . 0.0 112.319 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 51.35 102.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.281 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.95 67.77 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -158.72 -172.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.993 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.66 62.97 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.399 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.4 ' HA2' ' N ' ' A' ' 77' ' ' ALA . . . -157.54 -119.81 0.6 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.059 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 63.6 t -146.33 140.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.506 0.193 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 85.7 t -78.07 155.03 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.346 0.593 . . . . 0.0 111.308 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.43 ' N ' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -127.09 -46.02 1.54 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.189 179.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -107.96 165.09 11.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.319 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.433 HG13 ' CG2' ' A' ' 25' ' ' VAL . 14.6 p -162.17 123.81 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 78.37 1.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.595 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.433 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.13 148.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.374 -179.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -139.47 167.58 21.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.456 ' N ' ' CG2' ' A' ' 21' ' ' VAL . 11.2 p -81.75 55.69 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.266 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.12 61.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.817 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 1.7 p30 -148.98 150.48 32.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -64.76 122.48 16.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.19 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.432 HG23 ' CG2' ' A' ' 16' ' ' VAL . 1.1 tp -131.04 169.63 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.436 ' HB3' ' CA ' ' A' ' 14' ' ' GLU . 4.7 p -151.94 150.5 30.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mt-10 -50.58 98.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.83 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.09 55.73 0.6 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.475 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.73 18.4 29.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.391 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 9.0 tp 45.33 47.7 10.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.046 0.451 . . . . 0.0 110.775 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 5.8 mt -43.18 -82.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.333 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.435 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 22.0 m -127.39 148.38 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 111.728 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 93.9 t -118.42 133.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.943 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.477 ' CG2' ' CG1' ' A' ' 51' ' ' VAL . 25.4 m -118.95 166.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 112.417 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -77.54 -36.32 52.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.509 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.002 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.825 0.345 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.478 ' CB ' ' CG1' ' A' ' 51' ' ' VAL . 33.9 t -152.66 161.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.438 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -135.12 91.2 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.002 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.423 HD13 ' CG1' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -53.05 169.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -158.11 161.69 37.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 72' ' ' ILE . 83.4 t -52.64 139.96 38.82 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 38.5 Cg_endo -70.04 -168.16 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.094 1.863 . . . . 0.0 112.949 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.69 60.37 1.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.759 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.417 ' HB ' ' CG2' ' A' ' 40' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.585 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.672 0.272 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.73 91.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG1' HG23 ' A' ' 40' ' ' THR . 9.3 m -127.79 -154.56 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.716 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -140.42 121.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 20.6 mt -65.0 163.78 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -127.12 -12.46 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.053 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.35 161.82 42.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 0.0 111.607 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.444 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 13.3 p -146.61 133.24 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.05 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -161.26 75.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 58' ' ' VAL . 2.4 m -149.08 114.44 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -116.65 96.02 5.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.535 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.3 m -43.28 110.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.553 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.05 17.43 4.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.38 149.82 41.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.792 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.9 m -77.38 142.94 39.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.471 ' CD1' ' CG2' ' A' ' 51' ' ' VAL . 2.8 pp -143.1 166.06 15.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.65 -171.27 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.351 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 6.1 t -90.39 43.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 p30 178.28 68.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.32 107.1 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -44.16 119.32 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.169 0.509 . . . . 0.0 112.096 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.437 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 82.9 mt -92.02 -45.3 8.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.856 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.463 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -154.78 179.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.444 0.64 . . . . 0.0 112.091 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.423 ' HB ' HG12 ' A' ' 19' ' ' ILE . 59.7 m -138.81 116.94 11.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.457 ' CD2' HG22 ' A' ' 66' ' ' ILE . 4.2 mp -111.6 175.34 5.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 112.148 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -177.4 157.16 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.454 HG23 ' CG1' ' A' ' 16' ' ' VAL . 6.5 p -131.49 -58.96 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 110.816 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 40' ' ' THR . 8.7 t70 -175.24 -38.3 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.765 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -75.06 -26.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 175.38 170.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.927 0.394 . . . . 0.0 111.334 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -109.66 130.36 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -109.09 -168.56 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 0.0 111.545 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -176.84 167.36 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.234 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.423 ' CG1' HD13 ' A' ' 5' ' ' LEU . 99.6 t -127.41 125.51 23.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.983 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -89.74 30.41 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.032 2.488 . . . . 0.0 112.494 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . 53.53 106.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 111.394 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.95 69.56 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.142 0.496 . . . . 0.0 110.167 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.478 ' CG1' ' CB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -158.53 -170.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.71 -178.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -159.76 56.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.798 0.333 . . . . 0.0 111.363 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.82 -121.92 0.59 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.39 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.428 HG11 ' N ' ' A' ' 55' ' ' VAL . 51.1 t -137.62 139.15 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 111.44 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 95.6 t -71.31 148.19 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.182 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.414 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -117.02 -49.76 2.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.684 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -111.22 175.17 5.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.629 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.438 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 7.1 p -165.6 128.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.038 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 71.88 1.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.49 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -170.21 148.53 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.746 -179.335 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.442 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -155.39 -174.31 4.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.588 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.78 78.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.326 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.38 45.72 0.13 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.645 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 20.0 p-10 -130.81 170.65 14.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.899 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 6.0 mttt -91.96 114.78 27.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.528 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.457 HG22 ' CD2' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -131.13 160.26 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.696 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.09 148.53 35.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.965 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 27.3 tt0 -47.44 99.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 99.47 66.33 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.359 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -128.88 29.08 4.03 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.76 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.9 tp 42.84 74.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 1.4 mt -66.75 -76.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.955 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 17.0 m -129.02 148.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 0.0 111.77 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 67.7 t -101.47 142.32 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.922 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.432 ' CG1' HD12 ' A' ' 29' ' ' ILE . 2.4 t -125.73 153.4 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.253 0.549 . . . . 0.0 112.08 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 3.2 tt0 -102.61 45.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.848 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HA ' ' C ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.454 -0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.665 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.414 ' N ' HD21 ' A' ' 2' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.976 0.417 . . . . 0.0 110.893 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 4.3 t -128.4 162.1 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.5 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 45.5 mt-10 -124.34 89.86 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.426 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -50.63 151.27 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.975 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.23 150.23 43.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.445 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 91.7 t -48.02 141.11 8.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.89 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 60.0 Cg_endo -73.13 -166.69 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.318 2.012 . . . . 0.0 112.667 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 45' ' ' MET . 1.2 m-20 -95.43 79.05 3.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.914 0.388 . . . . 0.0 111.184 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.201 0.524 . . . . 0.0 111.077 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' GLU . 7.4 p30 46.01 71.09 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.57 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.435 ' CG2' HG21 ' A' ' 66' ' ' ILE . 24.1 m -121.93 -170.8 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.13 124.57 37.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 111.541 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 11.6 mt -61.0 163.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.834 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.468 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -127.68 -12.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.956 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.72 154.43 38.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.379 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.438 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 11.0 p -146.32 115.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.216 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -119.46 -30.69 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.344 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.427 ' CG1' HG12 ' A' ' 73' ' ' VAL . 11.6 m -64.19 129.07 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.92 0.39 . . . . 0.0 111.259 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -139.48 12.74 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' CG2' HG13 ' A' ' 58' ' ' VAL . 85.6 t 63.03 118.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.29 8.6 35.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.62 148.28 25.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.33 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.1 m -81.85 106.19 13.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.442 ' CD1' HG22 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -93.31 155.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.514 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.33 -177.66 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.785 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 16.6 t -90.26 44.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 2.1 p30 163.75 70.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.352 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -148.33 119.8 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.697 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -56.31 114.92 2.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 0.0 111.35 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.403 ' O ' HG21 ' A' ' 36' ' ' ILE . 87.5 mt -88.72 -43.76 11.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.32 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.469 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -152.62 -178.51 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.214 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.441 ' CG2' ' CD1' ' A' ' 19' ' ' ILE . 55.0 m -144.17 120.81 11.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.44 ' CA ' HG22 ' A' ' 19' ' ' ILE . 4.3 mp -112.3 166.54 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.143 0.497 . . . . 0.0 111.737 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.448 ' N ' HG23 ' A' ' 10' ' ' ILE . 80.4 tt0 -168.38 161.82 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.727 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 3.5 p -120.32 -58.35 1.86 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -179.54 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.817 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -12.57 13.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.534 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.29 137.78 30.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.977 0.418 . . . . 0.0 111.465 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -120.96 127.98 52.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.435 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.425 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -120.01 -166.31 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.146 0.498 . . . . 0.0 111.795 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -179.28 172.96 1.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.434 ' CG1' HD12 ' A' ' 5' ' ' LEU . 95.8 t -126.65 113.7 22.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 121.174 -0.21 . . . . 0.0 111.377 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 57.4 Cg_endo -90.28 30.64 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.11 2.54 . . . . 0.0 112.427 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 56.17 164.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 26.2 tt0 -160.61 46.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' CG2' ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -173.16 161.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.71 86.58 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA2' ' N ' ' A' ' 77' ' ' ALA . . . -160.58 -140.4 2.88 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.152 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -130.39 140.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.609 0.242 . . . . 0.0 111.081 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 53.7 t -77.04 139.28 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.313 0.577 . . . . 0.0 111.396 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -107.66 -48.63 3.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.228 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 29.0 mt-10 -111.11 166.11 11.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.365 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.426 HG13 ' CG2' ' A' ' 25' ' ' VAL . 6.4 p -154.81 114.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.389 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -128.97 74.81 1.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -174.73 150.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.615 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.423 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -172.56 128.6 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -47.09 102.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.35 25.79 2.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.726 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.427 ' OD1' ' CD1' ' A' ' 18' ' ' ILE . 21.5 p-10 -121.11 175.81 5.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.42 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -97.98 147.77 24.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.439 ' CG2' HG13 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -141.3 167.54 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.2 p -144.95 51.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.433 ' CG ' HD12 ' A' ' 10' ' ' ILE . 98.8 mt-10 40.72 50.17 2.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.801 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.438 ' N ' ' HB ' ' A' ' 7' ' ' VAL . . . 144.01 71.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.47 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.82 33.0 4.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.717 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.2 tp 44.21 56.9 4.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 3.4 mt -46.31 -83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.312 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.466 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 33.8 m -120.29 164.9 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.113 0.483 . . . . 0.0 111.951 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 59.1 t -132.34 117.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.944 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.484 ' CG2' ' CG2' ' A' ' 51' ' ' VAL . 28.0 m -108.31 157.68 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -68.08 -35.29 77.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.075 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 121.125 0.488 . . . . 0.0 112.038 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.929 0.395 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 2.6 t -141.04 161.44 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.746 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 4.3 mp0 -135.9 121.27 19.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.4 HD21 ' CG2' ' A' ' 73' ' ' VAL . 1.3 tp -73.46 154.23 40.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -149.59 59.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 67.2 t 60.83 145.62 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 33.5 Cg_endo -67.99 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.621 1.547 . . . . 0.0 112.77 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER 166.6 56.83 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.736 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.481 ' N ' ' CD1' ' A' ' 10' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.056 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 2.2 mt-10 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.14 0.495 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 1.9 p30 176.97 85.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.637 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' CG2' HD22 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -147.46 145.29 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.332 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.74 145.57 40.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.339 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 6.1 mt -71.77 163.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.564 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.461 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -132.27 -4.25 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.626 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -155.68 151.62 27.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.27 . . . . 0.0 110.928 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HA ' HG21 ' A' ' 36' ' ' ILE . 11.1 p -137.9 134.04 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.466 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -155.17 25.48 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.429 ' CG2' HG22 ' A' ' 58' ' ' VAL . 3.1 m -117.46 122.91 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -133.89 11.76 3.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.485 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 85.4 t 60.63 120.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.51 35.11 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.982 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.4 146.72 27.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -69.85 132.89 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.423 ' CD1' HG22 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -124.25 143.58 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.57 -173.73 2.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.85 39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.361 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p30 168.19 64.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.673 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -140.85 114.3 8.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.77 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.98 115.72 2.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 111.496 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 33.5 mt -91.25 -32.07 15.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.426 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -162.77 -177.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.934 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.443 ' HB ' HG13 ' A' ' 19' ' ' ILE . 60.7 m -141.92 122.33 14.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 109.901 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.479 HD22 ' CG2' ' A' ' 10' ' ' ILE . 2.2 tp -102.99 167.83 9.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.432 ' CB ' HG23 ' A' ' 19' ' ' ILE . 2.1 tm-20 -167.72 166.43 13.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.44 ' CG2' ' CG1' ' A' ' 10' ' ' ILE . 5.5 p -124.76 -59.39 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.682 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.0 t70 -171.84 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.51 -29.61 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.22 131.75 56.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 111.374 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.429 ' CG2' ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -115.41 138.54 50.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.411 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -126.89 -178.33 4.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.408 . . . . 0.0 111.332 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.6 p30 -167.29 162.45 14.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.649 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.434 ' CG2' HD12 ' A' ' 36' ' ' ILE . 89.4 t -113.67 109.75 50.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.0 Cg_endo -88.82 43.53 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.098 2.532 . . . . 0.0 111.823 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 54.35 171.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.706 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 5.3 pt-20 -156.09 33.03 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.449 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -172.37 170.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.144 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.97 86.01 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.75 -134.38 1.66 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.018 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 76' ' ' GLU . 91.3 t -135.12 141.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 57.4 t -74.4 143.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.349 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.419 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -111.2 -47.62 3.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.45 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 22.9 mt-10 -113.32 172.15 7.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.664 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 7.5 p -160.57 119.6 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.5 mttm -134.81 62.72 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.575 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -169.12 149.94 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.438 ' N ' HG21 ' A' ' 60' ' ' VAL . 10.9 mttm -140.67 -169.74 2.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.57 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.49 42.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.086 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.52 71.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.553 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 4.1 p-10 -156.7 145.06 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 110.991 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 131.53 45.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.463 ' CG2' HD23 ' A' ' 38' ' ' LEU . 1.2 tp -135.64 178.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 66' ' ' ILE . 2.4 m -155.43 118.17 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.565 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -38.46 91.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.636 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 127.35 49.17 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.938 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -112.3 -121.16 3.9 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.601 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -157.58 44.37 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.376 0.608 . . . . 0.0 109.663 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 7.1 mt -40.63 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.041 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 20.7 m -131.66 143.96 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.166 0.508 . . . . 0.0 112.317 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 61.8 t -108.08 140.31 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.137 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.165 0.507 . . . . 0.0 112.156 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' VAL . 3.9 tt0 -75.42 -39.34 59.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.07 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.451 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 112.067 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.933 0.397 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.477 ' CG2' ' CG1' ' A' ' 51' ' ' VAL . 4.1 t -140.71 161.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.47 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 1.6 mp0 -142.73 101.36 3.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 72' ' ' ILE . 2.4 mm? -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.093 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' CB ' ' HA3' ' A' ' 69' ' ' GLY . 1.9 mttt -134.16 64.18 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 111.746 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 45.4 t 59.83 139.46 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.345 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 39.4 Cg_endo -72.65 -166.59 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.107 1.871 . . . . 0.0 112.817 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.68 72.24 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.339 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.437 ' CG2' HD22 ' A' ' 38' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.491 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.814 0.34 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 1.2 p-10 44.49 85.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 38' ' ' LEU . 20.5 m -123.23 159.8 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.877 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -92.68 128.4 38.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.177 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 6.9 mt -77.84 161.29 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.26 -41.66 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.393 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HB1' ' N ' ' A' ' 37' ' ' THR . . . -116.94 157.77 25.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HA ' HG21 ' A' ' 36' ' ' ILE . 10.4 p -157.24 115.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -135.85 72.32 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.417 HG12 ' CG1' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -146.49 118.92 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -119.89 18.79 12.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.175 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.435 ' CG2' HG13 ' A' ' 58' ' ' VAL . 74.0 t 66.07 -86.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.949 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 60.65 1.41 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.833 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 162.99 25.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -87.6 120.53 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.438 HD11 ' CG1' ' A' ' 75' ' ' VAL . 1.1 pt -115.5 137.33 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.94 -169.01 1.88 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.64 43.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.167 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 p30 171.84 68.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 1.1 p-10 -147.55 102.09 3.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -48.5 117.62 2.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.477 . . . . 0.0 111.582 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 22' ' ' GLU . 32.6 mt -91.83 -37.79 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.713 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' CD1' ' HB ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -155.17 -160.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.963 179.135 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.485 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 94.4 m -161.3 38.13 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.83 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.437 HD22 ' CG2' ' A' ' 10' ' ' ILE . 2.7 tp -31.87 152.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.088 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 40' ' ' THR . 52.8 tt0 -168.95 157.89 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 3.9 p -123.9 -58.01 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.3 m-20 174.78 -34.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.699 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.85 -35.24 26.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.63 157.52 35.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.962 0.41 . . . . 0.0 111.426 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -114.97 119.87 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.393 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.43 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -112.86 141.93 46.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.629 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 15.3 p-10 -126.88 174.97 8.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.648 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 36' ' ' ILE . 63.2 t -141.86 120.17 7.7 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.919 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 82.9 Cg_endo -90.79 31.33 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.978 2.452 . . . . 0.0 112.179 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 49.4 99.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.071 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -91.89 66.55 5.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 0.0 110.649 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -170.47 151.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.411 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.5 76.2 1.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.652 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.45 -124.93 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.106 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.6 t -143.79 138.57 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.496 0.188 . . . . 0.0 111.242 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 60.1 t -79.64 150.9 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.211 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -120.3 -44.97 2.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.344 178.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -108.9 165.99 11.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.435 HG13 ' CG2' ' A' ' 25' ' ' VAL . 7.6 p -157.78 118.21 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.288 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 72' ' ' ILE . 6.0 mttt -133.81 71.71 1.46 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.627 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -175.22 160.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -164.9 -161.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.811 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.7 t -108.45 71.28 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.82 43.43 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.674 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -136.41 172.32 13.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -97.55 131.89 43.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.787 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.453 HG21 ' CG2' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -139.14 151.35 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.882 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.9 OUTLIER -140.63 140.22 34.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.328 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 3.3 mp0 -40.54 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 6' ' ' LYS . . . 116.68 57.08 0.31 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.965 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.66 12.79 8.26 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.105 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 6.2 tp 48.51 57.75 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 0.0 110.884 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.455 HD13 ' CA ' ' A' ' 7' ' ' VAL . 2.8 mt -53.88 -70.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.076 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.417 ' CG1' HG12 ' A' ' 23' ' ' VAL . 18.3 m -131.65 151.26 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.747 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 71' ' ' LEU . 20.3 t -122.3 134.54 65.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.959 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 27.7 m -123.32 175.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -86.6 -40.85 14.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.929 179.686 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.939 0.399 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 4.8 t -152.6 160.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.459 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 18.0 mp0 -138.63 108.84 6.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.61 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.43 HD13 ' CG1' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -68.14 176.55 2.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.754 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -157.73 162.83 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.306 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 86.1 t -51.9 147.97 11.36 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.635 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 17.0 Cg_exo -66.76 -156.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.084 1.856 . . . . 0.0 112.671 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -120.84 53.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 40' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.94 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.75 0.31 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 44.0 78.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.351 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.448 ' CG2' ' CD2' ' A' ' 38' ' ' LEU . 33.6 m -122.36 160.5 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.47 118.19 32.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.253 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CD1' HG21 ' A' ' 60' ' ' VAL . 8.9 mt -60.12 162.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.449 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -121.55 -41.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.135 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB1' ' N ' ' A' ' 37' ' ' THR . . . -115.53 164.28 14.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' CG2' ' CA ' ' A' ' 62' ' ' VAL . 27.9 t -145.25 138.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -159.28 41.8 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -141.28 116.17 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.02 13.86 3.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.345 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 91.5 t 62.72 124.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.44 -23.3 18.37 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.13 138.74 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -73.77 103.58 4.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.791 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 53' ' ' GLY . 4.0 pt -76.55 147.95 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.273 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . . . -128.19 -173.24 2.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.71 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.18 39.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.949 0.404 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.35 64.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.669 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.403 ' OD2' ' CB ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -138.86 101.47 4.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.718 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -47.15 115.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 111.535 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.419 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 16.7 mt -89.42 -38.07 14.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.678 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -162.06 179.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.634 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.447 ' HB ' HG12 ' A' ' 19' ' ' ILE . 62.1 m -144.03 53.82 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.468 0.651 . . . . 0.0 110.207 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.448 ' CD2' ' CG2' ' A' ' 16' ' ' VAL . 4.4 tp -38.13 154.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.243 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 8.0 tm-20 -160.4 117.88 2.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.743 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.448 ' CG2' ' HB ' ' A' ' 10' ' ' ILE . 53.1 p -70.94 -85.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' N ' ' OG1' ' A' ' 40' ' ' THR . 10.5 p30 -153.0 23.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -177.28 -43.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.709 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.85 125.66 50.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.022 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.427 ' CG2' ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -111.66 118.49 35.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.044 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -112.9 153.44 27.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -136.55 165.44 25.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.43 ' CG1' HD13 ' A' ' 5' ' ' LEU . 79.0 t -127.54 119.28 21.6 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.7 Cg_endo -90.39 30.6 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.131 2.554 . . . . 0.0 112.466 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.403 ' CB ' ' OD2' ' A' ' 33' ' ' ASP . . . 50.34 99.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 2.4 mp0 -91.64 62.27 4.44 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 1.3 p 161.75 144.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.381 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -91.28 -173.49 3.63 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.476 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 117.13 -146.94 18.88 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.634 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.434 ' O ' ' CE ' ' A' ' 56' ' ' LYS . 63.2 t -143.19 140.42 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 HG21 ' CG2' ' A' ' 29' ' ' ILE . 59.0 t -76.13 144.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.229 0.538 . . . . 0.0 111.94 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -114.78 -50.16 2.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.946 178.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 23.5 mt-10 -110.47 173.36 6.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.174 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 7.5 p -164.14 123.87 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -132.96 67.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -170.86 150.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.892 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' N ' HG21 ' A' ' 60' ' ' VAL . 7.7 mmtt -130.86 -163.85 1.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.492 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.456 ' CA ' ' CG2' ' A' ' 21' ' ' VAL . 9.0 p -99.63 36.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.046 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.83 65.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.513 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.5 161.97 33.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.991 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -73.61 113.34 10.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.439 HG21 ' CG2' ' A' ' 7' ' ' VAL . 1.1 tp -129.44 166.58 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.253 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.409 ' N ' HG21 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -145.13 137.73 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.271 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 5.1 mp0 -40.23 106.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 90.22 69.16 1.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.288 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.97 24.39 4.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.707 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 6.1 tp 48.38 79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -73.19 -73.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.161 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 18.4 m -130.28 145.3 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 83.5 t -107.02 134.99 47.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.845 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.471 ' CG2' ' CD1' ' A' ' 29' ' ' ILE . 12.6 m -123.63 171.6 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.183 0.515 . . . . 0.0 112.3 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -79.3 -24.56 42.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.92 0.39 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 25.5 t -151.6 159.2 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.472 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -135.37 99.31 4.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.344 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.0 mt -62.37 132.23 51.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.589 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -128.12 73.35 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.484 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 72.0 t 58.55 149.27 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.625 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.447 ' CD ' ' CG1' ' A' ' 7' ' ' VAL . 0.9 OUTLIER -83.17 -157.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.866 2.377 . . . . 0.0 112.216 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.64 99.4 9.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 38' ' ' LEU . 1.2 pp . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.431 ' HB2' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.892 0.377 . . . . 0.0 111.165 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 14' ' ' GLU . 8.3 p30 47.93 86.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.615 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.429 HG12 ' CD1' ' A' ' 10' ' ' ILE . 10.5 m -137.94 -155.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.125 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.93 138.24 20.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.979 0.418 . . . . 0.0 111.393 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 7.8 mt -76.99 162.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.847 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.471 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -133.52 -9.62 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.887 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -149.55 149.06 30.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.473 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 89.6 t -140.71 121.66 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -142.39 28.39 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -117.76 125.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -137.28 11.56 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 89.9 t 62.33 127.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -21.9 22.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -77.67 152.28 33.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 m -84.06 121.3 27.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.443 ' CD1' HG22 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -108.46 153.54 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.81 -176.1 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.863 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.66 47.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 166.85 74.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 0.9 OUTLIER -160.46 117.72 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.97 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.44 117.9 5.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 63.0 mt -93.1 -44.95 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.466 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -153.13 -179.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.738 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.432 ' N ' ' HB2' ' A' ' 20' ' ' ALA . 2.7 m -133.05 145.66 51.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.993 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.459 ' HB3' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -127.11 -172.54 2.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -172.19 172.7 4.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.427 HG21 ' HB ' ' A' ' 10' ' ' ILE . 1.2 p -142.25 -157.35 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 -19.69 65.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.864 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -172.79 53.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -173.47 134.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.24 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -107.71 153.86 22.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -172.07 4.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.17 174.11 2.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 8' ' ' PRO . 96.9 t -126.38 123.46 24.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.267 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.5 Cg_endo -90.76 29.93 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 0.0 112.23 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . 46.72 93.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.469 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.35 61.74 3.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.449 HG23 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.45 149.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.142 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.52 75.0 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.9 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' HA2' ' N ' ' A' ' 77' ' ' ALA . . . -163.77 -132.22 1.32 Allowed Glycine 0 C--N 1.317 -0.478 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.752 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 86.8 t -137.26 138.95 44.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.751 -0.225 . . . . 0.0 110.959 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' CG1' ' A' ' 75' ' ' VAL . 58.6 t -74.3 146.5 9.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.368 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.45 -46.1 2.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.57 178.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -113.89 173.95 6.17 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.694 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.8 116.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.374 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -134.14 79.42 1.81 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -174.62 152.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.209 0.528 . . . . 0.0 111.029 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -138.79 173.34 11.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.484 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.422 ' N ' HG22 ' A' ' 21' ' ' VAL . 11.8 p -92.38 52.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.065 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.28 52.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.9 p-10 -129.98 -175.66 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.767 0.317 . . . . 0.0 110.973 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -105.95 149.78 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.434 ' CG1' HG23 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -138.34 170.84 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.434 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 1.5 p -154.59 49.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.484 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 85.8 mt-10 39.9 63.68 1.01 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.643 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 146.83 68.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.62 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.27 17.61 6.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.747 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.435 ' CD1' ' HB2' ' A' ' 4' ' ' GLU . 10.2 tp 45.06 50.46 9.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.066 0.46 . . . . 0.0 110.73 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 3.8 mt -45.05 -83.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.466 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.465 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 24.1 m -120.95 145.07 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.985 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 87.8 t -114.38 138.89 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.605 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG1' ' CG2' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -131.77 174.32 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.94 -33.31 22.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.572 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' N ' ' HA2' ' A' ' 53' ' ' GLY . . . . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.645 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.788 0.328 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp 56.59 172.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 5.9 t -149.36 161.99 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.492 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -134.38 106.88 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.429 HD12 ' CG1' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -51.87 -176.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.264 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' CD ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 mttp -164.62 142.78 6.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.78 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 67.8 t -49.17 138.38 14.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 53.2 Cg_endo -72.7 -167.05 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.356 2.037 . . . . 0.0 112.92 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.67 69.13 3.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.976 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.441 ' HB ' ' CG2' ' A' ' 40' ' ' THR . 0.3 OUTLIER -55.88 -19.57 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' N ' HD11 ' A' ' 10' ' ' ILE . . . 111.6 -54.03 0.56 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.716 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' C ' ' CG ' ' A' ' 13' ' ' HIS . . . -63.65 -87.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.601 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 175.06 -85.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 110.893 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HA ' ' CB ' ' A' ' 67' ' ' SER . 1.3 pt-20 -113.3 177.47 4.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 8.1 p-10 44.73 69.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 66' ' ' ILE . 20.0 m -125.97 124.91 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.32 122.97 20.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.706 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 3.6 mt -62.12 164.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.577 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.461 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -126.53 -13.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.845 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 36' ' ' ILE . . . -153.14 144.66 23.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.351 . . . . 0.0 111.372 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.445 ' HA ' HG21 ' A' ' 36' ' ' ILE . 13.4 p -145.13 122.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.218 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 2.5 pt-20 -140.09 47.72 1.8 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 m -144.71 123.37 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.266 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -128.42 18.62 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 95.0 t 65.4 112.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.36 -21.28 5.75 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.499 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -81.41 147.59 29.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.3 m -71.81 155.9 39.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.477 ' CD1' ' CG2' ' A' ' 51' ' ' VAL . 1.7 pp -144.19 144.28 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.214 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.72 -179.06 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.03 48.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.3 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 p30 163.65 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.523 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' CB ' ' A' ' 49' ' ' ALA . 8.1 p-10 -155.29 115.47 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -50.66 117.29 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.153 0.501 . . . . 0.0 111.488 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.428 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 13.8 mt -87.58 -43.6 11.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.009 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.475 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -158.06 -180.0 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.314 0.578 . . . . 0.0 111.86 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.432 ' CG2' HG12 ' A' ' 19' ' ' ILE . 99.9 m -140.05 117.49 11.42 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.455 ' CD2' HG22 ' A' ' 66' ' ' ILE . 5.9 mp -111.61 171.83 7.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.023 0.44 . . . . 0.0 112.187 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 40' ' ' THR . 49.4 tt0 -172.06 157.91 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.643 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.441 ' CG2' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.55 -89.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.904 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.26 21.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.71 -43.44 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.07 169.54 19.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.6 p -108.5 115.93 31.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.493 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -101.1 -175.82 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.161 0.505 . . . . 0.0 111.534 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -172.92 170.43 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.241 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.429 ' CG1' HD12 ' A' ' 5' ' ' LEU . 97.3 t -126.35 124.51 24.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.813 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -88.71 27.03 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.975 2.45 . . . . 0.0 112.702 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.405 ' CB ' ' OD1' ' A' ' 33' ' ' ASP . . . 59.67 150.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.304 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -149.35 70.62 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.476 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -178.33 -178.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.494 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -148.28 67.79 1.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.818 0.342 . . . . 0.0 111.838 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.48 -134.84 1.75 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.115 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 76' ' ' GLU . 88.5 t -126.23 144.4 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.61 0.243 . . . . 0.0 111.183 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 95.2 t -76.56 145.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.152 0.501 . . . . 0.0 111.303 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.423 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -115.49 -46.92 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.556 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.63 175.3 5.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.498 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.6 p -165.37 119.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.573 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -132.36 66.41 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.587 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -172.82 156.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.694 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -170.97 -159.93 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.737 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.07 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.54 -15.72 3.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.57 163.77 12.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.044 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.08 148.62 24.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.475 HG21 ' N ' ' A' ' 67' ' ' SER . 1.3 tp -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.477 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.475 ' N ' HG21 ' A' ' 66' ' ' ILE . 6.9 m -142.97 138.32 30.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 111.272 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.463 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 95.0 mt-10 -39.57 115.66 0.54 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.427 ' HA3' ' CD ' ' A' ' 6' ' ' LYS . . . 70.17 74.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.221 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -137.64 31.64 2.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.447 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 4' ' ' GLU . 13.7 tp 49.06 95.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.982 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 0.8 OUTLIER -95.2 -74.86 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.654 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.482 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 19.7 m -125.05 136.93 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 111.787 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 61.9 t -104.96 141.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.097 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 33.1 m -127.62 171.47 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.244 0.545 . . . . 0.0 112.362 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 54' ' ' VAL . 1.8 tm-20 -84.49 -39.37 18.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.293 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . 57.12 138.04 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.246 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 52' ' ' ALA . 3.1 tt0 39.27 39.82 0.47 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.684 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.09 160.48 26.09 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.513 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.7 p -127.35 167.96 15.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 0.0 110.841 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.14 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.962 0.41 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.438 ' CD2' ' HD2' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -77.53 172.69 12.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.074 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 30.7 t -136.3 159.3 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -134.67 108.61 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.999 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.435 ' CD2' HG12 ' A' ' 47' ' ' VAL . 2.9 tp -63.39 161.07 14.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.454 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 139.52 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.767 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.447 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 96.9 t -42.12 141.21 1.42 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.139 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 61.1 Cg_endo -75.37 -169.36 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.436 2.091 . . . . 0.0 113.102 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 45' ' ' MET . 5.2 t0 -83.95 94.56 8.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 38' ' ' LEU . 1.1 pp -99.1 63.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.076 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.93 -90.96 1.69 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.491 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.93 35.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.424 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.15 159.85 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.728 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -88.25 -177.32 5.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.236 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 6.5 p-10 46.01 94.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.434 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' CG2' HG12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -137.82 166.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -97.87 133.1 42.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.658 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 8.6 mt -74.76 163.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.896 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.468 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -131.04 -8.75 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.736 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -151.09 150.18 30.39 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 80.0 t -142.03 120.39 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.844 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -146.41 59.48 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.981 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.432 ' CG2' HG22 ' A' ' 58' ' ' VAL . 2.0 m -140.01 115.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.432 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 1.6 t30 -93.99 12.23 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.44 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 24' ' ' ASN . 5.4 p 43.04 63.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.487 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.09 45.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.476 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -136.71 173.25 11.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.996 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.6 m -79.17 132.91 36.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.761 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.435 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -127.5 150.33 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.31 178.82 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 4.0 t -87.96 47.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.61 70.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.546 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.51 100.42 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.483 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -42.98 115.22 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.197 0.523 . . . . 0.0 111.774 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 23.6 mt -87.16 -50.16 6.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.914 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.494 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -149.41 -178.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 111.73 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.429 ' N ' ' HB2' ' A' ' 20' ' ' ALA . 3.5 m -131.96 130.69 41.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.669 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.463 ' CD1' ' CG1' ' A' ' 18' ' ' ILE . 1.9 mm? -116.04 165.15 13.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.799 0.333 . . . . 0.0 110.826 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 40' ' ' THR . 48.9 tt0 -178.21 164.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.447 ' N ' ' CG ' ' A' ' 39' ' ' GLU . 3.5 p -121.28 -59.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.684 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.3 t0 -172.68 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -109.64 -36.8 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.033 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.74 141.38 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -126.9 130.14 49.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.829 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.43 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -117.25 -164.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.287 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -179.66 172.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 34' ' ' THR . 78.8 t -121.15 116.8 30.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.81 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.4 Cg_endo -86.63 18.56 1.55 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.993 2.462 . . . . 0.0 112.7 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 56.1 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.875 0.369 . . . . 0.0 111.551 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -110.6 70.69 0.72 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.446 ' CB ' HG23 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.35 -172.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.116 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -160.59 63.77 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.661 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.53 -124.38 0.74 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.243 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 77.1 t -139.96 138.17 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.473 0.178 . . . . 0.0 111.165 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 58.2 t -75.04 145.02 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.114 0.483 . . . . 0.0 111.476 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HD2' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -115.54 -44.24 2.98 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.497 178.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 17.8 mt-10 -115.06 174.24 6.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.606 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 HG22 ' CG2' ' A' ' 23' ' ' VAL . 15.0 p -160.86 122.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.363 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -134.19 74.62 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.749 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.439 HG21 ' N ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -173.58 148.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.491 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' N ' HG21 ' A' ' 60' ' ' VAL . 6.5 mttt -143.85 -166.26 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.984 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG21 ' CG2' ' A' ' 21' ' ' VAL . 59.6 t -106.71 86.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.09 18.99 4.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.85 171.71 7.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.794 0.33 . . . . 0.0 110.662 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.97 123.35 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.413 HG23 ' CG2' ' A' ' 16' ' ' VAL . 1.1 tp -122.44 167.17 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.408 ' N ' HG21 ' A' ' 66' ' ' ILE . 82.4 p -151.28 141.13 21.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 26.0 mt-10 -42.9 95.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.204 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.37 61.46 0.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.393 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.31 20.18 23.65 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.472 ' CD1' ' CB ' ' A' ' 4' ' ' GLU . 11.2 tp 49.92 50.01 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.796 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 4.3 mt -48.07 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.256 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.458 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 17.6 m -117.0 141.07 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.148 0.499 . . . . 0.0 112.029 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 91.5 t -113.6 131.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 27.8 m -121.95 169.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.425 ' N ' ' HE2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -78.61 -36.46 44.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.607 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . 56.73 147.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.176 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 52' ' ' ALA . 11.4 pt-20 39.54 49.32 1.95 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.695 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.85 154.52 18.76 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.487 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.63 112.54 24.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.32 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.103 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' N ' ' OE2' ' A' ' 78' ' ' GLU . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.843 0.354 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.9 176.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 6.5 t -148.92 161.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.951 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.485 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 69.0 mt-10 -133.39 115.29 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.198 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.439 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -73.45 160.8 31.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -147.34 150.09 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 111.405 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 84.0 t -46.05 140.43 4.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.432 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' CD ' ' CD2' ' A' ' 38' ' ' LEU . 74.1 Cg_endo -76.38 -166.17 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.592 2.195 . . . . 0.0 112.614 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 45' ' ' MET . 16.5 t70 -94.47 88.74 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.054 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.445 HG12 ' CG2' ' A' ' 16' ' ' VAL . 1.0 OUTLIER -96.36 61.73 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.98 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.53 -91.33 1.04 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.437 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.39 37.35 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.603 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -144.44 -175.9 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 110.976 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -104.86 -175.18 2.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.084 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 44.89 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.445 ' CG2' HG12 ' A' ' 10' ' ' ILE . 34.6 m -143.72 115.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.569 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 128.21 35.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.556 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.466 ' CG1' ' CD1' ' A' ' 38' ' ' LEU . 4.2 mt -65.39 164.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.461 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -126.93 -35.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.275 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -118.59 148.11 43.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HA ' HG21 ' A' ' 36' ' ' ILE . 7.8 p -134.9 119.22 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.991 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -146.3 40.09 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.432 ' CG2' HG22 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -133.72 117.82 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -132.6 12.25 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.377 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 90.0 t 62.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.35 . . . . 0.0 111.085 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.08 -21.54 13.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.779 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.42 139.41 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 111.107 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.2 m -74.76 102.29 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.448 ' CD1' HG22 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -87.16 153.91 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.38 -174.36 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.841 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 8.9 t -89.94 42.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.395 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER 163.7 72.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.591 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -148.78 115.16 5.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.78 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.58 115.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.527 . . . . 0.0 111.45 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.403 ' O ' HG21 ' A' ' 36' ' ' ILE . 98.3 mt -88.98 -40.97 12.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.541 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.6 OUTLIER -159.31 -177.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.441 ' N ' ' HB2' ' A' ' 20' ' ' ALA . 23.2 m -136.04 133.17 37.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.811 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.466 ' CD1' ' CG1' ' A' ' 18' ' ' ILE . 1.8 mm? -116.11 150.59 37.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.864 0.364 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 40' ' ' THR . 41.7 tt0 -159.91 163.18 34.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.428 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -133.03 -82.92 0.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.656 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 40' ' ' THR . 12.0 p-10 -143.79 -43.48 0.27 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 42.63 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.65 133.64 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.193 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 p -129.4 118.48 22.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.431 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -117.29 -167.95 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.572 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -177.23 167.62 2.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.13 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.434 ' CG1' HD12 ' A' ' 5' ' ' LEU . 57.8 t -121.85 111.8 32.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.409 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 58.9 Cg_endo -89.64 33.35 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.115 2.544 . . . . 0.0 112.401 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 56.57 163.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.96 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -157.76 44.83 0.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.097 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -173.45 163.37 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.96 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -120.7 87.92 2.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.19 -139.68 2.7 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.939 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.11 136.58 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 59.5 t -72.87 143.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.105 0.478 . . . . 0.0 111.397 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -112.51 -47.69 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.338 178.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.7 mm-40 -112.18 173.38 6.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 HG22 ' CG2' ' A' ' 23' ' ' VAL . 7.6 p -163.14 120.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.306 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.7 mttm -132.05 64.09 1.6 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.533 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.436 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -173.05 151.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.672 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.99 175.52 2.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.658 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.22 68.34 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.43 55.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.893 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 10.7 p-10 -173.15 132.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -76.28 119.76 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.437 HG21 ' CG1' ' A' ' 7' ' ' VAL . 1.7 tp -104.6 172.74 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.8 m -144.13 137.66 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 72.4 mt-10 -40.48 130.52 2.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.0 61.73 3.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.037 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.27 129.05 5.44 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.131 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -53.06 94.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 110.584 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 1.3 mt -92.45 -78.83 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.476 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 19.6 m -126.77 137.6 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.0 111.873 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 85.3 t -108.77 136.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.782 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -126.06 167.52 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.212 0.529 . . . . 0.0 112.32 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . 3.7 tt0 -71.59 -38.87 70.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.612 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.441 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . 56.39 124.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.311 0.577 . . . . 0.0 112.169 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ALA . 20.3 pt-20 42.78 44.91 4.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.304 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.26 105.32 1.4 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.543 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.7 p -111.27 -71.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.157 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.754 0.311 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.76 176.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.861 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 3.3 t -142.91 162.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.882 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 2.0 mt-10 -130.86 91.08 3.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.494 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -48.41 155.18 0.54 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.784 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.435 ' CD ' ' HA3' ' A' ' 69' ' ' GLY . 10.9 mttm -147.06 150.18 34.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 111.492 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 91.1 t -50.13 140.75 16.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.628 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 37.8 Cg_endo -68.73 -166.66 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.285 1.99 . . . . 0.0 112.88 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -99.22 69.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.432 ' HB ' ' CG2' ' A' ' 40' ' ' THR . 0.4 OUTLIER -66.12 -10.6 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.3 71.95 0.61 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.739 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.45 -64.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.463 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.445 ' CD2' ' OD1' ' A' ' 15' ' ' ASN . 0.3 OUTLIER 171.26 176.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.755 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 4.8 mt-10 -83.34 69.99 10.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.171 0.51 . . . . 0.0 110.712 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.445 ' OD1' ' CD2' ' A' ' 13' ' ' HIS . 1.5 p30 169.82 66.75 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.459 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.48 ' CG1' ' CG2' ' A' ' 40' ' ' THR . 1.0 OUTLIER -120.0 137.74 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.556 -179.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.86 131.88 37.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.972 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 11.5 mt -67.64 162.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -125.95 -16.42 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.706 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' A' ' 36' ' ' ILE . . . -145.7 150.36 36.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 13.5 p -138.78 129.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -150.23 44.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.59 124.16 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -135.55 10.32 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.46 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 87.7 t 64.51 118.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.081 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.94 -23.29 8.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.54 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -71.73 165.7 23.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.2 m -100.44 108.87 20.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.436 HG12 ' CG1' ' A' ' 75' ' ' VAL . 1.1 pt -93.55 138.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.36 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.14 39.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 168.29 68.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -145.03 123.25 12.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.88 116.12 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.279 0.561 . . . . 0.0 111.278 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.412 ' CD1' ' HG ' ' A' ' 5' ' ' LEU . 49.1 mt -88.33 -43.0 11.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.417 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.466 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -153.94 -178.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.516 179.013 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.448 ' CG2' ' CD1' ' A' ' 19' ' ' ILE . 44.6 m -144.9 123.42 12.43 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.471 ' CD2' ' CG2' ' A' ' 66' ' ' ILE . 1.2 mp -116.24 -179.37 3.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.437 ' HG3' ' CG2' ' A' ' 44' ' ' THR . 5.8 tm-20 -174.87 160.04 2.82 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.48 ' CG2' ' CG1' ' A' ' 16' ' ' VAL . 5.5 p -116.54 -61.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 20.7 m-20 -151.0 -43.28 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -141.4 25.43 2.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.12 98.69 2.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.19 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.437 ' CG2' ' HG3' ' A' ' 39' ' ' GLU . 17.8 p -93.51 116.26 28.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.62 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -105.83 -176.32 3.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.076 0.465 . . . . 0.0 111.482 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -168.3 167.12 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.342 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.403 HG13 ' CD1' ' A' ' 5' ' ' LEU . 96.4 t -123.0 115.24 29.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.17 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -90.86 35.81 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.047 2.498 . . . . 0.0 112.137 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 59.72 175.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 15.7 tt0 -162.85 43.31 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.548 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 176.23 167.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -117.12 89.35 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.24 -156.95 8.87 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.006 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' GLU . 81.6 t -113.93 146.28 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.53 0.205 . . . . 0.0 111.246 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 67.6 t -81.3 144.93 9.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.293 0.568 . . . . 0.0 111.348 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.435 ' CA ' ' HE2' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -112.7 -51.27 2.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.193 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.3 mt-10 -106.2 172.92 6.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.672 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 7.4 p -166.2 126.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.626 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -147.5 74.22 1.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.437 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -171.3 150.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -160.42 -163.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.904 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.7 93.32 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.107 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.38 33.86 0.8 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.622 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 12.3 p-10 -129.34 140.96 51.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' CD ' ' HB2' ' A' ' 15' ' ' ASN . 6.8 mttt -73.22 130.47 40.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.471 ' CG2' ' CD2' ' A' ' 38' ' ' LEU . 1.1 tp -130.86 170.75 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.453 ' N ' HG21 ' A' ' 66' ' ' ILE . 8.7 m -147.62 135.99 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mp0 -41.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.435 ' HA3' ' CD ' ' A' ' 6' ' ' LYS . . . 107.53 62.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.378 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.04 23.03 8.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 3.2 tp 45.76 57.22 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.029 0.443 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 2.9 mt -49.35 -80.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 21.3 m -124.94 157.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.415 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 78.4 t -118.46 131.32 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.284 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 16.8 m -118.36 165.57 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' VAL . 4.5 tp10 -72.4 -38.84 68.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.032 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . 57.57 122.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.151 0.5 . . . . 0.0 111.893 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ALA . 11.0 pt-20 43.82 55.37 5.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.243 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.21 -49.83 72.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.54 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -138.26 168.98 18.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.067 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 1.5 mt -137.84 177.27 8.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.991 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 8.4 t -161.63 159.58 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 2.0 mp0 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.361 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 49' ' ' ALA . 1.2 mt -59.2 164.82 2.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.748 0.309 . . . . 0.0 110.676 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HD3' ' HA3' ' A' ' 69' ' ' GLY . 20.3 mttt -143.81 172.41 12.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.58 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.461 ' CG2' HG22 ' A' ' 66' ' ' ILE . 23.7 t -72.83 140.04 80.72 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.032 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 19.4 Cg_endo -63.32 -166.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 112.86 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' A' ' 10' ' ' ILE . 24.5 t70 -93.19 -13.35 28.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.463 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.449 ' CD1' ' O ' ' A' ' 9' ' ' ASP . 1.5 pp 33.19 34.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . 39.74 34.16 0.46 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.232 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.25 -115.57 1.57 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.602 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -157.31 -85.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.712 0.291 . . . . 0.0 110.964 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 11.8 mt-10 -133.2 177.28 7.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.066 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.434 ' N ' ' HB3' ' A' ' 67' ' ' SER . 8.0 p-10 44.33 95.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.507 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 66' ' ' ILE . 27.1 m -152.49 141.06 14.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.66 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -82.02 130.32 35.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.56 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 22.0 mt -62.56 164.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.469 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -128.18 -12.47 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.294 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -146.96 158.25 43.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.002 0.429 . . . . 0.0 111.61 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 7.4 p -148.66 123.87 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.078 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -149.07 44.45 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.429 ' CG2' HG22 ' A' ' 58' ' ' VAL . 2.5 m -135.22 120.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -128.95 10.97 6.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.401 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG12 ' CA ' ' A' ' 56' ' ' LYS . 84.6 t 58.84 112.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.2 -15.32 5.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.833 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.97 142.52 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 127.84 33.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.481 ' CD1' ' CG2' ' A' ' 51' ' ' VAL . 1.1 pp -108.54 154.7 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.02 179.53 5.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.1 t -85.66 48.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.351 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 164.11 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.59 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -156.74 99.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.768 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -45.49 117.5 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.147 0.498 . . . . 0.0 111.822 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 36' ' ' ILE . 20.5 mt -92.79 -42.5 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.389 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.475 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 1.2 pp -148.77 -175.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.057 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.446 ' CG2' ' CD1' ' A' ' 19' ' ' ILE . 32.4 m -149.24 124.55 10.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.449 ' CA ' HG22 ' A' ' 19' ' ' ILE . 2.4 mp -113.2 167.18 10.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' N ' HG23 ' A' ' 10' ' ' ILE . 70.3 tt0 -161.91 164.15 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.692 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.432 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 6.2 p -121.93 -57.54 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -175.33 -37.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -116.59 -19.3 10.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.622 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.14 148.42 49.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.628 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -131.2 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.439 ' HG3' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -121.06 -173.51 2.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.223 0.535 . . . . 0.0 111.675 -179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -168.76 159.35 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.044 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.416 ' CG1' HD23 ' A' ' 5' ' ' LEU . 54.6 t -123.08 126.67 25.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.356 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 86.5 Cg_endo -89.58 34.13 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.882 2.388 . . . . 0.0 112.325 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 5' ' ' LEU . . . 81.64 -51.25 0.26 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' C ' ' CG2' ' A' ' 51' ' ' VAL . 5.0 tp10 55.03 56.16 6.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -174.16 -169.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.21 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -156.42 65.9 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.84 -139.7 2.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.129 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.04 135.56 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.386 0.136 . . . . 0.0 110.642 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 58.3 t -71.93 144.37 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.293 0.568 . . . . 0.0 111.636 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' CA ' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.54 -47.05 2.74 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.265 178.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -110.28 172.53 6.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.429 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.429 HG22 ' CG2' ' A' ' 23' ' ' VAL . 7.2 p -164.81 128.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.873 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -146.06 75.81 1.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.642 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -172.5 155.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.491 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.43 -160.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.774 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.427 HG21 ' CG1' ' A' ' 21' ' ' VAL . 61.3 t -110.13 76.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.216 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.52 41.23 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.811 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 16.7 p-10 -128.73 138.63 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.924 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -72.05 110.71 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.792 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.461 HG22 ' CG2' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -137.99 168.83 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -152.85 162.7 40.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 111.283 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -42.19 107.4 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.488 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 6' ' ' LYS . . . 98.91 70.41 0.96 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.783 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.95 21.35 4.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.373 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 1.7 tp 43.52 57.54 3.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.113 0.482 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.444 HD13 ' CA ' ' A' ' 7' ' ' VAL . 3.7 mt -49.95 -73.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.096 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.427 ' CG1' ' HA ' ' A' ' 58' ' ' VAL . 18.1 m -135.45 145.23 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 92.4 t -104.97 136.74 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 1.2 m -126.69 167.54 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.0 112.295 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -101.1 46.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.433 ' HA ' ' C ' ' A' ' 52' ' ' ALA . . . -36.04 143.37 0.06 Allowed 'General case' 0 C--N 1.335 -0.058 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 77' ' ' ALA . 6.6 pt-20 48.3 27.41 1.33 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.528 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -50.52 156.93 2.3 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.597 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.2 t -112.61 -28.21 7.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 110.913 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.069 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.778 0.323 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp -101.05 178.34 4.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 2.7 t -142.86 161.62 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -136.51 117.59 14.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.401 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.432 ' CD2' HD13 ' A' ' 35' ' ' LEU . 1.6 tp -68.65 160.81 29.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -143.75 144.42 31.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 111.415 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.442 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 86.8 t -41.19 140.58 1.16 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.035 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 61.0 Cg_endo -75.32 -168.04 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.24 1.96 . . . . 0.0 113.076 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 45' ' ' MET . 0.1 OUTLIER -98.65 83.78 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.952 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.441 ' CG2' HD22 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -78.53 1.43 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.429 ' N ' HD11 ' A' ' 10' ' ' ILE . . . 72.09 -58.16 1.45 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.21 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -39.48 -85.42 0.01 OUTLIER Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.288 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -179.08 -174.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.898 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -64.7 174.8 1.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.418 ' CA ' ' O ' ' A' ' 66' ' ' ILE . 5.5 p-10 43.75 78.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.405 HG21 HG23 ' A' ' 66' ' ' ILE . 25.1 m -122.26 -178.02 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.433 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -106.59 118.45 36.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.915 0.388 . . . . 0.0 111.401 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 19.5 mt -55.21 165.29 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.475 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -136.5 2.99 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.508 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.32 152.21 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.297 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.427 ' HA ' HG21 ' A' ' 36' ' ' ILE . 81.2 t -137.26 120.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.759 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -148.42 60.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.926 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG2' HG22 ' A' ' 58' ' ' VAL . 2.4 m -142.1 113.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -120.94 96.25 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 63.3 t -40.21 116.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.56 15.13 7.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.66 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.91 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 m -70.25 146.29 50.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.466 ' CD1' ' O ' ' A' ' 52' ' ' ALA . 2.8 pt -136.69 154.81 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.51 -174.88 3.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 t -91.94 47.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 p30 172.68 67.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.058 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.99 108.58 3.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.564 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -46.95 119.12 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.092 0.472 . . . . 0.0 111.874 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.432 HD13 ' CD2' ' A' ' 5' ' ' LEU . 21.5 mt -94.52 -39.39 10.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.877 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.452 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -161.11 -177.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.349 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.44 ' CG2' HG12 ' A' ' 19' ' ' ILE . 70.5 m -142.53 109.11 5.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.743 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.441 HD22 ' CG2' ' A' ' 10' ' ' ILE . 1.8 tp -95.02 155.93 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.679 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' CB ' HG22 ' A' ' 19' ' ' ILE . 33.6 tt0 -166.31 144.63 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.655 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.44 ' CG2' ' HB ' ' A' ' 10' ' ' ILE . 3.4 p -104.99 -59.46 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.425 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.7 p30 -174.63 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.34 35.75 4.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 177.25 131.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.252 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.434 HG23 ' CG ' ' A' ' 39' ' ' GLU . 73.6 p -119.21 116.33 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.406 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -123.7 128.02 49.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.253 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.0 OUTLIER -113.23 174.47 5.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.757 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' CG2' HD12 ' A' ' 36' ' ' ILE . 76.9 t -120.59 116.3 31.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 85.2 Cg_endo -87.37 37.27 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.94 2.427 . . . . 0.0 112.359 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 46.83 93.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.856 0.36 . . . . 0.0 111.11 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -93.38 63.03 3.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.426 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 1.0 OUTLIER 163.43 148.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.333 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -96.35 -168.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.368 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.449 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 102.14 -146.52 16.98 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.839 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.95 135.4 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.538 0.209 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 56' ' ' LYS . 61.5 t -68.22 147.05 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.69 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.67 -50.75 2.4 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.277 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.81 166.32 13.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.409 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 23' ' ' VAL . 5.4 p -152.17 138.56 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.318 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' N ' HG21 ' A' ' 58' ' ' VAL . 6.9 mmtt -140.65 59.35 1.55 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.306 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.433 ' CG2' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -157.47 143.58 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -146.61 -174.2 4.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.76 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.5 t -98.04 92.73 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.45 35.57 1.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.628 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 19.6 p-10 -119.13 172.89 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.958 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.54 123.06 40.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.434 HG13 ' CG2' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -129.16 161.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.161 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.9 p -135.42 127.28 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.421 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.435 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 42.5 mt-10 -40.91 115.02 0.53 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 88.17 64.65 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.011 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.78 -165.83 11.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.024 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 4' ' ' GLU . 8.5 tp -104.49 89.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.969 0.414 . . . . 0.0 110.372 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 2.1 mt -87.35 -80.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.944 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 17.4 m -122.41 135.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.064 0.459 . . . . 0.0 111.891 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 41.4 t -103.78 144.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.338 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG2' ' HB ' ' A' ' 3' ' ' VAL . 10.9 m -129.07 165.41 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.122 0.487 . . . . 0.0 112.008 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 6.3 tt0 -83.73 -26.49 29.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.58 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . 60.99 116.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.075 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 45.61 57.69 4.8 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.154 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.85 116.58 4.65 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.445 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.3 133.12 47.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.044 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.82 0.343 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mp -63.99 172.57 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.444 ' HB ' ' CG2' ' A' ' 75' ' ' VAL . 19.8 t -139.27 146.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 1.3 mp0 -124.34 100.63 6.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.435 HD13 ' CD1' ' A' ' 35' ' ' LEU . 44.1 mt -63.88 131.24 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.72 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.2 mtmt -130.29 55.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.483 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 38.2 t 58.75 147.04 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.442 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' CD ' ' CD2' ' A' ' 38' ' ' LEU . 98.8 Cg_endo -94.29 -178.39 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.756 2.304 . . . . 0.0 112.453 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 45' ' ' MET . 0.4 OUTLIER -64.2 173.69 1.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.012 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -169.71 28.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.754 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 38.35 94.96 0.01 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.366 -0.445 . . . . 0.0 113.397 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.37 -106.63 0.33 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.576 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.04 -175.96 5.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.892 0.377 . . . . 0.0 111.023 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.52 -168.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.194 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.468 ' N ' ' CB ' ' A' ' 67' ' ' SER . 3.6 p30 44.15 94.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.453 HG21 ' CB ' ' A' ' 67' ' ' SER . 0.1 OUTLIER -142.64 -176.08 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.372 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -112.06 138.68 48.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 28.8 mt -73.45 161.91 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.471 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -134.62 -7.02 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.929 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -152.85 155.26 36.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 61.5 t -147.57 126.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.313 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -153.3 32.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.98 123.46 68.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -135.0 9.76 3.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.492 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.42 HG22 ' CG1' ' A' ' 58' ' ' VAL . 87.3 t 63.4 131.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.85 -22.51 18.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.371 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.51 139.03 30.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.7 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -68.16 162.22 25.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.437 HG12 ' CG1' ' A' ' 75' ' ' VAL . 1.2 pp -143.73 130.19 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.15 -174.43 4.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.935 0.398 . . . . 0.0 111.008 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 t -90.32 41.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 168.05 67.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -141.78 116.62 9.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.867 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -59.65 115.32 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.435 ' CD1' HD13 ' A' ' 5' ' ' LEU . 16.6 mt -90.37 -41.95 11.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.406 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.48 ' CD1' ' CD2' ' A' ' 38' ' ' LEU . 1.3 pp -150.43 -175.97 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.884 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.432 ' N ' ' HB2' ' A' ' 20' ' ' ALA . 3.7 m -133.3 152.59 51.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.491 ' CD2' ' CD ' ' A' ' 8' ' ' PRO . 2.4 mm? -134.45 166.8 22.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 40' ' ' THR . 76.0 tt0 -174.4 164.07 3.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.401 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.466 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 13.5 p -120.71 -72.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.892 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.466 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.9 m-20 -159.72 25.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.731 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm 176.24 -43.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.65 128.76 45.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 p -116.71 115.81 26.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.44 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -104.07 -165.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 5.7 p30 -175.69 167.34 3.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' THR . 74.0 t -112.03 104.15 55.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 70.3 Cg_endo -89.35 42.11 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.118 2.545 . . . . 0.0 111.886 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.7 177.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 23.1 pt-20 -163.19 38.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.442 ' CB ' ' HB1' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 175.74 168.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -112.27 93.15 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.961 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.35 -140.15 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.259 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.08 145.24 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 0.0 111.065 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 63.2 t -75.16 145.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 0.0 111.397 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.413 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -115.13 -47.59 2.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.466 178.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.92 167.2 10.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.644 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 12.4 p -162.87 124.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.93 80.93 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.32 151.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -149.56 -173.87 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.97 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.427 HG21 ' CG2' ' A' ' 21' ' ' VAL . 46.3 t -101.31 77.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.7 41.49 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' OD1' ' CD1' ' A' ' 18' ' ' ILE . 3.9 p30 -132.8 164.04 27.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.418 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -88.76 105.0 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.18 0.514 . . . . 0.0 110.705 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.443 HG21 ' CG2' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -132.89 164.61 34.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.369 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.468 ' CB ' ' N ' ' A' ' 15' ' ' ASN . 54.3 p -167.2 168.32 13.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -45.72 91.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.196 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 124.34 57.56 0.18 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.76 9.02 6.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.928 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 4.2 tp 47.25 46.86 16.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.679 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.454 HD13 ' CG2' ' A' ' 7' ' ' VAL . 9.1 mt -43.26 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 58' ' ' VAL . 18.5 m -135.36 147.25 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.51 . . . . 0.0 111.99 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 98.5 t -109.84 140.72 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.705 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 3' ' ' VAL . 16.4 m -123.16 161.91 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.127 0.489 . . . . 0.0 112.303 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -68.58 -42.28 78.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.016 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 51' ' ' VAL . . . 59.4 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.97 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 52' ' ' ALA . 3.2 pt-20 37.78 59.87 1.24 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.772 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.3 -134.54 5.73 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.529 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t 174.34 114.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.099 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' N ' ' OE2' ' A' ' 78' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -90.19 175.18 7.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.788 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 6.2 t -125.51 162.76 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.451 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 11.2 mt-10 -125.48 90.32 3.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.428 ' CB ' HG21 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -51.84 152.16 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.572 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -140.12 151.54 45.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.205 0.526 . . . . 0.0 111.626 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 85.2 t -47.11 143.13 4.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.88 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 43.5 Cg_endo -70.78 -167.47 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.149 1.9 . . . . 0.0 112.738 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 76.86 2.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.562 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.464 ' HB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -88.05 60.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.683 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -24.28 84.53 0.0 OUTLIER Glycine 0 C--N 1.34 0.799 0 O-C-N 123.986 0.804 . . . . 0.0 114.494 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -161.54 -62.4 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.216 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 0.1 OUTLIER 169.43 158.63 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' CA ' ' HA ' ' A' ' 67' ' ' SER . 0.3 OUTLIER -72.47 63.74 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.65 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -179.34 57.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.437 HG22 ' CD2' ' A' ' 38' ' ' LEU . 17.1 m -106.38 -175.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.173 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.18 130.6 52.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 5.6 mt -66.15 161.15 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.956 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.456 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -126.6 -37.98 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -118.08 166.18 12.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.0 p -159.38 116.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -135.64 61.4 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.415 ' CG2' HG21 ' A' ' 58' ' ' VAL . 5.8 m -145.18 118.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.69 23.17 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' CG2' HG13 ' A' ' 58' ' ' VAL . 71.8 t 66.73 -86.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.991 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.7 62.03 0.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.946 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -129.94 171.03 13.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.709 0.29 . . . . 0.0 110.761 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 m -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.903 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.4 HD12 HG22 ' A' ' 75' ' ' VAL . 1.1 pt -132.21 153.2 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 0.0 111.344 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.91 174.06 11.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 3.1 t -78.51 54.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 3.6 p30 162.09 70.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.83 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -153.81 124.39 7.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.78 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.53 117.38 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.277 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 19.1 mt -90.42 -40.78 11.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.849 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -157.68 -161.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.862 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.453 ' N ' HG12 ' A' ' 36' ' ' ILE . 93.1 m -157.7 51.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.329 0.585 . . . . 0.0 109.846 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.437 ' CD2' HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -41.83 163.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.859 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 40' ' ' THR . 70.1 tt0 -172.76 154.42 2.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.464 ' CG2' ' HB ' ' A' ' 10' ' ' ILE . 50.2 p -102.01 -82.87 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' N ' ' OG1' ' A' ' 40' ' ' THR . 16.7 t70 -150.96 21.41 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -179.98 -41.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.03 105.58 17.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.234 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -91.74 115.07 27.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -95.43 138.9 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.478 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 3.7 m-20 -119.89 144.41 47.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.955 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 8' ' ' PRO . 76.5 t -122.09 112.8 31.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 83.6 Cg_endo -88.4 35.41 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.963 2.442 . . . . 0.0 112.331 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 54.23 168.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.035 0.445 . . . . 0.0 111.176 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -165.65 67.88 0.12 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.484 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.445 HG22 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -173.87 176.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.237 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -139.67 79.01 1.69 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.627 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 77' ' ' ALA . . . -167.99 -140.66 2.97 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.308 -1.425 . . . . 0.0 113.857 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -130.94 139.09 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.83 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 57.7 t -79.53 146.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.408 0.623 . . . . 0.0 111.527 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.424 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -118.59 -44.45 2.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.045 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -109.88 158.0 18.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.453 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.437 HG13 ' CG2' ' A' ' 25' ' ' VAL . 7.7 p -151.44 119.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -131.07 68.89 1.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.683 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.437 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -172.46 154.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.643 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -169.11 170.69 8.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.591 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.427 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 54.1 t -82.03 88.42 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.28 46.88 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.72 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 19.0 p-10 -139.46 176.53 8.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.772 0.32 . . . . 0.0 111.042 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 7.8 tttt -104.07 156.09 18.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.669 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -140.76 172.56 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 7.2 p -147.13 48.39 1.13 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.433 ' CG ' HD13 ' A' ' 10' ' ' ILE . 36.4 mt-10 39.95 55.21 2.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 138.0 69.97 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.442 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.93 29.07 6.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.553 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.9 tp 48.09 56.67 7.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 0.0 110.571 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 3.3 mt -45.98 -82.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.457 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 27.3 m -122.0 160.15 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.17 0.51 . . . . 0.0 111.875 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 76.3 t -128.93 120.58 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.907 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 29.7 m -112.09 156.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -31.08 72.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.656 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' N ' ' HA2' ' A' ' 53' ' ' GLY . . . 53.62 159.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.061 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 52' ' ' ALA . 3.5 mt-10 72.46 -65.41 0.35 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.612 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.13 -178.4 38.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.542 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -177.35 -49.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.887 0.375 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.101 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.806 0.336 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -53.17 174.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.437 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 7.9 t -141.84 152.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.426 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 7.3 mt-10 -128.37 100.79 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.376 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.442 HD23 ' CG1' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -60.93 157.56 15.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.069 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' CD ' ' HA3' ' A' ' 69' ' ' GLY . 8.5 mttp -142.13 145.07 33.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.314 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.458 ' CG1' HG21 ' A' ' 66' ' ' ILE . 95.9 t -48.23 141.24 8.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.04 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 38.0 Cg_endo -68.72 -166.08 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.2 1.934 . . . . 0.0 112.24 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -92.59 -13.04 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.645 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 9' ' ' ASP . 1.2 pp 33.88 33.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . 36.63 31.67 0.05 OUTLIER Glycine 0 C--N 1.336 0.531 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.684 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.65 -132.19 2.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.643 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -129.92 -162.49 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.739 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' O ' ' CD2' ' A' ' 13' ' ' HIS . 8.5 mt-10 -68.09 -179.67 1.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.99 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 44.03 95.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 66' ' ' ILE . 30.9 m -146.54 137.12 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.92 126.22 29.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.522 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 3.7 mt -55.72 165.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -140.75 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.066 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.436 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -177.95 146.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 111.099 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HA ' HG21 ' A' ' 36' ' ' ILE . 13.4 p -137.81 124.39 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.981 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mm-40 -148.82 39.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.426 ' CG2' HG22 ' A' ' 58' ' ' VAL . 3.0 m -120.07 112.77 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.357 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -122.84 97.6 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 23.5 m -39.05 111.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.921 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.93 21.17 4.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.67 143.11 50.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -69.83 127.08 31.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.453 HD12 ' CG1' ' A' ' 75' ' ' VAL . 2.6 pt -108.09 169.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -178.58 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 t -94.34 33.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 176.23 62.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.93 108.34 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -48.76 116.23 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.187 0.518 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.429 ' CD1' ' CD1' ' A' ' 5' ' ' LEU . 70.2 mt -94.63 -44.29 7.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.788 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.496 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -149.93 -173.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.433 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.439 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 47.5 m -149.12 107.67 3.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.486 ' CD2' ' CD1' ' A' ' 36' ' ' ILE . 2.7 mm? -92.19 151.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.45 ' CB ' HG22 ' A' ' 19' ' ' ILE . 78.2 tt0 -155.51 150.1 26.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.892 0.377 . . . . 0.0 110.991 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 3.0 p -112.06 -61.39 1.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.988 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 15.3 t0 -168.53 -41.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 37.77 3.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.51 118.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -113.04 119.95 39.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.43 ' HG3' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.03 153.56 21.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.4 p30 -133.12 143.91 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.572 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.442 ' CG1' HD23 ' A' ' 5' ' ' LEU . 93.8 t -105.87 108.09 60.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 71.0 Cg_endo -88.07 37.74 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.043 2.495 . . . . 0.0 112.469 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 44.66 95.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 111.338 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 4.2 mt-10 -87.39 53.66 2.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.441 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 1.2 p 161.85 141.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -83.14 -162.26 0.59 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.79 -145.17 15.93 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.089 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 76' ' ' GLU . 45.7 t -145.44 138.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.401 0.143 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.446 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 60.0 t -76.25 146.98 8.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.316 0.579 . . . . 0.0 111.796 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -119.71 -47.87 2.4 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.122 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -109.54 172.4 6.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.652 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 7.6 p -164.39 137.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.27 67.96 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.402 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -169.59 152.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.639 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -171.81 -167.24 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.521 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.87 90.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.45 -19.94 0.71 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.892 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 2.3 p-10 -98.59 167.25 10.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.095 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.54 134.61 44.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.458 HG21 ' CG1' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -127.92 162.83 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.054 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -145.87 144.63 30.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -41.08 106.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' HA3' ' CD ' ' A' ' 6' ' ' LYS . . . 94.26 70.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.608 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.35 21.13 3.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.416 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.431 HD12 ' CG2' ' A' ' 74' ' ' VAL . 5.5 tp 47.58 59.67 3.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.429 HD13 ' CA ' ' A' ' 7' ' ' VAL . 3.6 mt -52.35 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 58' ' ' VAL . 20.8 m -129.83 148.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 111.597 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 79.3 t -115.1 134.25 58.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.453 ' CG1' HD12 ' A' ' 29' ' ' ILE . 32.0 m -121.84 177.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.155 0.502 . . . . 0.0 112.205 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' VAL . 1.5 tt0 -82.81 -33.53 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.268 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . 70.23 29.81 3.58 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.442 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -67.22 0.28 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.494 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.444 ' CA ' ' HB3' ' A' ' 52' ' ' ALA . . . 44.14 92.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.228 -0.896 . . . . 0.0 113.055 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.9 p -120.54 98.44 6.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.777 0.323 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.095 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 mp -55.18 177.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.485 ' CG2' ' CG1' ' A' ' 51' ' ' VAL . 3.6 t -144.31 161.27 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.471 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 63.5 mt-10 -129.87 100.06 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.552 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.428 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -57.75 164.09 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.023 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' CD ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -154.18 155.61 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.273 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 96.5 t -53.76 140.74 48.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HG3' HD21 ' A' ' 38' ' ' LEU . 70.5 Cg_endo -73.69 -168.44 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.65 2.233 . . . . 0.0 113.03 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.4 OUTLIER -82.9 92.94 7.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.79 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.426 HG12 ' CG2' ' A' ' 16' ' ' VAL . 1.3 pp -112.23 70.23 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.042 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.23 -89.9 1.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.56 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.33 41.46 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.631 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.02 179.63 7.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.743 0.306 . . . . 0.0 111.037 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 2.8 mp0 -117.31 81.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 169.32 73.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.437 ' CG2' HG23 ' A' ' 66' ' ' ILE . 4.0 m -134.88 130.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.366 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.68 140.76 49.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.475 ' CG1' ' CD1' ' A' ' 38' ' ' LEU . 5.8 mt -74.9 161.33 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.709 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -124.35 -38.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.794 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.95 170.8 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.735 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.474 ' HA ' HG21 ' A' ' 36' ' ' ILE . 10.6 p -159.93 124.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.313 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 39.1 mt-10 -158.64 90.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 22' ' ' GLU . 2.6 m -163.95 113.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.361 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.5 m120 -114.7 96.23 5.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.506 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.408 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 2.3 m -42.68 92.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.546 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 136.31 -15.73 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.588 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.28 169.92 16.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.84 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 m -96.36 103.16 15.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.06 158.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.45 -176.79 4.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.941 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -90.21 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.316 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 172.08 73.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.783 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -150.25 107.84 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.614 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -48.76 118.6 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 111.417 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.407 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 81.8 mt -92.55 -39.5 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.08 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.474 HG21 ' HA ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -161.81 -178.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.626 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 76.3 m -142.08 56.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.669 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.475 ' CD1' ' CG1' ' A' ' 18' ' ' ILE . 3.2 mm? -41.45 166.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 40' ' ' THR . 67.1 tt0 -168.52 153.89 6.53 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.306 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 29.9 p -100.04 -72.65 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.707 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.1 p-10 -160.22 26.99 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.601 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.04 -42.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.875 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.85 124.26 43.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.044 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.9 p -107.5 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.054 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.434 ' HG3' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -97.5 133.09 42.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 2.9 p30 -118.3 144.31 45.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.229 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 34' ' ' THR . 92.4 t -113.34 116.58 46.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.417 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 78.4 Cg_endo -87.42 27.8 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.964 2.443 . . . . 0.0 112.619 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 59.28 151.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 111.297 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.42 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 9.4 tp10 -145.98 70.9 1.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.485 ' CG1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 176.81 153.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.038 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -121.87 77.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.77 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.98 -130.84 1.23 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.179 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 61.8 t -137.18 138.77 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.45 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 70.4 t -78.6 146.59 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.519 . . . . 0.0 111.291 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -116.6 -47.08 2.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.589 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.05 175.04 5.58 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.82 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.419 HG22 ' CG2' ' A' ' 23' ' ' VAL . 7.5 p -163.39 126.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.525 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.1 mttt -136.87 69.01 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' CG2' ' N ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -171.78 159.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.723 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.437 ' N ' ' CG2' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -171.89 -172.89 1.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.523 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.61 79.19 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.272 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.13 44.21 0.07 OUTLIER Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.701 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 7.7 p-10 -148.01 147.01 29.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.88 0.371 . . . . 0.0 111.108 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 137.18 40.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.437 HG23 ' CG2' ' A' ' 16' ' ' VAL . 1.1 tp -131.27 172.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.441 ' CB ' ' HB3' ' A' ' 14' ' ' GLU . 7.1 p -152.2 142.78 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.203 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 76.9 mt-10 -44.74 97.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.201 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.8 62.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -114.26 22.03 14.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.357 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 13.9 tp 48.15 53.58 11.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.977 0.418 . . . . 0.0 110.686 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.436 HD13 ' CG2' ' A' ' 7' ' ' VAL . 3.7 mt -48.11 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.044 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' CG2' ' HB2' ' A' ' 5' ' ' LEU . 22.8 m -123.05 159.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.559 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 27.9 t -127.75 132.52 68.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.934 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 33.2 m -119.38 -179.64 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -93.2 -37.19 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.514 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . 57.21 133.44 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.342 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 52' ' ' ALA . 10.9 pt-20 40.78 58.13 2.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.666 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.8 -21.32 74.69 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.421 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.1 p 55.68 177.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.82 0.343 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.086 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.874 0.369 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mp -62.63 173.79 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.955 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 13.7 t -134.69 160.27 41.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 31.0 mp0 -133.01 103.98 6.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.552 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.434 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -60.9 159.05 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.651 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' CD ' ' HA3' ' A' ' 69' ' ' GLY . 15.5 mttt -148.72 145.04 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 72.3 t -47.91 140.45 8.66 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.998 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' CD2' ' A' ' 38' ' ' LEU . 71.8 Cg_endo -76.94 -169.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.677 2.252 . . . . 0.0 112.89 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.44 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -81.85 84.45 6.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.791 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.473 ' O ' ' CD2' ' A' ' 13' ' ' HIS . 1.1 pp -103.43 66.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 0.0 110.923 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.489 ' HA2' ' CE1' ' A' ' 13' ' ' HIS . . . 89.06 11.38 65.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.072 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.93 17.51 29.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.82 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.489 ' CE1' ' HA2' ' A' ' 11' ' ' GLY . 0.4 OUTLIER -123.32 -175.83 3.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.856 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 25.7 mp0 -105.45 176.65 5.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.993 0.425 . . . . 0.0 111.451 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 7.0 p-10 45.38 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' CG1' HD12 ' A' ' 10' ' ' ILE . 35.3 m -136.18 -175.67 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.355 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.33 120.34 38.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.824 0.345 . . . . 0.0 111.369 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 27.2 mt -68.18 159.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.449 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -126.19 -15.81 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.51 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.0 150.47 32.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 p -140.21 124.19 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -132.09 34.69 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 m -132.93 115.21 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.405 ' O ' HG11 ' A' ' 25' ' ' VAL . 16.1 t30 -114.75 14.91 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER 62.24 118.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.15 23.39 32.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.45 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.82 148.03 30.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 m -69.47 136.17 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.462 HG13 ' N ' ' A' ' 53' ' ' GLY . 2.9 pt -126.86 160.33 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.363 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.19 -176.21 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.9 t -91.55 41.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.247 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 167.14 71.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.489 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.5 p30 -145.58 120.32 9.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.974 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -54.55 117.06 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 47.5 mt -92.62 -36.33 13.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.876 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 ' CD1' ' HB ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -159.11 -176.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.266 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 84.9 m -144.56 45.79 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.502 0.667 . . . . 0.0 109.447 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.456 ' CD2' ' HD2' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -39.69 165.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.362 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 40' ' ' THR . 76.6 tt0 -174.63 164.55 3.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.086 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.438 ' N ' ' CG ' ' A' ' 39' ' ' GLU . 6.6 p -120.35 -158.38 0.75 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.38 -22.96 66.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 54.81 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.78 113.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.434 ' HA ' ' CB ' ' A' ' 39' ' ' GLU . 2.1 p -98.9 141.81 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.189 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.44 ' HG3' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -143.34 131.38 21.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.059 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.39 173.59 7.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 36' ' ' ILE . 94.4 t -143.72 116.78 5.85 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 65.1 Cg_endo -90.92 36.83 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.203 2.602 . . . . 0.0 112.087 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 57.88 160.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 3.5 mt-10 -139.33 35.53 2.07 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.424 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER 165.25 153.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.417 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -85.49 -165.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.069 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.462 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 111.46 -157.24 15.08 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.715 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.73 134.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 58.2 t -68.35 145.39 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.245 0.545 . . . . 0.0 111.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.428 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.24 -44.56 2.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.251 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 19.6 mm-40 -111.86 174.66 5.77 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.636 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.4 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 12.5 p -173.83 137.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.508 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -153.12 51.01 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.107 0.479 . . . . 0.0 110.231 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.435 ' CG1' HG12 ' A' ' 72' ' ' ILE . 28.3 m -155.15 164.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.155 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -170.72 145.78 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -55.99 86.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . 122.91 62.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.512 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 2.0 p30 -153.34 178.58 9.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -94.83 112.92 24.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.445 HG21 ' CG2' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -125.99 165.48 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.443 ' N ' HG21 ' A' ' 66' ' ' ILE . 4.5 p -147.53 141.11 25.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.96 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.46 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 28.7 mt-10 -43.08 109.14 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA3' ' CD ' ' A' ' 6' ' ' LYS . . . 83.83 70.43 1.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.24 10.83 9.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.716 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp 60.51 48.48 7.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.423 0.63 . . . . 0.0 109.964 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.455 HD13 ' CG2' ' A' ' 7' ' ' VAL . 56.0 mt -46.84 -83.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.725 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 5' ' ' LEU . 29.3 m -118.38 159.13 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 0.0 111.616 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 75' ' ' VAL . 90.7 t -131.4 141.1 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.91 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 24.4 m -121.87 -178.51 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.242 0.544 . . . . 0.0 112.4 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.42 ' HG3' ' CE ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -95.56 -27.35 15.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.498 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . 65.08 107.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.704 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 47.61 38.5 8.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.49 -98.97 0.1 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.532 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -107.01 -25.69 11.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.111 -179.941 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.868 0.366 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 mp -83.09 171.31 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.05 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 13.8 t -134.8 150.21 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.711 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -119.46 104.01 9.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.221 179.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.73 161.09 30.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.007 0.432 . . . . 0.0 111.264 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.81 159.7 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 87.1 t -50.0 140.06 16.7 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' CD ' ' CD2' ' A' ' 38' ' ' LEU . 60.9 Cg_endo -73.79 -168.17 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.578 2.185 . . . . 0.0 113.052 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -89.87 86.89 6.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.745 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.46 HG12 ' CG2' ' A' ' 16' ' ' VAL . 1.2 pp -101.05 51.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.57 -80.34 0.28 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.509 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.9 41.69 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.546 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -148.66 162.35 39.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.734 0.302 . . . . 0.0 110.798 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.436 ' CA ' ' HB3' ' A' ' 67' ' ' SER . 6.2 mt-10 -104.12 87.21 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 4.2 p30 162.64 76.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.434 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.46 ' CG2' HG12 ' A' ' 10' ' ' ILE . 32.6 m -138.83 133.6 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.547 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -76.06 137.05 39.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.047 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.471 ' CG1' ' CD1' ' A' ' 38' ' ' LEU . 7.9 mt -72.16 161.18 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.026 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.18 -20.98 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.825 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' A' ' 36' ' ' ILE . . . -140.07 158.52 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 111.423 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 62' ' ' VAL . 97.1 t -145.92 127.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.9 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -149.92 77.11 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -160.66 141.62 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.224 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -137.58 18.42 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.256 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 ' CG2' HG13 ' A' ' 58' ' ' VAL . 73.8 t 65.92 -82.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 58.84 2.48 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -128.4 166.73 18.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.743 0.306 . . . . 0.0 110.821 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.5 m -90.52 125.49 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.798 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.434 ' CD1' HG22 ' A' ' 51' ' ' VAL . 1.1 pt -120.35 143.24 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.06 -171.78 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.218 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 t -90.0 44.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.62 73.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -152.69 98.82 2.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -45.12 116.4 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.183 0.516 . . . . 0.0 111.611 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' O ' HG21 ' A' ' 36' ' ' ILE . 26.4 mt -91.09 -41.68 10.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.067 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.459 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -154.88 -178.39 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.455 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.476 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 96.4 m -144.39 57.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.475 ' CD2' ' CD ' ' A' ' 8' ' ' PRO . 2.1 mm? -39.16 162.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.322 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.446 ' CB ' HG22 ' A' ' 19' ' ' ILE . 65.3 tt0 -175.41 156.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.786 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.417 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -123.71 -83.79 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.585 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.6 OUTLIER -144.56 -42.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.29 42.93 3.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 176.21 136.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.304 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -129.48 120.77 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.569 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.43 ' HG3' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -108.58 156.17 19.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -179.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 9.0 p-10 -141.43 144.82 34.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.458 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 34' ' ' THR . 93.9 t -117.29 118.34 35.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 87.7 Cg_endo -90.02 30.13 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.015 2.477 . . . . 0.0 112.319 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 51.35 102.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.281 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.95 67.77 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -158.72 -172.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.993 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -159.66 62.97 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.4 ' HA2' ' N ' ' A' ' 77' ' ' ALA . . . -157.54 -119.81 0.6 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.059 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 63.6 t -146.33 140.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.506 0.193 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 85.7 t -78.07 155.03 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.346 0.593 . . . . 0.0 111.308 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.43 ' N ' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -127.09 -46.02 1.54 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.189 179.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -107.96 165.09 11.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.319 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.433 HG13 ' CG2' ' A' ' 25' ' ' VAL . 14.6 p -162.17 123.81 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 78.37 1.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.595 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.13 148.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.374 -179.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -139.47 167.58 21.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.456 ' N ' ' CG2' ' A' ' 21' ' ' VAL . 11.2 p -81.75 55.69 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.266 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.12 61.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.817 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 1.7 p30 -148.98 150.48 32.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -64.76 122.48 16.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.19 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.432 HG23 ' CG2' ' A' ' 16' ' ' VAL . 1.1 tp -131.04 169.63 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.436 ' HB3' ' CA ' ' A' ' 14' ' ' GLU . 4.7 p -151.94 150.5 30.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mt-10 -50.58 98.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.83 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.09 55.73 0.6 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.475 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.73 18.4 29.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.391 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 9.0 tp 45.33 47.7 10.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.046 0.451 . . . . 0.0 110.775 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 5.8 mt -43.18 -82.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.333 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.435 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 22.0 m -127.39 148.38 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 111.728 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 93.9 t -118.42 133.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.943 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.477 ' CG2' ' CG1' ' A' ' 51' ' ' VAL . 25.4 m -118.95 166.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 112.417 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -77.54 -36.32 52.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.509 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . 56.94 149.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.002 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 52' ' ' ALA . 4.4 pt-20 38.57 55.16 1.9 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.754 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.94 -90.23 1.41 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.578 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.6 p -103.4 179.92 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.904 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.058 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.881 0.372 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.26 -178.36 4.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.478 ' CB ' ' CG1' ' A' ' 51' ' ' VAL . 33.9 t -152.66 161.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.438 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -135.12 91.2 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.002 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.423 HD13 ' CG1' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -53.05 169.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -158.11 161.69 37.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 72' ' ' ILE . 83.4 t -52.64 139.96 38.82 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 38.5 Cg_endo -70.04 -168.16 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.094 1.863 . . . . 0.0 112.949 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.69 60.37 1.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.759 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 11' ' ' GLY . 0.4 OUTLIER -47.49 -24.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.585 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.429 ' N ' HD11 ' A' ' 10' ' ' ILE . . . 69.1 56.91 8.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.475 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.75 -71.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.418 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 13' ' ' HIS . 0.2 OUTLIER 172.84 -176.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 0.0 110.837 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -69.08 172.22 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.651 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.73 91.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG1' HG23 ' A' ' 40' ' ' THR . 9.3 m -127.79 -154.56 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.716 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -140.42 121.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 20.6 mt -65.0 163.78 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -127.12 -12.46 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.053 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.35 161.82 42.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 0.0 111.607 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.444 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 13.3 p -146.61 133.24 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.05 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -161.26 75.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 58' ' ' VAL . 2.4 m -149.08 114.44 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -116.65 96.02 5.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.535 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.3 m -43.28 110.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.553 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.05 17.43 4.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.38 149.82 41.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.792 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.9 m -77.38 142.94 39.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.471 ' CD1' ' CG2' ' A' ' 51' ' ' VAL . 2.8 pp -143.1 166.06 15.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.65 -171.27 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.351 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 6.1 t -90.39 43.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 p30 178.28 68.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.32 107.1 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -44.16 119.32 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.169 0.509 . . . . 0.0 112.096 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.437 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 82.9 mt -92.02 -45.3 8.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.856 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.463 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -154.78 179.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.444 0.64 . . . . 0.0 112.091 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.423 ' HB ' HG12 ' A' ' 19' ' ' ILE . 59.7 m -138.81 116.94 11.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.457 ' CD2' HG22 ' A' ' 66' ' ' ILE . 4.2 mp -111.6 175.34 5.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 112.148 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -177.4 157.16 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.454 HG23 ' CG1' ' A' ' 16' ' ' VAL . 6.5 p -131.49 -58.96 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 110.816 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 40' ' ' THR . 8.7 t70 -175.24 -38.3 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.765 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -75.06 -26.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 175.38 170.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.927 0.394 . . . . 0.0 111.334 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -109.66 130.36 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -109.09 -168.56 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 0.0 111.545 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -176.84 167.36 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.234 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.423 ' CG1' HD13 ' A' ' 5' ' ' LEU . 99.6 t -127.41 125.51 23.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.983 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -89.74 30.41 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.032 2.488 . . . . 0.0 112.494 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . 53.53 106.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 111.394 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.95 69.56 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.142 0.496 . . . . 0.0 110.167 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.478 ' CG1' ' CB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -158.53 -170.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.71 -178.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -159.76 56.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.798 0.333 . . . . 0.0 111.363 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.82 -121.92 0.59 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.39 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.428 HG11 ' N ' ' A' ' 55' ' ' VAL . 51.1 t -137.62 139.15 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 111.44 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 95.6 t -71.31 148.19 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.182 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.414 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -117.02 -49.76 2.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.684 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -111.22 175.17 5.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.629 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.438 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 7.1 p -165.6 128.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.038 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 71.88 1.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.49 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -170.21 148.53 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.746 -179.335 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -155.39 -174.31 4.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.588 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.78 78.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.326 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.38 45.72 0.13 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.645 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 20.0 p-10 -130.81 170.65 14.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.899 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 6.0 mttt -91.96 114.78 27.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.528 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.457 HG22 ' CD2' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -131.13 160.26 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.696 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.09 148.53 35.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.965 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 27.3 tt0 -47.44 99.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 99.47 66.33 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.359 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -128.88 29.08 4.03 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.76 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.9 tp 42.84 74.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 1.4 mt -66.75 -76.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.955 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 17.0 m -129.02 148.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 0.0 111.77 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 67.7 t -101.47 142.32 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.922 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.432 ' CG1' HD12 ' A' ' 29' ' ' ILE . 2.4 t -125.73 153.4 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.253 0.549 . . . . 0.0 112.08 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 3.2 tt0 -102.61 45.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.848 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HA ' ' C ' ' A' ' 52' ' ' ALA . . . -39.94 152.55 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.665 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER 48.01 46.03 19.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.978 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.5 113.53 4.68 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.548 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.2 p -62.09 153.63 29.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.313 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.151 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.414 ' N ' HD21 ' A' ' 2' ' ' LEU . 0.4 OUTLIER -77.32 171.86 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 4.3 t -128.4 162.1 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.5 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 45.5 mt-10 -124.34 89.86 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.426 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -50.63 151.27 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.975 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.23 150.23 43.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.445 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 91.7 t -48.02 141.11 8.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.89 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 60.0 Cg_endo -73.13 -166.69 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.318 2.012 . . . . 0.0 112.667 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 45' ' ' MET . 1.2 m-20 -95.43 79.05 3.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -82.18 57.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.914 0.388 . . . . 0.0 111.184 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.87 -86.91 0.52 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.611 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.84 38.13 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.547 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.405 ' NE2' HG23 ' A' ' 40' ' ' THR . 4.6 p-80 -150.11 179.97 7.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.833 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -110.49 -169.96 1.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.201 0.524 . . . . 0.0 111.077 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' GLU . 7.4 p30 46.01 71.09 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.57 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.435 ' CG2' HG21 ' A' ' 66' ' ' ILE . 24.1 m -121.93 -170.8 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.13 124.57 37.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 111.541 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 11.6 mt -61.0 163.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.834 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.468 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -127.68 -12.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.956 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.72 154.43 38.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.379 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.438 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 11.0 p -146.32 115.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.216 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -119.46 -30.69 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.344 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.427 ' CG1' HG12 ' A' ' 73' ' ' VAL . 11.6 m -64.19 129.07 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.92 0.39 . . . . 0.0 111.259 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -139.48 12.74 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' CG2' HG13 ' A' ' 58' ' ' VAL . 85.6 t 63.03 118.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.29 8.6 35.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.62 148.28 25.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.33 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.1 m -81.85 106.19 13.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.442 ' CD1' HG22 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -93.31 155.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.514 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.33 -177.66 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.785 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 16.6 t -90.26 44.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 2.1 p30 163.75 70.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.352 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -148.33 119.8 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.697 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -56.31 114.92 2.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 0.0 111.35 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.403 ' O ' HG21 ' A' ' 36' ' ' ILE . 87.5 mt -88.72 -43.76 11.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.32 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.469 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -152.62 -178.51 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.214 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.441 ' CG2' ' CD1' ' A' ' 19' ' ' ILE . 55.0 m -144.17 120.81 11.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.44 ' CA ' HG22 ' A' ' 19' ' ' ILE . 4.3 mp -112.3 166.54 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.143 0.497 . . . . 0.0 111.737 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.448 ' N ' HG23 ' A' ' 10' ' ' ILE . 80.4 tt0 -168.38 161.82 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.727 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 3.5 p -120.32 -58.35 1.86 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -179.54 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.817 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -12.57 13.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.534 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.29 137.78 30.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.977 0.418 . . . . 0.0 111.465 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -120.96 127.98 52.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.435 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.425 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -120.01 -166.31 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.146 0.498 . . . . 0.0 111.795 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -179.28 172.96 1.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.434 ' CG1' HD12 ' A' ' 5' ' ' LEU . 95.8 t -126.65 113.7 22.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 121.174 -0.21 . . . . 0.0 111.377 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 57.4 Cg_endo -90.28 30.64 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.11 2.54 . . . . 0.0 112.427 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 56.17 164.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 26.2 tt0 -160.61 46.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' CG2' ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -173.16 161.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -120.71 86.58 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA2' ' N ' ' A' ' 77' ' ' ALA . . . -160.58 -140.4 2.88 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.152 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -130.39 140.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.609 0.242 . . . . 0.0 111.081 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 53.7 t -77.04 139.28 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.313 0.577 . . . . 0.0 111.396 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -107.66 -48.63 3.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.228 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 29.0 mt-10 -111.11 166.11 11.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.365 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.426 HG13 ' CG2' ' A' ' 25' ' ' VAL . 6.4 p -154.81 114.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.389 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -128.97 74.81 1.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -174.73 150.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.615 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.423 ' N ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -172.56 128.6 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -47.09 102.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.35 25.79 2.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.726 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.427 ' OD1' ' CD1' ' A' ' 18' ' ' ILE . 21.5 p-10 -121.11 175.81 5.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.42 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -97.98 147.77 24.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.439 ' CG2' HG13 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -141.3 167.54 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.2 p -144.95 51.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.433 ' CG ' HD12 ' A' ' 10' ' ' ILE . 98.8 mt-10 40.72 50.17 2.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.801 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.438 ' N ' ' HB ' ' A' ' 7' ' ' VAL . . . 144.01 71.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.47 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.82 33.0 4.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.717 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.2 tp 44.21 56.9 4.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 3.4 mt -46.31 -83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.312 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.466 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 33.8 m -120.29 164.9 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.113 0.483 . . . . 0.0 111.951 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 59.1 t -132.34 117.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.944 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.484 ' CG2' ' CG2' ' A' ' 51' ' ' VAL . 28.0 m -108.31 157.68 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -68.08 -35.29 77.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.075 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . 58.35 139.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.125 0.488 . . . . 0.0 112.038 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' ALA . 14.9 pt-20 37.78 42.25 0.39 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.909 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.84 117.63 2.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.536 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.8 p 50.62 33.99 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.747 0.308 . . . . 0.0 110.86 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.12 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.72 0.295 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mp -92.87 176.59 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.784 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 2.6 t -141.04 161.44 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.746 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 4.3 mp0 -135.9 121.27 19.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.4 HD21 ' CG2' ' A' ' 73' ' ' VAL . 1.3 tp -73.46 154.23 40.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -149.59 59.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 67.2 t 60.83 145.62 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 33.5 Cg_endo -67.99 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.621 1.547 . . . . 0.0 112.77 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER 166.6 56.83 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.736 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.481 ' N ' ' CD1' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -37.79 -31.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.056 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.02 40.7 10.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.563 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.84 -42.09 0.13 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.292 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 170.97 164.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.896 0.379 . . . . 0.0 110.873 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 2.2 mt-10 -82.06 64.49 6.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 110.351 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 1.9 p30 176.97 85.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.637 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' CG2' HD22 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -147.46 145.29 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.332 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.74 145.57 40.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.339 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 6.1 mt -71.77 163.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.564 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.461 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -132.27 -4.25 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.626 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -155.68 151.62 27.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.27 . . . . 0.0 110.928 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HA ' HG21 ' A' ' 36' ' ' ILE . 11.1 p -137.9 134.04 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.466 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -155.17 25.48 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.429 ' CG2' HG22 ' A' ' 58' ' ' VAL . 3.1 m -117.46 122.91 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -133.89 11.76 3.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.485 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 85.4 t 60.63 120.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.51 35.11 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.982 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.4 146.72 27.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -69.85 132.89 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.423 ' CD1' HG22 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -124.25 143.58 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.57 -173.73 2.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.85 39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.361 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p30 168.19 64.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.673 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -140.85 114.3 8.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.77 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.98 115.72 2.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 111.496 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 33.5 mt -91.25 -32.07 15.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.426 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -162.77 -177.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.934 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.443 ' HB ' HG13 ' A' ' 19' ' ' ILE . 60.7 m -141.92 122.33 14.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 109.901 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.479 HD22 ' CG2' ' A' ' 10' ' ' ILE . 2.2 tp -102.99 167.83 9.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.432 ' CB ' HG23 ' A' ' 19' ' ' ILE . 2.1 tm-20 -167.72 166.43 13.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.44 ' CG2' ' CG1' ' A' ' 10' ' ' ILE . 5.5 p -124.76 -59.39 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.682 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.0 t70 -171.84 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.51 -29.61 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.22 131.75 56.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 111.374 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.429 ' CG2' ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -115.41 138.54 50.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.411 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -126.89 -178.33 4.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.408 . . . . 0.0 111.332 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.6 p30 -167.29 162.45 14.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.649 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.434 ' CG2' HD12 ' A' ' 36' ' ' ILE . 89.4 t -113.67 109.75 50.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.0 Cg_endo -88.82 43.53 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.098 2.532 . . . . 0.0 111.823 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 54.35 171.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.706 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 5.3 pt-20 -156.09 33.03 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.449 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -172.37 170.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.144 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -121.97 86.01 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.75 -134.38 1.66 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.018 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 76' ' ' GLU . 91.3 t -135.12 141.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 57.4 t -74.4 143.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.349 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -111.2 -47.62 3.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.45 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 22.9 mt-10 -113.32 172.15 7.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.664 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 7.5 p -160.57 119.6 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.5 mttm -134.81 62.72 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.575 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -169.12 149.94 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.438 ' N ' HG21 ' A' ' 60' ' ' VAL . 10.9 mttm -140.67 -169.74 2.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.57 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.49 42.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.086 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.52 71.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.553 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 4.1 p-10 -156.7 145.06 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 110.991 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 131.53 45.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.463 ' CG2' HD23 ' A' ' 38' ' ' LEU . 1.2 tp -135.64 178.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 66' ' ' ILE . 2.4 m -155.43 118.17 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.565 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -38.46 91.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.636 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 127.35 49.17 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.938 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -112.3 -121.16 3.9 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.601 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -157.58 44.37 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.376 0.608 . . . . 0.0 109.663 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 7.1 mt -40.63 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.041 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 20.7 m -131.66 143.96 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.166 0.508 . . . . 0.0 112.317 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 61.8 t -108.08 140.31 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.137 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.165 0.507 . . . . 0.0 112.156 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' VAL . 3.9 tt0 -75.42 -39.34 59.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.07 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.451 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . 59.6 132.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 112.067 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ALA . 25.4 pt-20 38.87 31.32 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.796 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 81' ' ' ALA . . . 42.8 85.8 0.01 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.842 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.3 p -57.43 85.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' GLY . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.138 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.803 0.335 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.91 172.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.993 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.477 ' CG2' ' CG1' ' A' ' 51' ' ' VAL . 4.1 t -140.71 161.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.47 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 1.6 mp0 -142.73 101.36 3.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 72' ' ' ILE . 2.4 mm? -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.093 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' CB ' ' HA3' ' A' ' 69' ' ' GLY . 1.9 mttt -134.16 64.18 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 111.746 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 45.4 t 59.83 139.46 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.345 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 39.4 Cg_endo -72.65 -166.59 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.107 1.871 . . . . 0.0 112.817 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.68 72.24 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.339 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.437 ' CG2' HD22 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -65.58 -12.34 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.491 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 45.35 67.14 1.3 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.897 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.16 -59.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.291 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.3 p80 170.28 171.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.696 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -67.23 177.49 1.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 1.2 p-10 44.49 85.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 38' ' ' LEU . 20.5 m -123.23 159.8 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.877 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -92.68 128.4 38.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.177 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 6.9 mt -77.84 161.29 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.26 -41.66 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.393 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HB1' ' N ' ' A' ' 37' ' ' THR . . . -116.94 157.77 25.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HA ' HG21 ' A' ' 36' ' ' ILE . 10.4 p -157.24 115.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -135.85 72.32 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.417 HG12 ' CG1' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -146.49 118.92 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -119.89 18.79 12.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.175 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.435 ' CG2' HG13 ' A' ' 58' ' ' VAL . 74.0 t 66.07 -86.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.949 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 60.65 1.41 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.833 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 162.99 25.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -87.6 120.53 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.438 HD11 ' CG1' ' A' ' 75' ' ' VAL . 1.1 pt -115.5 137.33 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.94 -169.01 1.88 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.64 43.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.167 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 p30 171.84 68.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 1.1 p-10 -147.55 102.09 3.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -48.5 117.62 2.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.477 . . . . 0.0 111.582 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 22' ' ' GLU . 32.6 mt -91.83 -37.79 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.713 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' CD1' ' HB ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -155.17 -160.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.963 179.135 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.485 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 94.4 m -161.3 38.13 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.83 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.437 HD22 ' CG2' ' A' ' 10' ' ' ILE . 2.7 tp -31.87 152.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.088 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 40' ' ' THR . 52.8 tt0 -168.95 157.89 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 3.9 p -123.9 -58.01 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.3 m-20 174.78 -34.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.699 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.85 -35.24 26.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.63 157.52 35.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.962 0.41 . . . . 0.0 111.426 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -114.97 119.87 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.393 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.43 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -112.86 141.93 46.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.629 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 15.3 p-10 -126.88 174.97 8.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.648 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 36' ' ' ILE . 63.2 t -141.86 120.17 7.7 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.919 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 82.9 Cg_endo -90.79 31.33 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.978 2.452 . . . . 0.0 112.179 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 49.4 99.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.071 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -91.89 66.55 5.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 0.0 110.649 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -170.47 151.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.411 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -121.5 76.2 1.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.652 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.45 -124.93 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.106 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.6 t -143.79 138.57 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.496 0.188 . . . . 0.0 111.242 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 60.1 t -79.64 150.9 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.211 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -120.3 -44.97 2.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.344 178.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -108.9 165.99 11.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.435 HG13 ' CG2' ' A' ' 25' ' ' VAL . 7.6 p -157.78 118.21 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.288 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 72' ' ' ILE . 6.0 mttt -133.81 71.71 1.46 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.627 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -175.22 160.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -164.9 -161.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.811 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.7 t -108.45 71.28 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.82 43.43 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.674 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -136.41 172.32 13.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -97.55 131.89 43.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.787 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.453 HG21 ' CG2' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -139.14 151.35 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.882 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.9 OUTLIER -140.63 140.22 34.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.328 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 3.3 mp0 -40.54 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 6' ' ' LYS . . . 116.68 57.08 0.31 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.965 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.66 12.79 8.26 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.105 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 6.2 tp 48.51 57.75 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 0.0 110.884 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.455 HD13 ' CA ' ' A' ' 7' ' ' VAL . 2.8 mt -53.88 -70.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.076 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.417 ' CG1' HG12 ' A' ' 23' ' ' VAL . 18.3 m -131.65 151.26 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.747 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 71' ' ' LEU . 20.3 t -122.3 134.54 65.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.959 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 27.7 m -123.32 175.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -86.6 -40.85 14.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' CG ' ' A' ' 78' ' ' GLU . . . 57.71 125.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.929 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 52' ' ' ALA . 7.8 pt-20 45.81 40.66 6.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.167 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.15 -65.25 2.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.3 p -88.32 158.06 18.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.205 -0.903 . . . . 0.0 111.046 179.963 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.784 0.326 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mt 56.55 175.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 4.8 t -152.6 160.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 18.0 mp0 -138.63 108.84 6.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.61 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.43 HD13 ' CG1' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -68.14 176.55 2.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.754 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -157.73 162.83 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.306 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 86.1 t -51.9 147.97 11.36 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.635 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 7' ' ' VAL . 17.0 Cg_exo -66.76 -156.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.084 1.856 . . . . 0.0 112.671 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -120.84 53.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 40' ' ' THR . 0.4 OUTLIER -46.44 -25.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.94 -179.145 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' N ' HD11 ' A' ' 10' ' ' ILE . . . 87.96 -41.0 3.06 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.882 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.82 -89.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.695 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -169.74 -172.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.61 176.34 2.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.778 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 44.0 78.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.351 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.448 ' CG2' ' CD2' ' A' ' 38' ' ' LEU . 33.6 m -122.36 160.5 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.47 118.19 32.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.253 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CD1' HG21 ' A' ' 60' ' ' VAL . 8.9 mt -60.12 162.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.449 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -121.55 -41.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.135 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB1' ' N ' ' A' ' 37' ' ' THR . . . -115.53 164.28 14.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' CG2' ' CA ' ' A' ' 62' ' ' VAL . 27.9 t -145.25 138.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -159.28 41.8 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -141.28 116.17 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.02 13.86 3.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.345 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 91.5 t 62.72 124.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.44 -23.3 18.37 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.13 138.74 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -73.77 103.58 4.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.791 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 53' ' ' GLY . 4.0 pt -76.55 147.95 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.273 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . . . -128.19 -173.24 2.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.71 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.18 39.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.949 0.404 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.35 64.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.669 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.403 ' OD2' ' CB ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -138.86 101.47 4.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.718 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -47.15 115.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 111.535 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.419 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 16.7 mt -89.42 -38.07 14.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.678 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -162.06 179.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.634 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.447 ' HB ' HG12 ' A' ' 19' ' ' ILE . 62.1 m -144.03 53.82 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.468 0.651 . . . . 0.0 110.207 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.448 ' CD2' ' CG2' ' A' ' 16' ' ' VAL . 4.4 tp -38.13 154.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.243 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 8.0 tm-20 -160.4 117.88 2.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.743 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.448 ' CG2' ' HB ' ' A' ' 10' ' ' ILE . 53.1 p -70.94 -85.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' N ' ' OG1' ' A' ' 40' ' ' THR . 10.5 p30 -153.0 23.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -177.28 -43.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.709 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.85 125.66 50.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.022 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.427 ' CG2' ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -111.66 118.49 35.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.044 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -112.9 153.44 27.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -136.55 165.44 25.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.43 ' CG1' HD13 ' A' ' 5' ' ' LEU . 79.0 t -127.54 119.28 21.6 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.7 Cg_endo -90.39 30.6 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.131 2.554 . . . . 0.0 112.466 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.403 ' CB ' ' OD2' ' A' ' 33' ' ' ASP . . . 50.34 99.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 2.4 mp0 -91.64 62.27 4.44 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 1.3 p 161.75 144.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.381 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -91.28 -173.49 3.63 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.476 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 117.13 -146.94 18.88 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.634 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' O ' ' CE ' ' A' ' 56' ' ' LYS . 63.2 t -143.19 140.42 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 HG21 ' CG2' ' A' ' 29' ' ' ILE . 59.0 t -76.13 144.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.229 0.538 . . . . 0.0 111.94 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -114.78 -50.16 2.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.946 178.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 23.5 mt-10 -110.47 173.36 6.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.174 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 7.5 p -164.14 123.87 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -132.96 67.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -170.86 150.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.892 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' N ' HG21 ' A' ' 60' ' ' VAL . 7.7 mmtt -130.86 -163.85 1.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.492 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.456 ' CA ' ' CG2' ' A' ' 21' ' ' VAL . 9.0 p -99.63 36.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.046 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.83 65.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.513 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.5 161.97 33.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.991 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -73.61 113.34 10.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.439 HG21 ' CG2' ' A' ' 7' ' ' VAL . 1.1 tp -129.44 166.58 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.253 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.409 ' N ' HG21 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -145.13 137.73 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.271 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 5.1 mp0 -40.23 106.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 90.22 69.16 1.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.288 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.97 24.39 4.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.707 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 6.1 tp 48.38 79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -73.19 -73.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.161 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 18.4 m -130.28 145.3 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 83.5 t -107.02 134.99 47.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.845 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.471 ' CG2' ' CD1' ' A' ' 29' ' ' ILE . 12.6 m -123.63 171.6 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.183 0.515 . . . . 0.0 112.3 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -79.3 -24.56 42.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . 84.39 -178.43 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.01 95.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.397 . . . . 0.0 110.907 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.92 -70.65 1.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.583 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -160.14 -177.53 6.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.854 0.359 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.124 179.944 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.801 0.334 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.12 170.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 25.5 t -151.6 159.2 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.472 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -135.37 99.31 4.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.344 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.0 mt -62.37 132.23 51.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.589 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -128.12 73.35 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.484 ' HB ' ' HA ' ' A' ' 68' ' ' GLU . 72.0 t 58.55 149.27 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.625 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' CD ' ' CG1' ' A' ' 7' ' ' VAL . 0.9 OUTLIER -83.17 -157.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.866 2.377 . . . . 0.0 112.216 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.64 99.4 9.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.473 ' O ' ' CE1' ' A' ' 13' ' ' HIS . 1.2 pp -111.08 68.82 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.28 -7.16 65.0 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.924 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.16 3.89 81.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.94 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.473 ' CE1' ' O ' ' A' ' 10' ' ' ILE . 51.9 p-80 -109.18 177.32 4.79 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.84 0.353 . . . . 0.0 110.97 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.431 ' HB2' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -103.4 -172.36 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.165 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 14' ' ' GLU . 8.3 p30 47.93 86.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.615 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.429 HG12 ' CD1' ' A' ' 10' ' ' ILE . 10.5 m -137.94 -155.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.125 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.93 138.24 20.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.979 0.418 . . . . 0.0 111.393 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 19' ' ' ILE . 7.8 mt -76.99 162.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.847 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.471 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -133.52 -9.62 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.887 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB2' ' N ' ' A' ' 37' ' ' THR . . . -149.55 149.06 30.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.473 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 36' ' ' ILE . 89.6 t -140.71 121.66 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -142.39 28.39 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -117.76 125.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -137.28 11.56 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 89.9 t 62.33 127.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -21.9 22.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -77.67 152.28 33.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 m -84.06 121.3 27.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' CD1' HG22 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -108.46 153.54 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.81 -176.1 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.863 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.66 47.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 166.85 74.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 0.9 OUTLIER -160.46 117.72 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.97 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.44 117.9 5.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 63.0 mt -93.1 -44.95 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.466 ' C ' ' CD1' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -153.13 -179.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.738 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.432 ' N ' ' HB2' ' A' ' 20' ' ' ALA . 2.7 m -133.05 145.66 51.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.993 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 ' HB3' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -127.11 -172.54 2.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -172.19 172.7 4.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.427 HG21 ' HB ' ' A' ' 10' ' ' ILE . 1.2 p -142.25 -157.35 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 -19.69 65.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.864 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -172.79 53.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -173.47 134.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.24 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -107.71 153.86 22.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -172.07 4.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.17 174.11 2.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 8' ' ' PRO . 96.9 t -126.38 123.46 24.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.267 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.5 Cg_endo -90.76 29.93 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 0.0 112.23 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . 46.72 93.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.469 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.35 61.74 3.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.449 HG23 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.45 149.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.142 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -116.52 75.0 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.9 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' HA2' ' N ' ' A' ' 77' ' ' ALA . . . -163.77 -132.22 1.32 Allowed Glycine 0 C--N 1.317 -0.478 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.752 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 86.8 t -137.26 138.95 44.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.751 -0.225 . . . . 0.0 110.959 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' CG1' ' A' ' 75' ' ' VAL . 58.6 t -74.3 146.5 9.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.368 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.45 -46.1 2.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.57 178.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -113.89 173.95 6.17 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.694 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.8 116.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.374 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -134.14 79.42 1.81 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -174.62 152.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.209 0.528 . . . . 0.0 111.029 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -138.79 173.34 11.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.484 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.422 ' N ' HG22 ' A' ' 21' ' ' VAL . 11.8 p -92.38 52.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.065 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.28 52.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.9 p-10 -129.98 -175.66 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.767 0.317 . . . . 0.0 110.973 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -105.95 149.78 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.434 ' CG1' HG23 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -138.34 170.84 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.434 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 1.5 p -154.59 49.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.484 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 85.8 mt-10 39.9 63.68 1.01 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.643 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 146.83 68.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.62 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.27 17.61 6.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.747 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.435 ' CD1' ' HB2' ' A' ' 4' ' ' GLU . 10.2 tp 45.06 50.46 9.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.066 0.46 . . . . 0.0 110.73 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 73' ' ' VAL . 3.8 mt -45.05 -83.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.466 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.465 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 24.1 m -120.95 145.07 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.985 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 87.8 t -114.38 138.89 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.605 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG1' ' CG2' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -131.77 174.32 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.94 -33.31 22.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.572 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' N ' ' HA2' ' A' ' 53' ' ' GLY . . . 54.06 162.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.645 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 52' ' ' ALA . 4.0 mt-10 69.63 -67.95 0.21 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.588 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.401 ' O ' ' CG2' ' A' ' 80' ' ' THR . . . 127.35 118.19 2.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.632 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 79' ' ' GLY . 60.5 p -159.33 35.3 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.823 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.108 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 76' ' ' GLU . 1.2 mp . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.812 0.339 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.8 ' HB ' HG11 ' A' ' 51' ' ' VAL . 5.9 t -149.36 161.99 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.589 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -134.38 106.88 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.93 HD11 HG11 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -51.87 -176.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.264 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 2.4 mttp -164.62 142.78 6.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.78 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.838 HG22 HD11 ' A' ' 72' ' ' ILE . 67.8 t -49.17 138.38 14.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.6 ' CG ' HD13 ' A' ' 38' ' ' LEU . 53.2 Cg_endo -72.7 -167.05 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.356 2.037 . . . . 0.0 112.92 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.67 69.13 3.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.976 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.879 ' HB ' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 67' ' ' SER . 1.3 pt-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.883 0.373 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 8.1 p-10 44.73 69.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.811 HG11 HG12 ' A' ' 10' ' ' ILE . 20.0 m -125.97 124.91 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.32 122.97 20.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.706 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.684 HD13 HG23 ' A' ' 60' ' ' VAL . 3.6 mt -62.12 164.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.577 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.691 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -126.53 -13.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.845 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -153.14 144.66 23.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.351 . . . . 0.0 111.372 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.812 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.4 p -145.13 122.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.218 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 2.5 pt-20 -140.09 47.72 1.8 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.778 HG21 HG11 ' A' ' 73' ' ' VAL . 8.2 m -144.71 123.37 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.266 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -128.42 18.62 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 56' ' ' LYS . 95.0 t 65.4 112.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.36 -21.28 5.75 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.499 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -81.41 147.59 29.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.3 m -71.81 155.9 39.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.945 HD13 HG23 ' A' ' 51' ' ' VAL . 1.7 pp -144.19 144.28 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.214 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.72 -179.06 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.03 48.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.3 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 p30 163.65 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.523 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 8.1 p-10 -155.29 115.47 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -50.66 117.29 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.153 0.501 . . . . 0.0 111.488 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 36' ' ' ILE . 13.8 mt -87.58 -43.6 11.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.009 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -158.06 -180.0 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.314 0.578 . . . . 0.0 111.86 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.645 ' O ' HG23 ' A' ' 19' ' ' ILE . 99.9 m -140.05 117.49 11.42 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.732 HD22 HG13 ' A' ' 7' ' ' VAL . 5.9 mp -111.61 171.83 7.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.023 0.44 . . . . 0.0 112.187 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.619 ' HB2' HG22 ' A' ' 44' ' ' THR . 49.4 tt0 -172.06 157.91 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.643 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.879 HG22 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.55 -89.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.904 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.444 ' H ' HG23 ' A' ' 40' ' ' THR . 0.3 OUTLIER -150.26 21.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.741 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.71 -43.44 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.07 169.54 19.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 39' ' ' GLU . 71.6 p -108.5 115.93 31.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.493 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -101.1 -175.82 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.161 0.505 . . . . 0.0 111.534 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 1.2 p30 -172.92 170.43 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.241 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.93 HG11 HD11 ' A' ' 5' ' ' LEU . 97.3 t -126.35 124.51 24.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.813 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.2 Cg_endo -88.71 27.03 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.975 2.45 . . . . 0.0 112.702 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.724 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.67 150.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.304 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.571 ' C ' HG22 ' A' ' 51' ' ' VAL . 44.0 tt0 -149.35 70.62 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.476 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.945 HG23 HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -178.33 -178.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.494 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.28 67.79 1.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.818 0.342 . . . . 0.0 111.838 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.48 -134.84 1.75 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.115 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 76' ' ' GLU . 88.5 t -126.23 144.4 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.61 0.243 . . . . 0.0 111.183 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.683 HG22 HG12 ' A' ' 75' ' ' VAL . 95.2 t -76.56 145.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.152 0.501 . . . . 0.0 111.303 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.49 -46.92 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.556 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.63 175.3 5.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.498 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HA ' HG12 ' A' ' 73' ' ' VAL . 8.6 p -165.37 119.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -132.36 66.41 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.587 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.718 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -172.82 156.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.694 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -170.97 -159.93 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.737 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.723 HG23 HG12 ' A' ' 21' ' ' VAL . 59.6 t -112.07 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.54 -15.72 3.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.57 163.77 12.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.044 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -101.08 148.62 24.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.664 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.693 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.3 tp -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.477 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 14' ' ' GLU . 6.9 m -142.97 138.32 30.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 111.272 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.489 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 95.0 mt-10 -39.57 115.66 0.54 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 70.17 74.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.221 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -137.64 31.64 2.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.447 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 4' ' ' GLU . 13.7 tp 49.06 95.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.982 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.838 HD11 HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -95.2 -74.86 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.654 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 23' ' ' VAL . 19.7 m -125.05 136.93 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 111.787 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 3' ' ' VAL . 61.9 t -104.96 141.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.097 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.887 HG21 HG21 ' A' ' 51' ' ' VAL . 33.1 m -127.62 171.47 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.244 0.545 . . . . 0.0 112.362 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.458 ' HA ' HD23 ' A' ' 2' ' ' LEU . 1.8 tm-20 -84.49 -39.37 18.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.293 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.246 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.916 0.389 . . . . 0.0 111.074 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.755 ' O ' HG13 ' A' ' 74' ' ' VAL . 30.7 t -136.3 159.3 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.581 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -134.67 108.61 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.999 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.981 HD21 HG11 ' A' ' 47' ' ' VAL . 2.9 tp -63.39 161.07 14.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.454 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HG2' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -146.44 139.52 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.767 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 72' ' ' ILE . 96.9 t -42.12 141.21 1.42 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.139 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.676 ' CD ' HD23 ' A' ' 38' ' ' LEU . 61.1 Cg_endo -75.37 -169.36 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.436 2.091 . . . . 0.0 113.102 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 45' ' ' MET . 5.2 t0 -83.95 94.56 8.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.956 HG12 HG21 ' A' ' 16' ' ' VAL . 1.1 pp . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.076 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.02 0.438 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 6.5 p-10 46.01 94.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.434 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.956 HG21 HG12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -137.82 166.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 64' ' ' ASP . 82.4 m-20 -97.87 133.1 42.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.658 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.111 HD13 HG23 ' A' ' 60' ' ' VAL . 8.6 mt -74.76 163.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.896 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.715 HG23 ' C ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -131.04 -8.75 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.736 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -151.09 150.18 30.39 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 36' ' ' ILE . 80.0 t -142.03 120.39 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.844 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -146.41 59.48 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.981 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.937 HG11 HG11 ' A' ' 73' ' ' VAL . 2.0 m -140.01 115.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.432 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 1.6 t30 -93.99 12.23 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.44 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 25' ' ' VAL . 5.4 p 43.04 63.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.487 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.09 45.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.476 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -136.71 173.25 11.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.996 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.6 m -79.17 132.91 36.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.761 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.602 HD13 HG11 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -127.5 150.33 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.31 178.82 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 51' ' ' VAL . 4.0 t -87.96 47.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.61 70.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.546 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.51 100.42 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.483 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -42.98 115.22 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.197 0.523 . . . . 0.0 111.774 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.633 HD12 HD22 ' A' ' 5' ' ' LEU . 23.6 mt -87.16 -50.16 6.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.914 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -149.41 -178.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 111.73 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.715 ' C ' HG23 ' A' ' 19' ' ' ILE . 3.5 m -131.96 130.69 41.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.669 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.69 HD11 HG12 ' A' ' 18' ' ' ILE . 1.9 mm? -116.04 165.15 13.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.799 0.333 . . . . 0.0 110.826 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.737 ' CD ' HG22 ' A' ' 44' ' ' THR . 48.9 tt0 -178.21 164.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.854 HG22 HG11 ' A' ' 16' ' ' VAL . 3.5 p -121.28 -59.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.684 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.3 t0 -172.68 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -109.64 -36.8 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.033 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.74 141.38 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.737 HG22 ' CD ' ' A' ' 39' ' ' GLU . 1.4 p -126.9 130.14 49.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.43 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -117.25 -164.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.287 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 22.5 p-10 -179.66 172.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.981 HG11 HD21 ' A' ' 5' ' ' LEU . 78.8 t -121.15 116.8 30.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.81 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.4 Cg_endo -86.63 18.56 1.55 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.993 2.462 . . . . 0.0 112.7 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.1 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.875 0.369 . . . . 0.0 111.551 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -110.6 70.69 0.72 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.758 HG11 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.35 -172.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.116 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.59 63.77 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.661 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.53 -124.38 0.74 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.243 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.1 t -139.96 138.17 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.473 0.178 . . . . 0.0 111.165 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.771 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.2 t -75.04 145.02 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.114 0.483 . . . . 0.0 111.476 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HE2' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -115.54 -44.24 2.98 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.497 178.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 17.8 mt-10 -115.06 174.24 6.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.606 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 58' ' ' VAL . 15.0 p -160.86 122.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.363 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -134.19 74.62 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.749 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.111 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.58 148.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.491 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -143.85 -166.26 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.984 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 21' ' ' VAL . 59.6 t -106.71 86.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.09 18.99 4.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.564 ' CG ' HD12 ' A' ' 18' ' ' ILE . 5.3 p-10 -99.85 171.71 7.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.794 0.33 . . . . 0.0 110.662 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.97 123.35 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.933 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -122.44 167.17 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.4 p -151.28 141.13 21.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 26.0 mt-10 -42.9 95.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.204 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 100.37 61.46 0.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.393 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.31 20.18 23.65 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 4' ' ' GLU . 11.2 tp 49.92 50.01 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.796 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.891 HG22 HG13 ' A' ' 73' ' ' VAL . 4.3 mt -48.07 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.256 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.937 HG11 HG11 ' A' ' 23' ' ' VAL . 17.6 m -117.0 141.07 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.148 0.499 . . . . 0.0 112.029 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 3' ' ' VAL . 91.5 t -113.6 131.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.771 ' CG1' HG22 ' A' ' 55' ' ' VAL . 27.8 m -121.95 169.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.772 ' HA ' HD23 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -78.61 -36.46 44.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.607 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.176 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.894 0.378 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.053 HG21 HG11 ' A' ' 51' ' ' VAL . 6.5 t -148.92 161.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.951 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 74' ' ' VAL . 69.0 mt-10 -133.39 115.29 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.198 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.714 ' CD1' HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -73.45 160.8 31.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -147.34 150.09 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 111.405 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.688 HG22 HD11 ' A' ' 72' ' ' ILE . 84.0 t -46.05 140.43 4.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.432 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.786 ' CD ' HD23 ' A' ' 38' ' ' LEU . 74.1 Cg_endo -76.38 -166.17 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.592 2.195 . . . . 0.0 112.614 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 45' ' ' MET . 16.5 t70 -94.47 88.74 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.054 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.899 HG12 HG21 ' A' ' 16' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.98 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.973 0.416 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 44.89 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.899 HG21 HG12 ' A' ' 10' ' ' ILE . 34.6 m -143.72 115.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.569 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 128.21 35.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.556 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.783 HD13 HG23 ' A' ' 60' ' ' VAL . 4.2 mt -65.39 164.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.93 -35.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.275 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.71 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -118.59 148.11 43.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.728 ' HA ' HG22 ' A' ' 36' ' ' ILE . 7.8 p -134.9 119.22 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.991 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -146.3 40.09 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.018 HG11 HG11 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -133.72 117.82 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -132.6 12.25 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.377 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 90.0 t 62.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.35 . . . . 0.0 111.085 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.08 -21.54 13.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.779 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.42 139.41 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 111.107 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.2 m -74.76 102.29 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.552 HG12 HG11 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -87.16 153.91 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.38 -174.36 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.841 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.9 t -89.94 42.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.395 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER 163.7 72.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.591 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -148.78 115.16 5.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.78 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.58 115.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.527 . . . . 0.0 111.45 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 36' ' ' ILE . 98.3 mt -88.98 -40.97 12.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.541 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.756 HD13 HD22 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -159.31 -177.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 19' ' ' ILE . 23.2 m -136.04 133.17 37.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.811 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.786 HD23 ' CD ' ' A' ' 8' ' ' PRO . 1.8 mm? -116.11 150.59 37.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.864 0.364 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' OE2' HG22 ' A' ' 44' ' ' THR . 41.7 tt0 -159.91 163.18 34.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.547 ' HB ' HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -133.03 -82.92 0.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.656 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 40' ' ' THR . 12.0 p-10 -143.79 -43.48 0.27 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 42.63 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.65 133.64 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.193 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.54 HG22 ' OE2' ' A' ' 39' ' ' GLU . 10.6 p -129.4 118.48 22.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.449 ' O ' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -117.29 -167.95 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.572 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -177.23 167.62 2.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.13 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.714 HG11 ' CD1' ' A' ' 5' ' ' LEU . 57.8 t -121.85 111.8 32.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.409 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 58.9 Cg_endo -89.64 33.35 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.115 2.544 . . . . 0.0 112.401 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.516 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.57 163.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.96 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.832 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -157.76 44.83 0.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.097 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.053 HG11 HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -173.45 163.37 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.96 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.7 87.92 2.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -162.19 -139.68 2.7 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.939 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.11 136.58 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.737 HG22 ' CG1' ' A' ' 75' ' ' VAL . 59.5 t -72.87 143.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.105 0.478 . . . . 0.0 111.397 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -112.51 -47.69 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.338 178.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.7 mm-40 -112.18 173.38 6.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.626 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -163.14 120.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.306 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.7 mttm -132.05 64.09 1.6 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.533 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.783 HG23 HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -173.05 151.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.672 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -173.99 175.52 2.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.658 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 62' ' ' VAL . 58.1 t -79.22 68.34 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.43 55.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.893 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 10.7 p-10 -173.15 132.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -76.28 119.76 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.7 tp -104.6 172.74 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.8 m -144.13 137.66 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.471 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 72.4 mt-10 -40.48 130.52 2.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.0 61.73 3.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.037 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.27 129.05 5.44 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.131 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -53.06 94.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 110.584 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.766 HG23 ' CG1' ' A' ' 60' ' ' VAL . 1.3 mt -92.45 -78.83 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.018 HG11 HG11 ' A' ' 23' ' ' VAL . 19.6 m -126.77 137.6 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.0 111.873 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 3' ' ' VAL . 85.3 t -108.77 136.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.782 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.737 ' CG1' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -126.06 167.52 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.212 0.529 . . . . 0.0 112.32 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . 3.7 tt0 -71.59 -38.87 70.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.612 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' H ' ' HA3' ' A' ' 53' ' ' GLY . . . . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 121.311 0.577 . . . . 0.0 112.169 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.909 0.385 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.849 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.3 t -142.91 162.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.882 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.797 ' HB3' HD13 ' A' ' 71' ' ' LEU . 2.0 mt-10 -130.86 91.08 3.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.494 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.93 HD11 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -48.41 155.18 0.54 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.784 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.676 ' H ' HD13 ' A' ' 5' ' ' LEU . 10.9 mttm -147.06 150.18 34.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 111.492 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.718 HG21 HG23 ' A' ' 66' ' ' ILE . 91.1 t -50.13 140.75 16.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.628 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.915 ' HD2' HD13 ' A' ' 38' ' ' LEU . 37.8 Cg_endo -68.73 -166.66 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.285 1.99 . . . . 0.0 112.88 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -99.22 69.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.836 HG12 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 4.8 mt-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.171 0.51 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 1.5 p30 169.82 66.75 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.459 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.076 HG11 HG22 ' A' ' 40' ' ' THR . 1.0 OUTLIER -120.0 137.74 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.556 -179.014 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.86 131.88 37.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.972 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.101 HD13 HG23 ' A' ' 60' ' ' VAL . 11.5 mt -67.64 162.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.797 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -125.95 -16.42 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.706 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -145.7 150.36 36.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.803 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.5 p -138.78 129.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -150.23 44.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' CG2' HG23 ' A' ' 58' ' ' VAL . 4.4 m -136.59 124.16 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -135.55 10.32 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.46 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 87.7 t 64.51 118.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.081 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.94 -23.29 8.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.54 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -71.73 165.7 23.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.2 m -100.44 108.87 20.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -93.55 138.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.36 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.14 39.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 168.29 68.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -145.03 123.25 12.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -61.88 116.12 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.279 0.561 . . . . 0.0 111.278 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.452 HD13 ' HG ' ' A' ' 5' ' ' LEU . 49.1 mt -88.33 -43.0 11.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.417 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.803 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -153.94 -178.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.516 179.013 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 19' ' ' ILE . 44.6 m -144.9 123.42 12.43 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.915 HD13 ' HD2' ' A' ' 8' ' ' PRO . 1.2 mp -116.24 -179.37 3.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.864 ' HG3' HG22 ' A' ' 44' ' ' THR . 5.8 tm-20 -174.87 160.04 2.82 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 1.076 HG22 HG11 ' A' ' 16' ' ' VAL . 5.5 p -116.54 -61.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 20.7 m-20 -151.0 -43.28 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -141.4 25.43 2.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.12 98.69 2.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.19 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.864 HG22 ' HG3' ' A' ' 39' ' ' GLU . 17.8 p -93.51 116.26 28.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.62 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.419 ' O ' HG23 ' A' ' 37' ' ' THR . 0.2 OUTLIER -105.83 -176.32 3.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.076 0.465 . . . . 0.0 111.482 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -168.3 167.12 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.342 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.93 HG11 HD11 ' A' ' 5' ' ' LEU . 96.4 t -123.0 115.24 29.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.17 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 77.0 Cg_endo -90.86 35.81 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.047 2.498 . . . . 0.0 112.137 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.542 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.72 175.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.805 ' O ' HG13 ' A' ' 51' ' ' VAL . 15.7 tt0 -162.85 43.31 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.548 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 176.23 167.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.12 89.35 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -163.24 -156.95 8.87 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.006 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' GLU . 81.6 t -113.93 146.28 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.53 0.205 . . . . 0.0 111.246 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.744 HG22 HG12 ' A' ' 75' ' ' VAL . 67.6 t -81.3 144.93 9.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.293 0.568 . . . . 0.0 111.348 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.45 ' HE2' ' CA ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -112.7 -51.27 2.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.193 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.3 mt-10 -106.2 172.92 6.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.672 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.932 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.4 p -166.2 126.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.626 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -147.5 74.22 1.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.101 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -171.3 150.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HE3' HG21 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.42 -163.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.904 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.7 93.32 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.107 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.38 33.86 0.8 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.622 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.68 ' CG ' HD12 ' A' ' 18' ' ' ILE . 12.3 p-10 -129.34 140.96 51.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.43 ' CD ' ' HB2' ' A' ' 15' ' ' ASN . 6.8 mttt -73.22 130.47 40.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.785 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -130.86 170.75 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB3' ' CB ' ' A' ' 14' ' ' GLU . 8.7 m -147.62 135.99 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mp0 -41.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 107.53 62.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.378 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.04 23.03 8.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 4' ' ' GLU . 3.2 tp 45.76 57.22 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.029 0.443 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.781 HG22 HG13 ' A' ' 73' ' ' VAL . 2.9 mt -49.35 -80.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.932 HG12 ' HA ' ' A' ' 58' ' ' VAL . 21.3 m -124.94 157.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.415 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 3' ' ' VAL . 78.4 t -118.46 131.32 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.284 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.744 HG12 HG22 ' A' ' 55' ' ' VAL . 16.8 m -118.36 165.57 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' VAL . 4.5 tp10 -72.4 -38.84 68.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.032 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' H ' ' HA3' ' A' ' 53' ' ' GLY . . . . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 121.151 0.5 . . . . 0.0 111.893 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.667 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.5 mt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.906 0.384 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.804 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.4 t -161.63 159.58 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.731 ' HB3' HD13 ' A' ' 71' ' ' LEU . 2.0 mp0 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.361 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.707 HD11 ' HA ' ' A' ' 49' ' ' ALA . 1.2 mt -59.2 164.82 2.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.748 0.309 . . . . 0.0 110.676 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' C ' HD12 ' A' ' 72' ' ' ILE . 20.3 mttt -143.81 172.41 12.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.58 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.794 HG21 HG23 ' A' ' 66' ' ' ILE . 23.7 t -72.83 140.04 80.72 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.032 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.924 ' HD2' HD13 ' A' ' 38' ' ' LEU . 19.4 Cg_endo -63.32 -166.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 112.86 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.87 ' O ' HD12 ' A' ' 10' ' ' ILE . 24.5 t70 -93.19 -13.35 28.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.463 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 9' ' ' ASP . 1.5 pp . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 11.8 mt-10 . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.885 0.374 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.437 ' N ' ' HB3' ' A' ' 67' ' ' SER . 8.0 p-10 44.33 95.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.507 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.752 HG11 HG22 ' A' ' 40' ' ' THR . 27.1 m -152.49 141.06 14.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.66 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -82.02 130.32 35.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.56 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.976 HD13 HG23 ' A' ' 60' ' ' VAL . 22.0 mt -62.56 164.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.741 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -128.18 -12.47 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.294 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -146.96 158.25 43.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.002 0.429 . . . . 0.0 111.61 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.841 ' HA ' HG22 ' A' ' 36' ' ' ILE . 7.4 p -148.66 123.87 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.078 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -149.07 44.45 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.584 ' CG2' HG23 ' A' ' 58' ' ' VAL . 2.5 m -135.22 120.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -128.95 10.97 6.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.401 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 56' ' ' LYS . 84.6 t 58.84 112.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.2 -15.32 5.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.833 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.97 142.52 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 127.84 33.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.646 HD13 HG23 ' A' ' 51' ' ' VAL . 1.1 pp -108.54 154.7 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.02 179.53 5.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.1 t -85.66 48.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.351 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 164.11 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.59 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.406 ' C ' ' HA ' ' A' ' 48' ' ' PRO . 7.9 p-10 -156.74 99.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.768 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -45.49 117.5 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.147 0.498 . . . . 0.0 111.822 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.557 HD12 ' CD1' ' A' ' 5' ' ' LEU . 20.5 mt -92.79 -42.5 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.389 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.898 HD13 HD12 ' A' ' 38' ' ' LEU . 1.2 pp -148.77 -175.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.057 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 19' ' ' ILE . 32.4 m -149.24 124.55 10.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.924 HD13 ' HD2' ' A' ' 8' ' ' PRO . 2.4 mp -113.2 167.18 10.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.674 ' CG ' HG22 ' A' ' 44' ' ' THR . 70.3 tt0 -161.91 164.15 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.692 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.752 HG22 HG11 ' A' ' 16' ' ' VAL . 6.2 p -121.93 -57.54 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -175.33 -37.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -116.59 -19.3 10.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.622 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.14 148.42 49.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.628 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.674 HG22 ' CG ' ' A' ' 39' ' ' GLU . 1.7 p -131.2 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.478 ' O ' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -121.06 -173.51 2.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.223 0.535 . . . . 0.0 111.675 -179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -168.76 159.35 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.044 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.631 HG11 HD22 ' A' ' 5' ' ' LEU . 54.6 t -123.08 126.67 25.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.356 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 86.5 Cg_endo -89.58 34.13 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.882 2.388 . . . . 0.0 112.325 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HA ' HD11 ' A' ' 5' ' ' LEU . . . 81.64 -51.25 0.26 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.582 ' C ' HG22 ' A' ' 51' ' ' VAL . 5.0 tp10 55.03 56.16 6.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -174.16 -169.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.21 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -156.42 65.9 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 29' ' ' ILE . . . -160.84 -139.7 2.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.129 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.04 135.56 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.386 0.136 . . . . 0.0 110.642 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.715 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.3 t -71.93 144.37 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.293 0.568 . . . . 0.0 111.636 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.54 -47.05 2.74 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.265 178.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -110.28 172.53 6.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.429 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.915 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.2 p -164.81 128.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.873 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -146.06 75.81 1.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.642 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.976 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -172.5 155.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.491 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -161.43 -160.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.774 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 21' ' ' VAL . 61.3 t -110.13 76.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.216 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.52 41.23 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.811 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.807 ' CG ' HD12 ' A' ' 18' ' ' ILE . 16.7 p-10 -128.73 138.63 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.924 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.617 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -72.05 110.71 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.792 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.794 HG23 HG21 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -137.99 168.83 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -152.85 162.7 40.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 111.283 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.445 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -42.19 107.4 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.488 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' 6' ' ' LYS . . . 98.91 70.41 0.96 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.783 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.95 21.35 4.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.373 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 4' ' ' GLU . 1.7 tp 43.52 57.54 3.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.113 0.482 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.823 HG22 HG13 ' A' ' 73' ' ' VAL . 3.7 mt -49.95 -73.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.096 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.915 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.1 m -135.45 145.23 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 3' ' ' VAL . 92.4 t -104.97 136.74 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 51' ' ' VAL . 1.2 m -126.69 167.54 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.0 112.295 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HG3' ' CD2' ' A' ' 2' ' ' LEU . 1.3 mt-10 -101.1 46.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.665 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.335 -0.058 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.768 HG11 HG11 ' A' ' 51' ' ' VAL . 2.7 t -142.86 161.62 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.52 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -136.51 117.59 14.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.401 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.84 HD21 HG11 ' A' ' 47' ' ' VAL . 1.6 tp -68.65 160.81 29.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -143.75 144.42 31.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 111.415 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.63 HG22 HD11 ' A' ' 72' ' ' ILE . 86.8 t -41.19 140.58 1.16 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.035 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.61 ' HD2' HG13 ' A' ' 7' ' ' VAL . 61.0 Cg_endo -75.32 -168.04 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.24 1.96 . . . . 0.0 113.076 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 45' ' ' MET . 0.1 OUTLIER -98.65 83.78 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.952 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.923 ' CG2' HD23 ' A' ' 38' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.895 0.378 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.418 ' CA ' ' O ' ' A' ' 66' ' ' ILE . 5.5 p-10 43.75 78.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.77 HG11 HG22 ' A' ' 40' ' ' THR . 25.1 m -122.26 -178.02 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.433 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -106.59 118.45 36.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.915 0.388 . . . . 0.0 111.401 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.998 HD13 HG23 ' A' ' 60' ' ' VAL . 19.5 mt -55.21 165.29 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.898 HG12 HG22 ' A' ' 37' ' ' THR . 0.6 OUTLIER -136.5 2.99 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.508 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -167.32 152.21 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.297 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.757 ' HA ' HG22 ' A' ' 36' ' ' ILE . 81.2 t -137.26 120.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.759 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -148.42 60.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.926 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.661 HG11 HG11 ' A' ' 73' ' ' VAL . 2.4 m -142.1 113.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -120.94 96.25 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 56' ' ' LYS . 63.3 t -40.21 116.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.56 15.13 7.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.66 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.91 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 m -70.25 146.29 50.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.039 HD13 HG11 ' A' ' 75' ' ' VAL . 2.8 pt -136.69 154.81 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.51 -174.88 3.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG13 ' OE2' ' A' ' 50' ' ' GLU . 11.6 t -91.94 47.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 p30 172.68 67.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.058 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -152.99 108.58 3.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.564 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -46.95 119.12 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.092 0.472 . . . . 0.0 111.874 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 36' ' ' ILE . 21.5 mt -94.52 -39.39 10.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.877 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.11 -177.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.349 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.898 HG22 HG12 ' A' ' 19' ' ' ILE . 70.5 m -142.53 109.11 5.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.743 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.923 HD23 ' CG2' ' A' ' 10' ' ' ILE . 1.8 tp -95.02 155.93 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.679 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.731 ' HB3' HG21 ' A' ' 19' ' ' ILE . 33.6 tt0 -166.31 144.63 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.655 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.798 HG23 ' HB ' ' A' ' 10' ' ' ILE . 3.4 p -104.99 -59.46 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.425 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.7 p30 -174.63 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -124.34 35.75 4.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . 177.25 131.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.252 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.706 HG22 ' CG ' ' A' ' 39' ' ' GLU . 73.6 p -119.21 116.33 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -123.7 128.02 49.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.253 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.434 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 1.0 OUTLIER -113.23 174.47 5.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.757 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.84 HG11 HD21 ' A' ' 5' ' ' LEU . 76.9 t -120.59 116.3 31.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 85.2 Cg_endo -87.37 37.27 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.94 2.427 . . . . 0.0 112.359 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.54 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 46.83 93.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.856 0.36 . . . . 0.0 111.11 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.598 ' C ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -93.38 63.03 3.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.768 HG11 HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER 163.43 148.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.333 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.571 ' O ' HD11 ' A' ' 29' ' ' ILE . . . -96.35 -168.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.368 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 102.14 -146.52 16.98 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.839 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.95 135.4 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.538 0.209 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.588 ' HA ' HG12 ' A' ' 75' ' ' VAL . 61.5 t -68.22 147.05 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.69 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.53 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.67 -50.75 2.4 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.277 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.81 166.32 13.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.409 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 73' ' ' VAL . 5.4 p -152.17 138.56 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.318 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ILE . 6.9 mmtt -140.65 59.35 1.55 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.306 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.998 HG23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -157.47 143.58 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.61 -174.2 4.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.76 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 21' ' ' VAL . 60.5 t -98.04 92.73 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.45 35.57 1.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.628 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.93 ' OD1' HD12 ' A' ' 18' ' ' ILE . 19.6 p-10 -119.13 172.89 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.958 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -96.54 123.06 40.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -129.16 161.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.161 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.9 p -135.42 127.28 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.421 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.47 ' OE2' HD12 ' A' ' 10' ' ' ILE . 42.5 mt-10 -40.91 115.02 0.53 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 88.17 64.65 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.011 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.78 -165.83 11.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.024 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 4' ' ' GLU . 8.5 tp -104.49 89.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.969 0.414 . . . . 0.0 110.372 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.798 HG23 ' CG1' ' A' ' 60' ' ' VAL . 2.1 mt -87.35 -80.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.944 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.787 HG13 HG22 ' A' ' 72' ' ' ILE . 17.4 m -122.41 135.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.064 0.459 . . . . 0.0 111.891 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 3' ' ' VAL . 41.4 t -103.78 144.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.338 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.039 HG11 HD13 ' A' ' 29' ' ' ILE . 10.9 m -129.07 165.41 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.122 0.487 . . . . 0.0 112.008 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 6.3 tt0 -83.73 -26.49 29.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.58 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.075 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.832 0.348 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.754 ' O ' HG13 ' A' ' 74' ' ' VAL . 19.8 t -139.27 146.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 1.3 mp0 -124.34 100.63 6.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.877 ' CD1' HD12 ' A' ' 35' ' ' LEU . 44.1 mt -63.88 131.24 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.72 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.2 mtmt -130.29 55.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.861 HG22 HD11 ' A' ' 72' ' ' ILE . 38.2 t 58.75 147.04 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.442 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.741 ' CD ' HD23 ' A' ' 38' ' ' LEU . 98.8 Cg_endo -94.29 -178.39 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.756 2.304 . . . . 0.0 112.453 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.672 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -64.2 173.69 1.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.012 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 9' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.754 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.175 0.512 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.468 ' N ' ' CB ' ' A' ' 67' ' ' SER . 3.6 p30 44.15 94.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.895 HG11 HG22 ' A' ' 40' ' ' THR . 0.1 OUTLIER -142.64 -176.08 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.372 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -112.06 138.68 48.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.055 HD13 HG23 ' A' ' 60' ' ' VAL . 28.8 mt -73.45 161.91 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 37' ' ' THR . 0.2 OUTLIER -134.62 -7.02 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.929 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -152.85 155.26 36.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.863 ' HA ' HG22 ' A' ' 36' ' ' ILE . 61.5 t -147.57 126.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.313 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -153.3 32.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.484 ' CB ' HG11 ' A' ' 73' ' ' VAL . 2.3 m -122.98 123.46 68.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -135.0 9.76 3.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.492 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 58' ' ' VAL . 87.3 t 63.4 131.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.85 -22.51 18.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.371 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.51 139.03 30.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.7 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -68.16 162.22 25.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 75' ' ' VAL . 1.2 pp -143.73 130.19 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.15 -174.43 4.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.935 0.398 . . . . 0.0 111.008 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 31' ' ' VAL . 11.1 t -90.32 41.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER 168.05 67.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.905 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -141.78 116.62 9.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.867 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -59.65 115.32 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.877 HD12 ' CD1' ' A' ' 5' ' ' LEU . 16.6 mt -90.37 -41.95 11.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.406 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.863 HG22 ' HA ' ' A' ' 21' ' ' VAL . 1.3 pp -150.43 -175.97 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.884 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.79 ' C ' HG23 ' A' ' 19' ' ' ILE . 3.7 m -133.3 152.59 51.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.763 ' CD2' HD13 ' A' ' 36' ' ' ILE . 2.4 mm? -134.45 166.8 22.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.72 ' CD ' HG22 ' A' ' 44' ' ' THR . 76.0 tt0 -174.4 164.07 3.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.401 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.895 HG22 HG11 ' A' ' 16' ' ' VAL . 13.5 p -120.71 -72.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.892 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.466 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.9 m-20 -159.72 25.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.731 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm 176.24 -43.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.65 128.76 45.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.72 HG22 ' CD ' ' A' ' 39' ' ' GLU . 5.2 p -116.71 115.81 26.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.44 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -104.07 -165.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 5.7 p30 -175.69 167.34 3.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.73 HG11 HD13 ' A' ' 5' ' ' LEU . 74.0 t -112.03 104.15 55.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 70.3 Cg_endo -89.35 42.11 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.118 2.545 . . . . 0.0 111.886 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.7 177.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.774 ' O ' HG13 ' A' ' 51' ' ' VAL . 23.1 pt-20 -163.19 38.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 175.74 168.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 29' ' ' ILE . . . -112.27 93.15 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.961 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -165.35 -140.15 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.259 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 76' ' ' GLU . 90.9 t -135.08 145.24 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 0.0 111.065 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 75' ' ' VAL . 63.2 t -75.16 145.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 0.0 111.397 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -47.59 2.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.466 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.92 167.2 10.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.644 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.939 ' HA ' HG12 ' A' ' 73' ' ' VAL . 12.4 p -162.87 124.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.93 80.93 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.055 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.32 151.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.56 -173.87 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.97 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 21' ' ' VAL . 46.3 t -101.31 77.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.7 41.49 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.94 ' OD1' HD12 ' A' ' 18' ' ' ILE . 3.9 p30 -132.8 164.04 27.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.708 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -88.76 105.0 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.18 0.514 . . . . 0.0 110.705 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.734 HG23 HG21 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -132.89 164.61 34.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.369 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.468 ' CB ' ' N ' ' A' ' 15' ' ' ASN . 54.3 p -167.2 168.32 13.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -45.72 91.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.196 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 124.34 57.56 0.18 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.76 9.02 6.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.928 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.467 HD11 ' CG2' ' A' ' 74' ' ' VAL . 4.2 tp 47.25 46.86 16.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.679 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.861 HD11 HG22 ' A' ' 7' ' ' VAL . 9.1 mt -43.26 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.5 m -135.36 147.25 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.51 . . . . 0.0 111.99 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 3' ' ' VAL . 98.5 t -109.84 140.72 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.705 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.599 HG12 HG22 ' A' ' 55' ' ' VAL . 16.4 m -123.16 161.91 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.127 0.489 . . . . 0.0 112.303 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' VAL . 2.8 tt0 -68.58 -42.28 78.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.016 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.97 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.938 0.399 . . . . 0.0 110.788 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.827 ' O ' HG13 ' A' ' 74' ' ' VAL . 6.2 t -125.51 162.76 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.451 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HB3' HD13 ' A' ' 71' ' ' LEU . 11.2 mt-10 -125.48 90.32 3.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.434 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -51.84 152.16 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.572 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -140.12 151.54 45.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.205 0.526 . . . . 0.0 111.626 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.753 HG11 HG21 ' A' ' 66' ' ' ILE . 85.2 t -47.11 143.13 4.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.88 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.665 ' HD2' HG13 ' A' ' 7' ' ' VAL . 43.5 Cg_endo -70.78 -167.47 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.149 1.9 . . . . 0.0 112.738 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 76.86 2.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.562 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.86 HG12 HG21 ' A' ' 16' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.683 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' CA ' ' HA ' ' A' ' 67' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.047 0.451 . . . . 0.0 110.65 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -179.34 57.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.79 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.86 HG21 HG12 ' A' ' 10' ' ' ILE . 17.1 m -106.38 -175.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.173 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.18 130.6 52.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.933 HD13 HG23 ' A' ' 60' ' ' VAL . 5.6 mt -66.15 161.15 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.956 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.6 -37.98 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.593 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -118.08 166.18 12.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 21' ' ' VAL . 15.0 p -159.38 116.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -135.64 61.4 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.913 HG11 HG11 ' A' ' 73' ' ' VAL . 5.8 m -145.18 118.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.69 23.17 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 56' ' ' LYS . 71.8 t 66.73 -86.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.991 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.7 62.03 0.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.946 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 25' ' ' VAL . 2.2 t0 -129.94 171.03 13.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.709 0.29 . . . . 0.0 110.761 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 m -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.903 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.478 HD13 HG23 ' A' ' 51' ' ' VAL . 1.1 pt -132.21 153.2 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 0.0 111.344 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.91 174.06 11.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 3.1 t -78.51 54.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 3.6 p30 162.09 70.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.83 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -153.81 124.39 7.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.78 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.53 117.38 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.277 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.423 HD13 ' HG ' ' A' ' 5' ' ' LEU . 19.1 mt -90.42 -40.78 11.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.849 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.591 HD13 ' HB ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -157.68 -161.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.862 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.593 ' N ' ' HB3' ' A' ' 20' ' ' ALA . 93.1 m -157.7 51.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.329 0.585 . . . . 0.0 109.846 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -41.83 163.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.859 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.912 ' CD ' HG22 ' A' ' 44' ' ' THR . 70.1 tt0 -172.76 154.42 2.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.829 HG22 ' CG1' ' A' ' 16' ' ' VAL . 50.2 p -102.01 -82.87 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' N ' ' OG1' ' A' ' 40' ' ' THR . 16.7 t70 -150.96 21.41 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -179.98 -41.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.03 105.58 17.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.234 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.912 HG22 ' CD ' ' A' ' 39' ' ' GLU . 3.5 p -91.74 115.07 27.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -95.43 138.9 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.478 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 37' ' ' THR . 3.7 m-20 -119.89 144.41 47.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.955 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.591 ' HB ' HD13 ' A' ' 36' ' ' ILE . 76.5 t -122.09 112.8 31.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 83.6 Cg_endo -88.4 35.41 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.963 2.442 . . . . 0.0 112.331 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.536 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 54.23 168.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.035 0.445 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.2 tp10 -165.65 67.88 0.12 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.484 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -173.87 176.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.237 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.67 79.01 1.69 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.627 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.43 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -167.99 -140.66 2.97 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.308 -1.425 . . . . 0.0 113.857 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -130.94 139.09 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.83 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.077 HG22 HG12 ' A' ' 75' ' ' VAL . 57.7 t -79.53 146.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.408 0.623 . . . . 0.0 111.527 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.59 -44.45 2.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.045 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -109.88 158.0 18.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.453 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.602 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.7 p -151.44 119.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -131.07 68.89 1.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.683 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.933 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -172.46 154.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.643 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -169.11 170.69 8.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.591 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.443 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 54.1 t -82.03 88.42 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.28 46.88 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.72 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.793 ' OD1' HD12 ' A' ' 18' ' ' ILE . 19.0 p-10 -139.46 176.53 8.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.772 0.32 . . . . 0.0 111.042 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.857 ' O ' HD12 ' A' ' 66' ' ' ILE . 7.8 tttt -104.07 156.09 18.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.669 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -140.76 172.56 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.565 ' N ' HG23 ' A' ' 66' ' ' ILE . 7.2 p -147.13 48.39 1.13 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 36.4 mt-10 39.95 55.21 2.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 138.0 69.97 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.442 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.93 29.07 6.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.553 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 4' ' ' GLU . 9.9 tp 48.09 56.67 7.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 0.0 110.571 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.787 HG23 ' CG1' ' A' ' 60' ' ' VAL . 3.3 mt -45.98 -82.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.913 HG11 HG11 ' A' ' 23' ' ' VAL . 27.3 m -122.0 160.15 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.17 0.51 . . . . 0.0 111.875 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 3' ' ' VAL . 76.3 t -128.93 120.58 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.907 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.077 HG12 HG22 ' A' ' 55' ' ' VAL . 29.7 m -112.09 156.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.496 ' HG2' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -64.84 -31.08 72.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.656 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.061 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.89 0.376 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 51' ' ' VAL . 7.9 t -141.84 152.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.762 ' HB3' HD13 ' A' ' 71' ' ' LEU . 7.3 mt-10 -128.37 100.79 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.376 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -60.93 157.56 15.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.069 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.451 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 8.5 mttp -142.13 145.07 33.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.314 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.78 HG22 HD11 ' A' ' 72' ' ' ILE . 95.9 t -48.23 141.24 8.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.04 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.753 ' CD ' HD23 ' A' ' 38' ' ' LEU . 38.0 Cg_endo -68.72 -166.08 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.2 1.934 . . . . 0.0 112.24 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.926 ' O ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -92.59 -13.04 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.645 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.926 HD12 ' O ' ' A' ' 9' ' ' ASP . 1.2 pp . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.924 0.392 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 44.03 95.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.881 HG11 HG22 ' A' ' 40' ' ' THR . 30.9 m -146.54 137.12 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.92 126.22 29.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.522 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.659 HD13 ' H ' ' A' ' 61' ' ' LYS . 3.7 mt -55.72 165.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.894 HG12 HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -140.75 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.066 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.568 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -177.95 146.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 111.099 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.804 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.4 p -137.81 124.39 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.981 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mm-40 -148.82 39.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.436 ' CB ' HG11 ' A' ' 73' ' ' VAL . 3.0 m -120.07 112.77 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.357 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -122.84 97.6 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 25' ' ' VAL . 23.5 m -39.05 111.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.921 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.93 21.17 4.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.67 143.11 50.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 54' ' ' VAL . 2.2 m -69.83 127.08 31.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.779 ' CD1' HG11 ' A' ' 75' ' ' VAL . 2.6 pt -108.09 169.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -178.58 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.4 t -94.34 33.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 176.23 62.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.409 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -140.93 108.34 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -48.76 116.23 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.187 0.518 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.52 HD12 HD11 ' A' ' 5' ' ' LEU . 70.2 mt -94.63 -44.29 7.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.788 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -149.93 -173.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.433 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.894 HG22 HG12 ' A' ' 19' ' ' ILE . 47.5 m -149.12 107.67 3.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 36' ' ' ILE . 2.7 mm? -92.19 151.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.755 ' CB ' HG21 ' A' ' 19' ' ' ILE . 78.2 tt0 -155.51 150.1 26.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.892 0.377 . . . . 0.0 110.991 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.881 HG22 HG11 ' A' ' 16' ' ' VAL . 3.0 p -112.06 -61.39 1.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.988 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 15.3 t0 -168.53 -41.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 37.77 3.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.51 118.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.606 HG22 ' CG ' ' A' ' 39' ' ' GLU . 2.3 p -113.04 119.95 39.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.965 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.03 153.56 21.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.4 p30 -133.12 143.91 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.572 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.633 ' CG2' HD11 ' A' ' 36' ' ' ILE . 93.8 t -105.87 108.09 60.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 71.0 Cg_endo -88.07 37.74 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.043 2.495 . . . . 0.0 112.469 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.445 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 44.66 95.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 111.338 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.595 ' C ' HG12 ' A' ' 51' ' ' VAL . 4.2 mt-10 -87.39 53.66 2.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 3' ' ' VAL . 1.2 p 161.85 141.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -83.14 -162.26 0.59 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.79 -145.17 15.93 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.089 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 76' ' ' GLU . 45.7 t -145.44 138.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.401 0.143 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.813 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.0 t -76.25 146.98 8.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.316 0.579 . . . . 0.0 111.796 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -119.71 -47.87 2.4 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.122 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -109.54 172.4 6.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.652 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.915 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -164.39 137.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HE2' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -152.27 67.96 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.402 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.712 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -169.59 152.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.639 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.659 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -171.81 -167.24 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.521 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.87 90.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.45 -19.94 0.71 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.892 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 2.3 p-10 -98.59 167.25 10.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.095 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.54 134.61 44.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -127.92 162.83 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.054 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -145.87 144.63 30.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -41.08 106.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 94.26 70.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.608 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.35 21.13 3.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.416 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.804 HD11 ' CG2' ' A' ' 74' ' ' VAL . 5.5 tp 47.58 59.67 3.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.788 HG22 HG13 ' A' ' 73' ' ' VAL . 3.6 mt -52.35 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.915 HG12 ' HA ' ' A' ' 58' ' ' VAL . 20.8 m -129.83 148.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 111.597 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.804 ' CG2' HD11 ' A' ' 71' ' ' LEU . 79.3 t -115.1 134.25 58.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 55' ' ' VAL . 32.0 m -121.84 177.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.155 0.502 . . . . 0.0 112.205 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' VAL . 1.5 tt0 -82.81 -33.53 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.268 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.442 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 75' ' ' VAL . 2.4 mp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.879 0.371 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.772 HG21 ' CG1' ' A' ' 51' ' ' VAL . 3.6 t -144.31 161.27 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HB3' HD13 ' A' ' 71' ' ' LEU . 63.5 mt-10 -129.87 100.06 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.552 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.651 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -57.75 164.09 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.023 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' CD ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -154.18 155.61 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.273 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.612 HG21 HG23 ' A' ' 66' ' ' ILE . 96.5 t -53.76 140.74 48.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.727 ' CD ' HD23 ' A' ' 38' ' ' LEU . 70.5 Cg_endo -73.69 -168.44 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.65 2.233 . . . . 0.0 113.03 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.4 OUTLIER -82.9 92.94 7.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.79 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.916 HG12 HG21 ' A' ' 16' ' ' VAL . 1.3 pp . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.042 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' CG ' ' HB2' ' A' ' 67' ' ' SER . 2.8 mp0 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.025 0.441 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 169.32 73.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.928 HG23 HG22 ' A' ' 66' ' ' ILE . 4.0 m -134.88 130.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.366 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.68 140.76 49.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.705 HD13 HG23 ' A' ' 60' ' ' VAL . 5.8 mt -74.9 161.33 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.709 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.511 HG12 ' HB ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -124.35 -38.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.794 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -117.95 170.8 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 36' ' ' ILE . 10.6 p -159.93 124.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.313 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.702 ' O ' HG13 ' A' ' 23' ' ' VAL . 39.1 mt-10 -158.64 90.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.831 HG11 HG11 ' A' ' 73' ' ' VAL . 2.6 m -163.95 113.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.361 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.5 m120 -114.7 96.23 5.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.506 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG12 ' C ' ' A' ' 56' ' ' LYS . 2.3 m -42.68 92.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.546 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 136.31 -15.73 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.588 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.5 m-20 -74.28 169.92 16.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.84 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 m -96.36 103.16 15.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.718 HD13 HG11 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -84.06 158.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.45 -176.79 4.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.941 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 31' ' ' VAL . 3.5 m -90.21 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.316 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 172.08 73.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.783 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 4.4 p-10 -150.25 107.84 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.614 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -48.76 118.6 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 111.417 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 36' ' ' ILE . 81.8 mt -92.55 -39.5 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.08 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -161.81 -178.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.626 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 19' ' ' ILE . 76.3 m -142.08 56.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.669 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.727 HD23 ' CD ' ' A' ' 8' ' ' PRO . 3.2 mm? -41.45 166.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HB2' HG22 ' A' ' 44' ' ' THR . 67.1 tt0 -168.52 153.89 6.53 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.306 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.605 HG22 HG11 ' A' ' 16' ' ' VAL . 29.9 p -100.04 -72.65 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.707 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.1 p-10 -160.22 26.99 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.601 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.04 -42.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.875 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.85 124.26 43.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.044 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.591 HG22 ' HB2' ' A' ' 39' ' ' GLU . 56.9 p -107.5 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.054 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.441 ' HB3' ' CG ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -97.5 133.09 42.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 2.9 p30 -118.3 144.31 45.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.229 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.651 HG11 HD11 ' A' ' 5' ' ' LEU . 92.4 t -113.34 116.58 46.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.417 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 78.4 Cg_endo -87.42 27.8 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.964 2.443 . . . . 0.0 112.619 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.644 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.28 151.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 111.297 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.767 ' O ' HG13 ' A' ' 51' ' ' VAL . 9.4 tp10 -145.98 70.9 1.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.772 ' CG1' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER 176.81 153.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.038 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.87 77.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.77 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.98 -130.84 1.23 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.179 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 27' ' ' ASP . 61.8 t -137.18 138.77 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.45 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.835 HG22 HG12 ' A' ' 75' ' ' VAL . 70.4 t -78.6 146.59 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.519 . . . . 0.0 111.291 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' C ' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.6 -47.08 2.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.589 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.05 175.04 5.58 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.82 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.642 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -163.39 126.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.525 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.1 mttt -136.87 69.01 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.766 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -171.78 159.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.723 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.556 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -171.89 -172.89 1.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.523 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.61 79.19 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.272 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.13 44.21 0.07 OUTLIER Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.701 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.514 ' CG ' HD12 ' A' ' 18' ' ' ILE . 7.7 p-10 -148.01 147.01 29.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.88 0.371 . . . . 0.0 111.108 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 137.18 40.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.928 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -131.27 172.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.457 ' HB2' ' CG ' ' A' ' 14' ' ' GLU . 7.1 p -152.2 142.78 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.203 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 76.9 mt-10 -44.74 97.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.201 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 99.8 62.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -114.26 22.03 14.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.357 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 4' ' ' GLU . 13.9 tp 48.15 53.58 11.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.977 0.418 . . . . 0.0 110.686 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.842 HG22 HG13 ' A' ' 73' ' ' VAL . 3.7 mt -48.11 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.044 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 72' ' ' ILE . 22.8 m -123.05 159.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.559 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 3' ' ' VAL . 27.9 t -127.75 132.52 68.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.934 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.835 HG12 HG22 ' A' ' 55' ' ' VAL . 33.2 m -119.38 -179.64 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -93.2 -37.19 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.514 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.153 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.342 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 75' ' ' VAL . 3.0 mp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.862 0.363 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.894 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.7 t -134.69 160.27 41.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HG3' HG22 ' A' ' 74' ' ' VAL . 31.0 mp0 -133.01 103.98 6.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.552 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.447 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -60.9 159.05 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.651 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.452 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 15.5 mttt -148.72 145.04 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.76 HG22 HD11 ' A' ' 72' ' ' ILE . 72.3 t -47.91 140.45 8.66 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.998 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.941 ' HD2' HD22 ' A' ' 38' ' ' LEU . 71.8 Cg_endo -76.94 -169.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.677 2.252 . . . . 0.0 112.89 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.443 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -81.85 84.45 6.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.791 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.867 HG12 HG21 ' A' ' 16' ' ' VAL . 1.1 pp . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 25.7 mp0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.993 0.425 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 7.0 p-10 45.38 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.867 HG21 HG12 ' A' ' 10' ' ' ILE . 35.3 m -136.18 -175.67 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.355 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.33 120.34 38.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.824 0.345 . . . . 0.0 111.369 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.783 HD12 ' OD2' ' A' ' 64' ' ' ASP . 27.2 mt -68.18 159.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.19 -15.81 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.51 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.601 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.0 150.47 32.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 21' ' ' VAL . 12.8 p -140.21 124.19 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.933 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -132.09 34.69 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG21 HG11 ' A' ' 73' ' ' VAL . 7.8 m -132.93 115.21 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.416 ' O ' HG12 ' A' ' 25' ' ' VAL . 16.1 t30 -114.75 14.91 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER 62.24 118.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.15 23.39 32.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.45 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.82 148.03 30.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 m -69.47 136.17 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.023 HD13 HG11 ' A' ' 75' ' ' VAL . 2.9 pt -126.86 160.33 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.363 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.19 -176.21 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.9 t -91.55 41.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.247 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 167.14 71.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.489 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 49' ' ' ALA . 1.5 p30 -145.58 120.32 9.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.974 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -54.55 117.06 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 47.5 mt -92.62 -36.33 13.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.876 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.529 HG12 HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -159.11 -176.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.266 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.601 ' N ' ' HB3' ' A' ' 20' ' ' ALA . 84.9 m -144.56 45.79 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.502 0.667 . . . . 0.0 109.447 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.941 HD22 ' HD2' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -39.69 165.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.362 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.913 ' CD ' HG22 ' A' ' 44' ' ' THR . 76.6 tt0 -174.63 164.55 3.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.086 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 10' ' ' ILE . 6.6 p -120.35 -158.38 0.75 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.38 -22.96 66.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 54.81 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.78 113.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.913 HG22 ' CD ' ' A' ' 39' ' ' GLU . 2.1 p -98.9 141.81 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.189 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.443 ' HG3' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -143.34 131.38 21.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.059 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.39 173.59 7.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ALA . 94.4 t -143.72 116.78 5.85 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 65.1 Cg_endo -90.92 36.83 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.203 2.602 . . . . 0.0 112.087 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 57.88 160.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.632 ' C ' HG12 ' A' ' 51' ' ' VAL . 3.5 mt-10 -139.33 35.53 2.07 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.881 HG11 HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER 165.25 153.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.417 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 51' ' ' VAL . . . -85.49 -165.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.069 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 111.46 -157.24 15.08 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.715 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.73 134.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 75' ' ' VAL . 58.2 t -68.35 145.39 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.245 0.545 . . . . 0.0 111.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.51 ' O ' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.24 -44.56 2.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.251 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 19.6 mm-40 -111.86 174.66 5.77 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.636 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.534 ' HA ' HG12 ' A' ' 73' ' ' VAL . 12.5 p -173.83 137.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.508 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.12 51.01 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.107 0.479 . . . . 0.0 110.231 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.813 ' CG1' HG23 ' A' ' 72' ' ' ILE . 28.3 m -155.15 164.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.155 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -170.72 145.78 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 62' ' ' VAL . 7.2 p -55.99 86.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . 122.91 62.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.512 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.783 ' OD2' HD12 ' A' ' 18' ' ' ILE . 2.0 p30 -153.34 178.58 9.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -94.83 112.92 24.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.861 HG21 HD21 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -125.99 165.48 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.483 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.447 ' HB2' ' CB ' ' A' ' 14' ' ' GLU . 4.5 p -147.53 141.11 25.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.96 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 28.7 mt-10 -43.08 109.14 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 83.83 70.43 1.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.24 10.83 9.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.716 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp 60.51 48.48 7.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.423 0.63 . . . . 0.0 109.964 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.942 HG22 HG13 ' A' ' 73' ' ' VAL . 56.0 mt -46.84 -83.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.725 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.942 HG13 HG22 ' A' ' 72' ' ' ILE . 29.3 m -118.38 159.13 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 0.0 111.616 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 3' ' ' VAL . 90.7 t -131.4 141.1 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.91 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.023 HG11 HD13 ' A' ' 29' ' ' ILE . 24.4 m -121.87 -178.51 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.242 0.544 . . . . 0.0 112.4 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HG3' ' CE ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -95.56 -27.35 15.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.498 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.704 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 76' ' ' GLU . 2.6 mp . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.882 0.373 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.8 t -134.8 150.21 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.711 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.559 ' HA ' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -119.46 104.01 9.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.221 179.212 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.761 HD21 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -69.73 161.09 30.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.007 0.432 . . . . 0.0 111.264 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -152.81 159.7 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.727 HG21 HG23 ' A' ' 66' ' ' ILE . 87.1 t -50.0 140.06 16.7 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.776 ' CD ' HD23 ' A' ' 38' ' ' LEU . 60.9 Cg_endo -73.79 -168.17 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.578 2.185 . . . . 0.0 113.052 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -89.87 86.89 6.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.745 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.975 HG12 HG21 ' A' ' 16' ' ' VAL . 1.2 pp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' CA ' ' HB3' ' A' ' 67' ' ' SER . 6.2 mt-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER 162.64 76.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.434 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.975 HG21 HG12 ' A' ' 10' ' ' ILE . 32.6 m -138.83 133.6 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.547 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -76.06 137.05 39.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.047 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.136 HD13 HG23 ' A' ' 60' ' ' VAL . 7.9 mt -72.16 161.18 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.026 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.18 -20.98 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.825 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.702 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -140.07 158.52 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 111.423 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.58 HG21 ' N ' ' A' ' 62' ' ' VAL . 97.1 t -145.92 127.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.9 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.612 ' O ' HG13 ' A' ' 23' ' ' VAL . 45.5 mm-40 -149.92 77.11 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.7 m -160.66 141.62 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.224 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -137.58 18.42 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.256 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 56' ' ' LYS . 73.8 t 65.92 -82.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 58.84 2.48 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.575 ' O ' HG13 ' A' ' 54' ' ' VAL . 6.6 t0 -128.4 166.73 18.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.743 0.306 . . . . 0.0 110.821 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.5 m -90.52 125.49 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.798 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.805 HD13 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -120.35 143.24 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.06 -171.78 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.218 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.5 t -90.0 44.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.62 73.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.519 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 4.0 p-10 -152.69 98.82 2.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -45.12 116.4 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.183 0.516 . . . . 0.0 111.611 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.534 ' HG ' ' HB2' ' A' ' 49' ' ' ALA . 26.4 mt -91.09 -41.68 10.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.067 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -154.88 -178.39 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.455 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.583 ' O ' HG23 ' A' ' 19' ' ' ILE . 96.4 m -144.39 57.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.776 HD23 ' CD ' ' A' ' 8' ' ' PRO . 2.1 mm? -39.16 162.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.322 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.728 ' HG3' HG22 ' A' ' 44' ' ' THR . 65.3 tt0 -175.41 156.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.786 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.431 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -123.71 -83.79 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.585 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.6 OUTLIER -144.56 -42.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -125.29 42.93 3.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . 176.21 136.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.304 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.728 HG22 ' HG3' ' A' ' 39' ' ' GLU . 2.4 p -129.48 120.77 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.569 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.613 ' HB2' HG23 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -108.58 156.17 19.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -179.556 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 9.0 p-10 -141.43 144.82 34.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.458 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.761 HG11 HD21 ' A' ' 5' ' ' LEU . 93.9 t -117.29 118.34 35.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 87.7 Cg_endo -90.02 30.13 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.015 2.477 . . . . 0.0 112.319 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.668 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 51.35 102.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.281 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.95 67.77 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.855 HG11 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -158.72 -172.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.993 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.66 62.97 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.399 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -157.54 -119.81 0.6 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.059 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 27' ' ' ASP . 63.6 t -146.33 140.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.506 0.193 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.91 HG22 HG12 ' A' ' 75' ' ' VAL . 85.7 t -78.07 155.03 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.346 0.593 . . . . 0.0 111.308 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.662 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -127.09 -46.02 1.54 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.189 179.072 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -107.96 165.09 11.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.319 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.801 ' HA ' HG12 ' A' ' 73' ' ' VAL . 14.6 p -162.17 123.81 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -143.41 78.37 1.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.595 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.136 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.13 148.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.374 -179.368 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -139.47 167.58 21.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 62' ' ' VAL . 11.2 p -81.75 55.69 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.266 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.12 61.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.817 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' CG ' HD12 ' A' ' 18' ' ' ILE . 1.7 p30 -148.98 150.48 32.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -64.76 122.48 16.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.19 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.727 HG23 HG21 ' A' ' 7' ' ' VAL . 1.1 tp -131.04 169.63 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.461 ' HB3' ' CA ' ' A' ' 14' ' ' GLU . 4.7 p -151.94 150.5 30.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mt-10 -50.58 98.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.83 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 108.09 55.73 0.6 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.475 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.73 18.4 29.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.391 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD11 ' CG2' ' A' ' 74' ' ' VAL . 9.0 tp 45.33 47.7 10.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.046 0.451 . . . . 0.0 110.775 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.807 HG23 ' CG1' ' A' ' 60' ' ' VAL . 5.8 mt -43.18 -82.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.333 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 58' ' ' VAL . 22.0 m -127.39 148.38 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 111.728 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.779 HG13 ' O ' ' A' ' 3' ' ' VAL . 93.9 t -118.42 133.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.943 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.91 HG12 HG22 ' A' ' 55' ' ' VAL . 25.4 m -118.95 166.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 112.417 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' HD23 ' A' ' 2' ' ' LEU . 0.9 OUTLIER -77.54 -36.32 52.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.509 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.002 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.825 0.345 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.753 ' O ' HG13 ' A' ' 74' ' ' VAL . 33.9 t -152.66 161.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.438 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -135.12 91.2 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.002 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.786 HD11 HG11 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -53.05 169.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.631 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -158.11 161.69 37.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.781 HG13 HD22 ' A' ' 38' ' ' LEU . 83.4 t -52.64 139.96 38.82 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.754 ' CD ' HD13 ' A' ' 38' ' ' LEU . 38.5 Cg_endo -70.04 -168.16 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.094 1.863 . . . . 0.0 112.949 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.69 60.37 1.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.759 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.716 ' HB ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.585 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 4.3 pm0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.672 0.272 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.73 91.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 66' ' ' ILE . 9.3 m -127.79 -154.56 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.716 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 16' ' ' VAL . 31.1 m-20 -140.42 121.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.012 HD13 HG23 ' A' ' 60' ' ' VAL . 20.6 mt -65.0 163.78 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.782 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -127.12 -12.46 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.053 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 37' ' ' THR . . . -152.35 161.82 42.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 0.0 111.607 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.808 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.3 p -146.61 133.24 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.05 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -161.26 75.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.511 HG21 HG23 ' A' ' 58' ' ' VAL . 2.4 m -149.08 114.44 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -116.65 96.02 5.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.535 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 25' ' ' VAL . 35.3 m -43.28 110.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.553 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.05 17.43 4.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -120.38 149.82 41.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.792 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.452 ' HA ' HG22 ' A' ' 54' ' ' VAL . 7.9 m -77.38 142.94 39.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.945 HD13 HG23 ' A' ' 51' ' ' VAL . 2.8 pp -143.1 166.06 15.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.65 -171.27 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.351 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 51' ' ' VAL . 6.1 t -90.39 43.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 p30 178.28 68.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.32 107.1 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -44.16 119.32 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.169 0.509 . . . . 0.0 112.096 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 82.9 mt -92.02 -45.3 8.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.856 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.808 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -154.78 179.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.444 0.64 . . . . 0.0 112.091 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 19' ' ' ILE . 59.7 m -138.81 116.94 11.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.782 ' HA ' HG23 ' A' ' 19' ' ' ILE . 4.2 mp -111.6 175.34 5.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 112.148 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.958 ' HG3' HG22 ' A' ' 44' ' ' THR . 6.3 tm-20 -177.4 157.16 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.716 HG23 ' HB ' ' A' ' 10' ' ' ILE . 6.5 p -131.49 -58.96 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 110.816 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 40' ' ' THR . 8.7 t70 -175.24 -38.3 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.765 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 8.1 mmtt -75.06 -26.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . 175.38 170.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.927 0.394 . . . . 0.0 111.334 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.958 HG22 ' HG3' ' A' ' 39' ' ' GLU . 2.5 p -109.66 130.36 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -109.09 -168.56 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 0.0 111.545 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -176.84 167.36 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.234 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.786 HG11 HD11 ' A' ' 5' ' ' LEU . 99.6 t -127.41 125.51 23.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.983 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 86.1 Cg_endo -89.74 30.41 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.032 2.488 . . . . 0.0 112.494 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.669 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 53.53 106.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 111.394 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.95 69.56 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.142 0.496 . . . . 0.0 110.167 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -158.53 -170.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.71 -178.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -159.76 56.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.798 0.333 . . . . 0.0 111.363 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.82 -121.92 0.59 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.39 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 27' ' ' ASP . 51.1 t -137.62 139.15 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 111.44 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 95.6 t -71.31 148.19 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.182 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.02 -49.76 2.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.684 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -111.22 175.17 5.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.629 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.938 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.1 p -165.6 128.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.038 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 71.88 1.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.49 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.012 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -170.21 148.53 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.746 -179.335 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.39 -174.31 4.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.588 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.78 78.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.326 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.38 45.72 0.13 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.645 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.923 ' OD1' HD12 ' A' ' 18' ' ' ILE . 20.0 p-10 -130.81 170.65 14.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.899 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 6.0 mttt -91.96 114.78 27.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.528 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -131.13 160.26 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.696 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.427 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -144.09 148.53 35.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.965 179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.436 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 27.3 tt0 -47.44 99.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 99.47 66.33 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.359 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -128.88 29.08 4.03 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.76 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.9 tp 42.84 74.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.747 ' CG2' HG13 ' A' ' 73' ' ' VAL . 1.4 mt -66.75 -76.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.955 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.938 HG12 ' HA ' ' A' ' 58' ' ' VAL . 17.0 m -129.02 148.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 0.0 111.77 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 3' ' ' VAL . 67.7 t -101.47 142.32 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.922 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 51' ' ' VAL . 2.4 t -125.73 153.4 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.253 0.549 . . . . 0.0 112.08 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 76' ' ' GLU . 3.2 tt0 -102.61 45.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.848 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.665 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.796 HD22 ' HA ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.976 0.417 . . . . 0.0 110.893 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.953 HG21 HG11 ' A' ' 51' ' ' VAL . 4.3 t -128.4 162.1 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.5 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.682 ' HB3' HD13 ' A' ' 71' ' ' LEU . 45.5 mt-10 -124.34 89.86 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.426 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.763 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -50.63 151.27 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.975 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.23 150.23 43.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.756 HG13 HD22 ' A' ' 38' ' ' LEU . 91.7 t -48.02 141.11 8.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.89 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.878 ' CD ' HD13 ' A' ' 38' ' ' LEU . 60.0 Cg_endo -73.13 -166.69 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.318 2.012 . . . . 0.0 112.667 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 45' ' ' MET . 1.2 m-20 -95.43 79.05 3.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 16' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.914 0.388 . . . . 0.0 111.184 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.201 0.524 . . . . 0.0 111.077 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' GLU . 7.4 p30 46.01 71.09 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.57 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 66' ' ' ILE . 24.1 m -121.93 -170.8 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.13 124.57 37.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 111.541 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.016 HD13 HG23 ' A' ' 60' ' ' VAL . 11.6 mt -61.0 163.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.834 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.715 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -127.68 -12.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.956 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.72 154.43 38.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.379 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.802 ' HA ' HG22 ' A' ' 36' ' ' ILE . 11.0 p -146.32 115.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.216 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -119.46 -30.69 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.344 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.803 HG11 HG11 ' A' ' 73' ' ' VAL . 11.6 m -64.19 129.07 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.92 0.39 . . . . 0.0 111.259 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -139.48 12.74 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.6 t 63.03 118.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.29 8.6 35.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.62 148.28 25.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.33 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.1 m -81.85 106.19 13.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -93.31 155.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.514 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.33 -177.66 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.785 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 31' ' ' VAL . 16.6 t -90.26 44.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 2.1 p30 163.75 70.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.352 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.415 ' H ' ' HB3' ' A' ' 49' ' ' ALA . 1.8 p-10 -148.33 119.8 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.697 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -56.31 114.92 2.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 0.0 111.35 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.72 -43.76 11.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.32 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.929 HD13 HD12 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -152.62 -178.51 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.214 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 19' ' ' ILE . 55.0 m -144.17 120.81 11.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.929 HD12 HD13 ' A' ' 36' ' ' ILE . 4.3 mp -112.3 166.54 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.143 0.497 . . . . 0.0 111.737 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.796 ' CD ' HG22 ' A' ' 44' ' ' THR . 80.4 tt0 -168.38 161.82 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.727 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.508 HG23 ' HB ' ' A' ' 10' ' ' ILE . 3.5 p -120.32 -58.35 1.86 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -179.54 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.817 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -12.57 13.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.534 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.29 137.78 30.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.977 0.418 . . . . 0.0 111.465 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.796 HG22 ' CD ' ' A' ' 39' ' ' GLU . 2.6 p -120.96 127.98 52.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.435 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.425 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -120.01 -166.31 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.146 0.498 . . . . 0.0 111.795 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -179.28 172.96 1.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.763 HG11 HD11 ' A' ' 5' ' ' LEU . 95.8 t -126.65 113.7 22.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 121.174 -0.21 . . . . 0.0 111.377 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 57.4 Cg_endo -90.28 30.64 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.11 2.54 . . . . 0.0 112.427 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.17 164.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.812 ' O ' HG13 ' A' ' 51' ' ' VAL . 26.2 tt0 -160.61 46.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.953 HG11 HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -173.16 161.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.71 86.58 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -160.58 -140.4 2.88 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.152 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -130.39 140.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.609 0.242 . . . . 0.0 111.081 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.869 HG22 HG12 ' A' ' 75' ' ' VAL . 53.7 t -77.04 139.28 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.313 0.577 . . . . 0.0 111.396 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HD2' HD13 ' A' ' 2' ' ' LEU . 1.1 mttm -107.66 -48.63 3.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.228 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 29.0 mt-10 -111.11 166.11 11.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.365 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.693 ' HA ' HG12 ' A' ' 73' ' ' VAL . 6.4 p -154.81 114.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.389 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -128.97 74.81 1.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.016 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -174.73 150.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.615 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -172.56 128.6 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.536 HG23 HG12 ' A' ' 21' ' ' VAL . 15.4 t -47.09 102.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.35 25.79 2.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.726 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.865 ' OD1' HD12 ' A' ' 18' ' ' ILE . 21.5 p-10 -121.11 175.81 5.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.809 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -97.98 147.77 24.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.86 HG22 HG22 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -141.3 167.54 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 66' ' ' ILE . 78.2 p -144.95 51.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' CG ' HD11 ' A' ' 10' ' ' ILE . 98.8 mt-10 40.72 50.17 2.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.801 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' N ' ' HB ' ' A' ' 7' ' ' VAL . . . 144.01 71.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.47 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.82 33.0 4.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.717 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.682 HD13 ' HB3' ' A' ' 4' ' ' GLU . 7.2 tp 44.21 56.9 4.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.798 HG23 ' CG1' ' A' ' 60' ' ' VAL . 3.4 mt -46.31 -83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.312 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.803 HG11 HG11 ' A' ' 23' ' ' VAL . 33.8 m -120.29 164.9 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.113 0.483 . . . . 0.0 111.951 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 3' ' ' VAL . 59.1 t -132.34 117.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.944 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.869 HG12 HG22 ' A' ' 55' ' ' VAL . 28.0 m -108.31 157.68 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.796 ' HA ' HD22 ' A' ' 2' ' ' LEU . 4.0 tt0 -68.08 -35.29 77.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.075 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 121.125 0.488 . . . . 0.0 112.038 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 76' ' ' GLU . 1.8 mp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.929 0.395 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.836 HG21 HG11 ' A' ' 51' ' ' VAL . 2.6 t -141.04 161.44 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.746 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 4.3 mp0 -135.9 121.27 19.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.694 ' CD2' HD12 ' A' ' 35' ' ' LEU . 1.3 tp -73.46 154.23 40.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -149.59 59.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.862 ' H ' HD12 ' A' ' 72' ' ' ILE . 67.2 t 60.83 145.62 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HD2' HG13 ' A' ' 7' ' ' VAL . 33.5 Cg_endo -67.99 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.621 1.547 . . . . 0.0 112.77 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER 166.6 56.83 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.736 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.985 HG23 HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.056 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 2.2 mt-10 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.14 0.495 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 176.97 85.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.637 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.966 HG11 HG22 ' A' ' 40' ' ' THR . 0.7 OUTLIER -147.46 145.29 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.332 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 64' ' ' ASP . 4.1 m-20 -75.74 145.57 40.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.339 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.076 HD13 HG23 ' A' ' 60' ' ' VAL . 6.1 mt -71.77 163.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.564 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.869 HG12 HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -132.27 -4.25 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.626 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -155.68 151.62 27.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.27 . . . . 0.0 110.928 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.78 ' HA ' HG22 ' A' ' 36' ' ' ILE . 11.1 p -137.9 134.04 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.466 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -155.17 25.48 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.635 HG11 HG11 ' A' ' 73' ' ' VAL . 3.1 m -117.46 122.91 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -133.89 11.76 3.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.485 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 85.4 t 60.63 120.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.51 35.11 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.982 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.4 146.72 27.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -69.85 132.89 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.514 ' CD1' HG11 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -124.25 143.58 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.57 -173.73 2.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.1 t -90.85 39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.361 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p30 168.19 64.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.673 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -140.85 114.3 8.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.77 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.98 115.72 2.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 111.496 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' A' ' 5' ' ' LEU . 33.5 mt -91.25 -32.07 15.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.426 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.78 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.77 -177.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.934 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.869 HG22 HG12 ' A' ' 19' ' ' ILE . 60.7 m -141.92 122.33 14.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 109.901 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.985 HD23 HG23 ' A' ' 10' ' ' ILE . 2.2 tp -102.99 167.83 9.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.869 ' HG3' HG22 ' A' ' 44' ' ' THR . 2.1 tm-20 -167.72 166.43 13.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.966 HG22 HG11 ' A' ' 16' ' ' VAL . 5.5 p -124.76 -59.39 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.682 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.0 t70 -171.84 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.51 -29.61 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.22 131.75 56.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 111.374 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.869 HG22 ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -115.41 138.54 50.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.89 -178.33 4.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.408 . . . . 0.0 111.332 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.6 p30 -167.29 162.45 14.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.649 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.641 HG11 HD21 ' A' ' 5' ' ' LEU . 89.4 t -113.67 109.75 50.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.0 Cg_endo -88.82 43.53 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.098 2.532 . . . . 0.0 111.823 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 54.35 171.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.706 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.839 ' O ' HG13 ' A' ' 51' ' ' VAL . 5.3 pt-20 -156.09 33.03 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.449 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.839 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -172.37 170.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.144 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' ILE . . . -121.97 86.01 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.401 ' O ' HG13 ' A' ' 29' ' ' ILE . . . -159.75 -134.38 1.66 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.018 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 76' ' ' GLU . 91.3 t -135.12 141.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.701 HG22 HG13 ' A' ' 75' ' ' VAL . 57.4 t -74.4 143.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.349 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.419 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -111.2 -47.62 3.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.45 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 22.9 mt-10 -113.32 172.15 7.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.664 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.921 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -160.57 119.6 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.5 mttm -134.81 62.72 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.575 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.076 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -169.12 149.94 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -140.67 -169.74 2.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.57 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 62' ' ' VAL . 14.6 p -93.49 42.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.086 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.52 71.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.553 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' CG ' HD12 ' A' ' 18' ' ' ILE . 4.1 p-10 -156.7 145.06 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 110.991 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 131.53 45.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.557 ' CG2' HD11 ' A' ' 38' ' ' LEU . 1.2 tp -135.64 178.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.484 ' N ' HG23 ' A' ' 66' ' ' ILE . 2.4 m -155.43 118.17 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.616 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -38.46 91.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.636 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 127.35 49.17 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.938 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -112.3 -121.16 3.9 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.601 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -157.58 44.37 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.376 0.608 . . . . 0.0 109.663 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.862 HD12 ' H ' ' A' ' 7' ' ' VAL . 7.1 mt -40.63 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.041 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 58' ' ' VAL . 20.7 m -131.66 143.96 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.166 0.508 . . . . 0.0 112.317 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 3' ' ' VAL . 61.8 t -108.08 140.31 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.137 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.701 HG13 HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.165 0.507 . . . . 0.0 112.156 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 2' ' ' LEU . 3.9 tt0 -75.42 -39.34 59.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.07 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 112.067 179.528 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 75' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.933 0.397 . . . . 0.0 110.993 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.758 HG21 ' CG1' ' A' ' 51' ' ' VAL . 4.1 t -140.71 161.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.584 ' HB3' HD13 ' A' ' 71' ' ' LEU . 1.6 mp0 -142.73 101.36 3.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.478 HD23 HG23 ' A' ' 73' ' ' VAL . 2.4 mm? -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.093 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.451 ' CB ' ' HA2' ' A' ' 69' ' ' GLY . 1.9 mttt -134.16 64.18 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 111.746 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.67 ' H ' HD12 ' A' ' 72' ' ' ILE . 45.4 t 59.83 139.46 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.345 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HD2' HD22 ' A' ' 38' ' ' LEU . 39.4 Cg_endo -72.65 -166.59 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.107 1.871 . . . . 0.0 112.817 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.68 72.24 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.339 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.738 ' CG2' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.491 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 3.7 pm0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.814 0.34 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 1.2 p-10 44.49 85.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 66' ' ' ILE . 20.5 m -123.23 159.8 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.877 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -92.68 128.4 38.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.177 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.926 HD13 HG23 ' A' ' 60' ' ' VAL . 6.9 mt -77.84 161.29 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.26 -41.66 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.393 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -116.94 157.77 25.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 21' ' ' VAL . 10.4 p -157.24 115.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -135.85 72.32 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.039 HG11 HG11 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -146.49 118.92 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -119.89 18.79 12.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.175 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 56' ' ' LYS . 74.0 t 66.07 -86.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.949 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 60.65 1.41 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.833 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 162.99 25.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -87.6 120.53 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.805 HD13 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -115.5 137.33 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.94 -169.01 1.88 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 31' ' ' VAL . 21.8 t -90.64 43.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.167 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 p30 171.84 68.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.581 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.1 p-10 -147.55 102.09 3.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -48.5 117.62 2.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.477 . . . . 0.0 111.582 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 49' ' ' ALA . 32.6 mt -91.83 -37.79 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.713 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.484 HD13 ' HB ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -155.17 -160.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.963 179.135 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 37' ' ' THR . 94.4 m -161.3 38.13 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.83 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.878 HD21 HG21 ' A' ' 16' ' ' VAL . 2.7 tp -31.87 152.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.088 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.806 ' CD ' HG22 ' A' ' 44' ' ' THR . 52.8 tt0 -168.95 157.89 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.48 HG22 ' CG1' ' A' ' 16' ' ' VAL . 3.9 p -123.9 -58.01 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.3 m-20 174.78 -34.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.699 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.85 -35.24 26.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.63 157.52 35.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.962 0.41 . . . . 0.0 111.426 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.806 HG22 ' CD ' ' A' ' 39' ' ' GLU . 3.1 p -114.97 119.87 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.393 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.471 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -112.86 141.93 46.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.629 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 15.3 p-10 -126.88 174.97 8.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.648 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 49' ' ' ALA . 63.2 t -141.86 120.17 7.7 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.919 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 82.9 Cg_endo -90.79 31.33 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.978 2.452 . . . . 0.0 112.179 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.67 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 49.4 99.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.071 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.764 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.3 tm-20 -91.89 66.55 5.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 0.0 110.649 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -170.47 151.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.411 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.5 76.2 1.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.652 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.45 -124.93 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.106 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.6 t -143.79 138.57 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.496 0.188 . . . . 0.0 111.242 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.847 HG22 HG12 ' A' ' 75' ' ' VAL . 60.1 t -79.64 150.9 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.211 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.632 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -120.3 -44.97 2.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.344 178.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -108.9 165.99 11.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -157.78 118.21 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.288 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 6.0 mttt -133.81 71.71 1.46 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.627 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.926 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -175.22 160.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -164.9 -161.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.811 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.511 HG23 ' CG1' ' A' ' 21' ' ' VAL . 67.7 t -108.45 71.28 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.82 43.43 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.674 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD2' HD12 ' A' ' 18' ' ' ILE . 7.3 p-10 -136.41 172.32 13.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.957 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.686 ' O ' HD12 ' A' ' 66' ' ' ILE . 21.9 mmtt -97.55 131.89 43.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.787 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.91 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -139.14 151.35 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.882 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.9 OUTLIER -140.63 140.22 34.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.328 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.581 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 3.3 mp0 -40.54 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' CB ' ' A' ' 6' ' ' LYS . . . 116.68 57.08 0.31 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.965 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.66 12.79 8.26 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.105 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.813 HD11 ' CG2' ' A' ' 74' ' ' VAL . 6.2 tp 48.51 57.75 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 0.0 110.884 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.852 HG22 HG13 ' A' ' 73' ' ' VAL . 2.8 mt -53.88 -70.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.076 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.039 HG11 HG11 ' A' ' 23' ' ' VAL . 18.3 m -131.65 151.26 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.747 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.813 ' CG2' HD11 ' A' ' 71' ' ' LEU . 20.3 t -122.3 134.54 65.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.959 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 51' ' ' VAL . 27.7 m -123.32 175.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HA ' ' HG ' ' A' ' 2' ' ' LEU . 2.1 tt0 -86.6 -40.85 14.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.929 179.686 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.939 0.399 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.807 ' O ' HG13 ' A' ' 74' ' ' VAL . 4.8 t -152.6 160.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.768 ' HB3' HD13 ' A' ' 71' ' ' LEU . 18.0 mp0 -138.63 108.84 6.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.61 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.791 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -68.14 176.55 2.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.754 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.608 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -157.73 162.83 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.306 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.738 ' N ' HD12 ' A' ' 72' ' ' ILE . 86.1 t -51.9 147.97 11.36 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.635 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HD2' HD22 ' A' ' 38' ' ' LEU . 17.0 Cg_exo -66.76 -156.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.084 1.856 . . . . 0.0 112.671 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -120.84 53.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.884 ' HB ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.94 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.75 0.31 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 44.0 78.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.351 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.044 HG21 HD21 ' A' ' 38' ' ' LEU . 33.6 m -122.36 160.5 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.47 118.19 32.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.253 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.048 HD13 HG23 ' A' ' 60' ' ' VAL . 8.9 mt -60.12 162.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.511 HG12 ' HB ' ' A' ' 37' ' ' THR . 0.2 OUTLIER -121.55 -41.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.135 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.8 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -115.53 164.28 14.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG21 ' HB ' ' A' ' 62' ' ' VAL . 27.9 t -145.25 138.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 35' ' ' LEU . 10.0 mt-10 -159.28 41.8 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.991 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.546 HG11 HG11 ' A' ' 73' ' ' VAL . 2.7 m -141.28 116.17 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.02 13.86 3.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.345 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 91.5 t 62.72 124.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.44 -23.3 18.37 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.13 138.74 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -73.77 103.58 4.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.791 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.774 HD13 HG21 ' A' ' 75' ' ' VAL . 4.0 pt -76.55 147.95 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.273 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . . . -128.19 -173.24 2.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.71 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.18 39.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.949 0.404 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.35 64.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.669 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.55 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -138.86 101.47 4.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.718 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -47.15 115.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 111.535 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 36' ' ' ILE . 16.7 mt -89.42 -38.07 14.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.678 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -162.06 179.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.634 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 19' ' ' ILE . 62.1 m -144.03 53.82 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.468 0.651 . . . . 0.0 110.207 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.044 HD21 HG21 ' A' ' 16' ' ' VAL . 4.4 tp -38.13 154.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.243 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.843 ' HG3' HG22 ' A' ' 44' ' ' THR . 8.0 tm-20 -160.4 117.88 2.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.743 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.928 HG22 HG11 ' A' ' 16' ' ' VAL . 53.1 p -70.94 -85.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' N ' ' OG1' ' A' ' 40' ' ' THR . 10.5 p30 -153.0 23.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -177.28 -43.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.709 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . -103.85 125.66 50.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.022 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.843 HG22 ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -111.66 118.49 35.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.044 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.443 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -112.9 153.44 27.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 36' ' ' ILE . 7.5 p30 -136.55 165.44 25.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 5' ' ' LEU . 79.0 t -127.54 119.28 21.6 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.7 Cg_endo -90.39 30.6 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.131 2.554 . . . . 0.0 112.466 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.658 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 50.34 99.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.587 ' C ' HG12 ' A' ' 51' ' ' VAL . 2.4 mp0 -91.64 62.27 4.44 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 3' ' ' VAL . 1.3 p 161.75 144.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.381 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -91.28 -173.49 3.63 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.486 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 117.13 -146.94 18.88 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.634 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.434 ' O ' ' CE ' ' A' ' 56' ' ' LYS . 63.2 t -143.19 140.42 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.68 HG22 ' CG1' ' A' ' 75' ' ' VAL . 59.0 t -76.13 144.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.229 0.538 . . . . 0.0 111.94 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -114.78 -50.16 2.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.946 178.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 23.5 mt-10 -110.47 173.36 6.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.174 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.944 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -164.14 123.87 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -132.96 67.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.048 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -170.86 150.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.892 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 21' ' ' VAL . 7.7 mmtt -130.86 -163.85 1.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.492 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.525 ' HB ' HG21 ' A' ' 21' ' ' VAL . 9.0 p -99.63 36.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.046 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.83 65.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.513 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.603 ' CG ' HD12 ' A' ' 18' ' ' ILE . 1.2 p-10 -133.5 161.97 33.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -73.61 113.34 10.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 7' ' ' VAL . 1.1 tp -129.44 166.58 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.253 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.13 137.73 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.271 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 5.1 mp0 -40.23 106.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 90.22 69.16 1.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.288 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.97 24.39 4.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.707 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.768 HD13 ' HB3' ' A' ' 4' ' ' GLU . 6.1 tp 48.38 79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.763 ' CG2' HG13 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -73.19 -73.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.161 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.944 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.4 m -130.28 145.3 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.807 HG13 ' O ' ' A' ' 3' ' ' VAL . 83.5 t -107.02 134.99 47.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.845 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 29' ' ' ILE . 12.6 m -123.63 171.6 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.183 0.515 . . . . 0.0 112.3 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.612 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -79.3 -24.56 42.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.92 0.39 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.758 ' O ' HG13 ' A' ' 74' ' ' VAL . 25.5 t -151.6 159.2 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.55 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -135.37 99.31 4.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.344 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.889 HD12 ' CG2' ' A' ' 73' ' ' VAL . 25.0 mt -62.37 132.23 51.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.589 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -128.12 73.35 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.858 ' H ' HD12 ' A' ' 72' ' ' ILE . 72.0 t 58.55 149.27 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.625 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.75 ' CG ' HD13 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -83.17 -157.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.866 2.377 . . . . 0.0 112.216 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.64 99.4 9.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.78 ' HB ' HG22 ' A' ' 40' ' ' THR . 1.2 pp . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.892 0.377 . . . . 0.0 111.165 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 4.0 p-10 47.93 86.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.615 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 66' ' ' ILE . 10.5 m -137.94 -155.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.125 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.46 ' N ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -149.93 138.24 20.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.979 0.418 . . . . 0.0 111.393 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.111 HD13 HG23 ' A' ' 60' ' ' VAL . 7.8 mt -76.99 162.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.847 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.799 HG23 ' C ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -133.52 -9.62 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.887 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.55 149.06 30.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.473 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.805 ' HA ' HG22 ' A' ' 36' ' ' ILE . 89.6 t -140.71 121.66 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -142.39 28.39 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.755 HG11 HG11 ' A' ' 73' ' ' VAL . 3.7 m -117.76 125.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -137.28 11.56 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 56' ' ' LYS . 89.9 t 62.33 127.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -21.9 22.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -77.67 152.28 33.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 m -84.06 121.3 27.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.509 HD13 HG23 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -108.46 153.54 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.81 -176.1 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.863 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.66 47.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 166.85 74.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.456 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -160.46 117.72 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.97 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.44 117.9 5.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 49' ' ' ALA . 63.0 mt -93.1 -44.95 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.805 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -153.13 -179.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.738 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.799 ' C ' HG23 ' A' ' 19' ' ' ILE . 2.7 m -133.05 145.66 51.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.993 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.753 HD23 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -127.11 -172.54 2.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.777 ' CD ' HG22 ' A' ' 44' ' ' THR . 10.0 tt0 -172.19 172.7 4.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.78 HG22 ' HB ' ' A' ' 10' ' ' ILE . 1.2 p -142.25 -157.35 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 -19.69 65.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.864 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -172.79 53.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -173.47 134.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.24 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.777 HG22 ' CD ' ' A' ' 39' ' ' GLU . 71.4 p -107.71 153.86 22.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -172.07 4.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 37' ' ' THR . 1.0 OUTLIER -176.17 174.11 2.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 49' ' ' ALA . 96.9 t -126.38 123.46 24.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.267 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.5 Cg_endo -90.76 29.93 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 0.0 112.23 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . 46.72 93.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.469 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.35 61.74 3.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.45 149.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.142 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.52 75.0 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.9 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -163.77 -132.22 1.32 Allowed Glycine 0 C--N 1.317 -0.478 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.752 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.8 t -137.26 138.95 44.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.751 -0.225 . . . . 0.0 110.959 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.776 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.6 t -74.3 146.5 9.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.368 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.45 -46.1 2.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.57 178.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -113.89 173.95 6.17 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.694 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.617 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.7 p -160.8 116.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -134.14 79.42 1.81 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.111 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -174.62 152.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.209 0.528 . . . . 0.0 111.029 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.545 ' C ' HG21 ' A' ' 21' ' ' VAL . 1.2 tptt -138.79 173.34 11.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.484 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 62' ' ' VAL . 11.8 p -92.38 52.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.065 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.28 52.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.594 ' OD2' HD12 ' A' ' 18' ' ' ILE . 3.9 p-10 -129.98 -175.66 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.767 0.317 . . . . 0.0 110.973 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.728 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -105.95 149.78 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.926 HG22 HG22 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -138.34 170.84 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.521 ' N ' HG23 ' A' ' 66' ' ' ILE . 1.5 p -154.59 49.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.773 ' HG3' HD11 ' A' ' 10' ' ' ILE . 85.8 mt-10 39.9 63.68 1.01 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.643 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 146.83 68.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.62 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.27 17.61 6.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.747 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.57 HD11 ' CG2' ' A' ' 74' ' ' VAL . 10.2 tp 45.06 50.46 9.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.066 0.46 . . . . 0.0 110.73 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.858 HD12 ' H ' ' A' ' 7' ' ' VAL . 3.8 mt -45.05 -83.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.466 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.889 ' CG2' HD12 ' A' ' 5' ' ' LEU . 24.1 m -120.95 145.07 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.985 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 3' ' ' VAL . 87.8 t -114.38 138.89 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.605 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -131.77 174.32 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.94 -33.31 22.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.572 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.724 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.645 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.788 0.328 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 76' ' ' GLU . 1.2 mp 56.59 172.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.8 ' HB ' HG11 ' A' ' 51' ' ' VAL . 5.9 t -149.36 161.99 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.589 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -134.38 106.88 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.93 HD11 HG11 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -51.87 -176.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.264 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 2.4 mttp -164.62 142.78 6.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.78 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.838 HG22 HD11 ' A' ' 72' ' ' ILE . 67.8 t -49.17 138.38 14.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.6 ' CG ' HD13 ' A' ' 38' ' ' LEU . 53.2 Cg_endo -72.7 -167.05 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.356 2.037 . . . . 0.0 112.92 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.67 69.13 3.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.976 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.879 ' HB ' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER -55.88 -19.57 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.563 ' H ' HD12 ' A' ' 10' ' ' ILE . . . 111.6 -54.03 0.56 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.716 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.627 ' H ' HG21 ' A' ' 40' ' ' THR . . . -63.65 -87.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.601 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 175.06 -85.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 110.893 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 67' ' ' SER . 1.3 pt-20 -113.3 177.47 4.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 8.1 p-10 44.73 69.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.811 HG11 HG12 ' A' ' 10' ' ' ILE . 20.0 m -125.97 124.91 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.32 122.97 20.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.706 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.684 HD13 HG23 ' A' ' 60' ' ' VAL . 3.6 mt -62.12 164.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.577 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.691 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -126.53 -13.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.845 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -153.14 144.66 23.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.351 . . . . 0.0 111.372 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.812 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.4 p -145.13 122.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.218 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 2.5 pt-20 -140.09 47.72 1.8 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.778 HG21 HG11 ' A' ' 73' ' ' VAL . 8.2 m -144.71 123.37 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.266 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -128.42 18.62 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 56' ' ' LYS . 95.0 t 65.4 112.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.36 -21.28 5.75 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.499 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -81.41 147.59 29.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.3 m -71.81 155.9 39.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.945 HD13 HG23 ' A' ' 51' ' ' VAL . 1.7 pp -144.19 144.28 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.214 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.72 -179.06 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.03 48.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.3 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 p30 163.65 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.523 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 8.1 p-10 -155.29 115.47 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -50.66 117.29 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.153 0.501 . . . . 0.0 111.488 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 36' ' ' ILE . 13.8 mt -87.58 -43.6 11.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.009 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -158.06 -180.0 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.314 0.578 . . . . 0.0 111.86 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.645 ' O ' HG23 ' A' ' 19' ' ' ILE . 99.9 m -140.05 117.49 11.42 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.732 HD22 HG13 ' A' ' 7' ' ' VAL . 5.9 mp -111.61 171.83 7.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.023 0.44 . . . . 0.0 112.187 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.619 ' HB2' HG22 ' A' ' 44' ' ' THR . 49.4 tt0 -172.06 157.91 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.643 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.879 HG22 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.55 -89.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.904 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.444 ' H ' HG23 ' A' ' 40' ' ' THR . 0.3 OUTLIER -150.26 21.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.741 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.71 -43.44 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.07 169.54 19.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 39' ' ' GLU . 71.6 p -108.5 115.93 31.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.493 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -101.1 -175.82 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.161 0.505 . . . . 0.0 111.534 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 1.2 p30 -172.92 170.43 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.241 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.93 HG11 HD11 ' A' ' 5' ' ' LEU . 97.3 t -126.35 124.51 24.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.813 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.2 Cg_endo -88.71 27.03 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.975 2.45 . . . . 0.0 112.702 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.724 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.67 150.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.304 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.571 ' C ' HG22 ' A' ' 51' ' ' VAL . 44.0 tt0 -149.35 70.62 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.476 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.945 HG23 HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -178.33 -178.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.494 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -148.28 67.79 1.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.818 0.342 . . . . 0.0 111.838 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.48 -134.84 1.75 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.115 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 76' ' ' GLU . 88.5 t -126.23 144.4 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.61 0.243 . . . . 0.0 111.183 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.683 HG22 HG12 ' A' ' 75' ' ' VAL . 95.2 t -76.56 145.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.152 0.501 . . . . 0.0 111.303 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.49 -46.92 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.556 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.63 175.3 5.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.498 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HA ' HG12 ' A' ' 73' ' ' VAL . 8.6 p -165.37 119.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -132.36 66.41 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.587 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.718 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -172.82 156.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.694 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -170.97 -159.93 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.737 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.723 HG23 HG12 ' A' ' 21' ' ' VAL . 59.6 t -112.07 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.54 -15.72 3.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.57 163.77 12.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.044 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -101.08 148.62 24.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.664 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.693 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.3 tp -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.477 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 14' ' ' GLU . 6.9 m -142.97 138.32 30.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 111.272 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 95.0 mt-10 -39.57 115.66 0.54 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 70.17 74.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.221 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -137.64 31.64 2.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.447 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 4' ' ' GLU . 13.7 tp 49.06 95.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.982 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.838 HD11 HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -95.2 -74.86 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.654 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 23' ' ' VAL . 19.7 m -125.05 136.93 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 111.787 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 3' ' ' VAL . 61.9 t -104.96 141.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.097 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.887 HG21 HG21 ' A' ' 51' ' ' VAL . 33.1 m -127.62 171.47 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.244 0.545 . . . . 0.0 112.362 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.458 ' HA ' HD23 ' A' ' 2' ' ' LEU . 1.8 tm-20 -84.49 -39.37 18.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.293 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . 57.12 138.04 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.246 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 52' ' ' ALA . 3.1 tt0 39.27 39.82 0.47 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.684 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.09 160.48 26.09 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.513 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.7 p -127.35 167.96 15.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 0.0 110.841 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.14 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.962 0.41 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -77.53 172.69 12.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.074 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.755 ' O ' HG13 ' A' ' 74' ' ' VAL . 30.7 t -136.3 159.3 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.581 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -134.67 108.61 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.999 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.981 HD21 HG11 ' A' ' 47' ' ' VAL . 2.9 tp -63.39 161.07 14.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.454 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HG2' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -146.44 139.52 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.767 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 72' ' ' ILE . 96.9 t -42.12 141.21 1.42 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.139 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.676 ' CD ' HD23 ' A' ' 38' ' ' LEU . 61.1 Cg_endo -75.37 -169.36 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.436 2.091 . . . . 0.0 113.102 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 45' ' ' MET . 5.2 t0 -83.95 94.56 8.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.956 HG12 HG21 ' A' ' 16' ' ' VAL . 1.1 pp -99.1 63.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.076 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.93 -90.96 1.69 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.491 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.93 35.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.424 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' NE2' HG21 ' A' ' 40' ' ' THR . 0.1 OUTLIER -146.15 159.85 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.728 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -88.25 -177.32 5.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.236 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 6.5 p-10 46.01 94.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.434 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.956 HG21 HG12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -137.82 166.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 64' ' ' ASP . 82.4 m-20 -97.87 133.1 42.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.658 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.111 HD13 HG23 ' A' ' 60' ' ' VAL . 8.6 mt -74.76 163.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.896 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.715 HG23 ' C ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -131.04 -8.75 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.736 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -151.09 150.18 30.39 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 36' ' ' ILE . 80.0 t -142.03 120.39 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.844 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -146.41 59.48 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.981 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.937 HG11 HG11 ' A' ' 73' ' ' VAL . 2.0 m -140.01 115.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.432 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 1.6 t30 -93.99 12.23 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.44 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 25' ' ' VAL . 5.4 p 43.04 63.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.487 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.09 45.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.476 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -136.71 173.25 11.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.996 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.6 m -79.17 132.91 36.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.761 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.602 HD13 HG11 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -127.5 150.33 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.31 178.82 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 51' ' ' VAL . 4.0 t -87.96 47.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.61 70.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.546 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.51 100.42 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.483 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -42.98 115.22 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.197 0.523 . . . . 0.0 111.774 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.633 HD12 HD22 ' A' ' 5' ' ' LEU . 23.6 mt -87.16 -50.16 6.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.914 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -149.41 -178.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 111.73 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.715 ' C ' HG23 ' A' ' 19' ' ' ILE . 3.5 m -131.96 130.69 41.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.669 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.69 HD11 HG12 ' A' ' 18' ' ' ILE . 1.9 mm? -116.04 165.15 13.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.799 0.333 . . . . 0.0 110.826 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.737 ' CD ' HG22 ' A' ' 44' ' ' THR . 48.9 tt0 -178.21 164.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.854 HG22 HG11 ' A' ' 16' ' ' VAL . 3.5 p -121.28 -59.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.684 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.3 t0 -172.68 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -109.64 -36.8 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.033 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.74 141.38 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.737 HG22 ' CD ' ' A' ' 39' ' ' GLU . 1.4 p -126.9 130.14 49.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.43 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -117.25 -164.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.287 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 22.5 p-10 -179.66 172.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.981 HG11 HD21 ' A' ' 5' ' ' LEU . 78.8 t -121.15 116.8 30.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.81 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.4 Cg_endo -86.63 18.56 1.55 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.993 2.462 . . . . 0.0 112.7 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.1 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.875 0.369 . . . . 0.0 111.551 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -110.6 70.69 0.72 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.758 HG11 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.35 -172.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.116 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -160.59 63.77 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.661 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.53 -124.38 0.74 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.243 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.1 t -139.96 138.17 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.473 0.178 . . . . 0.0 111.165 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.771 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.2 t -75.04 145.02 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.114 0.483 . . . . 0.0 111.476 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HE2' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -115.54 -44.24 2.98 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.497 178.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 17.8 mt-10 -115.06 174.24 6.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.606 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 58' ' ' VAL . 15.0 p -160.86 122.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.363 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -134.19 74.62 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.749 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.111 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.58 148.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.491 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -143.85 -166.26 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.984 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 21' ' ' VAL . 59.6 t -106.71 86.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.09 18.99 4.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.564 ' CG ' HD12 ' A' ' 18' ' ' ILE . 5.3 p-10 -99.85 171.71 7.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.794 0.33 . . . . 0.0 110.662 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.97 123.35 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.933 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -122.44 167.17 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.4 p -151.28 141.13 21.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 26.0 mt-10 -42.9 95.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.204 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 100.37 61.46 0.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.393 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.31 20.18 23.65 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 4' ' ' GLU . 11.2 tp 49.92 50.01 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.796 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.891 HG22 HG13 ' A' ' 73' ' ' VAL . 4.3 mt -48.07 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.256 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.937 HG11 HG11 ' A' ' 23' ' ' VAL . 17.6 m -117.0 141.07 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.148 0.499 . . . . 0.0 112.029 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 3' ' ' VAL . 91.5 t -113.6 131.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.771 ' CG1' HG22 ' A' ' 55' ' ' VAL . 27.8 m -121.95 169.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.772 ' HA ' HD23 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -78.61 -36.46 44.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.607 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . 56.73 147.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.176 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 52' ' ' ALA . 11.4 pt-20 39.54 49.32 1.95 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.695 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.85 154.52 18.76 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.487 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.63 112.54 24.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.32 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.103 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.843 0.354 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.9 176.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.053 HG21 HG11 ' A' ' 51' ' ' VAL . 6.5 t -148.92 161.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.951 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 74' ' ' VAL . 69.0 mt-10 -133.39 115.29 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.198 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.714 ' CD1' HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -73.45 160.8 31.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -147.34 150.09 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 111.405 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.688 HG22 HD11 ' A' ' 72' ' ' ILE . 84.0 t -46.05 140.43 4.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.432 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.786 ' CD ' HD23 ' A' ' 38' ' ' LEU . 74.1 Cg_endo -76.38 -166.17 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.592 2.195 . . . . 0.0 112.614 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 45' ' ' MET . 16.5 t70 -94.47 88.74 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.054 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.899 HG12 HG21 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -96.36 61.73 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.98 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.53 -91.33 1.04 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.437 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.39 37.35 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.603 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.407 ' NE2' HG21 ' A' ' 40' ' ' THR . 2.9 p-80 -144.44 -175.9 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 110.976 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -104.86 -175.18 2.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.084 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 44.89 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.899 HG21 HG12 ' A' ' 10' ' ' ILE . 34.6 m -143.72 115.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.569 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 128.21 35.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.556 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.783 HD13 HG23 ' A' ' 60' ' ' VAL . 4.2 mt -65.39 164.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.93 -35.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.275 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.71 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -118.59 148.11 43.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.728 ' HA ' HG22 ' A' ' 36' ' ' ILE . 7.8 p -134.9 119.22 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.991 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -146.3 40.09 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.018 HG11 HG11 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -133.72 117.82 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -132.6 12.25 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.377 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 90.0 t 62.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.35 . . . . 0.0 111.085 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.08 -21.54 13.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.779 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.42 139.41 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 111.107 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.2 m -74.76 102.29 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.552 HG12 HG11 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -87.16 153.91 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.38 -174.36 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.841 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.9 t -89.94 42.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.395 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER 163.7 72.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.591 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -148.78 115.16 5.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.78 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.58 115.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.527 . . . . 0.0 111.45 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 36' ' ' ILE . 98.3 mt -88.98 -40.97 12.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.541 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.756 HD13 HD22 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -159.31 -177.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 19' ' ' ILE . 23.2 m -136.04 133.17 37.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.811 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.786 HD23 ' CD ' ' A' ' 8' ' ' PRO . 1.8 mm? -116.11 150.59 37.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.864 0.364 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' OE2' HG22 ' A' ' 44' ' ' THR . 41.7 tt0 -159.91 163.18 34.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.547 ' HB ' HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -133.03 -82.92 0.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.656 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 40' ' ' THR . 12.0 p-10 -143.79 -43.48 0.27 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 42.63 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.65 133.64 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.193 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.54 HG22 ' OE2' ' A' ' 39' ' ' GLU . 10.6 p -129.4 118.48 22.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.449 ' O ' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -117.29 -167.95 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.572 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -177.23 167.62 2.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.13 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.714 HG11 ' CD1' ' A' ' 5' ' ' LEU . 57.8 t -121.85 111.8 32.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.409 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 58.9 Cg_endo -89.64 33.35 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.115 2.544 . . . . 0.0 112.401 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.516 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.57 163.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.96 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.832 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -157.76 44.83 0.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.097 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.053 HG11 HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -173.45 163.37 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.96 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -120.7 87.92 2.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -162.19 -139.68 2.7 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.939 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.11 136.58 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.737 HG22 ' CG1' ' A' ' 75' ' ' VAL . 59.5 t -72.87 143.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.105 0.478 . . . . 0.0 111.397 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -112.51 -47.69 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.338 178.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.7 mm-40 -112.18 173.38 6.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.626 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -163.14 120.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.306 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.7 mttm -132.05 64.09 1.6 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.533 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.783 HG23 HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -173.05 151.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.672 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -173.99 175.52 2.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.658 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 62' ' ' VAL . 58.1 t -79.22 68.34 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.43 55.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.893 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 10.7 p-10 -173.15 132.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -76.28 119.76 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.7 tp -104.6 172.74 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.8 m -144.13 137.66 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.471 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 72.4 mt-10 -40.48 130.52 2.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.0 61.73 3.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.037 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.27 129.05 5.44 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.131 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -53.06 94.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 110.584 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.766 HG23 ' CG1' ' A' ' 60' ' ' VAL . 1.3 mt -92.45 -78.83 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.018 HG11 HG11 ' A' ' 23' ' ' VAL . 19.6 m -126.77 137.6 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.0 111.873 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 3' ' ' VAL . 85.3 t -108.77 136.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.782 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.737 ' CG1' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -126.06 167.52 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.212 0.529 . . . . 0.0 112.32 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . 3.7 tt0 -71.59 -38.87 70.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.612 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 56.39 124.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.311 0.577 . . . . 0.0 112.169 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ALA . 20.3 pt-20 42.78 44.91 4.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.304 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.26 105.32 1.4 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.543 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.7 p -111.27 -71.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.157 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.754 0.311 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.76 176.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.861 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.849 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.3 t -142.91 162.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.882 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.797 ' HB3' HD13 ' A' ' 71' ' ' LEU . 2.0 mt-10 -130.86 91.08 3.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.494 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.93 HD11 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -48.41 155.18 0.54 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.784 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.676 ' H ' HD13 ' A' ' 5' ' ' LEU . 10.9 mttm -147.06 150.18 34.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 111.492 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.718 HG21 HG23 ' A' ' 66' ' ' ILE . 91.1 t -50.13 140.75 16.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.628 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.915 ' HD2' HD13 ' A' ' 38' ' ' LEU . 37.8 Cg_endo -68.73 -166.66 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.285 1.99 . . . . 0.0 112.88 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -99.22 69.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.836 HG12 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -66.12 -10.6 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.555 ' N ' HD12 ' A' ' 10' ' ' ILE . . . 53.3 71.95 0.61 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.739 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.579 ' HA3' HG21 ' A' ' 40' ' ' THR . . . -157.45 -64.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.463 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.26 176.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 4.8 mt-10 -83.34 69.99 10.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.171 0.51 . . . . 0.0 110.712 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 1.5 p30 169.82 66.75 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.459 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.076 HG11 HG22 ' A' ' 40' ' ' THR . 1.0 OUTLIER -120.0 137.74 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.556 -179.014 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.86 131.88 37.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.972 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.101 HD13 HG23 ' A' ' 60' ' ' VAL . 11.5 mt -67.64 162.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.797 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -125.95 -16.42 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.706 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -145.7 150.36 36.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.803 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.5 p -138.78 129.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -150.23 44.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' CG2' HG23 ' A' ' 58' ' ' VAL . 4.4 m -136.59 124.16 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -135.55 10.32 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.46 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 87.7 t 64.51 118.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.081 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.94 -23.29 8.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.54 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -71.73 165.7 23.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.2 m -100.44 108.87 20.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -93.55 138.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.36 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.14 39.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 168.29 68.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -145.03 123.25 12.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -61.88 116.12 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.279 0.561 . . . . 0.0 111.278 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.452 HD13 ' HG ' ' A' ' 5' ' ' LEU . 49.1 mt -88.33 -43.0 11.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.417 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.803 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -153.94 -178.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.516 179.013 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 19' ' ' ILE . 44.6 m -144.9 123.42 12.43 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.915 HD13 ' HD2' ' A' ' 8' ' ' PRO . 1.2 mp -116.24 -179.37 3.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.864 ' HG3' HG22 ' A' ' 44' ' ' THR . 5.8 tm-20 -174.87 160.04 2.82 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 1.076 HG22 HG11 ' A' ' 16' ' ' VAL . 5.5 p -116.54 -61.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 20.7 m-20 -151.0 -43.28 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -141.4 25.43 2.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.12 98.69 2.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.19 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.864 HG22 ' HG3' ' A' ' 39' ' ' GLU . 17.8 p -93.51 116.26 28.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.62 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.419 ' O ' HG23 ' A' ' 37' ' ' THR . 0.2 OUTLIER -105.83 -176.32 3.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.076 0.465 . . . . 0.0 111.482 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -168.3 167.12 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.342 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.93 HG11 HD11 ' A' ' 5' ' ' LEU . 96.4 t -123.0 115.24 29.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.17 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 77.0 Cg_endo -90.86 35.81 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.047 2.498 . . . . 0.0 112.137 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.542 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.72 175.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.805 ' O ' HG13 ' A' ' 51' ' ' VAL . 15.7 tt0 -162.85 43.31 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.548 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 176.23 167.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -117.12 89.35 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -163.24 -156.95 8.87 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.006 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' GLU . 81.6 t -113.93 146.28 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.53 0.205 . . . . 0.0 111.246 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.744 HG22 HG12 ' A' ' 75' ' ' VAL . 67.6 t -81.3 144.93 9.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.293 0.568 . . . . 0.0 111.348 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.45 ' HE2' ' CA ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -112.7 -51.27 2.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.193 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.3 mt-10 -106.2 172.92 6.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.672 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.932 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.4 p -166.2 126.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.626 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -147.5 74.22 1.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.101 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -171.3 150.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HE3' HG21 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.42 -163.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.904 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.7 93.32 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.107 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.38 33.86 0.8 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.622 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.68 ' CG ' HD12 ' A' ' 18' ' ' ILE . 12.3 p-10 -129.34 140.96 51.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.43 ' CD ' ' HB2' ' A' ' 15' ' ' ASN . 6.8 mttt -73.22 130.47 40.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.785 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -130.86 170.75 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB3' ' CB ' ' A' ' 14' ' ' GLU . 8.7 m -147.62 135.99 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mp0 -41.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 107.53 62.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.378 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.04 23.03 8.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 4' ' ' GLU . 3.2 tp 45.76 57.22 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.029 0.443 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.781 HG22 HG13 ' A' ' 73' ' ' VAL . 2.9 mt -49.35 -80.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.932 HG12 ' HA ' ' A' ' 58' ' ' VAL . 21.3 m -124.94 157.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.415 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 3' ' ' VAL . 78.4 t -118.46 131.32 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.284 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.744 HG12 HG22 ' A' ' 55' ' ' VAL . 16.8 m -118.36 165.57 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' VAL . 4.5 tp10 -72.4 -38.84 68.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.032 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 57.57 122.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.151 0.5 . . . . 0.0 111.893 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ALA . 11.0 pt-20 43.82 55.37 5.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.243 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.21 -49.83 72.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.54 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -138.26 168.98 18.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.067 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.667 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.5 mt -137.84 177.27 8.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.991 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.804 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.4 t -161.63 159.58 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.731 ' HB3' HD13 ' A' ' 71' ' ' LEU . 2.0 mp0 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.361 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.707 HD11 ' HA ' ' A' ' 49' ' ' ALA . 1.2 mt -59.2 164.82 2.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.748 0.309 . . . . 0.0 110.676 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' C ' HD12 ' A' ' 72' ' ' ILE . 20.3 mttt -143.81 172.41 12.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.58 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.794 HG21 HG23 ' A' ' 66' ' ' ILE . 23.7 t -72.83 140.04 80.72 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.032 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.924 ' HD2' HD13 ' A' ' 38' ' ' LEU . 19.4 Cg_endo -63.32 -166.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 112.86 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.87 ' O ' HD12 ' A' ' 10' ' ' ILE . 24.5 t70 -93.19 -13.35 28.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.463 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 9' ' ' ASP . 1.5 pp 33.19 34.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . 39.74 34.16 0.46 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.232 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.25 -115.57 1.57 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.602 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 -85.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.712 0.291 . . . . 0.0 110.964 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 11.8 mt-10 -133.2 177.28 7.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.066 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.437 ' N ' ' HB3' ' A' ' 67' ' ' SER . 8.0 p-10 44.33 95.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.507 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.752 HG11 HG22 ' A' ' 40' ' ' THR . 27.1 m -152.49 141.06 14.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.66 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -82.02 130.32 35.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.56 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.976 HD13 HG23 ' A' ' 60' ' ' VAL . 22.0 mt -62.56 164.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.741 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -128.18 -12.47 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.294 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -146.96 158.25 43.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.002 0.429 . . . . 0.0 111.61 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.841 ' HA ' HG22 ' A' ' 36' ' ' ILE . 7.4 p -148.66 123.87 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.078 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -149.07 44.45 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' CG2' HG23 ' A' ' 58' ' ' VAL . 2.5 m -135.22 120.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -128.95 10.97 6.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.401 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 56' ' ' LYS . 84.6 t 58.84 112.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.2 -15.32 5.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.833 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.97 142.52 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 127.84 33.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.646 HD13 HG23 ' A' ' 51' ' ' VAL . 1.1 pp -108.54 154.7 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.02 179.53 5.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.1 t -85.66 48.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.351 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 164.11 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.59 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' C ' ' HA ' ' A' ' 48' ' ' PRO . 7.9 p-10 -156.74 99.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.768 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -45.49 117.5 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.147 0.498 . . . . 0.0 111.822 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.557 HD12 ' CD1' ' A' ' 5' ' ' LEU . 20.5 mt -92.79 -42.5 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.389 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.898 HD13 HD12 ' A' ' 38' ' ' LEU . 1.2 pp -148.77 -175.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.057 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 19' ' ' ILE . 32.4 m -149.24 124.55 10.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.924 HD13 ' HD2' ' A' ' 8' ' ' PRO . 2.4 mp -113.2 167.18 10.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.674 ' CG ' HG22 ' A' ' 44' ' ' THR . 70.3 tt0 -161.91 164.15 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.692 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.752 HG22 HG11 ' A' ' 16' ' ' VAL . 6.2 p -121.93 -57.54 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -175.33 -37.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -116.59 -19.3 10.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.622 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.14 148.42 49.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.628 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.674 HG22 ' CG ' ' A' ' 39' ' ' GLU . 1.7 p -131.2 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.478 ' O ' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -121.06 -173.51 2.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.223 0.535 . . . . 0.0 111.675 -179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -168.76 159.35 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.044 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.631 HG11 HD22 ' A' ' 5' ' ' LEU . 54.6 t -123.08 126.67 25.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.356 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 86.5 Cg_endo -89.58 34.13 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.882 2.388 . . . . 0.0 112.325 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HA ' HD11 ' A' ' 5' ' ' LEU . . . 81.64 -51.25 0.26 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.582 ' C ' HG22 ' A' ' 51' ' ' VAL . 5.0 tp10 55.03 56.16 6.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -174.16 -169.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.21 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -156.42 65.9 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 29' ' ' ILE . . . -160.84 -139.7 2.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.129 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.04 135.56 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.386 0.136 . . . . 0.0 110.642 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.715 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.3 t -71.93 144.37 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.293 0.568 . . . . 0.0 111.636 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.54 -47.05 2.74 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.265 178.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -110.28 172.53 6.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.429 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.915 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.2 p -164.81 128.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.873 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -146.06 75.81 1.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.642 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.976 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -172.5 155.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.491 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -161.43 -160.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.774 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 21' ' ' VAL . 61.3 t -110.13 76.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.216 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.52 41.23 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.811 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.807 ' CG ' HD12 ' A' ' 18' ' ' ILE . 16.7 p-10 -128.73 138.63 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.924 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.617 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -72.05 110.71 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.792 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.794 HG23 HG21 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -137.99 168.83 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -152.85 162.7 40.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 111.283 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.445 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -42.19 107.4 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.488 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' 6' ' ' LYS . . . 98.91 70.41 0.96 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.783 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.95 21.35 4.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.373 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 4' ' ' GLU . 1.7 tp 43.52 57.54 3.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.113 0.482 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.823 HG22 HG13 ' A' ' 73' ' ' VAL . 3.7 mt -49.95 -73.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.096 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.915 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.1 m -135.45 145.23 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 3' ' ' VAL . 92.4 t -104.97 136.74 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 51' ' ' VAL . 1.2 m -126.69 167.54 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.0 112.295 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HG3' ' CD2' ' A' ' 2' ' ' LEU . 1.3 mt-10 -101.1 46.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.665 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -36.04 143.37 0.06 Allowed 'General case' 0 C--N 1.335 -0.058 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 77' ' ' ALA . 6.6 pt-20 48.3 27.41 1.33 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.528 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -50.52 156.93 2.3 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.597 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.2 t -112.61 -28.21 7.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 110.913 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.069 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.778 0.323 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp -101.05 178.34 4.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.768 HG11 HG11 ' A' ' 51' ' ' VAL . 2.7 t -142.86 161.62 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.52 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -136.51 117.59 14.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.401 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.84 HD21 HG11 ' A' ' 47' ' ' VAL . 1.6 tp -68.65 160.81 29.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -143.75 144.42 31.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 111.415 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.63 HG22 HD11 ' A' ' 72' ' ' ILE . 86.8 t -41.19 140.58 1.16 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.035 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.61 ' HD2' HG13 ' A' ' 7' ' ' VAL . 61.0 Cg_endo -75.32 -168.04 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.24 1.96 . . . . 0.0 113.076 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 45' ' ' MET . 0.1 OUTLIER -98.65 83.78 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.952 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.923 ' CG2' HD23 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -78.53 1.43 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.09 -58.16 1.45 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.21 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -39.48 -85.42 0.01 OUTLIER Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.288 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 16' ' ' VAL . 23.1 p80 -179.08 -174.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.898 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -64.7 174.8 1.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.418 ' CA ' ' O ' ' A' ' 66' ' ' ILE . 5.5 p-10 43.75 78.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.77 HG11 HG22 ' A' ' 40' ' ' THR . 25.1 m -122.26 -178.02 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.433 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -106.59 118.45 36.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.915 0.388 . . . . 0.0 111.401 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.998 HD13 HG23 ' A' ' 60' ' ' VAL . 19.5 mt -55.21 165.29 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.898 HG12 HG22 ' A' ' 37' ' ' THR . 0.6 OUTLIER -136.5 2.99 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.508 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -167.32 152.21 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.297 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.757 ' HA ' HG22 ' A' ' 36' ' ' ILE . 81.2 t -137.26 120.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.759 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -148.42 60.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.926 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.661 HG11 HG11 ' A' ' 73' ' ' VAL . 2.4 m -142.1 113.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -120.94 96.25 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 56' ' ' LYS . 63.3 t -40.21 116.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.56 15.13 7.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.66 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.91 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 m -70.25 146.29 50.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.039 HD13 HG11 ' A' ' 75' ' ' VAL . 2.8 pt -136.69 154.81 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.51 -174.88 3.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG13 ' OE2' ' A' ' 50' ' ' GLU . 11.6 t -91.94 47.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 p30 172.68 67.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.058 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -152.99 108.58 3.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.564 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -46.95 119.12 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.092 0.472 . . . . 0.0 111.874 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 36' ' ' ILE . 21.5 mt -94.52 -39.39 10.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.877 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.11 -177.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.349 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.898 HG22 HG12 ' A' ' 19' ' ' ILE . 70.5 m -142.53 109.11 5.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.743 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.923 HD23 ' CG2' ' A' ' 10' ' ' ILE . 1.8 tp -95.02 155.93 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.679 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.731 ' HB3' HG21 ' A' ' 19' ' ' ILE . 33.6 tt0 -166.31 144.63 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.655 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.798 HG23 ' HB ' ' A' ' 10' ' ' ILE . 3.4 p -104.99 -59.46 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.425 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.7 p30 -174.63 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -124.34 35.75 4.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . 177.25 131.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.252 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.706 HG22 ' CG ' ' A' ' 39' ' ' GLU . 73.6 p -119.21 116.33 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -123.7 128.02 49.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.253 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.434 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 1.0 OUTLIER -113.23 174.47 5.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.757 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.84 HG11 HD21 ' A' ' 5' ' ' LEU . 76.9 t -120.59 116.3 31.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 85.2 Cg_endo -87.37 37.27 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.94 2.427 . . . . 0.0 112.359 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.54 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 46.83 93.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.856 0.36 . . . . 0.0 111.11 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.598 ' C ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -93.38 63.03 3.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.768 HG11 HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER 163.43 148.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.333 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.571 ' O ' HD11 ' A' ' 29' ' ' ILE . . . -96.35 -168.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.368 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 102.14 -146.52 16.98 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.839 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.95 135.4 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.538 0.209 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.588 ' HA ' HG12 ' A' ' 75' ' ' VAL . 61.5 t -68.22 147.05 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.69 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.53 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.67 -50.75 2.4 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.277 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.81 166.32 13.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.409 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 73' ' ' VAL . 5.4 p -152.17 138.56 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.318 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ILE . 6.9 mmtt -140.65 59.35 1.55 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.306 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.998 HG23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -157.47 143.58 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.61 -174.2 4.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.76 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 21' ' ' VAL . 60.5 t -98.04 92.73 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.45 35.57 1.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.628 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.93 ' OD1' HD12 ' A' ' 18' ' ' ILE . 19.6 p-10 -119.13 172.89 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.958 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -96.54 123.06 40.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -129.16 161.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.161 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.9 p -135.42 127.28 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.421 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.47 ' OE2' HD12 ' A' ' 10' ' ' ILE . 42.5 mt-10 -40.91 115.02 0.53 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 88.17 64.65 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.011 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.78 -165.83 11.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.024 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 4' ' ' GLU . 8.5 tp -104.49 89.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.969 0.414 . . . . 0.0 110.372 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.798 HG23 ' CG1' ' A' ' 60' ' ' VAL . 2.1 mt -87.35 -80.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.944 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.787 HG13 HG22 ' A' ' 72' ' ' ILE . 17.4 m -122.41 135.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.064 0.459 . . . . 0.0 111.891 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 3' ' ' VAL . 41.4 t -103.78 144.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.338 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.039 HG11 HD13 ' A' ' 29' ' ' ILE . 10.9 m -129.07 165.41 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.122 0.487 . . . . 0.0 112.008 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 6.3 tt0 -83.73 -26.49 29.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.58 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . 60.99 116.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.075 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 45.61 57.69 4.8 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.154 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.85 116.58 4.65 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.445 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.3 133.12 47.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.044 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.82 0.343 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mp -63.99 172.57 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.754 ' O ' HG13 ' A' ' 74' ' ' VAL . 19.8 t -139.27 146.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 1.3 mp0 -124.34 100.63 6.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.877 ' CD1' HD12 ' A' ' 35' ' ' LEU . 44.1 mt -63.88 131.24 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.72 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.2 mtmt -130.29 55.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.861 HG22 HD11 ' A' ' 72' ' ' ILE . 38.2 t 58.75 147.04 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.442 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.741 ' CD ' HD23 ' A' ' 38' ' ' LEU . 98.8 Cg_endo -94.29 -178.39 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.756 2.304 . . . . 0.0 112.453 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.672 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -64.2 173.69 1.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.012 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -169.71 28.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.754 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 38.35 94.96 0.01 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.366 -0.445 . . . . 0.0 113.397 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.37 -106.63 0.33 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.576 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.04 -175.96 5.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.892 0.377 . . . . 0.0 111.023 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.52 -168.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.194 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.468 ' N ' ' CB ' ' A' ' 67' ' ' SER . 3.6 p30 44.15 94.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.895 HG11 HG22 ' A' ' 40' ' ' THR . 0.1 OUTLIER -142.64 -176.08 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.372 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -112.06 138.68 48.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.055 HD13 HG23 ' A' ' 60' ' ' VAL . 28.8 mt -73.45 161.91 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 37' ' ' THR . 0.2 OUTLIER -134.62 -7.02 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.929 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -152.85 155.26 36.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.863 ' HA ' HG22 ' A' ' 36' ' ' ILE . 61.5 t -147.57 126.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.313 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -153.3 32.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.484 ' CB ' HG11 ' A' ' 73' ' ' VAL . 2.3 m -122.98 123.46 68.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -135.0 9.76 3.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.492 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 58' ' ' VAL . 87.3 t 63.4 131.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.85 -22.51 18.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.371 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.51 139.03 30.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.7 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -68.16 162.22 25.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 75' ' ' VAL . 1.2 pp -143.73 130.19 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.15 -174.43 4.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.935 0.398 . . . . 0.0 111.008 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 31' ' ' VAL . 11.1 t -90.32 41.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER 168.05 67.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.905 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -141.78 116.62 9.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.867 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -59.65 115.32 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.877 HD12 ' CD1' ' A' ' 5' ' ' LEU . 16.6 mt -90.37 -41.95 11.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.406 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.863 HG22 ' HA ' ' A' ' 21' ' ' VAL . 1.3 pp -150.43 -175.97 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.884 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.79 ' C ' HG23 ' A' ' 19' ' ' ILE . 3.7 m -133.3 152.59 51.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.763 ' CD2' HD13 ' A' ' 36' ' ' ILE . 2.4 mm? -134.45 166.8 22.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.72 ' CD ' HG22 ' A' ' 44' ' ' THR . 76.0 tt0 -174.4 164.07 3.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.401 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.895 HG22 HG11 ' A' ' 16' ' ' VAL . 13.5 p -120.71 -72.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.892 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.466 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.9 m-20 -159.72 25.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.731 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm 176.24 -43.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.65 128.76 45.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.72 HG22 ' CD ' ' A' ' 39' ' ' GLU . 5.2 p -116.71 115.81 26.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.44 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -104.07 -165.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 5.7 p30 -175.69 167.34 3.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.73 HG11 HD13 ' A' ' 5' ' ' LEU . 74.0 t -112.03 104.15 55.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 70.3 Cg_endo -89.35 42.11 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.118 2.545 . . . . 0.0 111.886 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.7 177.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.774 ' O ' HG13 ' A' ' 51' ' ' VAL . 23.1 pt-20 -163.19 38.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 175.74 168.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -112.27 93.15 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.961 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -165.35 -140.15 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.259 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 76' ' ' GLU . 90.9 t -135.08 145.24 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 0.0 111.065 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 75' ' ' VAL . 63.2 t -75.16 145.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 0.0 111.397 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -47.59 2.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.466 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.92 167.2 10.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.644 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.939 ' HA ' HG12 ' A' ' 73' ' ' VAL . 12.4 p -162.87 124.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.93 80.93 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.055 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.32 151.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.56 -173.87 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.97 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 21' ' ' VAL . 46.3 t -101.31 77.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.7 41.49 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.94 ' OD1' HD12 ' A' ' 18' ' ' ILE . 3.9 p30 -132.8 164.04 27.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.708 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -88.76 105.0 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.18 0.514 . . . . 0.0 110.705 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.734 HG23 HG21 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -132.89 164.61 34.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.369 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.468 ' CB ' ' N ' ' A' ' 15' ' ' ASN . 54.3 p -167.2 168.32 13.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -45.72 91.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.196 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 124.34 57.56 0.18 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.76 9.02 6.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.928 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.467 HD11 ' CG2' ' A' ' 74' ' ' VAL . 4.2 tp 47.25 46.86 16.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.679 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.861 HD11 HG22 ' A' ' 7' ' ' VAL . 9.1 mt -43.26 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.5 m -135.36 147.25 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.51 . . . . 0.0 111.99 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 3' ' ' VAL . 98.5 t -109.84 140.72 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.705 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.599 HG12 HG22 ' A' ' 55' ' ' VAL . 16.4 m -123.16 161.91 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.127 0.489 . . . . 0.0 112.303 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' VAL . 2.8 tt0 -68.58 -42.28 78.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.016 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . 59.4 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.97 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 52' ' ' ALA . 3.2 pt-20 37.78 59.87 1.24 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.772 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 80' ' ' THR . . . -90.3 -134.54 5.73 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.529 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 1.5 t 174.34 114.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.099 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 2' ' ' LEU . 0.2 OUTLIER -90.19 175.18 7.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.788 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.827 ' O ' HG13 ' A' ' 74' ' ' VAL . 6.2 t -125.51 162.76 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.451 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HB3' HD13 ' A' ' 71' ' ' LEU . 11.2 mt-10 -125.48 90.32 3.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.434 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -51.84 152.16 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.572 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -140.12 151.54 45.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.205 0.526 . . . . 0.0 111.626 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.753 HG11 HG21 ' A' ' 66' ' ' ILE . 85.2 t -47.11 143.13 4.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.88 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.665 ' HD2' HG13 ' A' ' 7' ' ' VAL . 43.5 Cg_endo -70.78 -167.47 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.149 1.9 . . . . 0.0 112.738 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 76.86 2.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.562 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.86 HG12 HG21 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -88.05 60.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.683 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -24.28 84.53 0.0 OUTLIER Glycine 0 C--N 1.34 0.799 0 O-C-N 123.986 0.804 . . . . 0.0 114.494 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -161.54 -62.4 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.216 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 169.43 158.63 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' CA ' ' HA ' ' A' ' 67' ' ' SER . 0.3 OUTLIER -72.47 63.74 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.65 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -179.34 57.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.86 HG21 HG12 ' A' ' 10' ' ' ILE . 17.1 m -106.38 -175.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.173 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.18 130.6 52.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.933 HD13 HG23 ' A' ' 60' ' ' VAL . 5.6 mt -66.15 161.15 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.956 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.6 -37.98 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.593 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -118.08 166.18 12.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 21' ' ' VAL . 15.0 p -159.38 116.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -135.64 61.4 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.913 HG11 HG11 ' A' ' 73' ' ' VAL . 5.8 m -145.18 118.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.69 23.17 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 56' ' ' LYS . 71.8 t 66.73 -86.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.991 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.7 62.03 0.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.946 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 25' ' ' VAL . 2.2 t0 -129.94 171.03 13.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.709 0.29 . . . . 0.0 110.761 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 m -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.903 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.478 HD13 HG23 ' A' ' 51' ' ' VAL . 1.1 pt -132.21 153.2 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 0.0 111.344 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.91 174.06 11.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 3.1 t -78.51 54.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 3.6 p30 162.09 70.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.83 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -153.81 124.39 7.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.78 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.53 117.38 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.277 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.423 HD13 ' HG ' ' A' ' 5' ' ' LEU . 19.1 mt -90.42 -40.78 11.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.849 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.591 HD13 ' HB ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -157.68 -161.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.862 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.593 ' N ' ' HB3' ' A' ' 20' ' ' ALA . 93.1 m -157.7 51.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.329 0.585 . . . . 0.0 109.846 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -41.83 163.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.859 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.912 ' CD ' HG22 ' A' ' 44' ' ' THR . 70.1 tt0 -172.76 154.42 2.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.829 HG22 ' CG1' ' A' ' 16' ' ' VAL . 50.2 p -102.01 -82.87 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' N ' ' OG1' ' A' ' 40' ' ' THR . 16.7 t70 -150.96 21.41 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -179.98 -41.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.03 105.58 17.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.234 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.912 HG22 ' CD ' ' A' ' 39' ' ' GLU . 3.5 p -91.74 115.07 27.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -95.43 138.9 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.478 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 37' ' ' THR . 3.7 m-20 -119.89 144.41 47.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.955 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.591 ' HB ' HD13 ' A' ' 36' ' ' ILE . 76.5 t -122.09 112.8 31.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 83.6 Cg_endo -88.4 35.41 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.963 2.442 . . . . 0.0 112.331 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 54.23 168.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.035 0.445 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.2 tp10 -165.65 67.88 0.12 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.484 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -173.87 176.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.237 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -139.67 79.01 1.69 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.627 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.43 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -167.99 -140.66 2.97 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.308 -1.425 . . . . 0.0 113.857 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -130.94 139.09 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.83 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.077 HG22 HG12 ' A' ' 75' ' ' VAL . 57.7 t -79.53 146.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.408 0.623 . . . . 0.0 111.527 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.59 -44.45 2.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.045 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -109.88 158.0 18.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.453 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.602 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.7 p -151.44 119.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -131.07 68.89 1.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.683 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.933 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -172.46 154.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.643 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -169.11 170.69 8.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.591 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.443 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 54.1 t -82.03 88.42 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.28 46.88 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.72 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.793 ' OD1' HD12 ' A' ' 18' ' ' ILE . 19.0 p-10 -139.46 176.53 8.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.772 0.32 . . . . 0.0 111.042 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.857 ' O ' HD12 ' A' ' 66' ' ' ILE . 7.8 tttt -104.07 156.09 18.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.669 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -140.76 172.56 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.565 ' N ' HG23 ' A' ' 66' ' ' ILE . 7.2 p -147.13 48.39 1.13 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 36.4 mt-10 39.95 55.21 2.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 138.0 69.97 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.442 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.93 29.07 6.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.553 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 4' ' ' GLU . 9.9 tp 48.09 56.67 7.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 0.0 110.571 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.787 HG23 ' CG1' ' A' ' 60' ' ' VAL . 3.3 mt -45.98 -82.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.913 HG11 HG11 ' A' ' 23' ' ' VAL . 27.3 m -122.0 160.15 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.17 0.51 . . . . 0.0 111.875 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 3' ' ' VAL . 76.3 t -128.93 120.58 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.907 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.077 HG12 HG22 ' A' ' 55' ' ' VAL . 29.7 m -112.09 156.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.496 ' HG2' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -64.84 -31.08 72.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.656 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 53.62 159.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.061 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 52' ' ' ALA . 3.5 mt-10 72.46 -65.41 0.35 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.612 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.13 -178.4 38.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.542 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -177.35 -49.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.887 0.375 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.101 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.806 0.336 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -53.17 174.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 51' ' ' VAL . 7.9 t -141.84 152.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.762 ' HB3' HD13 ' A' ' 71' ' ' LEU . 7.3 mt-10 -128.37 100.79 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.376 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -60.93 157.56 15.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.069 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 8.5 mttp -142.13 145.07 33.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.314 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.78 HG22 HD11 ' A' ' 72' ' ' ILE . 95.9 t -48.23 141.24 8.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.04 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.753 ' CD ' HD23 ' A' ' 38' ' ' LEU . 38.0 Cg_endo -68.72 -166.08 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.2 1.934 . . . . 0.0 112.24 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.926 ' O ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -92.59 -13.04 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.645 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.926 HD12 ' O ' ' A' ' 9' ' ' ASP . 1.2 pp 33.88 33.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . 36.63 31.67 0.05 OUTLIER Glycine 0 C--N 1.336 0.531 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.684 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.65 -132.19 2.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.643 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.92 -162.49 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.739 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -68.09 -179.67 1.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 44.03 95.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.881 HG11 HG22 ' A' ' 40' ' ' THR . 30.9 m -146.54 137.12 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.92 126.22 29.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.522 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.659 HD13 ' H ' ' A' ' 61' ' ' LYS . 3.7 mt -55.72 165.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.894 HG12 HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -140.75 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.066 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.568 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -177.95 146.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 111.099 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.804 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.4 p -137.81 124.39 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.981 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mm-40 -148.82 39.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.436 ' CB ' HG11 ' A' ' 73' ' ' VAL . 3.0 m -120.07 112.77 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.357 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -122.84 97.6 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 25' ' ' VAL . 23.5 m -39.05 111.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.921 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.93 21.17 4.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.67 143.11 50.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 54' ' ' VAL . 2.2 m -69.83 127.08 31.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.779 ' CD1' HG11 ' A' ' 75' ' ' VAL . 2.6 pt -108.09 169.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -178.58 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.4 t -94.34 33.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 176.23 62.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.409 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -140.93 108.34 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -48.76 116.23 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.187 0.518 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.52 HD12 HD11 ' A' ' 5' ' ' LEU . 70.2 mt -94.63 -44.29 7.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.788 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -149.93 -173.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.433 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.894 HG22 HG12 ' A' ' 19' ' ' ILE . 47.5 m -149.12 107.67 3.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 36' ' ' ILE . 2.7 mm? -92.19 151.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.755 ' CB ' HG21 ' A' ' 19' ' ' ILE . 78.2 tt0 -155.51 150.1 26.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.892 0.377 . . . . 0.0 110.991 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.881 HG22 HG11 ' A' ' 16' ' ' VAL . 3.0 p -112.06 -61.39 1.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.988 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 15.3 t0 -168.53 -41.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 37.77 3.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.51 118.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.606 HG22 ' CG ' ' A' ' 39' ' ' GLU . 2.3 p -113.04 119.95 39.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.965 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.03 153.56 21.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.4 p30 -133.12 143.91 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.572 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.633 ' CG2' HD11 ' A' ' 36' ' ' ILE . 93.8 t -105.87 108.09 60.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 71.0 Cg_endo -88.07 37.74 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.043 2.495 . . . . 0.0 112.469 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 44.66 95.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 111.338 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.595 ' C ' HG12 ' A' ' 51' ' ' VAL . 4.2 mt-10 -87.39 53.66 2.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 3' ' ' VAL . 1.2 p 161.85 141.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -83.14 -162.26 0.59 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.79 -145.17 15.93 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.089 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 76' ' ' GLU . 45.7 t -145.44 138.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.401 0.143 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.813 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.0 t -76.25 146.98 8.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.316 0.579 . . . . 0.0 111.796 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -119.71 -47.87 2.4 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.122 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -109.54 172.4 6.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.652 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.915 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -164.39 137.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HE2' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -152.27 67.96 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.402 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.712 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -169.59 152.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.639 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.659 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -171.81 -167.24 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.521 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.87 90.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.45 -19.94 0.71 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.892 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 2.3 p-10 -98.59 167.25 10.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.095 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.54 134.61 44.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -127.92 162.83 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.054 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -145.87 144.63 30.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -41.08 106.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 94.26 70.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.608 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.35 21.13 3.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.416 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.804 HD11 ' CG2' ' A' ' 74' ' ' VAL . 5.5 tp 47.58 59.67 3.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.788 HG22 HG13 ' A' ' 73' ' ' VAL . 3.6 mt -52.35 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.915 HG12 ' HA ' ' A' ' 58' ' ' VAL . 20.8 m -129.83 148.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 111.597 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.804 ' CG2' HD11 ' A' ' 71' ' ' LEU . 79.3 t -115.1 134.25 58.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 55' ' ' VAL . 32.0 m -121.84 177.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.155 0.502 . . . . 0.0 112.205 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' VAL . 1.5 tt0 -82.81 -33.53 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.268 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . 70.23 29.81 3.58 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.442 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -67.22 0.28 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.494 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 52' ' ' ALA . . . 44.14 92.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.228 -0.896 . . . . 0.0 113.055 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.9 p -120.54 98.44 6.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.777 0.323 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.095 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 75' ' ' VAL . 2.4 mp -55.18 177.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.772 HG21 ' CG1' ' A' ' 51' ' ' VAL . 3.6 t -144.31 161.27 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HB3' HD13 ' A' ' 71' ' ' LEU . 63.5 mt-10 -129.87 100.06 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.552 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.651 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -57.75 164.09 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.023 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' CD ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -154.18 155.61 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.273 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.612 HG21 HG23 ' A' ' 66' ' ' ILE . 96.5 t -53.76 140.74 48.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.727 ' CD ' HD23 ' A' ' 38' ' ' LEU . 70.5 Cg_endo -73.69 -168.44 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.65 2.233 . . . . 0.0 113.03 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.4 OUTLIER -82.9 92.94 7.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.79 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.916 HG12 HG21 ' A' ' 16' ' ' VAL . 1.3 pp -112.23 70.23 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.042 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.23 -89.9 1.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.56 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.33 41.46 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.631 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.02 179.63 7.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.743 0.306 . . . . 0.0 111.037 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' CG ' ' HB2' ' A' ' 67' ' ' SER . 2.8 mp0 -117.31 81.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 169.32 73.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.928 HG23 HG22 ' A' ' 66' ' ' ILE . 4.0 m -134.88 130.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.366 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.68 140.76 49.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.705 HD13 HG23 ' A' ' 60' ' ' VAL . 5.8 mt -74.9 161.33 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.709 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.511 HG12 ' HB ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -124.35 -38.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.794 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -117.95 170.8 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 36' ' ' ILE . 10.6 p -159.93 124.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.313 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.702 ' O ' HG13 ' A' ' 23' ' ' VAL . 39.1 mt-10 -158.64 90.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.831 HG11 HG11 ' A' ' 73' ' ' VAL . 2.6 m -163.95 113.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.361 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.5 m120 -114.7 96.23 5.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.506 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG12 ' C ' ' A' ' 56' ' ' LYS . 2.3 m -42.68 92.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.546 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 136.31 -15.73 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.588 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.5 m-20 -74.28 169.92 16.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.84 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 m -96.36 103.16 15.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.718 HD13 HG11 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -84.06 158.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.45 -176.79 4.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.941 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 31' ' ' VAL . 3.5 m -90.21 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.316 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 172.08 73.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.783 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 4.4 p-10 -150.25 107.84 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.614 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -48.76 118.6 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 111.417 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 36' ' ' ILE . 81.8 mt -92.55 -39.5 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.08 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -161.81 -178.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.626 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 19' ' ' ILE . 76.3 m -142.08 56.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.669 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.727 HD23 ' CD ' ' A' ' 8' ' ' PRO . 3.2 mm? -41.45 166.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HB2' HG22 ' A' ' 44' ' ' THR . 67.1 tt0 -168.52 153.89 6.53 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.306 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.605 HG22 HG11 ' A' ' 16' ' ' VAL . 29.9 p -100.04 -72.65 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.707 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.1 p-10 -160.22 26.99 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.601 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.04 -42.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.875 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.85 124.26 43.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.044 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.591 HG22 ' HB2' ' A' ' 39' ' ' GLU . 56.9 p -107.5 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.054 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.441 ' HB3' ' CG ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -97.5 133.09 42.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 2.9 p30 -118.3 144.31 45.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.229 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.651 HG11 HD11 ' A' ' 5' ' ' LEU . 92.4 t -113.34 116.58 46.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.417 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 78.4 Cg_endo -87.42 27.8 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.964 2.443 . . . . 0.0 112.619 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.644 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.28 151.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 111.297 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.767 ' O ' HG13 ' A' ' 51' ' ' VAL . 9.4 tp10 -145.98 70.9 1.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.772 ' CG1' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER 176.81 153.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.038 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -121.87 77.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.77 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.98 -130.84 1.23 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.179 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 27' ' ' ASP . 61.8 t -137.18 138.77 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.45 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.835 HG22 HG12 ' A' ' 75' ' ' VAL . 70.4 t -78.6 146.59 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.519 . . . . 0.0 111.291 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' C ' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.6 -47.08 2.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.589 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.05 175.04 5.58 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.82 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.642 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -163.39 126.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.525 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.1 mttt -136.87 69.01 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.766 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -171.78 159.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.723 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.556 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -171.89 -172.89 1.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.523 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.61 79.19 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.272 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.13 44.21 0.07 OUTLIER Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.701 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.514 ' CG ' HD12 ' A' ' 18' ' ' ILE . 7.7 p-10 -148.01 147.01 29.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.88 0.371 . . . . 0.0 111.108 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 137.18 40.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.928 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -131.27 172.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.457 ' HB2' ' CG ' ' A' ' 14' ' ' GLU . 7.1 p -152.2 142.78 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.203 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 76.9 mt-10 -44.74 97.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.201 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 99.8 62.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -114.26 22.03 14.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.357 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 4' ' ' GLU . 13.9 tp 48.15 53.58 11.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.977 0.418 . . . . 0.0 110.686 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.842 HG22 HG13 ' A' ' 73' ' ' VAL . 3.7 mt -48.11 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.044 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 72' ' ' ILE . 22.8 m -123.05 159.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.559 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 3' ' ' VAL . 27.9 t -127.75 132.52 68.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.934 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.835 HG12 HG22 ' A' ' 55' ' ' VAL . 33.2 m -119.38 -179.64 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -93.2 -37.19 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.514 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 57.21 133.44 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.342 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 52' ' ' ALA . 10.9 pt-20 40.78 58.13 2.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.666 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.8 -21.32 74.69 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.421 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.1 p 55.68 177.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.82 0.343 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.086 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.874 0.369 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 75' ' ' VAL . 3.0 mp -62.63 173.79 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.955 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.894 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.7 t -134.69 160.27 41.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HG3' HG22 ' A' ' 74' ' ' VAL . 31.0 mp0 -133.01 103.98 6.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.552 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.447 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -60.9 159.05 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.651 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 15.5 mttt -148.72 145.04 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.76 HG22 HD11 ' A' ' 72' ' ' ILE . 72.3 t -47.91 140.45 8.66 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.998 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.941 ' HD2' HD22 ' A' ' 38' ' ' LEU . 71.8 Cg_endo -76.94 -169.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.677 2.252 . . . . 0.0 112.89 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.443 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -81.85 84.45 6.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.791 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.867 HG12 HG21 ' A' ' 16' ' ' VAL . 1.1 pp -103.43 66.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 0.0 110.923 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.497 ' HA3' ' CE1' ' A' ' 13' ' ' HIS . . . 89.06 11.38 65.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.072 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.93 17.51 29.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.82 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.497 ' CE1' ' HA3' ' A' ' 11' ' ' GLY . 0.4 OUTLIER -123.32 -175.83 3.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.856 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 25.7 mp0 -105.45 176.65 5.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.993 0.425 . . . . 0.0 111.451 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 7.0 p-10 45.38 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.867 HG21 HG12 ' A' ' 10' ' ' ILE . 35.3 m -136.18 -175.67 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.355 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.33 120.34 38.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.824 0.345 . . . . 0.0 111.369 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.783 HD12 ' OD2' ' A' ' 64' ' ' ASP . 27.2 mt -68.18 159.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.19 -15.81 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.51 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.601 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.0 150.47 32.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 21' ' ' VAL . 12.8 p -140.21 124.19 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.933 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -132.09 34.69 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG21 HG11 ' A' ' 73' ' ' VAL . 7.8 m -132.93 115.21 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.416 ' O ' HG12 ' A' ' 25' ' ' VAL . 16.1 t30 -114.75 14.91 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER 62.24 118.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.15 23.39 32.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.45 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.82 148.03 30.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 m -69.47 136.17 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.023 HD13 HG11 ' A' ' 75' ' ' VAL . 2.9 pt -126.86 160.33 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.363 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.19 -176.21 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.9 t -91.55 41.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.247 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 167.14 71.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.489 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 49' ' ' ALA . 1.5 p30 -145.58 120.32 9.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.974 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -54.55 117.06 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 47.5 mt -92.62 -36.33 13.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.876 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.529 HG12 HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -159.11 -176.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.266 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.601 ' N ' ' HB3' ' A' ' 20' ' ' ALA . 84.9 m -144.56 45.79 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.502 0.667 . . . . 0.0 109.447 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.941 HD22 ' HD2' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -39.69 165.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.362 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.913 ' CD ' HG22 ' A' ' 44' ' ' THR . 76.6 tt0 -174.63 164.55 3.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.086 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 10' ' ' ILE . 6.6 p -120.35 -158.38 0.75 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.38 -22.96 66.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 54.81 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.78 113.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.913 HG22 ' CD ' ' A' ' 39' ' ' GLU . 2.1 p -98.9 141.81 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.189 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.443 ' HG3' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -143.34 131.38 21.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.059 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.39 173.59 7.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ALA . 94.4 t -143.72 116.78 5.85 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 65.1 Cg_endo -90.92 36.83 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.203 2.602 . . . . 0.0 112.087 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 57.88 160.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.632 ' C ' HG12 ' A' ' 51' ' ' VAL . 3.5 mt-10 -139.33 35.53 2.07 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.881 HG11 HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER 165.25 153.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.417 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 51' ' ' VAL . . . -85.49 -165.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.069 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 111.46 -157.24 15.08 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.715 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.73 134.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 75' ' ' VAL . 58.2 t -68.35 145.39 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.245 0.545 . . . . 0.0 111.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.51 ' O ' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.24 -44.56 2.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.251 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 19.6 mm-40 -111.86 174.66 5.77 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.636 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.534 ' HA ' HG12 ' A' ' 73' ' ' VAL . 12.5 p -173.83 137.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.508 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.12 51.01 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.107 0.479 . . . . 0.0 110.231 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.813 ' CG1' HG23 ' A' ' 72' ' ' ILE . 28.3 m -155.15 164.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.155 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -170.72 145.78 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 62' ' ' VAL . 7.2 p -55.99 86.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . 122.91 62.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.512 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.783 ' OD2' HD12 ' A' ' 18' ' ' ILE . 2.0 p30 -153.34 178.58 9.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -94.83 112.92 24.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.861 HG21 HD21 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -125.99 165.48 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.483 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.447 ' HB2' ' CB ' ' A' ' 14' ' ' GLU . 4.5 p -147.53 141.11 25.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.96 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 28.7 mt-10 -43.08 109.14 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 83.83 70.43 1.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.24 10.83 9.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.716 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp 60.51 48.48 7.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.423 0.63 . . . . 0.0 109.964 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.942 HG22 HG13 ' A' ' 73' ' ' VAL . 56.0 mt -46.84 -83.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.725 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.942 HG13 HG22 ' A' ' 72' ' ' ILE . 29.3 m -118.38 159.13 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 0.0 111.616 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 3' ' ' VAL . 90.7 t -131.4 141.1 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.91 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.023 HG11 HD13 ' A' ' 29' ' ' ILE . 24.4 m -121.87 -178.51 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.242 0.544 . . . . 0.0 112.4 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HG3' ' CE ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -95.56 -27.35 15.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.498 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . 65.08 107.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.704 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 47.61 38.5 8.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.49 -98.97 0.1 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.532 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -107.01 -25.69 11.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.111 -179.941 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.868 0.366 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 76' ' ' GLU . 2.6 mp -83.09 171.31 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.05 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.8 t -134.8 150.21 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.711 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.559 ' HA ' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -119.46 104.01 9.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.221 179.212 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.761 HD21 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -69.73 161.09 30.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.007 0.432 . . . . 0.0 111.264 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -152.81 159.7 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.727 HG21 HG23 ' A' ' 66' ' ' ILE . 87.1 t -50.0 140.06 16.7 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.776 ' CD ' HD23 ' A' ' 38' ' ' LEU . 60.9 Cg_endo -73.79 -168.17 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.578 2.185 . . . . 0.0 113.052 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -89.87 86.89 6.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.745 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.975 HG12 HG21 ' A' ' 16' ' ' VAL . 1.2 pp -101.05 51.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.57 -80.34 0.28 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.509 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.9 41.69 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.546 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -148.66 162.35 39.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.734 0.302 . . . . 0.0 110.798 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' CA ' ' HB3' ' A' ' 67' ' ' SER . 6.2 mt-10 -104.12 87.21 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER 162.64 76.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.434 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.975 HG21 HG12 ' A' ' 10' ' ' ILE . 32.6 m -138.83 133.6 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.547 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -76.06 137.05 39.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.047 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.136 HD13 HG23 ' A' ' 60' ' ' VAL . 7.9 mt -72.16 161.18 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.026 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.18 -20.98 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.825 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.702 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -140.07 158.52 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 111.423 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.58 HG21 ' N ' ' A' ' 62' ' ' VAL . 97.1 t -145.92 127.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.9 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.612 ' O ' HG13 ' A' ' 23' ' ' VAL . 45.5 mm-40 -149.92 77.11 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.7 m -160.66 141.62 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.224 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -137.58 18.42 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.256 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 56' ' ' LYS . 73.8 t 65.92 -82.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 58.84 2.48 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.575 ' O ' HG13 ' A' ' 54' ' ' VAL . 6.6 t0 -128.4 166.73 18.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.743 0.306 . . . . 0.0 110.821 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.5 m -90.52 125.49 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.798 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.805 HD13 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -120.35 143.24 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.06 -171.78 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.218 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.5 t -90.0 44.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.62 73.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.519 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 4.0 p-10 -152.69 98.82 2.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -45.12 116.4 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.183 0.516 . . . . 0.0 111.611 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.534 ' HG ' ' HB2' ' A' ' 49' ' ' ALA . 26.4 mt -91.09 -41.68 10.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.067 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -154.88 -178.39 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.455 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.583 ' O ' HG23 ' A' ' 19' ' ' ILE . 96.4 m -144.39 57.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.776 HD23 ' CD ' ' A' ' 8' ' ' PRO . 2.1 mm? -39.16 162.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.322 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.728 ' HG3' HG22 ' A' ' 44' ' ' THR . 65.3 tt0 -175.41 156.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.786 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.431 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -123.71 -83.79 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.585 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.6 OUTLIER -144.56 -42.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -125.29 42.93 3.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . 176.21 136.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.304 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.728 HG22 ' HG3' ' A' ' 39' ' ' GLU . 2.4 p -129.48 120.77 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.569 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.613 ' HB2' HG23 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -108.58 156.17 19.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -179.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 9.0 p-10 -141.43 144.82 34.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.458 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.761 HG11 HD21 ' A' ' 5' ' ' LEU . 93.9 t -117.29 118.34 35.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 87.7 Cg_endo -90.02 30.13 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.015 2.477 . . . . 0.0 112.319 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.668 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 51.35 102.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.281 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.95 67.77 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.855 HG11 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -158.72 -172.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.993 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -159.66 62.97 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -157.54 -119.81 0.6 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.059 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 27' ' ' ASP . 63.6 t -146.33 140.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.506 0.193 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.91 HG22 HG12 ' A' ' 75' ' ' VAL . 85.7 t -78.07 155.03 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.346 0.593 . . . . 0.0 111.308 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.662 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -127.09 -46.02 1.54 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.189 179.072 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -107.96 165.09 11.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.319 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.801 ' HA ' HG12 ' A' ' 73' ' ' VAL . 14.6 p -162.17 123.81 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -143.41 78.37 1.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.595 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.136 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.13 148.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.374 -179.368 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -139.47 167.58 21.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 62' ' ' VAL . 11.2 p -81.75 55.69 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.266 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.12 61.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.817 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' CG ' HD12 ' A' ' 18' ' ' ILE . 1.7 p30 -148.98 150.48 32.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -64.76 122.48 16.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.19 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.727 HG23 HG21 ' A' ' 7' ' ' VAL . 1.1 tp -131.04 169.63 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.461 ' HB3' ' CA ' ' A' ' 14' ' ' GLU . 4.7 p -151.94 150.5 30.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mt-10 -50.58 98.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.83 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 108.09 55.73 0.6 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.475 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.73 18.4 29.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.391 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD11 ' CG2' ' A' ' 74' ' ' VAL . 9.0 tp 45.33 47.7 10.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.046 0.451 . . . . 0.0 110.775 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.807 HG23 ' CG1' ' A' ' 60' ' ' VAL . 5.8 mt -43.18 -82.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.333 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 58' ' ' VAL . 22.0 m -127.39 148.38 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 111.728 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.779 HG13 ' O ' ' A' ' 3' ' ' VAL . 93.9 t -118.42 133.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.943 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.91 HG12 HG22 ' A' ' 55' ' ' VAL . 25.4 m -118.95 166.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 112.417 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' HD23 ' A' ' 2' ' ' LEU . 0.9 OUTLIER -77.54 -36.32 52.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.509 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 56.94 149.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.002 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 52' ' ' ALA . 4.4 pt-20 38.57 55.16 1.9 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.754 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.94 -90.23 1.41 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.578 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.6 p -103.4 179.92 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.904 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.058 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.881 0.372 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.26 -178.36 4.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.753 ' O ' HG13 ' A' ' 74' ' ' VAL . 33.9 t -152.66 161.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.438 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -135.12 91.2 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.002 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.786 HD11 HG11 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -53.05 169.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.631 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -158.11 161.69 37.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.781 HG13 HD22 ' A' ' 38' ' ' LEU . 83.4 t -52.64 139.96 38.82 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.754 ' CD ' HD13 ' A' ' 38' ' ' LEU . 38.5 Cg_endo -70.04 -168.16 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.094 1.863 . . . . 0.0 112.949 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.69 60.37 1.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.759 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.716 ' HB ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -47.49 -24.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.585 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.611 ' H ' HD12 ' A' ' 10' ' ' ILE . . . 69.1 56.91 8.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.475 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.75 -71.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.418 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.84 -176.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 0.0 110.837 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 4.3 pm0 -69.08 172.22 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.651 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.73 91.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 66' ' ' ILE . 9.3 m -127.79 -154.56 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.716 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 16' ' ' VAL . 31.1 m-20 -140.42 121.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.012 HD13 HG23 ' A' ' 60' ' ' VAL . 20.6 mt -65.0 163.78 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.782 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -127.12 -12.46 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.053 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 37' ' ' THR . . . -152.35 161.82 42.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 0.0 111.607 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.808 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.3 p -146.61 133.24 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.05 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -161.26 75.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.511 HG21 HG23 ' A' ' 58' ' ' VAL . 2.4 m -149.08 114.44 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -116.65 96.02 5.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.535 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 25' ' ' VAL . 35.3 m -43.28 110.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.553 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.05 17.43 4.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -120.38 149.82 41.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.792 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.452 ' HA ' HG22 ' A' ' 54' ' ' VAL . 7.9 m -77.38 142.94 39.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.945 HD13 HG23 ' A' ' 51' ' ' VAL . 2.8 pp -143.1 166.06 15.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.65 -171.27 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.351 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 51' ' ' VAL . 6.1 t -90.39 43.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 p30 178.28 68.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.32 107.1 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -44.16 119.32 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.169 0.509 . . . . 0.0 112.096 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 82.9 mt -92.02 -45.3 8.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.856 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.808 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -154.78 179.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.444 0.64 . . . . 0.0 112.091 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 19' ' ' ILE . 59.7 m -138.81 116.94 11.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.782 ' HA ' HG23 ' A' ' 19' ' ' ILE . 4.2 mp -111.6 175.34 5.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 112.148 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.958 ' HG3' HG22 ' A' ' 44' ' ' THR . 6.3 tm-20 -177.4 157.16 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.716 HG23 ' HB ' ' A' ' 10' ' ' ILE . 6.5 p -131.49 -58.96 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 110.816 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 40' ' ' THR . 8.7 t70 -175.24 -38.3 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.765 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 8.1 mmtt -75.06 -26.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . 175.38 170.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.927 0.394 . . . . 0.0 111.334 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.958 HG22 ' HG3' ' A' ' 39' ' ' GLU . 2.5 p -109.66 130.36 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -109.09 -168.56 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 0.0 111.545 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -176.84 167.36 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.234 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.786 HG11 HD11 ' A' ' 5' ' ' LEU . 99.6 t -127.41 125.51 23.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.983 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 86.1 Cg_endo -89.74 30.41 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.032 2.488 . . . . 0.0 112.494 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.669 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 53.53 106.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 111.394 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.95 69.56 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.142 0.496 . . . . 0.0 110.167 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -158.53 -170.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.71 -178.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -159.76 56.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.798 0.333 . . . . 0.0 111.363 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.82 -121.92 0.59 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.39 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 27' ' ' ASP . 51.1 t -137.62 139.15 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 111.44 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 95.6 t -71.31 148.19 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.182 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.02 -49.76 2.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.684 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -111.22 175.17 5.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.629 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.938 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.1 p -165.6 128.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.038 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 71.88 1.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.49 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.012 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -170.21 148.53 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.746 -179.335 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.39 -174.31 4.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.588 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.78 78.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.326 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.38 45.72 0.13 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.645 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.923 ' OD1' HD12 ' A' ' 18' ' ' ILE . 20.0 p-10 -130.81 170.65 14.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.899 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 6.0 mttt -91.96 114.78 27.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.528 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -131.13 160.26 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.696 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.427 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -144.09 148.53 35.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.965 179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.436 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 27.3 tt0 -47.44 99.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 99.47 66.33 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.359 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -128.88 29.08 4.03 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.76 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.9 tp 42.84 74.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.747 ' CG2' HG13 ' A' ' 73' ' ' VAL . 1.4 mt -66.75 -76.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.955 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.938 HG12 ' HA ' ' A' ' 58' ' ' VAL . 17.0 m -129.02 148.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 0.0 111.77 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 3' ' ' VAL . 67.7 t -101.47 142.32 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.922 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 51' ' ' VAL . 2.4 t -125.73 153.4 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.253 0.549 . . . . 0.0 112.08 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 76' ' ' GLU . 3.2 tt0 -102.61 45.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.848 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -39.94 152.55 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.665 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER 48.01 46.03 19.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.978 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.5 113.53 4.68 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.548 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.2 p -62.09 153.63 29.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.313 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.151 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.796 HD22 ' HA ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -77.32 171.86 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.953 HG21 HG11 ' A' ' 51' ' ' VAL . 4.3 t -128.4 162.1 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.5 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.682 ' HB3' HD13 ' A' ' 71' ' ' LEU . 45.5 mt-10 -124.34 89.86 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.426 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.763 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -50.63 151.27 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.975 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.23 150.23 43.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.756 HG13 HD22 ' A' ' 38' ' ' LEU . 91.7 t -48.02 141.11 8.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.89 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.878 ' CD ' HD13 ' A' ' 38' ' ' LEU . 60.0 Cg_endo -73.13 -166.69 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.318 2.012 . . . . 0.0 112.667 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 45' ' ' MET . 1.2 m-20 -95.43 79.05 3.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -82.18 57.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.914 0.388 . . . . 0.0 111.184 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.87 -86.91 0.52 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.611 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.84 38.13 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.547 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -150.11 179.97 7.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.833 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -110.49 -169.96 1.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.201 0.524 . . . . 0.0 111.077 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' GLU . 7.4 p30 46.01 71.09 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.57 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 66' ' ' ILE . 24.1 m -121.93 -170.8 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.13 124.57 37.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 111.541 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.016 HD13 HG23 ' A' ' 60' ' ' VAL . 11.6 mt -61.0 163.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.834 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.715 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -127.68 -12.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.956 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.72 154.43 38.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.379 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.802 ' HA ' HG22 ' A' ' 36' ' ' ILE . 11.0 p -146.32 115.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.216 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -119.46 -30.69 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.344 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.803 HG11 HG11 ' A' ' 73' ' ' VAL . 11.6 m -64.19 129.07 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.92 0.39 . . . . 0.0 111.259 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -139.48 12.74 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.6 t 63.03 118.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.29 8.6 35.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.62 148.28 25.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.33 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.1 m -81.85 106.19 13.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -93.31 155.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.514 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.33 -177.66 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.785 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 31' ' ' VAL . 16.6 t -90.26 44.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 2.1 p30 163.75 70.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.352 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.415 ' H ' ' HB3' ' A' ' 49' ' ' ALA . 1.8 p-10 -148.33 119.8 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.697 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -56.31 114.92 2.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 0.0 111.35 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.72 -43.76 11.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.32 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.929 HD13 HD12 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -152.62 -178.51 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.214 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 19' ' ' ILE . 55.0 m -144.17 120.81 11.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.929 HD12 HD13 ' A' ' 36' ' ' ILE . 4.3 mp -112.3 166.54 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.143 0.497 . . . . 0.0 111.737 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.796 ' CD ' HG22 ' A' ' 44' ' ' THR . 80.4 tt0 -168.38 161.82 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.727 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.508 HG23 ' HB ' ' A' ' 10' ' ' ILE . 3.5 p -120.32 -58.35 1.86 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -179.54 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.817 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -12.57 13.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.534 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.29 137.78 30.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.977 0.418 . . . . 0.0 111.465 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.796 HG22 ' CD ' ' A' ' 39' ' ' GLU . 2.6 p -120.96 127.98 52.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.435 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.425 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -120.01 -166.31 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.146 0.498 . . . . 0.0 111.795 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -179.28 172.96 1.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.763 HG11 HD11 ' A' ' 5' ' ' LEU . 95.8 t -126.65 113.7 22.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 121.174 -0.21 . . . . 0.0 111.377 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 57.4 Cg_endo -90.28 30.64 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.11 2.54 . . . . 0.0 112.427 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.17 164.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.812 ' O ' HG13 ' A' ' 51' ' ' VAL . 26.2 tt0 -160.61 46.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.953 HG11 HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -173.16 161.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -120.71 86.58 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -160.58 -140.4 2.88 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.152 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -130.39 140.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.609 0.242 . . . . 0.0 111.081 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.869 HG22 HG12 ' A' ' 75' ' ' VAL . 53.7 t -77.04 139.28 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.313 0.577 . . . . 0.0 111.396 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HD2' HD13 ' A' ' 2' ' ' LEU . 1.1 mttm -107.66 -48.63 3.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.228 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 29.0 mt-10 -111.11 166.11 11.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.365 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.693 ' HA ' HG12 ' A' ' 73' ' ' VAL . 6.4 p -154.81 114.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.389 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -128.97 74.81 1.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.016 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -174.73 150.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.615 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -172.56 128.6 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.536 HG23 HG12 ' A' ' 21' ' ' VAL . 15.4 t -47.09 102.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.35 25.79 2.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.726 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.865 ' OD1' HD12 ' A' ' 18' ' ' ILE . 21.5 p-10 -121.11 175.81 5.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.809 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -97.98 147.77 24.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.86 HG22 HG22 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -141.3 167.54 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 66' ' ' ILE . 78.2 p -144.95 51.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' CG ' HD11 ' A' ' 10' ' ' ILE . 98.8 mt-10 40.72 50.17 2.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.801 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' N ' ' HB ' ' A' ' 7' ' ' VAL . . . 144.01 71.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.47 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.82 33.0 4.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.717 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.682 HD13 ' HB3' ' A' ' 4' ' ' GLU . 7.2 tp 44.21 56.9 4.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.798 HG23 ' CG1' ' A' ' 60' ' ' VAL . 3.4 mt -46.31 -83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.312 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.803 HG11 HG11 ' A' ' 23' ' ' VAL . 33.8 m -120.29 164.9 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.113 0.483 . . . . 0.0 111.951 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 3' ' ' VAL . 59.1 t -132.34 117.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.944 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.869 HG12 HG22 ' A' ' 55' ' ' VAL . 28.0 m -108.31 157.68 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.796 ' HA ' HD22 ' A' ' 2' ' ' LEU . 4.0 tt0 -68.08 -35.29 77.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.075 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 58.35 139.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.125 0.488 . . . . 0.0 112.038 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' ALA . 14.9 pt-20 37.78 42.25 0.39 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.909 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.84 117.63 2.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.536 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.8 p 50.62 33.99 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.747 0.308 . . . . 0.0 110.86 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.12 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.72 0.295 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.717 ' HG ' HG21 ' A' ' 80' ' ' THR . 1.8 mp -92.87 176.59 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.784 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.836 HG21 HG11 ' A' ' 51' ' ' VAL . 2.6 t -141.04 161.44 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.746 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 4.3 mp0 -135.9 121.27 19.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.694 ' CD2' HD12 ' A' ' 35' ' ' LEU . 1.3 tp -73.46 154.23 40.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -149.59 59.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.862 ' H ' HD12 ' A' ' 72' ' ' ILE . 67.2 t 60.83 145.62 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HD2' HG13 ' A' ' 7' ' ' VAL . 33.5 Cg_endo -67.99 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.621 1.547 . . . . 0.0 112.77 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER 166.6 56.83 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.736 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.985 HG23 HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -37.79 -31.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.056 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.02 40.7 10.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.563 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.84 -42.09 0.13 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.292 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 170.97 164.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.896 0.379 . . . . 0.0 110.873 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 2.2 mt-10 -82.06 64.49 6.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 110.351 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 176.97 85.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.637 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.966 HG11 HG22 ' A' ' 40' ' ' THR . 0.7 OUTLIER -147.46 145.29 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.332 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 64' ' ' ASP . 4.1 m-20 -75.74 145.57 40.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.339 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.076 HD13 HG23 ' A' ' 60' ' ' VAL . 6.1 mt -71.77 163.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.564 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.869 HG12 HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -132.27 -4.25 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.626 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -155.68 151.62 27.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.27 . . . . 0.0 110.928 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.78 ' HA ' HG22 ' A' ' 36' ' ' ILE . 11.1 p -137.9 134.04 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.466 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -155.17 25.48 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.635 HG11 HG11 ' A' ' 73' ' ' VAL . 3.1 m -117.46 122.91 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -133.89 11.76 3.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.485 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 85.4 t 60.63 120.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.51 35.11 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.982 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.4 146.72 27.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -69.85 132.89 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.514 ' CD1' HG11 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -124.25 143.58 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.57 -173.73 2.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.1 t -90.85 39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.361 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p30 168.19 64.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.673 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -140.85 114.3 8.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.77 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.98 115.72 2.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 111.496 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' A' ' 5' ' ' LEU . 33.5 mt -91.25 -32.07 15.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.426 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.78 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.77 -177.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.934 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.869 HG22 HG12 ' A' ' 19' ' ' ILE . 60.7 m -141.92 122.33 14.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 109.901 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.985 HD23 HG23 ' A' ' 10' ' ' ILE . 2.2 tp -102.99 167.83 9.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.869 ' HG3' HG22 ' A' ' 44' ' ' THR . 2.1 tm-20 -167.72 166.43 13.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.966 HG22 HG11 ' A' ' 16' ' ' VAL . 5.5 p -124.76 -59.39 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.682 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.0 t70 -171.84 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.51 -29.61 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.22 131.75 56.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 111.374 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.869 HG22 ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -115.41 138.54 50.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.89 -178.33 4.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.408 . . . . 0.0 111.332 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.6 p30 -167.29 162.45 14.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.649 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.641 HG11 HD21 ' A' ' 5' ' ' LEU . 89.4 t -113.67 109.75 50.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.0 Cg_endo -88.82 43.53 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.098 2.532 . . . . 0.0 111.823 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 54.35 171.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.706 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.839 ' O ' HG13 ' A' ' 51' ' ' VAL . 5.3 pt-20 -156.09 33.03 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.449 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.839 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -172.37 170.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.144 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -121.97 86.01 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.401 ' O ' HG13 ' A' ' 29' ' ' ILE . . . -159.75 -134.38 1.66 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.018 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 76' ' ' GLU . 91.3 t -135.12 141.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.701 HG22 HG13 ' A' ' 75' ' ' VAL . 57.4 t -74.4 143.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.349 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -111.2 -47.62 3.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.45 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 22.9 mt-10 -113.32 172.15 7.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.664 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.921 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -160.57 119.6 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.5 mttm -134.81 62.72 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.575 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.076 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -169.12 149.94 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -140.67 -169.74 2.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.57 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 62' ' ' VAL . 14.6 p -93.49 42.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.086 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.52 71.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.553 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' CG ' HD12 ' A' ' 18' ' ' ILE . 4.1 p-10 -156.7 145.06 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 110.991 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 131.53 45.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.557 ' CG2' HD11 ' A' ' 38' ' ' LEU . 1.2 tp -135.64 178.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.484 ' N ' HG23 ' A' ' 66' ' ' ILE . 2.4 m -155.43 118.17 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.616 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -38.46 91.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.636 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 127.35 49.17 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.938 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -112.3 -121.16 3.9 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.601 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -157.58 44.37 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.376 0.608 . . . . 0.0 109.663 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.862 HD12 ' H ' ' A' ' 7' ' ' VAL . 7.1 mt -40.63 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.041 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 58' ' ' VAL . 20.7 m -131.66 143.96 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.166 0.508 . . . . 0.0 112.317 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 3' ' ' VAL . 61.8 t -108.08 140.31 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.137 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.701 HG13 HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.165 0.507 . . . . 0.0 112.156 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 2' ' ' LEU . 3.9 tt0 -75.42 -39.34 59.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.07 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 59.6 132.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 112.067 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ALA . 25.4 pt-20 38.87 31.32 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.796 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 81' ' ' ALA . . . 42.8 85.8 0.01 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.842 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.717 HG21 ' HG ' ' A' ' 2' ' ' LEU . 17.3 p -57.43 85.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' GLY . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.138 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.803 0.335 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -51.91 172.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.993 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.758 HG21 ' CG1' ' A' ' 51' ' ' VAL . 4.1 t -140.71 161.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.584 ' HB3' HD13 ' A' ' 71' ' ' LEU . 1.6 mp0 -142.73 101.36 3.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.478 HD23 HG23 ' A' ' 73' ' ' VAL . 2.4 mm? -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.093 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' CB ' ' HA2' ' A' ' 69' ' ' GLY . 1.9 mttt -134.16 64.18 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 111.746 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.67 ' H ' HD12 ' A' ' 72' ' ' ILE . 45.4 t 59.83 139.46 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.345 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HD2' HD22 ' A' ' 38' ' ' LEU . 39.4 Cg_endo -72.65 -166.59 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.107 1.871 . . . . 0.0 112.817 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.68 72.24 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.339 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.738 ' CG2' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -65.58 -12.34 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.491 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.553 ' N ' HD12 ' A' ' 10' ' ' ILE . . . 45.35 67.14 1.3 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.897 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.16 -59.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.291 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 170.28 171.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.696 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 3.7 pm0 -67.23 177.49 1.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 1.2 p-10 44.49 85.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 66' ' ' ILE . 20.5 m -123.23 159.8 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.877 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -92.68 128.4 38.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.177 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.926 HD13 HG23 ' A' ' 60' ' ' VAL . 6.9 mt -77.84 161.29 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.26 -41.66 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.393 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -116.94 157.77 25.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 21' ' ' VAL . 10.4 p -157.24 115.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -135.85 72.32 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.039 HG11 HG11 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -146.49 118.92 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -119.89 18.79 12.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.175 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 56' ' ' LYS . 74.0 t 66.07 -86.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.949 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 60.65 1.41 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.833 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 162.99 25.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -87.6 120.53 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.805 HD13 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -115.5 137.33 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.94 -169.01 1.88 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 31' ' ' VAL . 21.8 t -90.64 43.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.167 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 p30 171.84 68.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.581 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.1 p-10 -147.55 102.09 3.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -48.5 117.62 2.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.477 . . . . 0.0 111.582 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 49' ' ' ALA . 32.6 mt -91.83 -37.79 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.713 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.484 HD13 ' HB ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -155.17 -160.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.963 179.135 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 37' ' ' THR . 94.4 m -161.3 38.13 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.83 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.878 HD21 HG21 ' A' ' 16' ' ' VAL . 2.7 tp -31.87 152.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.088 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.806 ' CD ' HG22 ' A' ' 44' ' ' THR . 52.8 tt0 -168.95 157.89 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.48 HG22 ' CG1' ' A' ' 16' ' ' VAL . 3.9 p -123.9 -58.01 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.3 m-20 174.78 -34.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.699 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.85 -35.24 26.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.63 157.52 35.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.962 0.41 . . . . 0.0 111.426 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.806 HG22 ' CD ' ' A' ' 39' ' ' GLU . 3.1 p -114.97 119.87 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.393 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.471 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -112.86 141.93 46.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.629 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 15.3 p-10 -126.88 174.97 8.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.648 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 49' ' ' ALA . 63.2 t -141.86 120.17 7.7 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.919 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 82.9 Cg_endo -90.79 31.33 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.978 2.452 . . . . 0.0 112.179 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.67 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 49.4 99.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.071 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.764 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.3 tm-20 -91.89 66.55 5.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 0.0 110.649 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -170.47 151.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.411 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -121.5 76.2 1.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.652 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.45 -124.93 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.106 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.6 t -143.79 138.57 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.496 0.188 . . . . 0.0 111.242 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.847 HG22 HG12 ' A' ' 75' ' ' VAL . 60.1 t -79.64 150.9 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.211 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.632 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -120.3 -44.97 2.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.344 178.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -108.9 165.99 11.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -157.78 118.21 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.288 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 6.0 mttt -133.81 71.71 1.46 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.627 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.926 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -175.22 160.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -164.9 -161.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.811 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.511 HG23 ' CG1' ' A' ' 21' ' ' VAL . 67.7 t -108.45 71.28 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.82 43.43 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.674 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD2' HD12 ' A' ' 18' ' ' ILE . 7.3 p-10 -136.41 172.32 13.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.957 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.686 ' O ' HD12 ' A' ' 66' ' ' ILE . 21.9 mmtt -97.55 131.89 43.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.787 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.91 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -139.14 151.35 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.882 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.9 OUTLIER -140.63 140.22 34.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.328 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.581 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 3.3 mp0 -40.54 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' CB ' ' A' ' 6' ' ' LYS . . . 116.68 57.08 0.31 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.965 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.66 12.79 8.26 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.105 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.813 HD11 ' CG2' ' A' ' 74' ' ' VAL . 6.2 tp 48.51 57.75 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 0.0 110.884 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.852 HG22 HG13 ' A' ' 73' ' ' VAL . 2.8 mt -53.88 -70.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.076 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.039 HG11 HG11 ' A' ' 23' ' ' VAL . 18.3 m -131.65 151.26 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.747 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.813 ' CG2' HD11 ' A' ' 71' ' ' LEU . 20.3 t -122.3 134.54 65.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.959 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 51' ' ' VAL . 27.7 m -123.32 175.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HA ' ' HG ' ' A' ' 2' ' ' LEU . 2.1 tt0 -86.6 -40.85 14.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' CG ' ' A' ' 78' ' ' GLU . . . 57.71 125.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.929 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 52' ' ' ALA . 7.8 pt-20 45.81 40.66 6.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.167 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.15 -65.25 2.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.3 p -88.32 158.06 18.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.205 -0.903 . . . . 0.0 111.046 179.963 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.784 0.326 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mt 56.55 175.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.807 ' O ' HG13 ' A' ' 74' ' ' VAL . 4.8 t -152.6 160.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.768 ' HB3' HD13 ' A' ' 71' ' ' LEU . 18.0 mp0 -138.63 108.84 6.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.61 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.791 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -68.14 176.55 2.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.754 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.608 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -157.73 162.83 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.306 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.738 ' N ' HD12 ' A' ' 72' ' ' ILE . 86.1 t -51.9 147.97 11.36 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.635 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HD2' HD22 ' A' ' 38' ' ' LEU . 17.0 Cg_exo -66.76 -156.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.084 1.856 . . . . 0.0 112.671 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -120.84 53.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.884 ' HB ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -46.44 -25.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.94 -179.145 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.633 ' H ' HD12 ' A' ' 10' ' ' ILE . . . 87.96 -41.0 3.06 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.882 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.572 ' HA3' HG21 ' A' ' 40' ' ' THR . . . -47.82 -89.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.695 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -169.74 -172.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.61 176.34 2.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.778 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 44.0 78.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.351 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.044 HG21 HD21 ' A' ' 38' ' ' LEU . 33.6 m -122.36 160.5 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.47 118.19 32.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.253 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.048 HD13 HG23 ' A' ' 60' ' ' VAL . 8.9 mt -60.12 162.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.511 HG12 ' HB ' ' A' ' 37' ' ' THR . 0.2 OUTLIER -121.55 -41.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.135 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.8 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -115.53 164.28 14.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG21 ' HB ' ' A' ' 62' ' ' VAL . 27.9 t -145.25 138.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 35' ' ' LEU . 10.0 mt-10 -159.28 41.8 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.991 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.546 HG11 HG11 ' A' ' 73' ' ' VAL . 2.7 m -141.28 116.17 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.02 13.86 3.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.345 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 91.5 t 62.72 124.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.44 -23.3 18.37 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.13 138.74 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -73.77 103.58 4.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.791 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.774 HD13 HG21 ' A' ' 75' ' ' VAL . 4.0 pt -76.55 147.95 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.273 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . . . -128.19 -173.24 2.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.71 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.18 39.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.949 0.404 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.35 64.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.669 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.55 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -138.86 101.47 4.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.718 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -47.15 115.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 111.535 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 36' ' ' ILE . 16.7 mt -89.42 -38.07 14.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.678 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -162.06 179.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.634 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 19' ' ' ILE . 62.1 m -144.03 53.82 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.468 0.651 . . . . 0.0 110.207 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.044 HD21 HG21 ' A' ' 16' ' ' VAL . 4.4 tp -38.13 154.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.243 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.843 ' HG3' HG22 ' A' ' 44' ' ' THR . 8.0 tm-20 -160.4 117.88 2.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.743 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.928 HG22 HG11 ' A' ' 16' ' ' VAL . 53.1 p -70.94 -85.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' N ' ' OG1' ' A' ' 40' ' ' THR . 10.5 p30 -153.0 23.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -177.28 -43.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.709 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . -103.85 125.66 50.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.022 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.843 HG22 ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -111.66 118.49 35.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.044 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.443 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -112.9 153.44 27.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 36' ' ' ILE . 7.5 p30 -136.55 165.44 25.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 5' ' ' LEU . 79.0 t -127.54 119.28 21.6 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.7 Cg_endo -90.39 30.6 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.131 2.554 . . . . 0.0 112.466 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.658 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 50.34 99.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.587 ' C ' HG12 ' A' ' 51' ' ' VAL . 2.4 mp0 -91.64 62.27 4.44 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 3' ' ' VAL . 1.3 p 161.75 144.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.381 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -91.28 -173.49 3.63 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.486 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 117.13 -146.94 18.88 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.634 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' O ' ' CE ' ' A' ' 56' ' ' LYS . 63.2 t -143.19 140.42 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.68 HG22 ' CG1' ' A' ' 75' ' ' VAL . 59.0 t -76.13 144.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.229 0.538 . . . . 0.0 111.94 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -114.78 -50.16 2.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.946 178.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 23.5 mt-10 -110.47 173.36 6.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.174 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.944 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -164.14 123.87 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -132.96 67.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.048 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -170.86 150.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.892 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 21' ' ' VAL . 7.7 mmtt -130.86 -163.85 1.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.492 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.525 ' HB ' HG21 ' A' ' 21' ' ' VAL . 9.0 p -99.63 36.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.046 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.83 65.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.513 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.603 ' CG ' HD12 ' A' ' 18' ' ' ILE . 1.2 p-10 -133.5 161.97 33.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -73.61 113.34 10.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 7' ' ' VAL . 1.1 tp -129.44 166.58 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.253 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.13 137.73 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.271 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 5.1 mp0 -40.23 106.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 90.22 69.16 1.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.288 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.97 24.39 4.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.707 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.768 HD13 ' HB3' ' A' ' 4' ' ' GLU . 6.1 tp 48.38 79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.763 ' CG2' HG13 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -73.19 -73.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.161 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.944 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.4 m -130.28 145.3 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.807 HG13 ' O ' ' A' ' 3' ' ' VAL . 83.5 t -107.02 134.99 47.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.845 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 29' ' ' ILE . 12.6 m -123.63 171.6 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.183 0.515 . . . . 0.0 112.3 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.612 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -79.3 -24.56 42.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 76' ' ' GLU . . . 84.39 -178.43 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -50.01 95.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.397 . . . . 0.0 110.907 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.92 -70.65 1.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.583 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -160.14 -177.53 6.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.854 0.359 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.124 179.944 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.801 0.334 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.12 170.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.758 ' O ' HG13 ' A' ' 74' ' ' VAL . 25.5 t -151.6 159.2 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.55 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -135.37 99.31 4.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.344 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.889 HD12 ' CG2' ' A' ' 73' ' ' VAL . 25.0 mt -62.37 132.23 51.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.589 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -128.12 73.35 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.858 ' H ' HD12 ' A' ' 72' ' ' ILE . 72.0 t 58.55 149.27 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.625 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.75 ' CG ' HD13 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -83.17 -157.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.866 2.377 . . . . 0.0 112.216 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.64 99.4 9.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.78 ' HB ' HG22 ' A' ' 40' ' ' THR . 1.2 pp -111.08 68.82 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.28 -7.16 65.0 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.924 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.16 3.89 81.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.94 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.473 ' CE1' ' O ' ' A' ' 10' ' ' ILE . 51.9 p-80 -109.18 177.32 4.79 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.84 0.353 . . . . 0.0 110.97 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -103.4 -172.36 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.165 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 4.0 p-10 47.93 86.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.615 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 66' ' ' ILE . 10.5 m -137.94 -155.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.125 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.46 ' N ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -149.93 138.24 20.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.979 0.418 . . . . 0.0 111.393 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.111 HD13 HG23 ' A' ' 60' ' ' VAL . 7.8 mt -76.99 162.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.847 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.799 HG23 ' C ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -133.52 -9.62 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.887 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.55 149.06 30.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.473 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.805 ' HA ' HG22 ' A' ' 36' ' ' ILE . 89.6 t -140.71 121.66 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -142.39 28.39 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.755 HG11 HG11 ' A' ' 73' ' ' VAL . 3.7 m -117.76 125.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -137.28 11.56 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 56' ' ' LYS . 89.9 t 62.33 127.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -21.9 22.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -77.67 152.28 33.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 m -84.06 121.3 27.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.509 HD13 HG23 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -108.46 153.54 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.81 -176.1 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.863 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.66 47.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 166.85 74.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.456 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -160.46 117.72 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.97 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.44 117.9 5.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 49' ' ' ALA . 63.0 mt -93.1 -44.95 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.805 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -153.13 -179.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.738 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.799 ' C ' HG23 ' A' ' 19' ' ' ILE . 2.7 m -133.05 145.66 51.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.993 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.753 HD23 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -127.11 -172.54 2.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.777 ' CD ' HG22 ' A' ' 44' ' ' THR . 10.0 tt0 -172.19 172.7 4.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.78 HG22 ' HB ' ' A' ' 10' ' ' ILE . 1.2 p -142.25 -157.35 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 -19.69 65.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.864 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -172.79 53.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -173.47 134.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.24 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.777 HG22 ' CD ' ' A' ' 39' ' ' GLU . 71.4 p -107.71 153.86 22.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -172.07 4.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 37' ' ' THR . 1.0 OUTLIER -176.17 174.11 2.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 49' ' ' ALA . 96.9 t -126.38 123.46 24.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.267 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.5 Cg_endo -90.76 29.93 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 0.0 112.23 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . 46.72 93.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.469 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.35 61.74 3.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.45 149.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.142 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -116.52 75.0 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.9 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -163.77 -132.22 1.32 Allowed Glycine 0 C--N 1.317 -0.478 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.752 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.8 t -137.26 138.95 44.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.751 -0.225 . . . . 0.0 110.959 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.776 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.6 t -74.3 146.5 9.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.368 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.45 -46.1 2.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.57 178.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -113.89 173.95 6.17 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.694 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.617 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.7 p -160.8 116.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -134.14 79.42 1.81 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.111 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -174.62 152.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.209 0.528 . . . . 0.0 111.029 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.545 ' C ' HG21 ' A' ' 21' ' ' VAL . 1.2 tptt -138.79 173.34 11.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.484 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 62' ' ' VAL . 11.8 p -92.38 52.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.065 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.28 52.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.594 ' OD2' HD12 ' A' ' 18' ' ' ILE . 3.9 p-10 -129.98 -175.66 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.767 0.317 . . . . 0.0 110.973 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.728 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -105.95 149.78 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.926 HG22 HG22 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -138.34 170.84 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.521 ' N ' HG23 ' A' ' 66' ' ' ILE . 1.5 p -154.59 49.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.773 ' HG3' HD11 ' A' ' 10' ' ' ILE . 85.8 mt-10 39.9 63.68 1.01 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.643 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 146.83 68.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.62 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.27 17.61 6.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.747 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.57 HD11 ' CG2' ' A' ' 74' ' ' VAL . 10.2 tp 45.06 50.46 9.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.066 0.46 . . . . 0.0 110.73 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.858 HD12 ' H ' ' A' ' 7' ' ' VAL . 3.8 mt -45.05 -83.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.466 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.889 ' CG2' HD12 ' A' ' 5' ' ' LEU . 24.1 m -120.95 145.07 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.985 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 3' ' ' VAL . 87.8 t -114.38 138.89 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.605 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -131.77 174.32 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.94 -33.31 22.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.572 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.724 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . 54.06 162.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.645 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 52' ' ' ALA . 4.0 mt-10 69.63 -67.95 0.21 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.588 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 80' ' ' THR . . . 127.35 118.19 2.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.632 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 79' ' ' GLY . 60.5 p -159.33 35.3 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.823 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.108 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 76' ' ' GLU . 1.2 mp . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.812 0.339 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.8 ' HB ' HG11 ' A' ' 51' ' ' VAL . 5.9 t -149.36 161.99 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.589 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -134.38 106.88 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.93 HD11 HG11 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -51.87 -176.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.264 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 2.4 mttp -164.62 142.78 6.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.78 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.838 HG22 HD11 ' A' ' 72' ' ' ILE . 67.8 t -49.17 138.38 14.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.6 ' CG ' HD13 ' A' ' 38' ' ' LEU . 53.2 Cg_endo -72.7 -167.05 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.356 2.037 . . . . 0.0 112.92 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.67 69.13 3.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.976 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.879 ' HB ' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 67' ' ' SER . 1.3 pt-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.883 0.373 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 8.1 p-10 44.73 69.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.811 HG11 HG12 ' A' ' 10' ' ' ILE . 20.0 m -125.97 124.91 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.32 122.97 20.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.706 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.684 HD13 HG23 ' A' ' 60' ' ' VAL . 3.6 mt -62.12 164.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.577 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.691 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -126.53 -13.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.845 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -153.14 144.66 23.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.351 . . . . 0.0 111.372 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.812 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.4 p -145.13 122.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.218 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 2.5 pt-20 -140.09 47.72 1.8 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.778 HG21 HG11 ' A' ' 73' ' ' VAL . 8.2 m -144.71 123.37 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.266 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -128.42 18.62 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 56' ' ' LYS . 95.0 t 65.4 112.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.36 -21.28 5.75 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.499 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -81.41 147.59 29.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.3 m -71.81 155.9 39.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.945 HD13 HG23 ' A' ' 51' ' ' VAL . 1.7 pp -144.19 144.28 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.214 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.72 -179.06 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.03 48.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.3 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 p30 163.65 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.523 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 8.1 p-10 -155.29 115.47 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -50.66 117.29 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.153 0.501 . . . . 0.0 111.488 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 36' ' ' ILE . 13.8 mt -87.58 -43.6 11.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.009 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -158.06 -180.0 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.314 0.578 . . . . 0.0 111.86 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.645 ' O ' HG23 ' A' ' 19' ' ' ILE . 99.9 m -140.05 117.49 11.42 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.732 HD22 HG13 ' A' ' 7' ' ' VAL . 5.9 mp -111.61 171.83 7.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.023 0.44 . . . . 0.0 112.187 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.619 ' HB2' HG22 ' A' ' 44' ' ' THR . 49.4 tt0 -172.06 157.91 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.643 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.879 HG22 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.55 -89.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.904 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.444 ' H ' HG23 ' A' ' 40' ' ' THR . 0.3 OUTLIER -150.26 21.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.741 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.71 -43.44 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.07 169.54 19.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 39' ' ' GLU . 71.6 p -108.5 115.93 31.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.493 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -101.1 -175.82 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.161 0.505 . . . . 0.0 111.534 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 1.2 p30 -172.92 170.43 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.241 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.93 HG11 HD11 ' A' ' 5' ' ' LEU . 97.3 t -126.35 124.51 24.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.813 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.2 Cg_endo -88.71 27.03 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.975 2.45 . . . . 0.0 112.702 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.724 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.67 150.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.304 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.571 ' C ' HG22 ' A' ' 51' ' ' VAL . 44.0 tt0 -149.35 70.62 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.476 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.945 HG23 HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -178.33 -178.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.494 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.28 67.79 1.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.818 0.342 . . . . 0.0 111.838 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.48 -134.84 1.75 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.115 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 76' ' ' GLU . 88.5 t -126.23 144.4 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.61 0.243 . . . . 0.0 111.183 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.683 HG22 HG12 ' A' ' 75' ' ' VAL . 95.2 t -76.56 145.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.152 0.501 . . . . 0.0 111.303 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.49 -46.92 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.556 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.63 175.3 5.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.498 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HA ' HG12 ' A' ' 73' ' ' VAL . 8.6 p -165.37 119.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -132.36 66.41 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.587 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.718 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -172.82 156.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.694 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -170.97 -159.93 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.737 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.723 HG23 HG12 ' A' ' 21' ' ' VAL . 59.6 t -112.07 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.54 -15.72 3.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.57 163.77 12.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.044 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -101.08 148.62 24.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.664 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.693 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.3 tp -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.477 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 14' ' ' GLU . 6.9 m -142.97 138.32 30.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 111.272 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.489 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 95.0 mt-10 -39.57 115.66 0.54 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 70.17 74.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.221 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -137.64 31.64 2.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.447 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 4' ' ' GLU . 13.7 tp 49.06 95.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.982 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.838 HD11 HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -95.2 -74.86 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.654 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 23' ' ' VAL . 19.7 m -125.05 136.93 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 111.787 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 3' ' ' VAL . 61.9 t -104.96 141.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.097 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.887 HG21 HG21 ' A' ' 51' ' ' VAL . 33.1 m -127.62 171.47 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.244 0.545 . . . . 0.0 112.362 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.458 ' HA ' HD23 ' A' ' 2' ' ' LEU . 1.8 tm-20 -84.49 -39.37 18.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.293 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.246 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.916 0.389 . . . . 0.0 111.074 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.755 ' O ' HG13 ' A' ' 74' ' ' VAL . 30.7 t -136.3 159.3 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.581 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -134.67 108.61 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.999 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.981 HD21 HG11 ' A' ' 47' ' ' VAL . 2.9 tp -63.39 161.07 14.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.454 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HG2' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -146.44 139.52 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.767 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 72' ' ' ILE . 96.9 t -42.12 141.21 1.42 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.139 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.676 ' CD ' HD23 ' A' ' 38' ' ' LEU . 61.1 Cg_endo -75.37 -169.36 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.436 2.091 . . . . 0.0 113.102 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 45' ' ' MET . 5.2 t0 -83.95 94.56 8.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.956 HG12 HG21 ' A' ' 16' ' ' VAL . 1.1 pp . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.076 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.02 0.438 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 6.5 p-10 46.01 94.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.434 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.956 HG21 HG12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -137.82 166.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 64' ' ' ASP . 82.4 m-20 -97.87 133.1 42.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.658 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.111 HD13 HG23 ' A' ' 60' ' ' VAL . 8.6 mt -74.76 163.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.896 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.715 HG23 ' C ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -131.04 -8.75 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.736 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -151.09 150.18 30.39 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 36' ' ' ILE . 80.0 t -142.03 120.39 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.844 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -146.41 59.48 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.981 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.937 HG11 HG11 ' A' ' 73' ' ' VAL . 2.0 m -140.01 115.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.432 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 1.6 t30 -93.99 12.23 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.44 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 25' ' ' VAL . 5.4 p 43.04 63.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.487 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.09 45.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.476 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -136.71 173.25 11.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.996 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.6 m -79.17 132.91 36.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.761 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.602 HD13 HG11 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -127.5 150.33 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.31 178.82 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 51' ' ' VAL . 4.0 t -87.96 47.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.61 70.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.546 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.51 100.42 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.483 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -42.98 115.22 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.197 0.523 . . . . 0.0 111.774 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.633 HD12 HD22 ' A' ' 5' ' ' LEU . 23.6 mt -87.16 -50.16 6.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.914 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -149.41 -178.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 111.73 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.715 ' C ' HG23 ' A' ' 19' ' ' ILE . 3.5 m -131.96 130.69 41.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.669 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.69 HD11 HG12 ' A' ' 18' ' ' ILE . 1.9 mm? -116.04 165.15 13.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.799 0.333 . . . . 0.0 110.826 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.737 ' CD ' HG22 ' A' ' 44' ' ' THR . 48.9 tt0 -178.21 164.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.854 HG22 HG11 ' A' ' 16' ' ' VAL . 3.5 p -121.28 -59.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.684 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.3 t0 -172.68 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -109.64 -36.8 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.033 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.74 141.38 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.737 HG22 ' CD ' ' A' ' 39' ' ' GLU . 1.4 p -126.9 130.14 49.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.43 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -117.25 -164.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.287 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 22.5 p-10 -179.66 172.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.981 HG11 HD21 ' A' ' 5' ' ' LEU . 78.8 t -121.15 116.8 30.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.81 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.4 Cg_endo -86.63 18.56 1.55 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.993 2.462 . . . . 0.0 112.7 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.1 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.875 0.369 . . . . 0.0 111.551 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -110.6 70.69 0.72 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.758 HG11 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.35 -172.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.116 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.59 63.77 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.661 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.53 -124.38 0.74 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.243 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.1 t -139.96 138.17 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.473 0.178 . . . . 0.0 111.165 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.771 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.2 t -75.04 145.02 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.114 0.483 . . . . 0.0 111.476 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HE2' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -115.54 -44.24 2.98 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.497 178.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 17.8 mt-10 -115.06 174.24 6.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.606 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 58' ' ' VAL . 15.0 p -160.86 122.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.363 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -134.19 74.62 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.749 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.111 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.58 148.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.491 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -143.85 -166.26 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.984 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 21' ' ' VAL . 59.6 t -106.71 86.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.09 18.99 4.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.564 ' CG ' HD12 ' A' ' 18' ' ' ILE . 5.3 p-10 -99.85 171.71 7.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.794 0.33 . . . . 0.0 110.662 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.97 123.35 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.933 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -122.44 167.17 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.4 p -151.28 141.13 21.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 26.0 mt-10 -42.9 95.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.204 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 100.37 61.46 0.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.393 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.31 20.18 23.65 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 4' ' ' GLU . 11.2 tp 49.92 50.01 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.796 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.891 HG22 HG13 ' A' ' 73' ' ' VAL . 4.3 mt -48.07 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.256 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.937 HG11 HG11 ' A' ' 23' ' ' VAL . 17.6 m -117.0 141.07 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.148 0.499 . . . . 0.0 112.029 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 3' ' ' VAL . 91.5 t -113.6 131.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.771 ' CG1' HG22 ' A' ' 55' ' ' VAL . 27.8 m -121.95 169.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.772 ' HA ' HD23 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -78.61 -36.46 44.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.607 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.176 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.894 0.378 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.053 HG21 HG11 ' A' ' 51' ' ' VAL . 6.5 t -148.92 161.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.951 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 74' ' ' VAL . 69.0 mt-10 -133.39 115.29 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.198 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.714 ' CD1' HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -73.45 160.8 31.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -147.34 150.09 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 111.405 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.688 HG22 HD11 ' A' ' 72' ' ' ILE . 84.0 t -46.05 140.43 4.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.432 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.786 ' CD ' HD23 ' A' ' 38' ' ' LEU . 74.1 Cg_endo -76.38 -166.17 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.592 2.195 . . . . 0.0 112.614 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 45' ' ' MET . 16.5 t70 -94.47 88.74 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.054 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.899 HG12 HG21 ' A' ' 16' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.98 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.973 0.416 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 44.89 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.899 HG21 HG12 ' A' ' 10' ' ' ILE . 34.6 m -143.72 115.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.569 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 128.21 35.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.556 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.783 HD13 HG23 ' A' ' 60' ' ' VAL . 4.2 mt -65.39 164.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.93 -35.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.275 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.71 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -118.59 148.11 43.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.728 ' HA ' HG22 ' A' ' 36' ' ' ILE . 7.8 p -134.9 119.22 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.991 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -146.3 40.09 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.018 HG11 HG11 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -133.72 117.82 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -132.6 12.25 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.377 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 90.0 t 62.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.35 . . . . 0.0 111.085 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.08 -21.54 13.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.779 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.42 139.41 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 111.107 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.2 m -74.76 102.29 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.552 HG12 HG11 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -87.16 153.91 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.38 -174.36 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.841 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.9 t -89.94 42.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.395 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER 163.7 72.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.591 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -148.78 115.16 5.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.78 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.58 115.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.527 . . . . 0.0 111.45 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 36' ' ' ILE . 98.3 mt -88.98 -40.97 12.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.541 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.756 HD13 HD22 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -159.31 -177.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 19' ' ' ILE . 23.2 m -136.04 133.17 37.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.811 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.786 HD23 ' CD ' ' A' ' 8' ' ' PRO . 1.8 mm? -116.11 150.59 37.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.864 0.364 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' OE2' HG22 ' A' ' 44' ' ' THR . 41.7 tt0 -159.91 163.18 34.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.547 ' HB ' HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -133.03 -82.92 0.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.656 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 40' ' ' THR . 12.0 p-10 -143.79 -43.48 0.27 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 42.63 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.65 133.64 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.193 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.54 HG22 ' OE2' ' A' ' 39' ' ' GLU . 10.6 p -129.4 118.48 22.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.449 ' O ' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -117.29 -167.95 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.572 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -177.23 167.62 2.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.13 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.714 HG11 ' CD1' ' A' ' 5' ' ' LEU . 57.8 t -121.85 111.8 32.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.409 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 58.9 Cg_endo -89.64 33.35 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.115 2.544 . . . . 0.0 112.401 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.516 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.57 163.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.96 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.832 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -157.76 44.83 0.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.097 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.053 HG11 HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -173.45 163.37 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.96 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.7 87.92 2.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -162.19 -139.68 2.7 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.939 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.11 136.58 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.737 HG22 ' CG1' ' A' ' 75' ' ' VAL . 59.5 t -72.87 143.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.105 0.478 . . . . 0.0 111.397 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -112.51 -47.69 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.338 178.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.7 mm-40 -112.18 173.38 6.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.626 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -163.14 120.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.306 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.7 mttm -132.05 64.09 1.6 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.533 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.783 HG23 HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -173.05 151.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.672 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -173.99 175.52 2.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.658 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 62' ' ' VAL . 58.1 t -79.22 68.34 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.43 55.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.893 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 10.7 p-10 -173.15 132.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -76.28 119.76 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.7 tp -104.6 172.74 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.8 m -144.13 137.66 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.471 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 72.4 mt-10 -40.48 130.52 2.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.0 61.73 3.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.037 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.27 129.05 5.44 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.131 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -53.06 94.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 110.584 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.766 HG23 ' CG1' ' A' ' 60' ' ' VAL . 1.3 mt -92.45 -78.83 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.018 HG11 HG11 ' A' ' 23' ' ' VAL . 19.6 m -126.77 137.6 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.0 111.873 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 3' ' ' VAL . 85.3 t -108.77 136.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.782 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.737 ' CG1' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -126.06 167.52 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.212 0.529 . . . . 0.0 112.32 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . 3.7 tt0 -71.59 -38.87 70.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.612 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' H ' ' HA3' ' A' ' 53' ' ' GLY . . . . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 121.311 0.577 . . . . 0.0 112.169 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.909 0.385 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.849 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.3 t -142.91 162.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.882 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.797 ' HB3' HD13 ' A' ' 71' ' ' LEU . 2.0 mt-10 -130.86 91.08 3.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.494 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.93 HD11 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -48.41 155.18 0.54 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.784 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.676 ' H ' HD13 ' A' ' 5' ' ' LEU . 10.9 mttm -147.06 150.18 34.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 111.492 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.718 HG21 HG23 ' A' ' 66' ' ' ILE . 91.1 t -50.13 140.75 16.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.628 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.915 ' HD2' HD13 ' A' ' 38' ' ' LEU . 37.8 Cg_endo -68.73 -166.66 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.285 1.99 . . . . 0.0 112.88 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -99.22 69.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.836 HG12 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 4.8 mt-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.171 0.51 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 1.5 p30 169.82 66.75 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.459 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.076 HG11 HG22 ' A' ' 40' ' ' THR . 1.0 OUTLIER -120.0 137.74 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.556 -179.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.86 131.88 37.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.972 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.101 HD13 HG23 ' A' ' 60' ' ' VAL . 11.5 mt -67.64 162.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.797 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -125.95 -16.42 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.706 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -145.7 150.36 36.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.803 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.5 p -138.78 129.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -150.23 44.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' CG2' HG23 ' A' ' 58' ' ' VAL . 4.4 m -136.59 124.16 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -135.55 10.32 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.46 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 87.7 t 64.51 118.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.081 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.94 -23.29 8.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.54 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -71.73 165.7 23.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.2 m -100.44 108.87 20.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -93.55 138.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.36 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.14 39.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 168.29 68.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -145.03 123.25 12.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -61.88 116.12 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.279 0.561 . . . . 0.0 111.278 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.452 HD13 ' HG ' ' A' ' 5' ' ' LEU . 49.1 mt -88.33 -43.0 11.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.417 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.803 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -153.94 -178.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.516 179.013 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 19' ' ' ILE . 44.6 m -144.9 123.42 12.43 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.915 HD13 ' HD2' ' A' ' 8' ' ' PRO . 1.2 mp -116.24 -179.37 3.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.864 ' HG3' HG22 ' A' ' 44' ' ' THR . 5.8 tm-20 -174.87 160.04 2.82 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 1.076 HG22 HG11 ' A' ' 16' ' ' VAL . 5.5 p -116.54 -61.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 20.7 m-20 -151.0 -43.28 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -141.4 25.43 2.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.12 98.69 2.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.19 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.864 HG22 ' HG3' ' A' ' 39' ' ' GLU . 17.8 p -93.51 116.26 28.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.62 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.419 ' O ' HG23 ' A' ' 37' ' ' THR . 0.2 OUTLIER -105.83 -176.32 3.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.076 0.465 . . . . 0.0 111.482 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -168.3 167.12 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.342 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.93 HG11 HD11 ' A' ' 5' ' ' LEU . 96.4 t -123.0 115.24 29.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.17 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 77.0 Cg_endo -90.86 35.81 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.047 2.498 . . . . 0.0 112.137 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.542 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.72 175.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.805 ' O ' HG13 ' A' ' 51' ' ' VAL . 15.7 tt0 -162.85 43.31 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.548 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 176.23 167.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.12 89.35 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -163.24 -156.95 8.87 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.006 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' GLU . 81.6 t -113.93 146.28 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.53 0.205 . . . . 0.0 111.246 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.744 HG22 HG12 ' A' ' 75' ' ' VAL . 67.6 t -81.3 144.93 9.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.293 0.568 . . . . 0.0 111.348 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.45 ' HE2' ' CA ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -112.7 -51.27 2.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.193 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.3 mt-10 -106.2 172.92 6.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.672 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.932 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.4 p -166.2 126.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.626 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -147.5 74.22 1.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.101 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -171.3 150.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HE3' HG21 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.42 -163.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.904 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.7 93.32 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.107 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.38 33.86 0.8 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.622 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.68 ' CG ' HD12 ' A' ' 18' ' ' ILE . 12.3 p-10 -129.34 140.96 51.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.43 ' CD ' ' HB2' ' A' ' 15' ' ' ASN . 6.8 mttt -73.22 130.47 40.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.785 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -130.86 170.75 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB3' ' CB ' ' A' ' 14' ' ' GLU . 8.7 m -147.62 135.99 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mp0 -41.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 107.53 62.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.378 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.04 23.03 8.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 4' ' ' GLU . 3.2 tp 45.76 57.22 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.029 0.443 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.781 HG22 HG13 ' A' ' 73' ' ' VAL . 2.9 mt -49.35 -80.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.932 HG12 ' HA ' ' A' ' 58' ' ' VAL . 21.3 m -124.94 157.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.415 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 3' ' ' VAL . 78.4 t -118.46 131.32 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.284 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.744 HG12 HG22 ' A' ' 55' ' ' VAL . 16.8 m -118.36 165.57 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' VAL . 4.5 tp10 -72.4 -38.84 68.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.032 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' H ' ' HA3' ' A' ' 53' ' ' GLY . . . . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 121.151 0.5 . . . . 0.0 111.893 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.667 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.5 mt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.906 0.384 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.804 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.4 t -161.63 159.58 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.731 ' HB3' HD13 ' A' ' 71' ' ' LEU . 2.0 mp0 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.361 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.707 HD11 ' HA ' ' A' ' 49' ' ' ALA . 1.2 mt -59.2 164.82 2.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.748 0.309 . . . . 0.0 110.676 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' C ' HD12 ' A' ' 72' ' ' ILE . 20.3 mttt -143.81 172.41 12.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.58 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.794 HG21 HG23 ' A' ' 66' ' ' ILE . 23.7 t -72.83 140.04 80.72 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.032 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.924 ' HD2' HD13 ' A' ' 38' ' ' LEU . 19.4 Cg_endo -63.32 -166.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 112.86 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.87 ' O ' HD12 ' A' ' 10' ' ' ILE . 24.5 t70 -93.19 -13.35 28.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.463 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 9' ' ' ASP . 1.5 pp . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 11.8 mt-10 . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.885 0.374 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.437 ' N ' ' HB3' ' A' ' 67' ' ' SER . 8.0 p-10 44.33 95.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.507 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.752 HG11 HG22 ' A' ' 40' ' ' THR . 27.1 m -152.49 141.06 14.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.66 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -82.02 130.32 35.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.56 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.976 HD13 HG23 ' A' ' 60' ' ' VAL . 22.0 mt -62.56 164.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.741 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -128.18 -12.47 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.294 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -146.96 158.25 43.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.002 0.429 . . . . 0.0 111.61 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.841 ' HA ' HG22 ' A' ' 36' ' ' ILE . 7.4 p -148.66 123.87 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.078 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -149.07 44.45 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.584 ' CG2' HG23 ' A' ' 58' ' ' VAL . 2.5 m -135.22 120.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -128.95 10.97 6.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.401 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 56' ' ' LYS . 84.6 t 58.84 112.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.2 -15.32 5.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.833 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.97 142.52 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 127.84 33.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.646 HD13 HG23 ' A' ' 51' ' ' VAL . 1.1 pp -108.54 154.7 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.02 179.53 5.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.1 t -85.66 48.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.351 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 164.11 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.59 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.406 ' C ' ' HA ' ' A' ' 48' ' ' PRO . 7.9 p-10 -156.74 99.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.768 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -45.49 117.5 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.147 0.498 . . . . 0.0 111.822 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.557 HD12 ' CD1' ' A' ' 5' ' ' LEU . 20.5 mt -92.79 -42.5 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.389 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.898 HD13 HD12 ' A' ' 38' ' ' LEU . 1.2 pp -148.77 -175.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.057 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 19' ' ' ILE . 32.4 m -149.24 124.55 10.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.924 HD13 ' HD2' ' A' ' 8' ' ' PRO . 2.4 mp -113.2 167.18 10.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.674 ' CG ' HG22 ' A' ' 44' ' ' THR . 70.3 tt0 -161.91 164.15 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.692 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.752 HG22 HG11 ' A' ' 16' ' ' VAL . 6.2 p -121.93 -57.54 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -175.33 -37.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -116.59 -19.3 10.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.622 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.14 148.42 49.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.628 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.674 HG22 ' CG ' ' A' ' 39' ' ' GLU . 1.7 p -131.2 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.478 ' O ' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -121.06 -173.51 2.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.223 0.535 . . . . 0.0 111.675 -179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -168.76 159.35 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.044 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.631 HG11 HD22 ' A' ' 5' ' ' LEU . 54.6 t -123.08 126.67 25.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.356 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 86.5 Cg_endo -89.58 34.13 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.882 2.388 . . . . 0.0 112.325 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HA ' HD11 ' A' ' 5' ' ' LEU . . . 81.64 -51.25 0.26 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.582 ' C ' HG22 ' A' ' 51' ' ' VAL . 5.0 tp10 55.03 56.16 6.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -174.16 -169.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.21 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -156.42 65.9 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 29' ' ' ILE . . . -160.84 -139.7 2.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.129 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.04 135.56 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.386 0.136 . . . . 0.0 110.642 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.715 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.3 t -71.93 144.37 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.293 0.568 . . . . 0.0 111.636 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.54 -47.05 2.74 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.265 178.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -110.28 172.53 6.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.429 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.915 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.2 p -164.81 128.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.873 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -146.06 75.81 1.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.642 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.976 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -172.5 155.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.491 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -161.43 -160.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.774 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 21' ' ' VAL . 61.3 t -110.13 76.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.216 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.52 41.23 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.811 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.807 ' CG ' HD12 ' A' ' 18' ' ' ILE . 16.7 p-10 -128.73 138.63 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.924 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.617 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -72.05 110.71 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.792 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.794 HG23 HG21 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -137.99 168.83 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -152.85 162.7 40.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 111.283 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.445 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -42.19 107.4 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.488 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' 6' ' ' LYS . . . 98.91 70.41 0.96 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.783 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.95 21.35 4.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.373 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 4' ' ' GLU . 1.7 tp 43.52 57.54 3.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.113 0.482 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.823 HG22 HG13 ' A' ' 73' ' ' VAL . 3.7 mt -49.95 -73.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.096 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.915 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.1 m -135.45 145.23 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 3' ' ' VAL . 92.4 t -104.97 136.74 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 51' ' ' VAL . 1.2 m -126.69 167.54 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.0 112.295 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HG3' ' CD2' ' A' ' 2' ' ' LEU . 1.3 mt-10 -101.1 46.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.665 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.335 -0.058 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.768 HG11 HG11 ' A' ' 51' ' ' VAL . 2.7 t -142.86 161.62 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.52 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -136.51 117.59 14.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.401 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.84 HD21 HG11 ' A' ' 47' ' ' VAL . 1.6 tp -68.65 160.81 29.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -143.75 144.42 31.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 111.415 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.63 HG22 HD11 ' A' ' 72' ' ' ILE . 86.8 t -41.19 140.58 1.16 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.035 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.61 ' HD2' HG13 ' A' ' 7' ' ' VAL . 61.0 Cg_endo -75.32 -168.04 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.24 1.96 . . . . 0.0 113.076 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 45' ' ' MET . 0.1 OUTLIER -98.65 83.78 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.952 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.923 ' CG2' HD23 ' A' ' 38' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.895 0.378 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.418 ' CA ' ' O ' ' A' ' 66' ' ' ILE . 5.5 p-10 43.75 78.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.77 HG11 HG22 ' A' ' 40' ' ' THR . 25.1 m -122.26 -178.02 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.433 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -106.59 118.45 36.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.915 0.388 . . . . 0.0 111.401 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.998 HD13 HG23 ' A' ' 60' ' ' VAL . 19.5 mt -55.21 165.29 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.898 HG12 HG22 ' A' ' 37' ' ' THR . 0.6 OUTLIER -136.5 2.99 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.508 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -167.32 152.21 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.297 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.757 ' HA ' HG22 ' A' ' 36' ' ' ILE . 81.2 t -137.26 120.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.759 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -148.42 60.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.926 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.661 HG11 HG11 ' A' ' 73' ' ' VAL . 2.4 m -142.1 113.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -120.94 96.25 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 56' ' ' LYS . 63.3 t -40.21 116.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.56 15.13 7.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.66 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.91 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 m -70.25 146.29 50.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.039 HD13 HG11 ' A' ' 75' ' ' VAL . 2.8 pt -136.69 154.81 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.51 -174.88 3.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG13 ' OE2' ' A' ' 50' ' ' GLU . 11.6 t -91.94 47.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 p30 172.68 67.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.058 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -152.99 108.58 3.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.564 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -46.95 119.12 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.092 0.472 . . . . 0.0 111.874 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 36' ' ' ILE . 21.5 mt -94.52 -39.39 10.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.877 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.11 -177.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.349 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.898 HG22 HG12 ' A' ' 19' ' ' ILE . 70.5 m -142.53 109.11 5.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.743 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.923 HD23 ' CG2' ' A' ' 10' ' ' ILE . 1.8 tp -95.02 155.93 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.679 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.731 ' HB3' HG21 ' A' ' 19' ' ' ILE . 33.6 tt0 -166.31 144.63 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.655 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.798 HG23 ' HB ' ' A' ' 10' ' ' ILE . 3.4 p -104.99 -59.46 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.425 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.7 p30 -174.63 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -124.34 35.75 4.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . 177.25 131.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.252 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.706 HG22 ' CG ' ' A' ' 39' ' ' GLU . 73.6 p -119.21 116.33 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -123.7 128.02 49.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.253 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.434 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 1.0 OUTLIER -113.23 174.47 5.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.757 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.84 HG11 HD21 ' A' ' 5' ' ' LEU . 76.9 t -120.59 116.3 31.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 85.2 Cg_endo -87.37 37.27 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.94 2.427 . . . . 0.0 112.359 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.54 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 46.83 93.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.856 0.36 . . . . 0.0 111.11 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.598 ' C ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -93.38 63.03 3.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.768 HG11 HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER 163.43 148.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.333 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.571 ' O ' HD11 ' A' ' 29' ' ' ILE . . . -96.35 -168.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.368 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 102.14 -146.52 16.98 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.839 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.95 135.4 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.538 0.209 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.588 ' HA ' HG12 ' A' ' 75' ' ' VAL . 61.5 t -68.22 147.05 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.69 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.53 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.67 -50.75 2.4 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.277 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.81 166.32 13.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.409 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 73' ' ' VAL . 5.4 p -152.17 138.56 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.318 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ILE . 6.9 mmtt -140.65 59.35 1.55 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.306 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.998 HG23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -157.47 143.58 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.61 -174.2 4.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.76 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 21' ' ' VAL . 60.5 t -98.04 92.73 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.45 35.57 1.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.628 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.93 ' OD1' HD12 ' A' ' 18' ' ' ILE . 19.6 p-10 -119.13 172.89 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.958 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -96.54 123.06 40.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -129.16 161.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.161 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.9 p -135.42 127.28 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.421 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.47 ' OE2' HD12 ' A' ' 10' ' ' ILE . 42.5 mt-10 -40.91 115.02 0.53 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 88.17 64.65 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.011 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.78 -165.83 11.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.024 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 4' ' ' GLU . 8.5 tp -104.49 89.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.969 0.414 . . . . 0.0 110.372 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.798 HG23 ' CG1' ' A' ' 60' ' ' VAL . 2.1 mt -87.35 -80.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.944 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.787 HG13 HG22 ' A' ' 72' ' ' ILE . 17.4 m -122.41 135.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.064 0.459 . . . . 0.0 111.891 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 3' ' ' VAL . 41.4 t -103.78 144.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.338 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.039 HG11 HD13 ' A' ' 29' ' ' ILE . 10.9 m -129.07 165.41 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.122 0.487 . . . . 0.0 112.008 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 6.3 tt0 -83.73 -26.49 29.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.58 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.075 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.832 0.348 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.754 ' O ' HG13 ' A' ' 74' ' ' VAL . 19.8 t -139.27 146.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 1.3 mp0 -124.34 100.63 6.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.877 ' CD1' HD12 ' A' ' 35' ' ' LEU . 44.1 mt -63.88 131.24 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.72 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.2 mtmt -130.29 55.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.861 HG22 HD11 ' A' ' 72' ' ' ILE . 38.2 t 58.75 147.04 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.442 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.741 ' CD ' HD23 ' A' ' 38' ' ' LEU . 98.8 Cg_endo -94.29 -178.39 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.756 2.304 . . . . 0.0 112.453 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.672 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -64.2 173.69 1.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.012 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 9' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.754 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.175 0.512 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.468 ' N ' ' CB ' ' A' ' 67' ' ' SER . 3.6 p30 44.15 94.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.895 HG11 HG22 ' A' ' 40' ' ' THR . 0.1 OUTLIER -142.64 -176.08 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.372 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -112.06 138.68 48.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.055 HD13 HG23 ' A' ' 60' ' ' VAL . 28.8 mt -73.45 161.91 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 37' ' ' THR . 0.2 OUTLIER -134.62 -7.02 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.929 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -152.85 155.26 36.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.863 ' HA ' HG22 ' A' ' 36' ' ' ILE . 61.5 t -147.57 126.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.313 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -153.3 32.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.484 ' CB ' HG11 ' A' ' 73' ' ' VAL . 2.3 m -122.98 123.46 68.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -135.0 9.76 3.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.492 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 58' ' ' VAL . 87.3 t 63.4 131.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.85 -22.51 18.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.371 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.51 139.03 30.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.7 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -68.16 162.22 25.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 75' ' ' VAL . 1.2 pp -143.73 130.19 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.15 -174.43 4.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.935 0.398 . . . . 0.0 111.008 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 31' ' ' VAL . 11.1 t -90.32 41.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER 168.05 67.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.905 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -141.78 116.62 9.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.867 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -59.65 115.32 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.877 HD12 ' CD1' ' A' ' 5' ' ' LEU . 16.6 mt -90.37 -41.95 11.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.406 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.863 HG22 ' HA ' ' A' ' 21' ' ' VAL . 1.3 pp -150.43 -175.97 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.884 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.79 ' C ' HG23 ' A' ' 19' ' ' ILE . 3.7 m -133.3 152.59 51.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.763 ' CD2' HD13 ' A' ' 36' ' ' ILE . 2.4 mm? -134.45 166.8 22.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.72 ' CD ' HG22 ' A' ' 44' ' ' THR . 76.0 tt0 -174.4 164.07 3.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.401 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.895 HG22 HG11 ' A' ' 16' ' ' VAL . 13.5 p -120.71 -72.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.892 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.466 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.9 m-20 -159.72 25.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.731 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm 176.24 -43.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.65 128.76 45.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.72 HG22 ' CD ' ' A' ' 39' ' ' GLU . 5.2 p -116.71 115.81 26.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.44 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -104.07 -165.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 5.7 p30 -175.69 167.34 3.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.73 HG11 HD13 ' A' ' 5' ' ' LEU . 74.0 t -112.03 104.15 55.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 70.3 Cg_endo -89.35 42.11 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.118 2.545 . . . . 0.0 111.886 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.7 177.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.774 ' O ' HG13 ' A' ' 51' ' ' VAL . 23.1 pt-20 -163.19 38.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 175.74 168.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 29' ' ' ILE . . . -112.27 93.15 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.961 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -165.35 -140.15 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.259 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 76' ' ' GLU . 90.9 t -135.08 145.24 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 0.0 111.065 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 75' ' ' VAL . 63.2 t -75.16 145.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 0.0 111.397 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -47.59 2.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.466 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.92 167.2 10.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.644 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.939 ' HA ' HG12 ' A' ' 73' ' ' VAL . 12.4 p -162.87 124.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.93 80.93 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.055 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.32 151.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.56 -173.87 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.97 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 21' ' ' VAL . 46.3 t -101.31 77.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.7 41.49 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.94 ' OD1' HD12 ' A' ' 18' ' ' ILE . 3.9 p30 -132.8 164.04 27.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.708 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -88.76 105.0 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.18 0.514 . . . . 0.0 110.705 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.734 HG23 HG21 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -132.89 164.61 34.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.369 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.468 ' CB ' ' N ' ' A' ' 15' ' ' ASN . 54.3 p -167.2 168.32 13.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -45.72 91.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.196 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 124.34 57.56 0.18 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.76 9.02 6.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.928 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.467 HD11 ' CG2' ' A' ' 74' ' ' VAL . 4.2 tp 47.25 46.86 16.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.679 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.861 HD11 HG22 ' A' ' 7' ' ' VAL . 9.1 mt -43.26 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.5 m -135.36 147.25 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.51 . . . . 0.0 111.99 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 3' ' ' VAL . 98.5 t -109.84 140.72 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.705 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.599 HG12 HG22 ' A' ' 55' ' ' VAL . 16.4 m -123.16 161.91 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.127 0.489 . . . . 0.0 112.303 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' VAL . 2.8 tt0 -68.58 -42.28 78.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.016 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.97 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.938 0.399 . . . . 0.0 110.788 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.827 ' O ' HG13 ' A' ' 74' ' ' VAL . 6.2 t -125.51 162.76 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.451 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HB3' HD13 ' A' ' 71' ' ' LEU . 11.2 mt-10 -125.48 90.32 3.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.434 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -51.84 152.16 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.572 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -140.12 151.54 45.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.205 0.526 . . . . 0.0 111.626 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.753 HG11 HG21 ' A' ' 66' ' ' ILE . 85.2 t -47.11 143.13 4.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.88 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.665 ' HD2' HG13 ' A' ' 7' ' ' VAL . 43.5 Cg_endo -70.78 -167.47 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.149 1.9 . . . . 0.0 112.738 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 76.86 2.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.562 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.86 HG12 HG21 ' A' ' 16' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.683 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' CA ' ' HA ' ' A' ' 67' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.047 0.451 . . . . 0.0 110.65 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -179.34 57.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.86 HG21 HG12 ' A' ' 10' ' ' ILE . 17.1 m -106.38 -175.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.173 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.18 130.6 52.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.933 HD13 HG23 ' A' ' 60' ' ' VAL . 5.6 mt -66.15 161.15 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.956 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.6 -37.98 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.593 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -118.08 166.18 12.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 21' ' ' VAL . 15.0 p -159.38 116.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -135.64 61.4 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.913 HG11 HG11 ' A' ' 73' ' ' VAL . 5.8 m -145.18 118.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.69 23.17 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 56' ' ' LYS . 71.8 t 66.73 -86.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.991 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.7 62.03 0.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.946 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 25' ' ' VAL . 2.2 t0 -129.94 171.03 13.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.709 0.29 . . . . 0.0 110.761 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 m -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.903 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.478 HD13 HG23 ' A' ' 51' ' ' VAL . 1.1 pt -132.21 153.2 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 0.0 111.344 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.91 174.06 11.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 3.1 t -78.51 54.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 3.6 p30 162.09 70.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.83 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -153.81 124.39 7.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.78 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.53 117.38 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.277 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.423 HD13 ' HG ' ' A' ' 5' ' ' LEU . 19.1 mt -90.42 -40.78 11.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.849 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.591 HD13 ' HB ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -157.68 -161.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.862 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.593 ' N ' ' HB3' ' A' ' 20' ' ' ALA . 93.1 m -157.7 51.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.329 0.585 . . . . 0.0 109.846 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -41.83 163.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.859 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.912 ' CD ' HG22 ' A' ' 44' ' ' THR . 70.1 tt0 -172.76 154.42 2.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.829 HG22 ' CG1' ' A' ' 16' ' ' VAL . 50.2 p -102.01 -82.87 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' N ' ' OG1' ' A' ' 40' ' ' THR . 16.7 t70 -150.96 21.41 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -179.98 -41.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.03 105.58 17.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.234 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.912 HG22 ' CD ' ' A' ' 39' ' ' GLU . 3.5 p -91.74 115.07 27.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -95.43 138.9 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.478 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 37' ' ' THR . 3.7 m-20 -119.89 144.41 47.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.955 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.591 ' HB ' HD13 ' A' ' 36' ' ' ILE . 76.5 t -122.09 112.8 31.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 83.6 Cg_endo -88.4 35.41 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.963 2.442 . . . . 0.0 112.331 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.536 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 54.23 168.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.035 0.445 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.2 tp10 -165.65 67.88 0.12 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.484 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -173.87 176.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.237 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.67 79.01 1.69 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.627 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.43 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -167.99 -140.66 2.97 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.308 -1.425 . . . . 0.0 113.857 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -130.94 139.09 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.83 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.077 HG22 HG12 ' A' ' 75' ' ' VAL . 57.7 t -79.53 146.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.408 0.623 . . . . 0.0 111.527 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.59 -44.45 2.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.045 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -109.88 158.0 18.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.453 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.602 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.7 p -151.44 119.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -131.07 68.89 1.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.683 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.933 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -172.46 154.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.643 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -169.11 170.69 8.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.591 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.443 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 54.1 t -82.03 88.42 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.28 46.88 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.72 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.793 ' OD1' HD12 ' A' ' 18' ' ' ILE . 19.0 p-10 -139.46 176.53 8.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.772 0.32 . . . . 0.0 111.042 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.857 ' O ' HD12 ' A' ' 66' ' ' ILE . 7.8 tttt -104.07 156.09 18.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.669 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -140.76 172.56 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.565 ' N ' HG23 ' A' ' 66' ' ' ILE . 7.2 p -147.13 48.39 1.13 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 36.4 mt-10 39.95 55.21 2.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 138.0 69.97 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.442 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.93 29.07 6.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.553 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 4' ' ' GLU . 9.9 tp 48.09 56.67 7.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 0.0 110.571 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.787 HG23 ' CG1' ' A' ' 60' ' ' VAL . 3.3 mt -45.98 -82.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.913 HG11 HG11 ' A' ' 23' ' ' VAL . 27.3 m -122.0 160.15 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.17 0.51 . . . . 0.0 111.875 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 3' ' ' VAL . 76.3 t -128.93 120.58 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.907 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.077 HG12 HG22 ' A' ' 55' ' ' VAL . 29.7 m -112.09 156.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.496 ' HG2' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -64.84 -31.08 72.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.656 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.061 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.89 0.376 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 51' ' ' VAL . 7.9 t -141.84 152.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.762 ' HB3' HD13 ' A' ' 71' ' ' LEU . 7.3 mt-10 -128.37 100.79 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.376 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -60.93 157.56 15.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.069 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.451 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 8.5 mttp -142.13 145.07 33.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.314 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.78 HG22 HD11 ' A' ' 72' ' ' ILE . 95.9 t -48.23 141.24 8.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.04 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.753 ' CD ' HD23 ' A' ' 38' ' ' LEU . 38.0 Cg_endo -68.72 -166.08 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.2 1.934 . . . . 0.0 112.24 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.926 ' O ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -92.59 -13.04 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.645 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.926 HD12 ' O ' ' A' ' 9' ' ' ASP . 1.2 pp . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.924 0.392 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 44.03 95.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.881 HG11 HG22 ' A' ' 40' ' ' THR . 30.9 m -146.54 137.12 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.92 126.22 29.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.522 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.659 HD13 ' H ' ' A' ' 61' ' ' LYS . 3.7 mt -55.72 165.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.894 HG12 HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -140.75 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.066 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.568 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -177.95 146.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 111.099 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.804 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.4 p -137.81 124.39 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.981 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mm-40 -148.82 39.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.436 ' CB ' HG11 ' A' ' 73' ' ' VAL . 3.0 m -120.07 112.77 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.357 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -122.84 97.6 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 25' ' ' VAL . 23.5 m -39.05 111.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.921 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.93 21.17 4.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.67 143.11 50.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 54' ' ' VAL . 2.2 m -69.83 127.08 31.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.779 ' CD1' HG11 ' A' ' 75' ' ' VAL . 2.6 pt -108.09 169.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -178.58 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.4 t -94.34 33.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 176.23 62.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.409 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -140.93 108.34 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -48.76 116.23 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.187 0.518 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.52 HD12 HD11 ' A' ' 5' ' ' LEU . 70.2 mt -94.63 -44.29 7.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.788 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -149.93 -173.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.433 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.894 HG22 HG12 ' A' ' 19' ' ' ILE . 47.5 m -149.12 107.67 3.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 36' ' ' ILE . 2.7 mm? -92.19 151.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.755 ' CB ' HG21 ' A' ' 19' ' ' ILE . 78.2 tt0 -155.51 150.1 26.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.892 0.377 . . . . 0.0 110.991 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.881 HG22 HG11 ' A' ' 16' ' ' VAL . 3.0 p -112.06 -61.39 1.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.988 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 15.3 t0 -168.53 -41.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 37.77 3.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.51 118.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.606 HG22 ' CG ' ' A' ' 39' ' ' GLU . 2.3 p -113.04 119.95 39.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.965 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.03 153.56 21.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.4 p30 -133.12 143.91 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.572 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.633 ' CG2' HD11 ' A' ' 36' ' ' ILE . 93.8 t -105.87 108.09 60.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 71.0 Cg_endo -88.07 37.74 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.043 2.495 . . . . 0.0 112.469 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.445 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 44.66 95.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 111.338 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.595 ' C ' HG12 ' A' ' 51' ' ' VAL . 4.2 mt-10 -87.39 53.66 2.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 3' ' ' VAL . 1.2 p 161.85 141.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -83.14 -162.26 0.59 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.79 -145.17 15.93 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.089 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 76' ' ' GLU . 45.7 t -145.44 138.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.401 0.143 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.813 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.0 t -76.25 146.98 8.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.316 0.579 . . . . 0.0 111.796 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -119.71 -47.87 2.4 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.122 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -109.54 172.4 6.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.652 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.915 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -164.39 137.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HE2' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -152.27 67.96 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.402 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.712 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -169.59 152.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.639 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.659 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -171.81 -167.24 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.521 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.87 90.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.45 -19.94 0.71 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.892 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 2.3 p-10 -98.59 167.25 10.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.095 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.54 134.61 44.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -127.92 162.83 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.054 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -145.87 144.63 30.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -41.08 106.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 94.26 70.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.608 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.35 21.13 3.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.416 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.804 HD11 ' CG2' ' A' ' 74' ' ' VAL . 5.5 tp 47.58 59.67 3.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.788 HG22 HG13 ' A' ' 73' ' ' VAL . 3.6 mt -52.35 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.915 HG12 ' HA ' ' A' ' 58' ' ' VAL . 20.8 m -129.83 148.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 111.597 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.804 ' CG2' HD11 ' A' ' 71' ' ' LEU . 79.3 t -115.1 134.25 58.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 55' ' ' VAL . 32.0 m -121.84 177.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.155 0.502 . . . . 0.0 112.205 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' VAL . 1.5 tt0 -82.81 -33.53 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.268 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.442 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 75' ' ' VAL . 2.4 mp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.879 0.371 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.772 HG21 ' CG1' ' A' ' 51' ' ' VAL . 3.6 t -144.31 161.27 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HB3' HD13 ' A' ' 71' ' ' LEU . 63.5 mt-10 -129.87 100.06 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.552 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.651 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -57.75 164.09 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.023 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' CD ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -154.18 155.61 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.273 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.612 HG21 HG23 ' A' ' 66' ' ' ILE . 96.5 t -53.76 140.74 48.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.727 ' CD ' HD23 ' A' ' 38' ' ' LEU . 70.5 Cg_endo -73.69 -168.44 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.65 2.233 . . . . 0.0 113.03 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.4 OUTLIER -82.9 92.94 7.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.79 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.916 HG12 HG21 ' A' ' 16' ' ' VAL . 1.3 pp . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.042 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' CG ' ' HB2' ' A' ' 67' ' ' SER . 2.8 mp0 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.025 0.441 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 169.32 73.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.928 HG23 HG22 ' A' ' 66' ' ' ILE . 4.0 m -134.88 130.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.366 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.68 140.76 49.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.705 HD13 HG23 ' A' ' 60' ' ' VAL . 5.8 mt -74.9 161.33 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.709 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.511 HG12 ' HB ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -124.35 -38.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.794 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -117.95 170.8 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 36' ' ' ILE . 10.6 p -159.93 124.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.313 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.702 ' O ' HG13 ' A' ' 23' ' ' VAL . 39.1 mt-10 -158.64 90.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.831 HG11 HG11 ' A' ' 73' ' ' VAL . 2.6 m -163.95 113.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.361 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.5 m120 -114.7 96.23 5.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.506 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG12 ' C ' ' A' ' 56' ' ' LYS . 2.3 m -42.68 92.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.546 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 136.31 -15.73 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.588 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.5 m-20 -74.28 169.92 16.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.84 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 m -96.36 103.16 15.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.718 HD13 HG11 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -84.06 158.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.45 -176.79 4.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.941 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 31' ' ' VAL . 3.5 m -90.21 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.316 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 172.08 73.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.783 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 4.4 p-10 -150.25 107.84 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.614 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -48.76 118.6 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 111.417 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 36' ' ' ILE . 81.8 mt -92.55 -39.5 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.08 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -161.81 -178.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.626 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 19' ' ' ILE . 76.3 m -142.08 56.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.669 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.727 HD23 ' CD ' ' A' ' 8' ' ' PRO . 3.2 mm? -41.45 166.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HB2' HG22 ' A' ' 44' ' ' THR . 67.1 tt0 -168.52 153.89 6.53 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.306 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.605 HG22 HG11 ' A' ' 16' ' ' VAL . 29.9 p -100.04 -72.65 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.707 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.1 p-10 -160.22 26.99 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.601 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.04 -42.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.875 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.85 124.26 43.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.044 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.591 HG22 ' HB2' ' A' ' 39' ' ' GLU . 56.9 p -107.5 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.054 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.441 ' HB3' ' CG ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -97.5 133.09 42.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 2.9 p30 -118.3 144.31 45.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.229 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.651 HG11 HD11 ' A' ' 5' ' ' LEU . 92.4 t -113.34 116.58 46.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.417 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 78.4 Cg_endo -87.42 27.8 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.964 2.443 . . . . 0.0 112.619 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.644 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.28 151.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 111.297 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.767 ' O ' HG13 ' A' ' 51' ' ' VAL . 9.4 tp10 -145.98 70.9 1.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.772 ' CG1' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER 176.81 153.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.038 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.87 77.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.77 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.98 -130.84 1.23 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.179 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 27' ' ' ASP . 61.8 t -137.18 138.77 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.45 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.835 HG22 HG12 ' A' ' 75' ' ' VAL . 70.4 t -78.6 146.59 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.519 . . . . 0.0 111.291 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' C ' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.6 -47.08 2.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.589 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.05 175.04 5.58 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.82 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.642 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -163.39 126.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.525 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.1 mttt -136.87 69.01 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.766 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -171.78 159.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.723 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.556 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -171.89 -172.89 1.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.523 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.61 79.19 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.272 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.13 44.21 0.07 OUTLIER Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.701 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.514 ' CG ' HD12 ' A' ' 18' ' ' ILE . 7.7 p-10 -148.01 147.01 29.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.88 0.371 . . . . 0.0 111.108 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 137.18 40.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.928 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -131.27 172.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.457 ' HB2' ' CG ' ' A' ' 14' ' ' GLU . 7.1 p -152.2 142.78 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.203 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 76.9 mt-10 -44.74 97.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.201 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 99.8 62.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -114.26 22.03 14.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.357 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 4' ' ' GLU . 13.9 tp 48.15 53.58 11.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.977 0.418 . . . . 0.0 110.686 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.842 HG22 HG13 ' A' ' 73' ' ' VAL . 3.7 mt -48.11 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.044 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 72' ' ' ILE . 22.8 m -123.05 159.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.559 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 3' ' ' VAL . 27.9 t -127.75 132.52 68.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.934 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.835 HG12 HG22 ' A' ' 55' ' ' VAL . 33.2 m -119.38 -179.64 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -93.2 -37.19 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.514 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.153 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.342 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 75' ' ' VAL . 3.0 mp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.862 0.363 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.894 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.7 t -134.69 160.27 41.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HG3' HG22 ' A' ' 74' ' ' VAL . 31.0 mp0 -133.01 103.98 6.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.552 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.447 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -60.9 159.05 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.651 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.452 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 15.5 mttt -148.72 145.04 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.76 HG22 HD11 ' A' ' 72' ' ' ILE . 72.3 t -47.91 140.45 8.66 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.998 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.941 ' HD2' HD22 ' A' ' 38' ' ' LEU . 71.8 Cg_endo -76.94 -169.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.677 2.252 . . . . 0.0 112.89 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.443 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -81.85 84.45 6.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.791 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.867 HG12 HG21 ' A' ' 16' ' ' VAL . 1.1 pp . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 25.7 mp0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.993 0.425 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 7.0 p-10 45.38 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.867 HG21 HG12 ' A' ' 10' ' ' ILE . 35.3 m -136.18 -175.67 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.355 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.33 120.34 38.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.824 0.345 . . . . 0.0 111.369 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.783 HD12 ' OD2' ' A' ' 64' ' ' ASP . 27.2 mt -68.18 159.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.19 -15.81 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.51 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.601 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.0 150.47 32.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 21' ' ' VAL . 12.8 p -140.21 124.19 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.933 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -132.09 34.69 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG21 HG11 ' A' ' 73' ' ' VAL . 7.8 m -132.93 115.21 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.416 ' O ' HG12 ' A' ' 25' ' ' VAL . 16.1 t30 -114.75 14.91 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER 62.24 118.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.15 23.39 32.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.45 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.82 148.03 30.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 m -69.47 136.17 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.023 HD13 HG11 ' A' ' 75' ' ' VAL . 2.9 pt -126.86 160.33 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.363 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.19 -176.21 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.9 t -91.55 41.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.247 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 167.14 71.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.489 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 49' ' ' ALA . 1.5 p30 -145.58 120.32 9.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.974 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -54.55 117.06 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 47.5 mt -92.62 -36.33 13.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.876 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.529 HG12 HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -159.11 -176.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.266 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.601 ' N ' ' HB3' ' A' ' 20' ' ' ALA . 84.9 m -144.56 45.79 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.502 0.667 . . . . 0.0 109.447 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.941 HD22 ' HD2' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -39.69 165.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.362 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.913 ' CD ' HG22 ' A' ' 44' ' ' THR . 76.6 tt0 -174.63 164.55 3.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.086 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 10' ' ' ILE . 6.6 p -120.35 -158.38 0.75 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.38 -22.96 66.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 54.81 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.78 113.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.913 HG22 ' CD ' ' A' ' 39' ' ' GLU . 2.1 p -98.9 141.81 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.189 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.443 ' HG3' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -143.34 131.38 21.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.059 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.39 173.59 7.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ALA . 94.4 t -143.72 116.78 5.85 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 65.1 Cg_endo -90.92 36.83 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.203 2.602 . . . . 0.0 112.087 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 57.88 160.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.632 ' C ' HG12 ' A' ' 51' ' ' VAL . 3.5 mt-10 -139.33 35.53 2.07 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.881 HG11 HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER 165.25 153.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.417 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 51' ' ' VAL . . . -85.49 -165.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.069 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 111.46 -157.24 15.08 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.715 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.73 134.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 75' ' ' VAL . 58.2 t -68.35 145.39 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.245 0.545 . . . . 0.0 111.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.51 ' O ' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.24 -44.56 2.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.251 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 19.6 mm-40 -111.86 174.66 5.77 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.636 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.534 ' HA ' HG12 ' A' ' 73' ' ' VAL . 12.5 p -173.83 137.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.508 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.12 51.01 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.107 0.479 . . . . 0.0 110.231 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.813 ' CG1' HG23 ' A' ' 72' ' ' ILE . 28.3 m -155.15 164.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.155 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -170.72 145.78 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 62' ' ' VAL . 7.2 p -55.99 86.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . 122.91 62.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.512 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.783 ' OD2' HD12 ' A' ' 18' ' ' ILE . 2.0 p30 -153.34 178.58 9.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -94.83 112.92 24.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.861 HG21 HD21 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -125.99 165.48 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.447 ' HB2' ' CB ' ' A' ' 14' ' ' GLU . 4.5 p -147.53 141.11 25.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.96 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 28.7 mt-10 -43.08 109.14 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 83.83 70.43 1.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.24 10.83 9.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.716 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp 60.51 48.48 7.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.423 0.63 . . . . 0.0 109.964 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.942 HG22 HG13 ' A' ' 73' ' ' VAL . 56.0 mt -46.84 -83.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.725 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.942 HG13 HG22 ' A' ' 72' ' ' ILE . 29.3 m -118.38 159.13 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 0.0 111.616 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 3' ' ' VAL . 90.7 t -131.4 141.1 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.91 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.023 HG11 HD13 ' A' ' 29' ' ' ILE . 24.4 m -121.87 -178.51 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.242 0.544 . . . . 0.0 112.4 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HG3' ' CE ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -95.56 -27.35 15.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.498 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.704 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 76' ' ' GLU . 2.6 mp . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.882 0.373 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.8 t -134.8 150.21 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.711 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.559 ' HA ' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -119.46 104.01 9.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.221 179.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.761 HD21 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -69.73 161.09 30.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.007 0.432 . . . . 0.0 111.264 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -152.81 159.7 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.727 HG21 HG23 ' A' ' 66' ' ' ILE . 87.1 t -50.0 140.06 16.7 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.776 ' CD ' HD23 ' A' ' 38' ' ' LEU . 60.9 Cg_endo -73.79 -168.17 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.578 2.185 . . . . 0.0 113.052 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -89.87 86.89 6.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.745 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.975 HG12 HG21 ' A' ' 16' ' ' VAL . 1.2 pp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' CA ' ' HB3' ' A' ' 67' ' ' SER . 6.2 mt-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 4.2 p30 162.64 76.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.434 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.975 HG21 HG12 ' A' ' 10' ' ' ILE . 32.6 m -138.83 133.6 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.547 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -76.06 137.05 39.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.047 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.136 HD13 HG23 ' A' ' 60' ' ' VAL . 7.9 mt -72.16 161.18 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.026 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.18 -20.98 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.825 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.702 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -140.07 158.52 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 111.423 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.58 HG21 ' N ' ' A' ' 62' ' ' VAL . 97.1 t -145.92 127.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.9 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.612 ' O ' HG13 ' A' ' 23' ' ' VAL . 45.5 mm-40 -149.92 77.11 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.7 m -160.66 141.62 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.224 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -137.58 18.42 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.256 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 56' ' ' LYS . 73.8 t 65.92 -82.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 58.84 2.48 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.575 ' O ' HG13 ' A' ' 54' ' ' VAL . 6.6 t0 -128.4 166.73 18.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.743 0.306 . . . . 0.0 110.821 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.5 m -90.52 125.49 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.798 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.805 HD13 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -120.35 143.24 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.06 -171.78 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.218 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.5 t -90.0 44.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.62 73.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.519 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 4.0 p-10 -152.69 98.82 2.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -45.12 116.4 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.183 0.516 . . . . 0.0 111.611 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.534 ' HG ' ' HB2' ' A' ' 49' ' ' ALA . 26.4 mt -91.09 -41.68 10.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.067 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -154.88 -178.39 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.455 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.583 ' O ' HG23 ' A' ' 19' ' ' ILE . 96.4 m -144.39 57.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.776 HD23 ' CD ' ' A' ' 8' ' ' PRO . 2.1 mm? -39.16 162.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.322 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.728 ' HG3' HG22 ' A' ' 44' ' ' THR . 65.3 tt0 -175.41 156.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.786 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.431 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -123.71 -83.79 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.585 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.6 OUTLIER -144.56 -42.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -125.29 42.93 3.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . 176.21 136.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.304 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.728 HG22 ' HG3' ' A' ' 39' ' ' GLU . 2.4 p -129.48 120.77 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.569 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.613 ' HB2' HG23 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -108.58 156.17 19.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -179.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 9.0 p-10 -141.43 144.82 34.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.458 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.761 HG11 HD21 ' A' ' 5' ' ' LEU . 93.9 t -117.29 118.34 35.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 87.7 Cg_endo -90.02 30.13 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.015 2.477 . . . . 0.0 112.319 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.668 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 51.35 102.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.281 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.95 67.77 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.855 HG11 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -158.72 -172.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.993 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.66 62.97 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.399 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -157.54 -119.81 0.6 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.059 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 27' ' ' ASP . 63.6 t -146.33 140.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.506 0.193 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.91 HG22 HG12 ' A' ' 75' ' ' VAL . 85.7 t -78.07 155.03 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.346 0.593 . . . . 0.0 111.308 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.662 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -127.09 -46.02 1.54 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.189 179.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -107.96 165.09 11.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.319 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.801 ' HA ' HG12 ' A' ' 73' ' ' VAL . 14.6 p -162.17 123.81 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -143.41 78.37 1.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.595 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.136 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.13 148.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.374 -179.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -139.47 167.58 21.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 62' ' ' VAL . 11.2 p -81.75 55.69 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.266 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.12 61.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.817 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' CG ' HD12 ' A' ' 18' ' ' ILE . 1.7 p30 -148.98 150.48 32.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -64.76 122.48 16.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.19 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.727 HG23 HG21 ' A' ' 7' ' ' VAL . 1.1 tp -131.04 169.63 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.461 ' HB3' ' CA ' ' A' ' 14' ' ' GLU . 4.7 p -151.94 150.5 30.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mt-10 -50.58 98.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.83 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 108.09 55.73 0.6 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.475 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.73 18.4 29.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.391 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD11 ' CG2' ' A' ' 74' ' ' VAL . 9.0 tp 45.33 47.7 10.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.046 0.451 . . . . 0.0 110.775 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.807 HG23 ' CG1' ' A' ' 60' ' ' VAL . 5.8 mt -43.18 -82.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.333 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 58' ' ' VAL . 22.0 m -127.39 148.38 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 111.728 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.779 HG13 ' O ' ' A' ' 3' ' ' VAL . 93.9 t -118.42 133.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.943 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.91 HG12 HG22 ' A' ' 55' ' ' VAL . 25.4 m -118.95 166.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 112.417 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' HD23 ' A' ' 2' ' ' LEU . 0.9 OUTLIER -77.54 -36.32 52.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.509 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.002 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.825 0.345 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.753 ' O ' HG13 ' A' ' 74' ' ' VAL . 33.9 t -152.66 161.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.438 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -135.12 91.2 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.002 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.786 HD11 HG11 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -53.05 169.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.631 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -158.11 161.69 37.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.781 HG13 HD22 ' A' ' 38' ' ' LEU . 83.4 t -52.64 139.96 38.82 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.754 ' CD ' HD13 ' A' ' 38' ' ' LEU . 38.5 Cg_endo -70.04 -168.16 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.094 1.863 . . . . 0.0 112.949 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.69 60.37 1.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.759 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.716 ' HB ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.585 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 4.3 pm0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.672 0.272 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.73 91.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 66' ' ' ILE . 9.3 m -127.79 -154.56 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.716 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 16' ' ' VAL . 31.1 m-20 -140.42 121.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.012 HD13 HG23 ' A' ' 60' ' ' VAL . 20.6 mt -65.0 163.78 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.782 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -127.12 -12.46 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.053 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 37' ' ' THR . . . -152.35 161.82 42.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 0.0 111.607 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.808 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.3 p -146.61 133.24 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.05 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -161.26 75.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.511 HG21 HG23 ' A' ' 58' ' ' VAL . 2.4 m -149.08 114.44 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -116.65 96.02 5.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.535 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 25' ' ' VAL . 35.3 m -43.28 110.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.553 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.05 17.43 4.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -120.38 149.82 41.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.792 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.452 ' HA ' HG22 ' A' ' 54' ' ' VAL . 7.9 m -77.38 142.94 39.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.945 HD13 HG23 ' A' ' 51' ' ' VAL . 2.8 pp -143.1 166.06 15.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.65 -171.27 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.351 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 51' ' ' VAL . 6.1 t -90.39 43.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 p30 178.28 68.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.32 107.1 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -44.16 119.32 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.169 0.509 . . . . 0.0 112.096 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 82.9 mt -92.02 -45.3 8.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.856 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.808 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -154.78 179.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.444 0.64 . . . . 0.0 112.091 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 19' ' ' ILE . 59.7 m -138.81 116.94 11.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.782 ' HA ' HG23 ' A' ' 19' ' ' ILE . 4.2 mp -111.6 175.34 5.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 112.148 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.958 ' HG3' HG22 ' A' ' 44' ' ' THR . 6.3 tm-20 -177.4 157.16 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.716 HG23 ' HB ' ' A' ' 10' ' ' ILE . 6.5 p -131.49 -58.96 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 110.816 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 40' ' ' THR . 8.7 t70 -175.24 -38.3 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.765 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 8.1 mmtt -75.06 -26.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . 175.38 170.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.927 0.394 . . . . 0.0 111.334 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.958 HG22 ' HG3' ' A' ' 39' ' ' GLU . 2.5 p -109.66 130.36 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -109.09 -168.56 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 0.0 111.545 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -176.84 167.36 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.234 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.786 HG11 HD11 ' A' ' 5' ' ' LEU . 99.6 t -127.41 125.51 23.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.983 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 86.1 Cg_endo -89.74 30.41 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.032 2.488 . . . . 0.0 112.494 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.669 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 53.53 106.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 111.394 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.95 69.56 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.142 0.496 . . . . 0.0 110.167 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -158.53 -170.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.71 -178.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -159.76 56.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.798 0.333 . . . . 0.0 111.363 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.82 -121.92 0.59 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.39 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 27' ' ' ASP . 51.1 t -137.62 139.15 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 111.44 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 95.6 t -71.31 148.19 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.182 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.02 -49.76 2.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.684 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -111.22 175.17 5.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.629 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.938 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.1 p -165.6 128.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.038 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 71.88 1.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.49 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.012 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -170.21 148.53 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.746 -179.335 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.39 -174.31 4.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.588 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.78 78.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.326 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.38 45.72 0.13 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.645 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.923 ' OD1' HD12 ' A' ' 18' ' ' ILE . 20.0 p-10 -130.81 170.65 14.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.899 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 6.0 mttt -91.96 114.78 27.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.528 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -131.13 160.26 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.696 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.427 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -144.09 148.53 35.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.965 179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.436 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 27.3 tt0 -47.44 99.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 99.47 66.33 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.359 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -128.88 29.08 4.03 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.76 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.9 tp 42.84 74.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.747 ' CG2' HG13 ' A' ' 73' ' ' VAL . 1.4 mt -66.75 -76.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.955 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.938 HG12 ' HA ' ' A' ' 58' ' ' VAL . 17.0 m -129.02 148.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 0.0 111.77 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 3' ' ' VAL . 67.7 t -101.47 142.32 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.922 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 51' ' ' VAL . 2.4 t -125.73 153.4 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.253 0.549 . . . . 0.0 112.08 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 76' ' ' GLU . 3.2 tt0 -102.61 45.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.848 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.665 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.796 HD22 ' HA ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.976 0.417 . . . . 0.0 110.893 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.953 HG21 HG11 ' A' ' 51' ' ' VAL . 4.3 t -128.4 162.1 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.5 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.682 ' HB3' HD13 ' A' ' 71' ' ' LEU . 45.5 mt-10 -124.34 89.86 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.426 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.763 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -50.63 151.27 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.975 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.23 150.23 43.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.756 HG13 HD22 ' A' ' 38' ' ' LEU . 91.7 t -48.02 141.11 8.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.89 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.878 ' CD ' HD13 ' A' ' 38' ' ' LEU . 60.0 Cg_endo -73.13 -166.69 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.318 2.012 . . . . 0.0 112.667 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 45' ' ' MET . 1.2 m-20 -95.43 79.05 3.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 16' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.914 0.388 . . . . 0.0 111.184 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.201 0.524 . . . . 0.0 111.077 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' GLU . 7.4 p30 46.01 71.09 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.57 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 66' ' ' ILE . 24.1 m -121.93 -170.8 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.13 124.57 37.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 111.541 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.016 HD13 HG23 ' A' ' 60' ' ' VAL . 11.6 mt -61.0 163.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.834 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.715 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -127.68 -12.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.956 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.72 154.43 38.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.379 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.802 ' HA ' HG22 ' A' ' 36' ' ' ILE . 11.0 p -146.32 115.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.216 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -119.46 -30.69 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.344 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.803 HG11 HG11 ' A' ' 73' ' ' VAL . 11.6 m -64.19 129.07 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.92 0.39 . . . . 0.0 111.259 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -139.48 12.74 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.6 t 63.03 118.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.29 8.6 35.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.62 148.28 25.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.33 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.1 m -81.85 106.19 13.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -93.31 155.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.514 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.33 -177.66 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.785 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 31' ' ' VAL . 16.6 t -90.26 44.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 2.1 p30 163.75 70.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.352 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.415 ' H ' ' HB3' ' A' ' 49' ' ' ALA . 1.8 p-10 -148.33 119.8 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.697 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -56.31 114.92 2.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 0.0 111.35 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.72 -43.76 11.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.32 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.929 HD13 HD12 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -152.62 -178.51 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.214 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 19' ' ' ILE . 55.0 m -144.17 120.81 11.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.929 HD12 HD13 ' A' ' 36' ' ' ILE . 4.3 mp -112.3 166.54 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.143 0.497 . . . . 0.0 111.737 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.796 ' CD ' HG22 ' A' ' 44' ' ' THR . 80.4 tt0 -168.38 161.82 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.727 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.508 HG23 ' HB ' ' A' ' 10' ' ' ILE . 3.5 p -120.32 -58.35 1.86 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -179.54 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.817 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -12.57 13.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.534 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.29 137.78 30.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.977 0.418 . . . . 0.0 111.465 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.796 HG22 ' CD ' ' A' ' 39' ' ' GLU . 2.6 p -120.96 127.98 52.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.435 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.425 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -120.01 -166.31 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.146 0.498 . . . . 0.0 111.795 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -179.28 172.96 1.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.763 HG11 HD11 ' A' ' 5' ' ' LEU . 95.8 t -126.65 113.7 22.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 121.174 -0.21 . . . . 0.0 111.377 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 57.4 Cg_endo -90.28 30.64 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.11 2.54 . . . . 0.0 112.427 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.17 164.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.812 ' O ' HG13 ' A' ' 51' ' ' VAL . 26.2 tt0 -160.61 46.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.953 HG11 HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -173.16 161.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.71 86.58 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -160.58 -140.4 2.88 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.152 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -130.39 140.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.609 0.242 . . . . 0.0 111.081 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.869 HG22 HG12 ' A' ' 75' ' ' VAL . 53.7 t -77.04 139.28 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.313 0.577 . . . . 0.0 111.396 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HD2' HD13 ' A' ' 2' ' ' LEU . 1.1 mttm -107.66 -48.63 3.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.228 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 29.0 mt-10 -111.11 166.11 11.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.365 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.693 ' HA ' HG12 ' A' ' 73' ' ' VAL . 6.4 p -154.81 114.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.389 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -128.97 74.81 1.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.016 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -174.73 150.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.615 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -172.56 128.6 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.536 HG23 HG12 ' A' ' 21' ' ' VAL . 15.4 t -47.09 102.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.35 25.79 2.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.726 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.865 ' OD1' HD12 ' A' ' 18' ' ' ILE . 21.5 p-10 -121.11 175.81 5.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.809 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -97.98 147.77 24.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.86 HG22 HG22 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -141.3 167.54 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 66' ' ' ILE . 78.2 p -144.95 51.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' CG ' HD11 ' A' ' 10' ' ' ILE . 98.8 mt-10 40.72 50.17 2.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.801 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' N ' ' HB ' ' A' ' 7' ' ' VAL . . . 144.01 71.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.47 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.82 33.0 4.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.717 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.682 HD13 ' HB3' ' A' ' 4' ' ' GLU . 7.2 tp 44.21 56.9 4.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.798 HG23 ' CG1' ' A' ' 60' ' ' VAL . 3.4 mt -46.31 -83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.312 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.803 HG11 HG11 ' A' ' 23' ' ' VAL . 33.8 m -120.29 164.9 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.113 0.483 . . . . 0.0 111.951 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 3' ' ' VAL . 59.1 t -132.34 117.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.944 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.869 HG12 HG22 ' A' ' 55' ' ' VAL . 28.0 m -108.31 157.68 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.796 ' HA ' HD22 ' A' ' 2' ' ' LEU . 4.0 tt0 -68.08 -35.29 77.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.075 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 121.125 0.488 . . . . 0.0 112.038 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 76' ' ' GLU . 1.8 mp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.929 0.395 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.836 HG21 HG11 ' A' ' 51' ' ' VAL . 2.6 t -141.04 161.44 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.746 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 4.3 mp0 -135.9 121.27 19.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.694 ' CD2' HD12 ' A' ' 35' ' ' LEU . 1.3 tp -73.46 154.23 40.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -149.59 59.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.862 ' H ' HD12 ' A' ' 72' ' ' ILE . 67.2 t 60.83 145.62 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HD2' HG13 ' A' ' 7' ' ' VAL . 33.5 Cg_endo -67.99 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.621 1.547 . . . . 0.0 112.77 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER 166.6 56.83 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.736 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.985 HG23 HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.056 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 2.2 mt-10 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.14 0.495 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 p30 176.97 85.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.637 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.966 HG11 HG22 ' A' ' 40' ' ' THR . 0.7 OUTLIER -147.46 145.29 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.332 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 64' ' ' ASP . 4.1 m-20 -75.74 145.57 40.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.339 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.076 HD13 HG23 ' A' ' 60' ' ' VAL . 6.1 mt -71.77 163.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.564 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.869 HG12 HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -132.27 -4.25 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.626 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -155.68 151.62 27.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.27 . . . . 0.0 110.928 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.78 ' HA ' HG22 ' A' ' 36' ' ' ILE . 11.1 p -137.9 134.04 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.466 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -155.17 25.48 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.635 HG11 HG11 ' A' ' 73' ' ' VAL . 3.1 m -117.46 122.91 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -133.89 11.76 3.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.485 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 85.4 t 60.63 120.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.51 35.11 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.982 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.4 146.72 27.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -69.85 132.89 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.514 ' CD1' HG11 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -124.25 143.58 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.57 -173.73 2.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.1 t -90.85 39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.361 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p30 168.19 64.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.673 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -140.85 114.3 8.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.77 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.98 115.72 2.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 111.496 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' A' ' 5' ' ' LEU . 33.5 mt -91.25 -32.07 15.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.426 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.78 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.77 -177.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.934 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.869 HG22 HG12 ' A' ' 19' ' ' ILE . 60.7 m -141.92 122.33 14.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 109.901 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.985 HD23 HG23 ' A' ' 10' ' ' ILE . 2.2 tp -102.99 167.83 9.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.869 ' HG3' HG22 ' A' ' 44' ' ' THR . 2.1 tm-20 -167.72 166.43 13.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.966 HG22 HG11 ' A' ' 16' ' ' VAL . 5.5 p -124.76 -59.39 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.682 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.0 t70 -171.84 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.51 -29.61 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.22 131.75 56.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 111.374 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.869 HG22 ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -115.41 138.54 50.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.89 -178.33 4.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.408 . . . . 0.0 111.332 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.6 p30 -167.29 162.45 14.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.649 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.641 HG11 HD21 ' A' ' 5' ' ' LEU . 89.4 t -113.67 109.75 50.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.0 Cg_endo -88.82 43.53 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.098 2.532 . . . . 0.0 111.823 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 54.35 171.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.706 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.839 ' O ' HG13 ' A' ' 51' ' ' VAL . 5.3 pt-20 -156.09 33.03 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.449 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.839 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -172.37 170.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.144 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' ILE . . . -121.97 86.01 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.401 ' O ' HG13 ' A' ' 29' ' ' ILE . . . -159.75 -134.38 1.66 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.018 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 76' ' ' GLU . 91.3 t -135.12 141.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.701 HG22 HG13 ' A' ' 75' ' ' VAL . 57.4 t -74.4 143.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.349 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.419 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -111.2 -47.62 3.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.45 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 22.9 mt-10 -113.32 172.15 7.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.664 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.921 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -160.57 119.6 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.5 mttm -134.81 62.72 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.575 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.076 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -169.12 149.94 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -140.67 -169.74 2.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.57 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 62' ' ' VAL . 14.6 p -93.49 42.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.086 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.52 71.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.553 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' CG ' HD12 ' A' ' 18' ' ' ILE . 4.1 p-10 -156.7 145.06 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 110.991 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 131.53 45.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.557 ' CG2' HD11 ' A' ' 38' ' ' LEU . 1.2 tp -135.64 178.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.484 ' N ' HG23 ' A' ' 66' ' ' ILE . 2.4 m -155.43 118.17 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.616 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -38.46 91.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.636 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 127.35 49.17 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.938 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -112.3 -121.16 3.9 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.601 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -157.58 44.37 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.376 0.608 . . . . 0.0 109.663 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.862 HD12 ' H ' ' A' ' 7' ' ' VAL . 7.1 mt -40.63 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.041 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 58' ' ' VAL . 20.7 m -131.66 143.96 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.166 0.508 . . . . 0.0 112.317 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 3' ' ' VAL . 61.8 t -108.08 140.31 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.137 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.701 HG13 HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.165 0.507 . . . . 0.0 112.156 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 2' ' ' LEU . 3.9 tt0 -75.42 -39.34 59.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.07 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 112.067 179.528 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 75' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.933 0.397 . . . . 0.0 110.993 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.758 HG21 ' CG1' ' A' ' 51' ' ' VAL . 4.1 t -140.71 161.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.584 ' HB3' HD13 ' A' ' 71' ' ' LEU . 1.6 mp0 -142.73 101.36 3.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.478 HD23 HG23 ' A' ' 73' ' ' VAL . 2.4 mm? -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.093 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.451 ' CB ' ' HA2' ' A' ' 69' ' ' GLY . 1.9 mttt -134.16 64.18 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 111.746 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.67 ' H ' HD12 ' A' ' 72' ' ' ILE . 45.4 t 59.83 139.46 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.345 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HD2' HD22 ' A' ' 38' ' ' LEU . 39.4 Cg_endo -72.65 -166.59 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.107 1.871 . . . . 0.0 112.817 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.68 72.24 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.339 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.738 ' CG2' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.491 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 3.7 pm0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.814 0.34 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 1.2 p-10 44.49 85.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 66' ' ' ILE . 20.5 m -123.23 159.8 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.877 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -92.68 128.4 38.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.177 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.926 HD13 HG23 ' A' ' 60' ' ' VAL . 6.9 mt -77.84 161.29 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.26 -41.66 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.393 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -116.94 157.77 25.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 21' ' ' VAL . 10.4 p -157.24 115.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -135.85 72.32 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.039 HG11 HG11 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -146.49 118.92 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -119.89 18.79 12.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.175 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 56' ' ' LYS . 74.0 t 66.07 -86.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.949 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 60.65 1.41 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.833 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 162.99 25.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -87.6 120.53 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.805 HD13 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -115.5 137.33 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.94 -169.01 1.88 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 31' ' ' VAL . 21.8 t -90.64 43.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.167 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 p30 171.84 68.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.581 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.1 p-10 -147.55 102.09 3.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -48.5 117.62 2.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.477 . . . . 0.0 111.582 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 49' ' ' ALA . 32.6 mt -91.83 -37.79 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.713 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.484 HD13 ' HB ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -155.17 -160.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.963 179.135 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 37' ' ' THR . 94.4 m -161.3 38.13 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.83 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.878 HD21 HG21 ' A' ' 16' ' ' VAL . 2.7 tp -31.87 152.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.088 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.806 ' CD ' HG22 ' A' ' 44' ' ' THR . 52.8 tt0 -168.95 157.89 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.48 HG22 ' CG1' ' A' ' 16' ' ' VAL . 3.9 p -123.9 -58.01 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.3 m-20 174.78 -34.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.699 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.85 -35.24 26.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.63 157.52 35.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.962 0.41 . . . . 0.0 111.426 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.806 HG22 ' CD ' ' A' ' 39' ' ' GLU . 3.1 p -114.97 119.87 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.393 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.471 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -112.86 141.93 46.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.629 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 15.3 p-10 -126.88 174.97 8.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.648 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 49' ' ' ALA . 63.2 t -141.86 120.17 7.7 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.919 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 82.9 Cg_endo -90.79 31.33 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.978 2.452 . . . . 0.0 112.179 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.67 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 49.4 99.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.071 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.764 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.3 tm-20 -91.89 66.55 5.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 0.0 110.649 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -170.47 151.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.411 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.5 76.2 1.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.652 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.45 -124.93 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.106 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.6 t -143.79 138.57 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.496 0.188 . . . . 0.0 111.242 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.847 HG22 HG12 ' A' ' 75' ' ' VAL . 60.1 t -79.64 150.9 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.211 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.632 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -120.3 -44.97 2.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.344 178.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -108.9 165.99 11.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -157.78 118.21 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.288 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 6.0 mttt -133.81 71.71 1.46 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.627 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.926 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -175.22 160.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -164.9 -161.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.811 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.511 HG23 ' CG1' ' A' ' 21' ' ' VAL . 67.7 t -108.45 71.28 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.82 43.43 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.674 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD2' HD12 ' A' ' 18' ' ' ILE . 7.3 p-10 -136.41 172.32 13.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.957 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.686 ' O ' HD12 ' A' ' 66' ' ' ILE . 21.9 mmtt -97.55 131.89 43.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.787 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.91 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -139.14 151.35 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.882 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.9 OUTLIER -140.63 140.22 34.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.328 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.581 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 3.3 mp0 -40.54 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' CB ' ' A' ' 6' ' ' LYS . . . 116.68 57.08 0.31 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.965 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.66 12.79 8.26 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.105 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.813 HD11 ' CG2' ' A' ' 74' ' ' VAL . 6.2 tp 48.51 57.75 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 0.0 110.884 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.852 HG22 HG13 ' A' ' 73' ' ' VAL . 2.8 mt -53.88 -70.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.076 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.039 HG11 HG11 ' A' ' 23' ' ' VAL . 18.3 m -131.65 151.26 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.747 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.813 ' CG2' HD11 ' A' ' 71' ' ' LEU . 20.3 t -122.3 134.54 65.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.959 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 51' ' ' VAL . 27.7 m -123.32 175.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HA ' ' HG ' ' A' ' 2' ' ' LEU . 2.1 tt0 -86.6 -40.85 14.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.929 179.686 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.939 0.399 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.807 ' O ' HG13 ' A' ' 74' ' ' VAL . 4.8 t -152.6 160.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.768 ' HB3' HD13 ' A' ' 71' ' ' LEU . 18.0 mp0 -138.63 108.84 6.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.61 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.791 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -68.14 176.55 2.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.754 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.608 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -157.73 162.83 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.306 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.738 ' N ' HD12 ' A' ' 72' ' ' ILE . 86.1 t -51.9 147.97 11.36 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.635 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HD2' HD22 ' A' ' 38' ' ' LEU . 17.0 Cg_exo -66.76 -156.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.084 1.856 . . . . 0.0 112.671 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -120.84 53.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.884 ' HB ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.94 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.75 0.31 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 44.0 78.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.351 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.044 HG21 HD21 ' A' ' 38' ' ' LEU . 33.6 m -122.36 160.5 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.47 118.19 32.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.253 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.048 HD13 HG23 ' A' ' 60' ' ' VAL . 8.9 mt -60.12 162.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.511 HG12 ' HB ' ' A' ' 37' ' ' THR . 0.2 OUTLIER -121.55 -41.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.135 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.8 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -115.53 164.28 14.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG21 ' HB ' ' A' ' 62' ' ' VAL . 27.9 t -145.25 138.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 35' ' ' LEU . 10.0 mt-10 -159.28 41.8 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.991 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.546 HG11 HG11 ' A' ' 73' ' ' VAL . 2.7 m -141.28 116.17 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.02 13.86 3.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.345 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 91.5 t 62.72 124.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.44 -23.3 18.37 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.13 138.74 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -73.77 103.58 4.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.791 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.774 HD13 HG21 ' A' ' 75' ' ' VAL . 4.0 pt -76.55 147.95 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.273 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . . . -128.19 -173.24 2.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.71 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.18 39.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.949 0.404 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.35 64.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.669 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.55 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -138.86 101.47 4.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.718 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -47.15 115.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 111.535 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 36' ' ' ILE . 16.7 mt -89.42 -38.07 14.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.678 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -162.06 179.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.634 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 19' ' ' ILE . 62.1 m -144.03 53.82 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.468 0.651 . . . . 0.0 110.207 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.044 HD21 HG21 ' A' ' 16' ' ' VAL . 4.4 tp -38.13 154.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.243 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.843 ' HG3' HG22 ' A' ' 44' ' ' THR . 8.0 tm-20 -160.4 117.88 2.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.743 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.928 HG22 HG11 ' A' ' 16' ' ' VAL . 53.1 p -70.94 -85.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' N ' ' OG1' ' A' ' 40' ' ' THR . 10.5 p30 -153.0 23.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -177.28 -43.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.709 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . -103.85 125.66 50.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.022 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.843 HG22 ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -111.66 118.49 35.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.044 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.443 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -112.9 153.44 27.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 36' ' ' ILE . 7.5 p30 -136.55 165.44 25.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 5' ' ' LEU . 79.0 t -127.54 119.28 21.6 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.7 Cg_endo -90.39 30.6 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.131 2.554 . . . . 0.0 112.466 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.658 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 50.34 99.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.587 ' C ' HG12 ' A' ' 51' ' ' VAL . 2.4 mp0 -91.64 62.27 4.44 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 3' ' ' VAL . 1.3 p 161.75 144.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.381 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -91.28 -173.49 3.63 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.486 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 117.13 -146.94 18.88 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.634 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.434 ' O ' ' CE ' ' A' ' 56' ' ' LYS . 63.2 t -143.19 140.42 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.68 HG22 ' CG1' ' A' ' 75' ' ' VAL . 59.0 t -76.13 144.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.229 0.538 . . . . 0.0 111.94 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -114.78 -50.16 2.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.946 178.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 23.5 mt-10 -110.47 173.36 6.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.174 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.944 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -164.14 123.87 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -132.96 67.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.048 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -170.86 150.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.892 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 21' ' ' VAL . 7.7 mmtt -130.86 -163.85 1.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.492 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.525 ' HB ' HG21 ' A' ' 21' ' ' VAL . 9.0 p -99.63 36.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.046 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.83 65.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.513 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.603 ' CG ' HD12 ' A' ' 18' ' ' ILE . 1.2 p-10 -133.5 161.97 33.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -73.61 113.34 10.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 7' ' ' VAL . 1.1 tp -129.44 166.58 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.253 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.13 137.73 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.271 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 5.1 mp0 -40.23 106.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 90.22 69.16 1.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.288 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.97 24.39 4.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.707 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.768 HD13 ' HB3' ' A' ' 4' ' ' GLU . 6.1 tp 48.38 79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.763 ' CG2' HG13 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -73.19 -73.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.161 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.944 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.4 m -130.28 145.3 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.807 HG13 ' O ' ' A' ' 3' ' ' VAL . 83.5 t -107.02 134.99 47.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.845 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 29' ' ' ILE . 12.6 m -123.63 171.6 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.183 0.515 . . . . 0.0 112.3 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.612 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -79.3 -24.56 42.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.92 0.39 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.758 ' O ' HG13 ' A' ' 74' ' ' VAL . 25.5 t -151.6 159.2 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.55 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -135.37 99.31 4.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.344 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.889 HD12 ' CG2' ' A' ' 73' ' ' VAL . 25.0 mt -62.37 132.23 51.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.589 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -128.12 73.35 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.858 ' H ' HD12 ' A' ' 72' ' ' ILE . 72.0 t 58.55 149.27 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.625 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.75 ' CG ' HD13 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -83.17 -157.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.866 2.377 . . . . 0.0 112.216 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.64 99.4 9.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.78 ' HB ' HG22 ' A' ' 40' ' ' THR . 1.2 pp . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.892 0.377 . . . . 0.0 111.165 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 14' ' ' GLU . 8.3 p30 47.93 86.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.615 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 66' ' ' ILE . 10.5 m -137.94 -155.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.125 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.46 ' N ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -149.93 138.24 20.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.979 0.418 . . . . 0.0 111.393 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.111 HD13 HG23 ' A' ' 60' ' ' VAL . 7.8 mt -76.99 162.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.847 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.799 HG23 ' C ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -133.52 -9.62 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.887 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.55 149.06 30.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.473 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.805 ' HA ' HG22 ' A' ' 36' ' ' ILE . 89.6 t -140.71 121.66 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -142.39 28.39 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.755 HG11 HG11 ' A' ' 73' ' ' VAL . 3.7 m -117.76 125.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -137.28 11.56 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 56' ' ' LYS . 89.9 t 62.33 127.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -21.9 22.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -77.67 152.28 33.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 m -84.06 121.3 27.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.509 HD13 HG23 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -108.46 153.54 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.81 -176.1 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.863 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.66 47.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 166.85 74.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.456 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -160.46 117.72 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.97 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.44 117.9 5.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 49' ' ' ALA . 63.0 mt -93.1 -44.95 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.805 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -153.13 -179.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.738 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.799 ' C ' HG23 ' A' ' 19' ' ' ILE . 2.7 m -133.05 145.66 51.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.993 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.753 HD23 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -127.11 -172.54 2.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.777 ' CD ' HG22 ' A' ' 44' ' ' THR . 10.0 tt0 -172.19 172.7 4.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.78 HG22 ' HB ' ' A' ' 10' ' ' ILE . 1.2 p -142.25 -157.35 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 -19.69 65.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.864 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -172.79 53.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -173.47 134.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.24 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.777 HG22 ' CD ' ' A' ' 39' ' ' GLU . 71.4 p -107.71 153.86 22.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -172.07 4.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 37' ' ' THR . 1.0 OUTLIER -176.17 174.11 2.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 49' ' ' ALA . 96.9 t -126.38 123.46 24.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.267 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.5 Cg_endo -90.76 29.93 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 0.0 112.23 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . 46.72 93.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.469 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.35 61.74 3.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.45 149.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.142 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.52 75.0 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.9 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -163.77 -132.22 1.32 Allowed Glycine 0 C--N 1.317 -0.478 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.752 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.8 t -137.26 138.95 44.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.751 -0.225 . . . . 0.0 110.959 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.776 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.6 t -74.3 146.5 9.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.368 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.45 -46.1 2.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.57 178.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -113.89 173.95 6.17 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.694 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.617 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.7 p -160.8 116.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -134.14 79.42 1.81 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.111 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -174.62 152.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.209 0.528 . . . . 0.0 111.029 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.545 ' C ' HG21 ' A' ' 21' ' ' VAL . 1.2 tptt -138.79 173.34 11.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.484 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 62' ' ' VAL . 11.8 p -92.38 52.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.065 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.28 52.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.594 ' OD2' HD12 ' A' ' 18' ' ' ILE . 3.9 p-10 -129.98 -175.66 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.767 0.317 . . . . 0.0 110.973 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.728 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -105.95 149.78 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.926 HG22 HG22 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -138.34 170.84 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.521 ' N ' HG23 ' A' ' 66' ' ' ILE . 1.5 p -154.59 49.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.773 ' HG3' HD11 ' A' ' 10' ' ' ILE . 85.8 mt-10 39.9 63.68 1.01 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.643 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 146.83 68.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.62 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.27 17.61 6.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.747 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.57 HD11 ' CG2' ' A' ' 74' ' ' VAL . 10.2 tp 45.06 50.46 9.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.066 0.46 . . . . 0.0 110.73 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.858 HD12 ' H ' ' A' ' 7' ' ' VAL . 3.8 mt -45.05 -83.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.466 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.889 ' CG2' HD12 ' A' ' 5' ' ' LEU . 24.1 m -120.95 145.07 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.985 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 3' ' ' VAL . 87.8 t -114.38 138.89 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.605 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -131.77 174.32 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.94 -33.31 22.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.572 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.724 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.645 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.788 0.328 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 76' ' ' GLU . 1.2 mp 56.59 172.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.8 ' HB ' HG11 ' A' ' 51' ' ' VAL . 5.9 t -149.36 161.99 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.589 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -134.38 106.88 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.93 HD11 HG11 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -51.87 -176.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.264 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 2.4 mttp -164.62 142.78 6.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.78 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.838 HG22 HD11 ' A' ' 72' ' ' ILE . 67.8 t -49.17 138.38 14.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.6 ' CG ' HD13 ' A' ' 38' ' ' LEU . 53.2 Cg_endo -72.7 -167.05 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.356 2.037 . . . . 0.0 112.92 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.67 69.13 3.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.976 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.879 ' HB ' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER -55.88 -19.57 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.563 ' H ' HD12 ' A' ' 10' ' ' ILE . . . 111.6 -54.03 0.56 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.716 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.627 ' H ' HG21 ' A' ' 40' ' ' THR . . . -63.65 -87.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.601 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 175.06 -85.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 110.893 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 67' ' ' SER . 1.3 pt-20 -113.3 177.47 4.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 8.1 p-10 44.73 69.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.811 HG11 HG12 ' A' ' 10' ' ' ILE . 20.0 m -125.97 124.91 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.32 122.97 20.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.706 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.684 HD13 HG23 ' A' ' 60' ' ' VAL . 3.6 mt -62.12 164.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.577 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.691 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -126.53 -13.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.845 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -153.14 144.66 23.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.351 . . . . 0.0 111.372 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.812 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.4 p -145.13 122.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.218 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 2.5 pt-20 -140.09 47.72 1.8 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.778 HG21 HG11 ' A' ' 73' ' ' VAL . 8.2 m -144.71 123.37 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.266 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -128.42 18.62 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 56' ' ' LYS . 95.0 t 65.4 112.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.36 -21.28 5.75 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.499 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -81.41 147.59 29.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.3 m -71.81 155.9 39.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.945 HD13 HG23 ' A' ' 51' ' ' VAL . 1.7 pp -144.19 144.28 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.214 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.72 -179.06 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.03 48.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.3 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 p30 163.65 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.523 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 8.1 p-10 -155.29 115.47 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -50.66 117.29 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.153 0.501 . . . . 0.0 111.488 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 36' ' ' ILE . 13.8 mt -87.58 -43.6 11.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.009 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -158.06 -180.0 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.314 0.578 . . . . 0.0 111.86 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.645 ' O ' HG23 ' A' ' 19' ' ' ILE . 99.9 m -140.05 117.49 11.42 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.732 HD22 HG13 ' A' ' 7' ' ' VAL . 5.9 mp -111.61 171.83 7.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.023 0.44 . . . . 0.0 112.187 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.619 ' HB2' HG22 ' A' ' 44' ' ' THR . 49.4 tt0 -172.06 157.91 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.643 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.879 HG22 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.55 -89.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.904 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.444 ' H ' HG23 ' A' ' 40' ' ' THR . 0.3 OUTLIER -150.26 21.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.781 0.324 . . . . 0.0 110.741 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.71 -43.44 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.07 169.54 19.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 39' ' ' GLU . 71.6 p -108.5 115.93 31.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.493 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -101.1 -175.82 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.161 0.505 . . . . 0.0 111.534 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 1.2 p30 -172.92 170.43 4.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.241 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.93 HG11 HD11 ' A' ' 5' ' ' LEU . 97.3 t -126.35 124.51 24.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.813 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.2 Cg_endo -88.71 27.03 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.975 2.45 . . . . 0.0 112.702 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.724 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.67 150.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.304 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.571 ' C ' HG22 ' A' ' 51' ' ' VAL . 44.0 tt0 -149.35 70.62 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.476 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.945 HG23 HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -178.33 -178.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.494 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -148.28 67.79 1.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.818 0.342 . . . . 0.0 111.838 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.48 -134.84 1.75 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.115 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 76' ' ' GLU . 88.5 t -126.23 144.4 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.61 0.243 . . . . 0.0 111.183 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.683 HG22 HG12 ' A' ' 75' ' ' VAL . 95.2 t -76.56 145.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.152 0.501 . . . . 0.0 111.303 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.49 -46.92 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.556 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.63 175.3 5.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.498 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HA ' HG12 ' A' ' 73' ' ' VAL . 8.6 p -165.37 119.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -132.36 66.41 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.587 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.718 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -172.82 156.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.694 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -170.97 -159.93 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.737 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.723 HG23 HG12 ' A' ' 21' ' ' VAL . 59.6 t -112.07 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.54 -15.72 3.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.57 163.77 12.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.044 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -101.08 148.62 24.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.664 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.693 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.3 tp -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.477 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 14' ' ' GLU . 6.9 m -142.97 138.32 30.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 111.272 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 95.0 mt-10 -39.57 115.66 0.54 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 70.17 74.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.221 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -137.64 31.64 2.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.447 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 4' ' ' GLU . 13.7 tp 49.06 95.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.982 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.838 HD11 HG22 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -95.2 -74.86 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.654 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 23' ' ' VAL . 19.7 m -125.05 136.93 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 111.787 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 3' ' ' VAL . 61.9 t -104.96 141.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.097 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.887 HG21 HG21 ' A' ' 51' ' ' VAL . 33.1 m -127.62 171.47 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.244 0.545 . . . . 0.0 112.362 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.458 ' HA ' HD23 ' A' ' 2' ' ' LEU . 1.8 tm-20 -84.49 -39.37 18.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.293 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . 57.12 138.04 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.246 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 52' ' ' ALA . 3.1 tt0 39.27 39.82 0.47 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.684 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.09 160.48 26.09 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.513 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.7 p -127.35 167.96 15.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 0.0 110.841 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.14 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.962 0.41 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -77.53 172.69 12.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.074 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.755 ' O ' HG13 ' A' ' 74' ' ' VAL . 30.7 t -136.3 159.3 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.581 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -134.67 108.61 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.999 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.981 HD21 HG11 ' A' ' 47' ' ' VAL . 2.9 tp -63.39 161.07 14.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.454 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HG2' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -146.44 139.52 25.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.767 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 72' ' ' ILE . 96.9 t -42.12 141.21 1.42 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.139 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.676 ' CD ' HD23 ' A' ' 38' ' ' LEU . 61.1 Cg_endo -75.37 -169.36 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.436 2.091 . . . . 0.0 113.102 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 45' ' ' MET . 5.2 t0 -83.95 94.56 8.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.956 HG12 HG21 ' A' ' 16' ' ' VAL . 1.1 pp -99.1 63.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.076 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.93 -90.96 1.69 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.491 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.93 35.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.424 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' NE2' HG21 ' A' ' 40' ' ' THR . 0.1 OUTLIER -146.15 159.85 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.728 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -88.25 -177.32 5.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.236 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 6.5 p-10 46.01 94.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.434 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.956 HG21 HG12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -137.82 166.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 64' ' ' ASP . 82.4 m-20 -97.87 133.1 42.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.658 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.111 HD13 HG23 ' A' ' 60' ' ' VAL . 8.6 mt -74.76 163.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.896 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.715 HG23 ' C ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -131.04 -8.75 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.736 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -151.09 150.18 30.39 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 36' ' ' ILE . 80.0 t -142.03 120.39 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.844 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -146.41 59.48 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.981 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.937 HG11 HG11 ' A' ' 73' ' ' VAL . 2.0 m -140.01 115.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.432 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 1.6 t30 -93.99 12.23 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.44 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 25' ' ' VAL . 5.4 p 43.04 63.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.487 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.09 45.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.476 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -136.71 173.25 11.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.996 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.6 m -79.17 132.91 36.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.761 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.602 HD13 HG11 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -127.5 150.33 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.31 178.82 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 51' ' ' VAL . 4.0 t -87.96 47.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.61 70.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.546 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -151.51 100.42 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.483 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -42.98 115.22 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.197 0.523 . . . . 0.0 111.774 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.633 HD12 HD22 ' A' ' 5' ' ' LEU . 23.6 mt -87.16 -50.16 6.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.914 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -149.41 -178.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 111.73 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.715 ' C ' HG23 ' A' ' 19' ' ' ILE . 3.5 m -131.96 130.69 41.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.669 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.69 HD11 HG12 ' A' ' 18' ' ' ILE . 1.9 mm? -116.04 165.15 13.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.799 0.333 . . . . 0.0 110.826 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.737 ' CD ' HG22 ' A' ' 44' ' ' THR . 48.9 tt0 -178.21 164.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.854 HG22 HG11 ' A' ' 16' ' ' VAL . 3.5 p -121.28 -59.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.684 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.3 t0 -172.68 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -109.64 -36.8 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.033 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.74 141.38 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.737 HG22 ' CD ' ' A' ' 39' ' ' GLU . 1.4 p -126.9 130.14 49.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.43 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -117.25 -164.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.287 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 22.5 p-10 -179.66 172.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.981 HG11 HD21 ' A' ' 5' ' ' LEU . 78.8 t -121.15 116.8 30.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.81 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.4 Cg_endo -86.63 18.56 1.55 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.993 2.462 . . . . 0.0 112.7 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.1 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.875 0.369 . . . . 0.0 111.551 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -110.6 70.69 0.72 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.758 HG11 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.35 -172.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.116 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -160.59 63.77 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.661 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.53 -124.38 0.74 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.243 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.1 t -139.96 138.17 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.473 0.178 . . . . 0.0 111.165 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.771 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.2 t -75.04 145.02 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.114 0.483 . . . . 0.0 111.476 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HE2' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -115.54 -44.24 2.98 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.497 178.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 17.8 mt-10 -115.06 174.24 6.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.606 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 58' ' ' VAL . 15.0 p -160.86 122.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.363 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -134.19 74.62 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.749 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.111 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.58 148.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.491 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -143.85 -166.26 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.984 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 21' ' ' VAL . 59.6 t -106.71 86.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.09 18.99 4.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.564 ' CG ' HD12 ' A' ' 18' ' ' ILE . 5.3 p-10 -99.85 171.71 7.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.794 0.33 . . . . 0.0 110.662 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.97 123.35 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.933 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -122.44 167.17 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.4 p -151.28 141.13 21.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 26.0 mt-10 -42.9 95.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.204 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 100.37 61.46 0.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.393 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.31 20.18 23.65 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 4' ' ' GLU . 11.2 tp 49.92 50.01 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.796 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.891 HG22 HG13 ' A' ' 73' ' ' VAL . 4.3 mt -48.07 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.256 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.937 HG11 HG11 ' A' ' 23' ' ' VAL . 17.6 m -117.0 141.07 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.148 0.499 . . . . 0.0 112.029 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 3' ' ' VAL . 91.5 t -113.6 131.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.771 ' CG1' HG22 ' A' ' 55' ' ' VAL . 27.8 m -121.95 169.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.772 ' HA ' HD23 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -78.61 -36.46 44.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.607 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . 56.73 147.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.176 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 52' ' ' ALA . 11.4 pt-20 39.54 49.32 1.95 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.695 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.85 154.52 18.76 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.487 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.63 112.54 24.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.32 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.103 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.843 0.354 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.9 176.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.053 HG21 HG11 ' A' ' 51' ' ' VAL . 6.5 t -148.92 161.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.951 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 74' ' ' VAL . 69.0 mt-10 -133.39 115.29 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.198 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.714 ' CD1' HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -73.45 160.8 31.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -147.34 150.09 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 111.405 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.688 HG22 HD11 ' A' ' 72' ' ' ILE . 84.0 t -46.05 140.43 4.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.432 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.786 ' CD ' HD23 ' A' ' 38' ' ' LEU . 74.1 Cg_endo -76.38 -166.17 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.592 2.195 . . . . 0.0 112.614 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 45' ' ' MET . 16.5 t70 -94.47 88.74 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.054 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.899 HG12 HG21 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -96.36 61.73 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.98 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.53 -91.33 1.04 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.437 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.39 37.35 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.603 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.407 ' NE2' HG21 ' A' ' 40' ' ' THR . 2.9 p-80 -144.44 -175.9 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 110.976 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -104.86 -175.18 2.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.084 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 44.89 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.899 HG21 HG12 ' A' ' 10' ' ' ILE . 34.6 m -143.72 115.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.569 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 128.21 35.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.556 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.783 HD13 HG23 ' A' ' 60' ' ' VAL . 4.2 mt -65.39 164.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.93 -35.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.275 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.71 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -118.59 148.11 43.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.728 ' HA ' HG22 ' A' ' 36' ' ' ILE . 7.8 p -134.9 119.22 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.991 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -146.3 40.09 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.018 HG11 HG11 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -133.72 117.82 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -132.6 12.25 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.377 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 90.0 t 62.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.35 . . . . 0.0 111.085 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.08 -21.54 13.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.779 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.42 139.41 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 111.107 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.2 m -74.76 102.29 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.552 HG12 HG11 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -87.16 153.91 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.38 -174.36 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.841 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.9 t -89.94 42.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.395 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER 163.7 72.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.591 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -148.78 115.16 5.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.78 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.58 115.25 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.527 . . . . 0.0 111.45 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 36' ' ' ILE . 98.3 mt -88.98 -40.97 12.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.541 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.756 HD13 HD22 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -159.31 -177.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 19' ' ' ILE . 23.2 m -136.04 133.17 37.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.811 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.786 HD23 ' CD ' ' A' ' 8' ' ' PRO . 1.8 mm? -116.11 150.59 37.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.864 0.364 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' OE2' HG22 ' A' ' 44' ' ' THR . 41.7 tt0 -159.91 163.18 34.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.547 ' HB ' HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -133.03 -82.92 0.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.656 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 40' ' ' THR . 12.0 p-10 -143.79 -43.48 0.27 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 42.63 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.65 133.64 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.193 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.54 HG22 ' OE2' ' A' ' 39' ' ' GLU . 10.6 p -129.4 118.48 22.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.449 ' O ' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -117.29 -167.95 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.572 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -177.23 167.62 2.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.13 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.714 HG11 ' CD1' ' A' ' 5' ' ' LEU . 57.8 t -121.85 111.8 32.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.409 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 58.9 Cg_endo -89.64 33.35 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.115 2.544 . . . . 0.0 112.401 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.516 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.57 163.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.96 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.832 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -157.76 44.83 0.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.097 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.053 HG11 HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -173.45 163.37 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.96 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -120.7 87.92 2.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -162.19 -139.68 2.7 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.939 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.11 136.58 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.737 HG22 ' CG1' ' A' ' 75' ' ' VAL . 59.5 t -72.87 143.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.105 0.478 . . . . 0.0 111.397 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -112.51 -47.69 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.338 178.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.7 mm-40 -112.18 173.38 6.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.402 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.626 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -163.14 120.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.306 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.7 mttm -132.05 64.09 1.6 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.533 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.783 HG23 HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -173.05 151.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.672 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -173.99 175.52 2.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.658 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 62' ' ' VAL . 58.1 t -79.22 68.34 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.43 55.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.893 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 10.7 p-10 -173.15 132.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -76.28 119.76 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.7 tp -104.6 172.74 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.8 m -144.13 137.66 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.471 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 72.4 mt-10 -40.48 130.52 2.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.0 61.73 3.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.037 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.27 129.05 5.44 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.131 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -53.06 94.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 110.584 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.766 HG23 ' CG1' ' A' ' 60' ' ' VAL . 1.3 mt -92.45 -78.83 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.018 HG11 HG11 ' A' ' 23' ' ' VAL . 19.6 m -126.77 137.6 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.0 111.873 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 3' ' ' VAL . 85.3 t -108.77 136.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.782 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.737 ' CG1' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -126.06 167.52 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.212 0.529 . . . . 0.0 112.32 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . 3.7 tt0 -71.59 -38.87 70.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.612 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 56.39 124.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.311 0.577 . . . . 0.0 112.169 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ALA . 20.3 pt-20 42.78 44.91 4.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.304 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.26 105.32 1.4 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.543 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.7 p -111.27 -71.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.157 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.754 0.311 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.76 176.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.861 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.849 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.3 t -142.91 162.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.882 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.797 ' HB3' HD13 ' A' ' 71' ' ' LEU . 2.0 mt-10 -130.86 91.08 3.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.494 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.93 HD11 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -48.41 155.18 0.54 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.784 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.676 ' H ' HD13 ' A' ' 5' ' ' LEU . 10.9 mttm -147.06 150.18 34.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 111.492 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.718 HG21 HG23 ' A' ' 66' ' ' ILE . 91.1 t -50.13 140.75 16.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.628 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.915 ' HD2' HD13 ' A' ' 38' ' ' LEU . 37.8 Cg_endo -68.73 -166.66 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.285 1.99 . . . . 0.0 112.88 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -99.22 69.57 1.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.836 HG12 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -66.12 -10.6 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.555 ' N ' HD12 ' A' ' 10' ' ' ILE . . . 53.3 71.95 0.61 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.739 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.579 ' HA3' HG21 ' A' ' 40' ' ' THR . . . -157.45 -64.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.463 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.445 ' CD2' ' OD1' ' A' ' 15' ' ' ASN . 0.3 OUTLIER 171.26 176.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.755 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 4.8 mt-10 -83.34 69.99 10.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.171 0.51 . . . . 0.0 110.712 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.445 ' OD1' ' CD2' ' A' ' 13' ' ' HIS . 1.5 p30 169.82 66.75 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.459 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.076 HG11 HG22 ' A' ' 40' ' ' THR . 1.0 OUTLIER -120.0 137.74 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.556 -179.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.86 131.88 37.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.972 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.101 HD13 HG23 ' A' ' 60' ' ' VAL . 11.5 mt -67.64 162.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.797 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -125.95 -16.42 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.706 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -145.7 150.36 36.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.803 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.5 p -138.78 129.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -150.23 44.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' CG2' HG23 ' A' ' 58' ' ' VAL . 4.4 m -136.59 124.16 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -135.55 10.32 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.46 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 87.7 t 64.51 118.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.081 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.94 -23.29 8.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.54 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -71.73 165.7 23.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.2 m -100.44 108.87 20.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -93.55 138.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.36 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.14 39.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 168.29 68.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -145.03 123.25 12.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -61.88 116.12 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.279 0.561 . . . . 0.0 111.278 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.452 HD13 ' HG ' ' A' ' 5' ' ' LEU . 49.1 mt -88.33 -43.0 11.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.417 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.803 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -153.94 -178.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.516 179.013 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 19' ' ' ILE . 44.6 m -144.9 123.42 12.43 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.915 HD13 ' HD2' ' A' ' 8' ' ' PRO . 1.2 mp -116.24 -179.37 3.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.864 ' HG3' HG22 ' A' ' 44' ' ' THR . 5.8 tm-20 -174.87 160.04 2.82 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 1.076 HG22 HG11 ' A' ' 16' ' ' VAL . 5.5 p -116.54 -61.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 20.7 m-20 -151.0 -43.28 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -141.4 25.43 2.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.12 98.69 2.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.19 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.864 HG22 ' HG3' ' A' ' 39' ' ' GLU . 17.8 p -93.51 116.26 28.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.62 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.419 ' O ' HG23 ' A' ' 37' ' ' THR . 0.2 OUTLIER -105.83 -176.32 3.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.076 0.465 . . . . 0.0 111.482 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -168.3 167.12 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.342 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.93 HG11 HD11 ' A' ' 5' ' ' LEU . 96.4 t -123.0 115.24 29.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.17 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 77.0 Cg_endo -90.86 35.81 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.047 2.498 . . . . 0.0 112.137 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.542 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.72 175.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.805 ' O ' HG13 ' A' ' 51' ' ' VAL . 15.7 tt0 -162.85 43.31 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.548 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 176.23 167.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -117.12 89.35 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -163.24 -156.95 8.87 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.006 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' GLU . 81.6 t -113.93 146.28 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.53 0.205 . . . . 0.0 111.246 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.744 HG22 HG12 ' A' ' 75' ' ' VAL . 67.6 t -81.3 144.93 9.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.293 0.568 . . . . 0.0 111.348 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.45 ' HE2' ' CA ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -112.7 -51.27 2.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.193 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 4.3 mt-10 -106.2 172.92 6.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.672 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.932 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.4 p -166.2 126.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.626 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -147.5 74.22 1.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.101 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -171.3 150.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HE3' HG21 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -160.42 -163.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.904 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.7 93.32 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.107 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.38 33.86 0.8 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.622 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.68 ' CG ' HD12 ' A' ' 18' ' ' ILE . 12.3 p-10 -129.34 140.96 51.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.43 ' CD ' ' HB2' ' A' ' 15' ' ' ASN . 6.8 mttt -73.22 130.47 40.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.785 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -130.86 170.75 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB3' ' CB ' ' A' ' 14' ' ' GLU . 8.7 m -147.62 135.99 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mp0 -41.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 107.53 62.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.378 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.04 23.03 8.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 4' ' ' GLU . 3.2 tp 45.76 57.22 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.029 0.443 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.781 HG22 HG13 ' A' ' 73' ' ' VAL . 2.9 mt -49.35 -80.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.932 HG12 ' HA ' ' A' ' 58' ' ' VAL . 21.3 m -124.94 157.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.415 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 3' ' ' VAL . 78.4 t -118.46 131.32 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.284 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.744 HG12 HG22 ' A' ' 55' ' ' VAL . 16.8 m -118.36 165.57 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' VAL . 4.5 tp10 -72.4 -38.84 68.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.032 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 57.57 122.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.151 0.5 . . . . 0.0 111.893 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ALA . 11.0 pt-20 43.82 55.37 5.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.243 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.21 -49.83 72.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.54 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -138.26 168.98 18.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.067 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.667 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.5 mt -137.84 177.27 8.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.991 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.804 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.4 t -161.63 159.58 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.731 ' HB3' HD13 ' A' ' 71' ' ' LEU . 2.0 mp0 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.361 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.707 HD11 ' HA ' ' A' ' 49' ' ' ALA . 1.2 mt -59.2 164.82 2.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.748 0.309 . . . . 0.0 110.676 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' C ' HD12 ' A' ' 72' ' ' ILE . 20.3 mttt -143.81 172.41 12.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.58 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.794 HG21 HG23 ' A' ' 66' ' ' ILE . 23.7 t -72.83 140.04 80.72 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.032 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.924 ' HD2' HD13 ' A' ' 38' ' ' LEU . 19.4 Cg_endo -63.32 -166.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 112.86 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.87 ' O ' HD12 ' A' ' 10' ' ' ILE . 24.5 t70 -93.19 -13.35 28.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.463 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 9' ' ' ASP . 1.5 pp 33.19 34.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . 39.74 34.16 0.46 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.232 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.25 -115.57 1.57 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.602 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.516 ' N ' ' CD2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -157.31 -85.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.712 0.291 . . . . 0.0 110.964 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 11.8 mt-10 -133.2 177.28 7.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.066 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.437 ' N ' ' HB3' ' A' ' 67' ' ' SER . 8.0 p-10 44.33 95.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.507 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.752 HG11 HG22 ' A' ' 40' ' ' THR . 27.1 m -152.49 141.06 14.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.66 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -82.02 130.32 35.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.56 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.976 HD13 HG23 ' A' ' 60' ' ' VAL . 22.0 mt -62.56 164.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.741 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -128.18 -12.47 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.294 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -146.96 158.25 43.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.002 0.429 . . . . 0.0 111.61 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.841 ' HA ' HG22 ' A' ' 36' ' ' ILE . 7.4 p -148.66 123.87 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.078 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -149.07 44.45 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' CG2' HG23 ' A' ' 58' ' ' VAL . 2.5 m -135.22 120.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -128.95 10.97 6.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.401 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 56' ' ' LYS . 84.6 t 58.84 112.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.2 -15.32 5.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.833 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.97 142.52 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 127.84 33.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.646 HD13 HG23 ' A' ' 51' ' ' VAL . 1.1 pp -108.54 154.7 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.02 179.53 5.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.1 t -85.66 48.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.351 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 164.11 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.59 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' C ' ' HA ' ' A' ' 48' ' ' PRO . 7.9 p-10 -156.74 99.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.768 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -45.49 117.5 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.147 0.498 . . . . 0.0 111.822 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.557 HD12 ' CD1' ' A' ' 5' ' ' LEU . 20.5 mt -92.79 -42.5 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.389 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.898 HD13 HD12 ' A' ' 38' ' ' LEU . 1.2 pp -148.77 -175.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.057 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 19' ' ' ILE . 32.4 m -149.24 124.55 10.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.924 HD13 ' HD2' ' A' ' 8' ' ' PRO . 2.4 mp -113.2 167.18 10.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.674 ' CG ' HG22 ' A' ' 44' ' ' THR . 70.3 tt0 -161.91 164.15 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.692 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.752 HG22 HG11 ' A' ' 16' ' ' VAL . 6.2 p -121.93 -57.54 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -175.33 -37.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -116.59 -19.3 10.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.622 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.14 148.42 49.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.628 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.674 HG22 ' CG ' ' A' ' 39' ' ' GLU . 1.7 p -131.2 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.478 ' O ' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -121.06 -173.51 2.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.223 0.535 . . . . 0.0 111.675 -179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -168.76 159.35 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.044 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.631 HG11 HD22 ' A' ' 5' ' ' LEU . 54.6 t -123.08 126.67 25.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.356 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 86.5 Cg_endo -89.58 34.13 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.882 2.388 . . . . 0.0 112.325 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HA ' HD11 ' A' ' 5' ' ' LEU . . . 81.64 -51.25 0.26 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.582 ' C ' HG22 ' A' ' 51' ' ' VAL . 5.0 tp10 55.03 56.16 6.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -174.16 -169.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.21 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -156.42 65.9 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 29' ' ' ILE . . . -160.84 -139.7 2.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.129 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.04 135.56 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.386 0.136 . . . . 0.0 110.642 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.715 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.3 t -71.93 144.37 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.293 0.568 . . . . 0.0 111.636 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.54 -47.05 2.74 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.265 178.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -110.28 172.53 6.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.429 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.915 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.2 p -164.81 128.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.873 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -146.06 75.81 1.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.642 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.976 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -172.5 155.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.491 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -161.43 -160.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.774 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 21' ' ' VAL . 61.3 t -110.13 76.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.216 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.52 41.23 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.811 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.807 ' CG ' HD12 ' A' ' 18' ' ' ILE . 16.7 p-10 -128.73 138.63 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.924 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.617 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -72.05 110.71 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.792 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.794 HG23 HG21 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -137.99 168.83 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -152.85 162.7 40.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 111.283 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.445 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -42.19 107.4 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.488 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' 6' ' ' LYS . . . 98.91 70.41 0.96 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.783 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.95 21.35 4.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.373 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 4' ' ' GLU . 1.7 tp 43.52 57.54 3.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.113 0.482 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.823 HG22 HG13 ' A' ' 73' ' ' VAL . 3.7 mt -49.95 -73.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.096 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.915 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.1 m -135.45 145.23 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 3' ' ' VAL . 92.4 t -104.97 136.74 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 51' ' ' VAL . 1.2 m -126.69 167.54 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.0 112.295 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HG3' ' CD2' ' A' ' 2' ' ' LEU . 1.3 mt-10 -101.1 46.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.665 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -36.04 143.37 0.06 Allowed 'General case' 0 C--N 1.335 -0.058 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 77' ' ' ALA . 6.6 pt-20 48.3 27.41 1.33 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.528 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -50.52 156.93 2.3 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.597 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.2 t -112.61 -28.21 7.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 110.913 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.069 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.778 0.323 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp -101.05 178.34 4.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.768 HG11 HG11 ' A' ' 51' ' ' VAL . 2.7 t -142.86 161.62 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.52 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -136.51 117.59 14.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.401 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.84 HD21 HG11 ' A' ' 47' ' ' VAL . 1.6 tp -68.65 160.81 29.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -143.75 144.42 31.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 111.415 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.63 HG22 HD11 ' A' ' 72' ' ' ILE . 86.8 t -41.19 140.58 1.16 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.035 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.61 ' HD2' HG13 ' A' ' 7' ' ' VAL . 61.0 Cg_endo -75.32 -168.04 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.24 1.96 . . . . 0.0 113.076 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 45' ' ' MET . 0.1 OUTLIER -98.65 83.78 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.952 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.923 ' CG2' HD23 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -78.53 1.43 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.09 -58.16 1.45 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.21 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -39.48 -85.42 0.01 OUTLIER Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.288 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 16' ' ' VAL . 23.1 p80 -179.08 -174.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.898 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -64.7 174.8 1.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.418 ' CA ' ' O ' ' A' ' 66' ' ' ILE . 5.5 p-10 43.75 78.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.77 HG11 HG22 ' A' ' 40' ' ' THR . 25.1 m -122.26 -178.02 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.433 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -106.59 118.45 36.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.915 0.388 . . . . 0.0 111.401 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.998 HD13 HG23 ' A' ' 60' ' ' VAL . 19.5 mt -55.21 165.29 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.898 HG12 HG22 ' A' ' 37' ' ' THR . 0.6 OUTLIER -136.5 2.99 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.508 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -167.32 152.21 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.297 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.757 ' HA ' HG22 ' A' ' 36' ' ' ILE . 81.2 t -137.26 120.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.759 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -148.42 60.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.926 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.661 HG11 HG11 ' A' ' 73' ' ' VAL . 2.4 m -142.1 113.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -120.94 96.25 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 56' ' ' LYS . 63.3 t -40.21 116.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.56 15.13 7.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.66 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.91 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 m -70.25 146.29 50.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.039 HD13 HG11 ' A' ' 75' ' ' VAL . 2.8 pt -136.69 154.81 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.51 -174.88 3.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG13 ' OE2' ' A' ' 50' ' ' GLU . 11.6 t -91.94 47.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 p30 172.68 67.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.058 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -152.99 108.58 3.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.564 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -46.95 119.12 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.092 0.472 . . . . 0.0 111.874 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 36' ' ' ILE . 21.5 mt -94.52 -39.39 10.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.877 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.11 -177.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.349 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.898 HG22 HG12 ' A' ' 19' ' ' ILE . 70.5 m -142.53 109.11 5.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.743 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.923 HD23 ' CG2' ' A' ' 10' ' ' ILE . 1.8 tp -95.02 155.93 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.679 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.731 ' HB3' HG21 ' A' ' 19' ' ' ILE . 33.6 tt0 -166.31 144.63 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.655 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.798 HG23 ' HB ' ' A' ' 10' ' ' ILE . 3.4 p -104.99 -59.46 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.425 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.7 p30 -174.63 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -124.34 35.75 4.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . 177.25 131.47 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.252 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.706 HG22 ' CG ' ' A' ' 39' ' ' GLU . 73.6 p -119.21 116.33 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -123.7 128.02 49.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.253 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.434 ' HB3' ' HA ' ' A' ' 37' ' ' THR . 1.0 OUTLIER -113.23 174.47 5.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.757 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.84 HG11 HD21 ' A' ' 5' ' ' LEU . 76.9 t -120.59 116.3 31.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 85.2 Cg_endo -87.37 37.27 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.94 2.427 . . . . 0.0 112.359 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.54 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 46.83 93.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.856 0.36 . . . . 0.0 111.11 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.598 ' C ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -93.38 63.03 3.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.768 HG11 HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER 163.43 148.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.333 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.571 ' O ' HD11 ' A' ' 29' ' ' ILE . . . -96.35 -168.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.368 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 102.14 -146.52 16.98 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.839 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.95 135.4 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.538 0.209 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.588 ' HA ' HG12 ' A' ' 75' ' ' VAL . 61.5 t -68.22 147.05 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.17 0.509 . . . . 0.0 111.69 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.53 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.67 -50.75 2.4 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.277 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.81 166.32 13.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.409 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 73' ' ' VAL . 5.4 p -152.17 138.56 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.318 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ILE . 6.9 mmtt -140.65 59.35 1.55 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.306 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.998 HG23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -157.47 143.58 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.61 -174.2 4.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.76 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 21' ' ' VAL . 60.5 t -98.04 92.73 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.45 35.57 1.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.628 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.93 ' OD1' HD12 ' A' ' 18' ' ' ILE . 19.6 p-10 -119.13 172.89 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.958 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -96.54 123.06 40.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -129.16 161.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.161 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.9 p -135.42 127.28 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.421 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.47 ' OE2' HD12 ' A' ' 10' ' ' ILE . 42.5 mt-10 -40.91 115.02 0.53 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 88.17 64.65 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.011 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.78 -165.83 11.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.024 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 4' ' ' GLU . 8.5 tp -104.49 89.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.969 0.414 . . . . 0.0 110.372 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.798 HG23 ' CG1' ' A' ' 60' ' ' VAL . 2.1 mt -87.35 -80.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.944 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.787 HG13 HG22 ' A' ' 72' ' ' ILE . 17.4 m -122.41 135.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.064 0.459 . . . . 0.0 111.891 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 3' ' ' VAL . 41.4 t -103.78 144.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.338 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.039 HG11 HD13 ' A' ' 29' ' ' ILE . 10.9 m -129.07 165.41 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.122 0.487 . . . . 0.0 112.008 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 6.3 tt0 -83.73 -26.49 29.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.58 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . 60.99 116.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.075 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 45.61 57.69 4.8 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.154 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.85 116.58 4.65 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.445 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.3 133.12 47.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.044 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.82 0.343 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mp -63.99 172.57 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.754 ' O ' HG13 ' A' ' 74' ' ' VAL . 19.8 t -139.27 146.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 1.3 mp0 -124.34 100.63 6.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.877 ' CD1' HD12 ' A' ' 35' ' ' LEU . 44.1 mt -63.88 131.24 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.72 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.2 mtmt -130.29 55.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.861 HG22 HD11 ' A' ' 72' ' ' ILE . 38.2 t 58.75 147.04 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.442 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.741 ' CD ' HD23 ' A' ' 38' ' ' LEU . 98.8 Cg_endo -94.29 -178.39 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.756 2.304 . . . . 0.0 112.453 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.672 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -64.2 173.69 1.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.012 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -169.71 28.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.754 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 38.35 94.96 0.01 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.366 -0.445 . . . . 0.0 113.397 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.37 -106.63 0.33 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.576 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.04 -175.96 5.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.892 0.377 . . . . 0.0 111.023 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.52 -168.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.194 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.468 ' N ' ' CB ' ' A' ' 67' ' ' SER . 3.6 p30 44.15 94.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.656 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.895 HG11 HG22 ' A' ' 40' ' ' THR . 0.1 OUTLIER -142.64 -176.08 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.372 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -112.06 138.68 48.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.055 HD13 HG23 ' A' ' 60' ' ' VAL . 28.8 mt -73.45 161.91 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 37' ' ' THR . 0.2 OUTLIER -134.62 -7.02 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.929 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -152.85 155.26 36.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.863 ' HA ' HG22 ' A' ' 36' ' ' ILE . 61.5 t -147.57 126.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.313 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -153.3 32.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.484 ' CB ' HG11 ' A' ' 73' ' ' VAL . 2.3 m -122.98 123.46 68.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -135.0 9.76 3.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.492 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 58' ' ' VAL . 87.3 t 63.4 131.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.85 -22.51 18.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.371 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.51 139.03 30.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.7 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -68.16 162.22 25.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 75' ' ' VAL . 1.2 pp -143.73 130.19 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.15 -174.43 4.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.935 0.398 . . . . 0.0 111.008 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 31' ' ' VAL . 11.1 t -90.32 41.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER 168.05 67.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.905 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -141.78 116.62 9.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.867 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -59.65 115.32 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.877 HD12 ' CD1' ' A' ' 5' ' ' LEU . 16.6 mt -90.37 -41.95 11.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.406 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.863 HG22 ' HA ' ' A' ' 21' ' ' VAL . 1.3 pp -150.43 -175.97 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.884 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.79 ' C ' HG23 ' A' ' 19' ' ' ILE . 3.7 m -133.3 152.59 51.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.763 ' CD2' HD13 ' A' ' 36' ' ' ILE . 2.4 mm? -134.45 166.8 22.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.72 ' CD ' HG22 ' A' ' 44' ' ' THR . 76.0 tt0 -174.4 164.07 3.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.401 . . . . 0.0 111.217 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.895 HG22 HG11 ' A' ' 16' ' ' VAL . 13.5 p -120.71 -72.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.892 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.466 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.9 m-20 -159.72 25.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.731 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm 176.24 -43.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.65 128.76 45.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.72 HG22 ' CD ' ' A' ' 39' ' ' GLU . 5.2 p -116.71 115.81 26.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.44 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -104.07 -165.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 5.7 p30 -175.69 167.34 3.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.73 HG11 HD13 ' A' ' 5' ' ' LEU . 74.0 t -112.03 104.15 55.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 70.3 Cg_endo -89.35 42.11 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.118 2.545 . . . . 0.0 111.886 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.7 177.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.774 ' O ' HG13 ' A' ' 51' ' ' VAL . 23.1 pt-20 -163.19 38.25 0.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 175.74 168.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 0.0 111.42 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -112.27 93.15 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.961 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' H ' ' A' ' 77' ' ' ALA . . . -165.35 -140.15 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.259 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 76' ' ' GLU . 90.9 t -135.08 145.24 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 0.0 111.065 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 75' ' ' VAL . 63.2 t -75.16 145.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 0.0 111.397 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -47.59 2.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.466 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.92 167.2 10.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.644 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.939 ' HA ' HG12 ' A' ' 73' ' ' VAL . 12.4 p -162.87 124.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.93 80.93 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.055 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.32 151.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.56 -173.87 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.97 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 21' ' ' VAL . 46.3 t -101.31 77.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.7 41.49 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.94 ' OD1' HD12 ' A' ' 18' ' ' ILE . 3.9 p30 -132.8 164.04 27.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.708 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -88.76 105.0 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.18 0.514 . . . . 0.0 110.705 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.734 HG23 HG21 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -132.89 164.61 34.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.369 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.468 ' CB ' ' N ' ' A' ' 15' ' ' ASN . 54.3 p -167.2 168.32 13.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -45.72 91.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.196 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 124.34 57.56 0.18 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.76 9.02 6.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.928 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.467 HD11 ' CG2' ' A' ' 74' ' ' VAL . 4.2 tp 47.25 46.86 16.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.679 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.861 HD11 HG22 ' A' ' 7' ' ' VAL . 9.1 mt -43.26 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.5 m -135.36 147.25 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.51 . . . . 0.0 111.99 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 3' ' ' VAL . 98.5 t -109.84 140.72 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.705 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.599 HG12 HG22 ' A' ' 55' ' ' VAL . 16.4 m -123.16 161.91 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.127 0.489 . . . . 0.0 112.303 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' VAL . 2.8 tt0 -68.58 -42.28 78.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.016 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . 59.4 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.97 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 52' ' ' ALA . 3.2 pt-20 37.78 59.87 1.24 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.772 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 80' ' ' THR . . . -90.3 -134.54 5.73 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.529 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 1.5 t 174.34 114.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.099 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 2' ' ' LEU . 0.2 OUTLIER -90.19 175.18 7.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.788 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.827 ' O ' HG13 ' A' ' 74' ' ' VAL . 6.2 t -125.51 162.76 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.451 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HB3' HD13 ' A' ' 71' ' ' LEU . 11.2 mt-10 -125.48 90.32 3.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.434 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -51.84 152.16 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.572 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -140.12 151.54 45.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.205 0.526 . . . . 0.0 111.626 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.753 HG11 HG21 ' A' ' 66' ' ' ILE . 85.2 t -47.11 143.13 4.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.88 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.665 ' HD2' HG13 ' A' ' 7' ' ' VAL . 43.5 Cg_endo -70.78 -167.47 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.149 1.9 . . . . 0.0 112.738 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 76.86 2.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.562 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.86 HG12 HG21 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -88.05 60.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.683 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -24.28 84.53 0.0 OUTLIER Glycine 0 C--N 1.34 0.799 0 O-C-N 123.986 0.804 . . . . 0.0 114.494 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -161.54 -62.4 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.216 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.484 ' N ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER 169.43 158.63 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' CA ' ' HA ' ' A' ' 67' ' ' SER . 0.3 OUTLIER -72.47 63.74 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.65 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -179.34 57.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.86 HG21 HG12 ' A' ' 10' ' ' ILE . 17.1 m -106.38 -175.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.173 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.18 130.6 52.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.933 HD13 HG23 ' A' ' 60' ' ' VAL . 5.6 mt -66.15 161.15 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.956 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.6 -37.98 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.593 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -118.08 166.18 12.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.075 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 21' ' ' VAL . 15.0 p -159.38 116.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -135.64 61.4 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.913 HG11 HG11 ' A' ' 73' ' ' VAL . 5.8 m -145.18 118.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.69 23.17 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 56' ' ' LYS . 71.8 t 66.73 -86.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.991 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.7 62.03 0.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.946 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 25' ' ' VAL . 2.2 t0 -129.94 171.03 13.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.709 0.29 . . . . 0.0 110.761 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 m -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.903 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.478 HD13 HG23 ' A' ' 51' ' ' VAL . 1.1 pt -132.21 153.2 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 0.0 111.344 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.91 174.06 11.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 3.1 t -78.51 54.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 3.6 p30 162.09 70.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.83 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -153.81 124.39 7.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.78 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.53 117.38 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.277 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.423 HD13 ' HG ' ' A' ' 5' ' ' LEU . 19.1 mt -90.42 -40.78 11.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.849 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.591 HD13 ' HB ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -157.68 -161.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.862 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.593 ' N ' ' HB3' ' A' ' 20' ' ' ALA . 93.1 m -157.7 51.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.329 0.585 . . . . 0.0 109.846 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -41.83 163.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.859 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.912 ' CD ' HG22 ' A' ' 44' ' ' THR . 70.1 tt0 -172.76 154.42 2.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.829 HG22 ' CG1' ' A' ' 16' ' ' VAL . 50.2 p -102.01 -82.87 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' N ' ' OG1' ' A' ' 40' ' ' THR . 16.7 t70 -150.96 21.41 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -179.98 -41.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.03 105.58 17.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.234 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.912 HG22 ' CD ' ' A' ' 39' ' ' GLU . 3.5 p -91.74 115.07 27.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -95.43 138.9 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.478 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 37' ' ' THR . 3.7 m-20 -119.89 144.41 47.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.955 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.591 ' HB ' HD13 ' A' ' 36' ' ' ILE . 76.5 t -122.09 112.8 31.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 83.6 Cg_endo -88.4 35.41 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.963 2.442 . . . . 0.0 112.331 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 54.23 168.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.035 0.445 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.2 tp10 -165.65 67.88 0.12 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.484 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -173.87 176.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.237 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -139.67 79.01 1.69 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.627 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.43 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -167.99 -140.66 2.97 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.308 -1.425 . . . . 0.0 113.857 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -130.94 139.09 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.83 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.077 HG22 HG12 ' A' ' 75' ' ' VAL . 57.7 t -79.53 146.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.408 0.623 . . . . 0.0 111.527 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.59 -44.45 2.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.045 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -109.88 158.0 18.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.453 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.602 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.7 p -151.44 119.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -131.07 68.89 1.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.683 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.933 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -172.46 154.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.643 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -169.11 170.69 8.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.591 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.443 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 54.1 t -82.03 88.42 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.28 46.88 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.72 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.793 ' OD1' HD12 ' A' ' 18' ' ' ILE . 19.0 p-10 -139.46 176.53 8.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.772 0.32 . . . . 0.0 111.042 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.857 ' O ' HD12 ' A' ' 66' ' ' ILE . 7.8 tttt -104.07 156.09 18.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.669 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -140.76 172.56 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 111.124 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.565 ' N ' HG23 ' A' ' 66' ' ' ILE . 7.2 p -147.13 48.39 1.13 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 36.4 mt-10 39.95 55.21 2.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 138.0 69.97 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.442 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.93 29.07 6.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.553 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 4' ' ' GLU . 9.9 tp 48.09 56.67 7.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 0.0 110.571 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.787 HG23 ' CG1' ' A' ' 60' ' ' VAL . 3.3 mt -45.98 -82.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.913 HG11 HG11 ' A' ' 23' ' ' VAL . 27.3 m -122.0 160.15 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.17 0.51 . . . . 0.0 111.875 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 3' ' ' VAL . 76.3 t -128.93 120.58 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.907 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.077 HG12 HG22 ' A' ' 55' ' ' VAL . 29.7 m -112.09 156.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.496 ' HG2' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -64.84 -31.08 72.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.656 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 53.62 159.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.061 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 52' ' ' ALA . 3.5 mt-10 72.46 -65.41 0.35 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.612 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.13 -178.4 38.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.542 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -177.35 -49.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.887 0.375 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.101 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.806 0.336 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -53.17 174.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 51' ' ' VAL . 7.9 t -141.84 152.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.762 ' HB3' HD13 ' A' ' 71' ' ' LEU . 7.3 mt-10 -128.37 100.79 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.376 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -60.93 157.56 15.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.069 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 8.5 mttp -142.13 145.07 33.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.314 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.78 HG22 HD11 ' A' ' 72' ' ' ILE . 95.9 t -48.23 141.24 8.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.04 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.753 ' CD ' HD23 ' A' ' 38' ' ' LEU . 38.0 Cg_endo -68.72 -166.08 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.2 1.934 . . . . 0.0 112.24 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.926 ' O ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -92.59 -13.04 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.645 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.926 HD12 ' O ' ' A' ' 9' ' ' ASP . 1.2 pp 33.88 33.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . 36.63 31.67 0.05 OUTLIER Glycine 0 C--N 1.336 0.531 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.684 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.65 -132.19 2.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.643 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -129.92 -162.49 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.739 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' O ' ' CD2' ' A' ' 13' ' ' HIS . 8.5 mt-10 -68.09 -179.67 1.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.99 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 44.03 95.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.881 HG11 HG22 ' A' ' 40' ' ' THR . 30.9 m -146.54 137.12 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.92 126.22 29.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.522 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.659 HD13 ' H ' ' A' ' 61' ' ' LYS . 3.7 mt -55.72 165.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.894 HG12 HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -140.75 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.066 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.568 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -177.95 146.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 111.099 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.804 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.4 p -137.81 124.39 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.981 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mm-40 -148.82 39.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.436 ' CB ' HG11 ' A' ' 73' ' ' VAL . 3.0 m -120.07 112.77 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.357 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -122.84 97.6 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 25' ' ' VAL . 23.5 m -39.05 111.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.921 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.93 21.17 4.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.67 143.11 50.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 54' ' ' VAL . 2.2 m -69.83 127.08 31.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.779 ' CD1' HG11 ' A' ' 75' ' ' VAL . 2.6 pt -108.09 169.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -178.58 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.4 t -94.34 33.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 176.23 62.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.409 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -140.93 108.34 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -48.76 116.23 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.187 0.518 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.52 HD12 HD11 ' A' ' 5' ' ' LEU . 70.2 mt -94.63 -44.29 7.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.788 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -149.93 -173.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.433 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.894 HG22 HG12 ' A' ' 19' ' ' ILE . 47.5 m -149.12 107.67 3.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 36' ' ' ILE . 2.7 mm? -92.19 151.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.755 ' CB ' HG21 ' A' ' 19' ' ' ILE . 78.2 tt0 -155.51 150.1 26.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.892 0.377 . . . . 0.0 110.991 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.881 HG22 HG11 ' A' ' 16' ' ' VAL . 3.0 p -112.06 -61.39 1.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.988 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' N ' ' OG1' ' A' ' 40' ' ' THR . 15.3 t0 -168.53 -41.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 37.77 3.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.51 118.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.606 HG22 ' CG ' ' A' ' 39' ' ' GLU . 2.3 p -113.04 119.95 39.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.965 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.03 153.56 21.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.4 p30 -133.12 143.91 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.572 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.633 ' CG2' HD11 ' A' ' 36' ' ' ILE . 93.8 t -105.87 108.09 60.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 71.0 Cg_endo -88.07 37.74 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.043 2.495 . . . . 0.0 112.469 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 44.66 95.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 111.338 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.595 ' C ' HG12 ' A' ' 51' ' ' VAL . 4.2 mt-10 -87.39 53.66 2.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 3' ' ' VAL . 1.2 p 161.85 141.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -83.14 -162.26 0.59 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.79 -145.17 15.93 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.089 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 76' ' ' GLU . 45.7 t -145.44 138.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.401 0.143 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.813 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.0 t -76.25 146.98 8.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.316 0.579 . . . . 0.0 111.796 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -119.71 -47.87 2.4 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.122 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -109.54 172.4 6.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.652 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.915 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -164.39 137.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HE2' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -152.27 67.96 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.402 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.712 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -169.59 152.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.639 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.659 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -171.81 -167.24 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.521 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.87 90.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.45 -19.94 0.71 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.892 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD2' ' CD1' ' A' ' 18' ' ' ILE . 2.3 p-10 -98.59 167.25 10.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.095 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.54 134.61 44.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -127.92 162.83 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.054 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -145.87 144.63 30.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -41.08 106.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 94.26 70.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.608 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.35 21.13 3.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.416 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.804 HD11 ' CG2' ' A' ' 74' ' ' VAL . 5.5 tp 47.58 59.67 3.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.788 HG22 HG13 ' A' ' 73' ' ' VAL . 3.6 mt -52.35 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.915 HG12 ' HA ' ' A' ' 58' ' ' VAL . 20.8 m -129.83 148.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 111.597 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.804 ' CG2' HD11 ' A' ' 71' ' ' LEU . 79.3 t -115.1 134.25 58.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 55' ' ' VAL . 32.0 m -121.84 177.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.155 0.502 . . . . 0.0 112.205 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' VAL . 1.5 tt0 -82.81 -33.53 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.268 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . 70.23 29.81 3.58 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.442 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -67.22 0.28 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.494 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 52' ' ' ALA . . . 44.14 92.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.228 -0.896 . . . . 0.0 113.055 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.9 p -120.54 98.44 6.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.777 0.323 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.095 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 75' ' ' VAL . 2.4 mp -55.18 177.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.772 HG21 ' CG1' ' A' ' 51' ' ' VAL . 3.6 t -144.31 161.27 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.938 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HB3' HD13 ' A' ' 71' ' ' LEU . 63.5 mt-10 -129.87 100.06 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.552 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.651 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -57.75 164.09 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.023 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' CD ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -154.18 155.61 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.273 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.612 HG21 HG23 ' A' ' 66' ' ' ILE . 96.5 t -53.76 140.74 48.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.727 ' CD ' HD23 ' A' ' 38' ' ' LEU . 70.5 Cg_endo -73.69 -168.44 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.65 2.233 . . . . 0.0 113.03 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.4 OUTLIER -82.9 92.94 7.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.79 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.916 HG12 HG21 ' A' ' 16' ' ' VAL . 1.3 pp -112.23 70.23 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.042 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.23 -89.9 1.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.56 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.33 41.46 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.631 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.02 179.63 7.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.743 0.306 . . . . 0.0 111.037 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' CG ' ' HB2' ' A' ' 67' ' ' SER . 2.8 mp0 -117.31 81.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 169.32 73.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.928 HG23 HG22 ' A' ' 66' ' ' ILE . 4.0 m -134.88 130.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.366 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.68 140.76 49.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.705 HD13 HG23 ' A' ' 60' ' ' VAL . 5.8 mt -74.9 161.33 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.709 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.511 HG12 ' HB ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -124.35 -38.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.794 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -117.95 170.8 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 36' ' ' ILE . 10.6 p -159.93 124.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.313 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.702 ' O ' HG13 ' A' ' 23' ' ' VAL . 39.1 mt-10 -158.64 90.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.831 HG11 HG11 ' A' ' 73' ' ' VAL . 2.6 m -163.95 113.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.361 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 26' ' ' GLY . 6.5 m120 -114.7 96.23 5.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.506 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG12 ' C ' ' A' ' 56' ' ' LYS . 2.3 m -42.68 92.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.546 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 136.31 -15.73 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.588 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.5 m-20 -74.28 169.92 16.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.84 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 m -96.36 103.16 15.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.718 HD13 HG11 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -84.06 158.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.45 -176.79 4.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.941 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 31' ' ' VAL . 3.5 m -90.21 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.316 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 172.08 73.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.783 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 4.4 p-10 -150.25 107.84 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.614 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -48.76 118.6 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 111.417 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 36' ' ' ILE . 81.8 mt -92.55 -39.5 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.08 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -161.81 -178.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.626 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 19' ' ' ILE . 76.3 m -142.08 56.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.669 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.727 HD23 ' CD ' ' A' ' 8' ' ' PRO . 3.2 mm? -41.45 166.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HB2' HG22 ' A' ' 44' ' ' THR . 67.1 tt0 -168.52 153.89 6.53 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.306 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.605 HG22 HG11 ' A' ' 16' ' ' VAL . 29.9 p -100.04 -72.65 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.707 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.1 p-10 -160.22 26.99 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.601 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.04 -42.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.875 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.85 124.26 43.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.044 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.591 HG22 ' HB2' ' A' ' 39' ' ' GLU . 56.9 p -107.5 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.054 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.441 ' HB3' ' CG ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -97.5 133.09 42.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 2.9 p30 -118.3 144.31 45.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.229 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.651 HG11 HD11 ' A' ' 5' ' ' LEU . 92.4 t -113.34 116.58 46.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.417 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 78.4 Cg_endo -87.42 27.8 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.964 2.443 . . . . 0.0 112.619 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.644 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 59.28 151.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 111.297 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.767 ' O ' HG13 ' A' ' 51' ' ' VAL . 9.4 tp10 -145.98 70.9 1.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.772 ' CG1' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER 176.81 153.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.038 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -121.87 77.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.77 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.98 -130.84 1.23 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.179 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 27' ' ' ASP . 61.8 t -137.18 138.77 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.45 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.835 HG22 HG12 ' A' ' 75' ' ' VAL . 70.4 t -78.6 146.59 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.519 . . . . 0.0 111.291 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' C ' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.6 -47.08 2.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.589 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.05 175.04 5.58 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.82 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.642 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -163.39 126.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.525 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.1 mttt -136.87 69.01 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.766 ' CG1' HG23 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -171.78 159.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.723 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.556 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -171.89 -172.89 1.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.523 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.61 79.19 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.272 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.13 44.21 0.07 OUTLIER Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.701 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.514 ' CG ' HD12 ' A' ' 18' ' ' ILE . 7.7 p-10 -148.01 147.01 29.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.88 0.371 . . . . 0.0 111.108 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 137.18 40.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.928 HG22 HG23 ' A' ' 16' ' ' VAL . 1.1 tp -131.27 172.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.457 ' HB2' ' CG ' ' A' ' 14' ' ' GLU . 7.1 p -152.2 142.78 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.203 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 76.9 mt-10 -44.74 97.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.201 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 99.8 62.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -114.26 22.03 14.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.357 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 4' ' ' GLU . 13.9 tp 48.15 53.58 11.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.977 0.418 . . . . 0.0 110.686 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.842 HG22 HG13 ' A' ' 73' ' ' VAL . 3.7 mt -48.11 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.044 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 72' ' ' ILE . 22.8 m -123.05 159.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.559 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 3' ' ' VAL . 27.9 t -127.75 132.52 68.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.934 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.835 HG12 HG22 ' A' ' 55' ' ' VAL . 33.2 m -119.38 -179.64 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -93.2 -37.19 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.514 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 57.21 133.44 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.342 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 52' ' ' ALA . 10.9 pt-20 40.78 58.13 2.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.666 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.8 -21.32 74.69 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.421 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.1 p 55.68 177.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.82 0.343 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.086 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.874 0.369 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 75' ' ' VAL . 3.0 mp -62.63 173.79 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.955 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.894 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.7 t -134.69 160.27 41.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HG3' HG22 ' A' ' 74' ' ' VAL . 31.0 mp0 -133.01 103.98 6.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.552 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.447 ' HB2' ' CG2' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -60.9 159.05 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.651 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' CD ' ' HA2' ' A' ' 69' ' ' GLY . 15.5 mttt -148.72 145.04 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.76 HG22 HD11 ' A' ' 72' ' ' ILE . 72.3 t -47.91 140.45 8.66 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.998 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.941 ' HD2' HD22 ' A' ' 38' ' ' LEU . 71.8 Cg_endo -76.94 -169.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.677 2.252 . . . . 0.0 112.89 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.443 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -81.85 84.45 6.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.791 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.867 HG12 HG21 ' A' ' 16' ' ' VAL . 1.1 pp -103.43 66.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 0.0 110.923 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.497 ' HA3' ' CE1' ' A' ' 13' ' ' HIS . . . 89.06 11.38 65.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.072 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.93 17.51 29.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.82 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.497 ' CE1' ' HA3' ' A' ' 11' ' ' GLY . 0.4 OUTLIER -123.32 -175.83 3.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.856 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 25.7 mp0 -105.45 176.65 5.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.993 0.425 . . . . 0.0 111.451 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 7.0 p-10 45.38 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.727 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.867 HG21 HG12 ' A' ' 10' ' ' ILE . 35.3 m -136.18 -175.67 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.355 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.33 120.34 38.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.824 0.345 . . . . 0.0 111.369 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.783 HD12 ' OD2' ' A' ' 64' ' ' ASP . 27.2 mt -68.18 159.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.19 -15.81 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.51 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.601 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.0 150.47 32.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 21' ' ' VAL . 12.8 p -140.21 124.19 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.933 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -132.09 34.69 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG21 HG11 ' A' ' 73' ' ' VAL . 7.8 m -132.93 115.21 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.416 ' O ' HG12 ' A' ' 25' ' ' VAL . 16.1 t30 -114.75 14.91 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER 62.24 118.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.15 23.39 32.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.45 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.82 148.03 30.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 m -69.47 136.17 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.023 HD13 HG11 ' A' ' 75' ' ' VAL . 2.9 pt -126.86 160.33 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.363 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.19 -176.21 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.9 t -91.55 41.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.247 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 167.14 71.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.489 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 49' ' ' ALA . 1.5 p30 -145.58 120.32 9.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.974 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -54.55 117.06 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 47.5 mt -92.62 -36.33 13.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.876 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.529 HG12 HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -159.11 -176.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.266 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.601 ' N ' ' HB3' ' A' ' 20' ' ' ALA . 84.9 m -144.56 45.79 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.502 0.667 . . . . 0.0 109.447 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.941 HD22 ' HD2' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -39.69 165.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.362 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.913 ' CD ' HG22 ' A' ' 44' ' ' THR . 76.6 tt0 -174.63 164.55 3.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.086 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 10' ' ' ILE . 6.6 p -120.35 -158.38 0.75 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.38 -22.96 66.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 54.81 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -178.78 113.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.913 HG22 ' CD ' ' A' ' 39' ' ' GLU . 2.1 p -98.9 141.81 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.189 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.443 ' HG3' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -143.34 131.38 21.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.059 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.39 173.59 7.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ALA . 94.4 t -143.72 116.78 5.85 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 65.1 Cg_endo -90.92 36.83 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.203 2.602 . . . . 0.0 112.087 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 57.88 160.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.632 ' C ' HG12 ' A' ' 51' ' ' VAL . 3.5 mt-10 -139.33 35.53 2.07 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.881 HG11 HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER 165.25 153.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.417 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 51' ' ' VAL . . . -85.49 -165.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.069 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 111.46 -157.24 15.08 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.715 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.73 134.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.779 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 75' ' ' VAL . 58.2 t -68.35 145.39 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.245 0.545 . . . . 0.0 111.583 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.51 ' O ' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.24 -44.56 2.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.251 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 19.6 mm-40 -111.86 174.66 5.77 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.636 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.534 ' HA ' HG12 ' A' ' 73' ' ' VAL . 12.5 p -173.83 137.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.508 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.12 51.01 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.107 0.479 . . . . 0.0 110.231 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.813 ' CG1' HG23 ' A' ' 72' ' ' ILE . 28.3 m -155.15 164.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.155 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -170.72 145.78 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 62' ' ' VAL . 7.2 p -55.99 86.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . 122.91 62.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.512 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.783 ' OD2' HD12 ' A' ' 18' ' ' ILE . 2.0 p30 -153.34 178.58 9.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -94.83 112.92 24.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.861 HG21 HD21 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -125.99 165.48 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.447 ' HB2' ' CB ' ' A' ' 14' ' ' GLU . 4.5 p -147.53 141.11 25.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.96 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 28.7 mt-10 -43.08 109.14 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 6' ' ' LYS . . . 83.83 70.43 1.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.24 10.83 9.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.716 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp 60.51 48.48 7.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.423 0.63 . . . . 0.0 109.964 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.942 HG22 HG13 ' A' ' 73' ' ' VAL . 56.0 mt -46.84 -83.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.725 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.942 HG13 HG22 ' A' ' 72' ' ' ILE . 29.3 m -118.38 159.13 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 0.0 111.616 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 3' ' ' VAL . 90.7 t -131.4 141.1 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.91 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.023 HG11 HD13 ' A' ' 29' ' ' ILE . 24.4 m -121.87 -178.51 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.242 0.544 . . . . 0.0 112.4 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HG3' ' CE ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -95.56 -27.35 15.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.498 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . 65.08 107.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.704 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 47.61 38.5 8.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.49 -98.97 0.1 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.532 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -107.01 -25.69 11.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.111 -179.941 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.868 0.366 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 76' ' ' GLU . 2.6 mp -83.09 171.31 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.05 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.8 t -134.8 150.21 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.711 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.559 ' HA ' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -119.46 104.01 9.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.221 179.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.761 HD21 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -69.73 161.09 30.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.007 0.432 . . . . 0.0 111.264 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -152.81 159.7 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.727 HG21 HG23 ' A' ' 66' ' ' ILE . 87.1 t -50.0 140.06 16.7 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.776 ' CD ' HD23 ' A' ' 38' ' ' LEU . 60.9 Cg_endo -73.79 -168.17 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.578 2.185 . . . . 0.0 113.052 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -89.87 86.89 6.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.745 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.975 HG12 HG21 ' A' ' 16' ' ' VAL . 1.2 pp -101.05 51.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.57 -80.34 0.28 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.509 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.9 41.69 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.546 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -148.66 162.35 39.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.734 0.302 . . . . 0.0 110.798 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' CA ' ' HB3' ' A' ' 67' ' ' SER . 6.2 mt-10 -104.12 87.21 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 4.2 p30 162.64 76.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.434 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.975 HG21 HG12 ' A' ' 10' ' ' ILE . 32.6 m -138.83 133.6 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.547 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -76.06 137.05 39.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.047 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.136 HD13 HG23 ' A' ' 60' ' ' VAL . 7.9 mt -72.16 161.18 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.026 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.18 -20.98 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.825 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.702 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -140.07 158.52 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 111.423 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.58 HG21 ' N ' ' A' ' 62' ' ' VAL . 97.1 t -145.92 127.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.9 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.612 ' O ' HG13 ' A' ' 23' ' ' VAL . 45.5 mm-40 -149.92 77.11 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.7 m -160.66 141.62 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.224 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -137.58 18.42 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.256 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 56' ' ' LYS . 73.8 t 65.92 -82.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 58.84 2.48 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.575 ' O ' HG13 ' A' ' 54' ' ' VAL . 6.6 t0 -128.4 166.73 18.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.743 0.306 . . . . 0.0 110.821 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.5 m -90.52 125.49 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.798 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.805 HD13 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -120.35 143.24 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.06 -171.78 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.218 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.5 t -90.0 44.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.62 73.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.519 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 4.0 p-10 -152.69 98.82 2.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -45.12 116.4 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.183 0.516 . . . . 0.0 111.611 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.534 ' HG ' ' HB2' ' A' ' 49' ' ' ALA . 26.4 mt -91.09 -41.68 10.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.067 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -154.88 -178.39 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.455 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.583 ' O ' HG23 ' A' ' 19' ' ' ILE . 96.4 m -144.39 57.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.776 HD23 ' CD ' ' A' ' 8' ' ' PRO . 2.1 mm? -39.16 162.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.322 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.728 ' HG3' HG22 ' A' ' 44' ' ' THR . 65.3 tt0 -175.41 156.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.786 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.431 ' N ' ' HG2' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -123.71 -83.79 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.585 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.6 OUTLIER -144.56 -42.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -125.29 42.93 3.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . 176.21 136.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.304 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.728 HG22 ' HG3' ' A' ' 39' ' ' GLU . 2.4 p -129.48 120.77 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.569 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.613 ' HB2' HG23 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -108.58 156.17 19.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -179.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 9.0 p-10 -141.43 144.82 34.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.458 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.761 HG11 HD21 ' A' ' 5' ' ' LEU . 93.9 t -117.29 118.34 35.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 87.7 Cg_endo -90.02 30.13 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.015 2.477 . . . . 0.0 112.319 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.668 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 51.35 102.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.281 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.95 67.77 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.855 HG11 ' CG2' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -158.72 -172.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.993 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -159.66 62.97 0.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -157.54 -119.81 0.6 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.059 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 27' ' ' ASP . 63.6 t -146.33 140.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.506 0.193 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.91 HG22 HG12 ' A' ' 75' ' ' VAL . 85.7 t -78.07 155.03 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.346 0.593 . . . . 0.0 111.308 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.662 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -127.09 -46.02 1.54 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.189 179.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -107.96 165.09 11.72 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.319 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.801 ' HA ' HG12 ' A' ' 73' ' ' VAL . 14.6 p -162.17 123.81 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -143.41 78.37 1.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.595 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.136 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -173.13 148.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.374 -179.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -139.47 167.58 21.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 62' ' ' VAL . 11.2 p -81.75 55.69 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.266 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.12 61.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.817 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' CG ' HD12 ' A' ' 18' ' ' ILE . 1.7 p30 -148.98 150.48 32.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -64.76 122.48 16.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.19 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.727 HG23 HG21 ' A' ' 7' ' ' VAL . 1.1 tp -131.04 169.63 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.067 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.461 ' HB3' ' CA ' ' A' ' 14' ' ' GLU . 4.7 p -151.94 150.5 30.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.7 mt-10 -50.58 98.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.83 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA2' ' HG2' ' A' ' 6' ' ' LYS . . . 108.09 55.73 0.6 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.475 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.73 18.4 29.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.391 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD11 ' CG2' ' A' ' 74' ' ' VAL . 9.0 tp 45.33 47.7 10.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.046 0.451 . . . . 0.0 110.775 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.807 HG23 ' CG1' ' A' ' 60' ' ' VAL . 5.8 mt -43.18 -82.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.333 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 58' ' ' VAL . 22.0 m -127.39 148.38 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 111.728 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.779 HG13 ' O ' ' A' ' 3' ' ' VAL . 93.9 t -118.42 133.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.943 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.91 HG12 HG22 ' A' ' 55' ' ' VAL . 25.4 m -118.95 166.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 112.417 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' HD23 ' A' ' 2' ' ' LEU . 0.9 OUTLIER -77.54 -36.32 52.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.509 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 56.94 149.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.002 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 52' ' ' ALA . 4.4 pt-20 38.57 55.16 1.9 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.754 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.94 -90.23 1.41 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.578 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.6 p -103.4 179.92 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.904 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.058 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.881 0.372 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.26 -178.36 4.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.753 ' O ' HG13 ' A' ' 74' ' ' VAL . 33.9 t -152.66 161.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.438 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -135.12 91.2 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.002 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.786 HD11 HG11 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -53.05 169.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.631 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -158.11 161.69 37.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.781 HG13 HD22 ' A' ' 38' ' ' LEU . 83.4 t -52.64 139.96 38.82 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.754 ' CD ' HD13 ' A' ' 38' ' ' LEU . 38.5 Cg_endo -70.04 -168.16 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.094 1.863 . . . . 0.0 112.949 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.69 60.37 1.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.759 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.716 ' HB ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -47.49 -24.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.585 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.611 ' H ' HD12 ' A' ' 10' ' ' ILE . . . 69.1 56.91 8.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.475 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.75 -71.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.418 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.46 ' N ' ' CD2' ' A' ' 13' ' ' HIS . 0.2 OUTLIER 172.84 -176.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 0.0 110.837 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 4.3 pm0 -69.08 172.22 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.651 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.73 91.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 66' ' ' ILE . 9.3 m -127.79 -154.56 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.716 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 16' ' ' VAL . 31.1 m-20 -140.42 121.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 0.0 111.556 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.012 HD13 HG23 ' A' ' 60' ' ' VAL . 20.6 mt -65.0 163.78 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.782 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -127.12 -12.46 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.053 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 37' ' ' THR . . . -152.35 161.82 42.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 0.0 111.607 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.808 ' HA ' HG22 ' A' ' 36' ' ' ILE . 13.3 p -146.61 133.24 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.05 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -161.26 75.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.511 HG21 HG23 ' A' ' 58' ' ' VAL . 2.4 m -149.08 114.44 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -116.65 96.02 5.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.535 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 25' ' ' VAL . 35.3 m -43.28 110.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.553 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.05 17.43 4.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -120.38 149.82 41.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.792 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.452 ' HA ' HG22 ' A' ' 54' ' ' VAL . 7.9 m -77.38 142.94 39.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.945 HD13 HG23 ' A' ' 51' ' ' VAL . 2.8 pp -143.1 166.06 15.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.65 -171.27 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.351 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 51' ' ' VAL . 6.1 t -90.39 43.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 p30 178.28 68.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.32 107.1 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -44.16 119.32 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.169 0.509 . . . . 0.0 112.096 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 82.9 mt -92.02 -45.3 8.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.856 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.808 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -154.78 179.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.444 0.64 . . . . 0.0 112.091 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 19' ' ' ILE . 59.7 m -138.81 116.94 11.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.782 ' HA ' HG23 ' A' ' 19' ' ' ILE . 4.2 mp -111.6 175.34 5.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 112.148 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.958 ' HG3' HG22 ' A' ' 44' ' ' THR . 6.3 tm-20 -177.4 157.16 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.716 HG23 ' HB ' ' A' ' 10' ' ' ILE . 6.5 p -131.49 -58.96 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 110.816 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 40' ' ' THR . 8.7 t70 -175.24 -38.3 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.765 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 8.1 mmtt -75.06 -26.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . 175.38 170.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.927 0.394 . . . . 0.0 111.334 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.958 HG22 ' HG3' ' A' ' 39' ' ' GLU . 2.5 p -109.66 130.36 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -109.09 -168.56 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 0.0 111.545 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -176.84 167.36 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.234 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.786 HG11 HD11 ' A' ' 5' ' ' LEU . 99.6 t -127.41 125.51 23.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.983 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 86.1 Cg_endo -89.74 30.41 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.032 2.488 . . . . 0.0 112.494 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.669 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 53.53 106.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 111.394 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.95 69.56 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.142 0.496 . . . . 0.0 110.167 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -158.53 -170.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.71 -178.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' C ' ' HA ' ' A' ' 77' ' ' ALA . . . -159.76 56.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.798 0.333 . . . . 0.0 111.363 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.82 -121.92 0.59 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.39 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 27' ' ' ASP . 51.1 t -137.62 139.15 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 111.44 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 95.6 t -71.31 148.19 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.182 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.02 -49.76 2.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.684 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -111.22 175.17 5.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.629 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.938 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.1 p -165.6 128.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.038 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 71.88 1.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.49 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.012 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -170.21 148.53 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.746 -179.335 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.39 -174.31 4.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.588 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.78 78.77 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.326 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.38 45.72 0.13 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.645 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.923 ' OD1' HD12 ' A' ' 18' ' ' ILE . 20.0 p-10 -130.81 170.65 14.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.899 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 6.0 mttt -91.96 114.78 27.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.528 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -131.13 160.26 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.696 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.427 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -144.09 148.53 35.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.965 179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.436 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 27.3 tt0 -47.44 99.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 99.47 66.33 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.359 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -128.88 29.08 4.03 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.76 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.9 tp 42.84 74.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.747 ' CG2' HG13 ' A' ' 73' ' ' VAL . 1.4 mt -66.75 -76.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.955 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.938 HG12 ' HA ' ' A' ' 58' ' ' VAL . 17.0 m -129.02 148.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 0.0 111.77 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 3' ' ' VAL . 67.7 t -101.47 142.32 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.922 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 51' ' ' VAL . 2.4 t -125.73 153.4 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.253 0.549 . . . . 0.0 112.08 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 76' ' ' GLU . 3.2 tt0 -102.61 45.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.848 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -39.94 152.55 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.665 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER 48.01 46.03 19.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.978 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.5 113.53 4.68 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.548 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.2 p -62.09 153.63 29.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.313 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.151 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.796 HD22 ' HA ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -77.32 171.86 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.953 HG21 HG11 ' A' ' 51' ' ' VAL . 4.3 t -128.4 162.1 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.5 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.682 ' HB3' HD13 ' A' ' 71' ' ' LEU . 45.5 mt-10 -124.34 89.86 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.426 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.763 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -50.63 151.27 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.975 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.23 150.23 43.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.756 HG13 HD22 ' A' ' 38' ' ' LEU . 91.7 t -48.02 141.11 8.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.89 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.878 ' CD ' HD13 ' A' ' 38' ' ' LEU . 60.0 Cg_endo -73.13 -166.69 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.318 2.012 . . . . 0.0 112.667 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 45' ' ' MET . 1.2 m-20 -95.43 79.05 3.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -82.18 57.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.914 0.388 . . . . 0.0 111.184 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.87 -86.91 0.52 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.611 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.84 38.13 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.547 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -150.11 179.97 7.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.833 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -110.49 -169.96 1.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.201 0.524 . . . . 0.0 111.077 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 14' ' ' GLU . 7.4 p30 46.01 71.09 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.57 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 66' ' ' ILE . 24.1 m -121.93 -170.8 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.13 124.57 37.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 111.541 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.016 HD13 HG23 ' A' ' 60' ' ' VAL . 11.6 mt -61.0 163.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.834 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.715 HG23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -127.68 -12.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.956 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.72 154.43 38.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.379 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.802 ' HA ' HG22 ' A' ' 36' ' ' ILE . 11.0 p -146.32 115.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.216 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -119.46 -30.69 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.344 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.803 HG11 HG11 ' A' ' 73' ' ' VAL . 11.6 m -64.19 129.07 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.92 0.39 . . . . 0.0 111.259 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -139.48 12.74 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.6 t 63.03 118.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.29 8.6 35.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.62 148.28 25.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.33 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.1 m -81.85 106.19 13.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -93.31 155.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.514 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.33 -177.66 3.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.785 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 31' ' ' VAL . 16.6 t -90.26 44.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 31' ' ' VAL . 2.1 p30 163.75 70.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.352 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.415 ' H ' ' HB3' ' A' ' 49' ' ' ALA . 1.8 p-10 -148.33 119.8 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.697 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -56.31 114.92 2.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 0.0 111.35 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.72 -43.76 11.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.32 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.929 HD13 HD12 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -152.62 -178.51 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.214 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 19' ' ' ILE . 55.0 m -144.17 120.81 11.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.929 HD12 HD13 ' A' ' 36' ' ' ILE . 4.3 mp -112.3 166.54 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.143 0.497 . . . . 0.0 111.737 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.796 ' CD ' HG22 ' A' ' 44' ' ' THR . 80.4 tt0 -168.38 161.82 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.727 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.508 HG23 ' HB ' ' A' ' 10' ' ' ILE . 3.5 p -120.32 -58.35 1.86 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -179.54 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.817 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -12.57 13.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.534 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.29 137.78 30.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.977 0.418 . . . . 0.0 111.465 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.796 HG22 ' CD ' ' A' ' 39' ' ' GLU . 2.6 p -120.96 127.98 52.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.435 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.425 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -120.01 -166.31 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.146 0.498 . . . . 0.0 111.795 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -179.28 172.96 1.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.763 HG11 HD11 ' A' ' 5' ' ' LEU . 95.8 t -126.65 113.7 22.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 121.174 -0.21 . . . . 0.0 111.377 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 57.4 Cg_endo -90.28 30.64 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.11 2.54 . . . . 0.0 112.427 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 56.17 164.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.812 ' O ' HG13 ' A' ' 51' ' ' VAL . 26.2 tt0 -160.61 46.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.953 HG11 HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -173.16 161.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -120.71 86.58 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -160.58 -140.4 2.88 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.152 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -130.39 140.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.609 0.242 . . . . 0.0 111.081 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.869 HG22 HG12 ' A' ' 75' ' ' VAL . 53.7 t -77.04 139.28 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.313 0.577 . . . . 0.0 111.396 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HD2' HD13 ' A' ' 2' ' ' LEU . 1.1 mttm -107.66 -48.63 3.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.228 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 29.0 mt-10 -111.11 166.11 11.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.365 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.693 ' HA ' HG12 ' A' ' 73' ' ' VAL . 6.4 p -154.81 114.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.389 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -128.97 74.81 1.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.016 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -174.73 150.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.615 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -172.56 128.6 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.536 HG23 HG12 ' A' ' 21' ' ' VAL . 15.4 t -47.09 102.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.35 25.79 2.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.726 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.865 ' OD1' HD12 ' A' ' 18' ' ' ILE . 21.5 p-10 -121.11 175.81 5.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.809 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -97.98 147.77 24.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.86 HG22 HG22 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -141.3 167.54 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 66' ' ' ILE . 78.2 p -144.95 51.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' CG ' HD11 ' A' ' 10' ' ' ILE . 98.8 mt-10 40.72 50.17 2.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.801 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' N ' ' HB ' ' A' ' 7' ' ' VAL . . . 144.01 71.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.47 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.82 33.0 4.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.717 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.682 HD13 ' HB3' ' A' ' 4' ' ' GLU . 7.2 tp 44.21 56.9 4.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.798 HG23 ' CG1' ' A' ' 60' ' ' VAL . 3.4 mt -46.31 -83.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.312 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.803 HG11 HG11 ' A' ' 23' ' ' VAL . 33.8 m -120.29 164.9 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.113 0.483 . . . . 0.0 111.951 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 3' ' ' VAL . 59.1 t -132.34 117.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.944 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.869 HG12 HG22 ' A' ' 55' ' ' VAL . 28.0 m -108.31 157.68 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.796 ' HA ' HD22 ' A' ' 2' ' ' LEU . 4.0 tt0 -68.08 -35.29 77.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.075 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 58.35 139.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.125 0.488 . . . . 0.0 112.038 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' ALA . 14.9 pt-20 37.78 42.25 0.39 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.909 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.84 117.63 2.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.536 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.8 p 50.62 33.99 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.747 0.308 . . . . 0.0 110.86 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.12 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.72 0.295 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.717 ' HG ' HG21 ' A' ' 80' ' ' THR . 1.8 mp -92.87 176.59 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.784 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.836 HG21 HG11 ' A' ' 51' ' ' VAL . 2.6 t -141.04 161.44 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.746 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 4.3 mp0 -135.9 121.27 19.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.694 ' CD2' HD12 ' A' ' 35' ' ' LEU . 1.3 tp -73.46 154.23 40.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -149.59 59.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.862 ' H ' HD12 ' A' ' 72' ' ' ILE . 67.2 t 60.83 145.62 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HD2' HG13 ' A' ' 7' ' ' VAL . 33.5 Cg_endo -67.99 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.621 1.547 . . . . 0.0 112.77 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER 166.6 56.83 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.736 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.985 HG23 HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -37.79 -31.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.056 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.02 40.7 10.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.563 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.84 -42.09 0.13 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.292 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.416 ' CD2' HG13 ' A' ' 16' ' ' VAL . 0.2 OUTLIER 170.97 164.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.896 0.379 . . . . 0.0 110.873 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 2.2 mt-10 -82.06 64.49 6.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 110.351 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 p30 176.97 85.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.637 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.966 HG11 HG22 ' A' ' 40' ' ' THR . 0.7 OUTLIER -147.46 145.29 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.332 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 64' ' ' ASP . 4.1 m-20 -75.74 145.57 40.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.339 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.076 HD13 HG23 ' A' ' 60' ' ' VAL . 6.1 mt -71.77 163.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.564 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.869 HG12 HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -132.27 -4.25 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.626 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -155.68 151.62 27.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.27 . . . . 0.0 110.928 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.78 ' HA ' HG22 ' A' ' 36' ' ' ILE . 11.1 p -137.9 134.04 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.466 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -155.17 25.48 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.635 HG11 HG11 ' A' ' 73' ' ' VAL . 3.1 m -117.46 122.91 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -133.89 11.76 3.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.485 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 85.4 t 60.63 120.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.51 35.11 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.982 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.4 146.72 27.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -69.85 132.89 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.514 ' CD1' HG11 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -124.25 143.58 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.57 -173.73 2.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.1 t -90.85 39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.361 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p30 168.19 64.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.673 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -140.85 114.3 8.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.77 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -53.98 115.72 2.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 111.496 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' A' ' 5' ' ' LEU . 33.5 mt -91.25 -32.07 15.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.426 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.78 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -162.77 -177.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.934 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.869 HG22 HG12 ' A' ' 19' ' ' ILE . 60.7 m -141.92 122.33 14.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 109.901 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.985 HD23 HG23 ' A' ' 10' ' ' ILE . 2.2 tp -102.99 167.83 9.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.869 ' HG3' HG22 ' A' ' 44' ' ' THR . 2.1 tm-20 -167.72 166.43 13.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.966 HG22 HG11 ' A' ' 16' ' ' VAL . 5.5 p -124.76 -59.39 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.682 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 40' ' ' THR . 17.0 t70 -171.84 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.51 -29.61 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.22 131.75 56.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 111.374 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.869 HG22 ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -115.41 138.54 50.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 37' ' ' THR . 0.1 OUTLIER -126.89 -178.33 4.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.408 . . . . 0.0 111.332 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 1.6 p30 -167.29 162.45 14.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.649 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.641 HG11 HD21 ' A' ' 5' ' ' LEU . 89.4 t -113.67 109.75 50.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.0 Cg_endo -88.82 43.53 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.098 2.532 . . . . 0.0 111.823 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 54.35 171.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.706 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.839 ' O ' HG13 ' A' ' 51' ' ' VAL . 5.3 pt-20 -156.09 33.03 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.449 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.839 HG13 ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -172.37 170.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.144 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -121.97 86.01 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.401 ' O ' HG13 ' A' ' 29' ' ' ILE . . . -159.75 -134.38 1.66 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.018 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 76' ' ' GLU . 91.3 t -135.12 141.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.55 0.214 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.701 HG22 HG13 ' A' ' 75' ' ' VAL . 57.4 t -74.4 143.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.349 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -111.2 -47.62 3.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.45 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 22.9 mt-10 -113.32 172.15 7.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.664 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.921 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -160.57 119.6 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' ILE . 1.5 mttm -134.81 62.72 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.575 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.076 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -169.12 149.94 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -140.67 -169.74 2.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.57 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 62' ' ' VAL . 14.6 p -93.49 42.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.086 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.52 71.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.553 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' CG ' HD12 ' A' ' 18' ' ' ILE . 4.1 p-10 -156.7 145.06 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 0.0 110.991 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 131.53 45.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.557 ' CG2' HD11 ' A' ' 38' ' ' LEU . 1.2 tp -135.64 178.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.484 ' N ' HG23 ' A' ' 66' ' ' ILE . 2.4 m -155.43 118.17 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.616 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -38.46 91.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.636 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 127.35 49.17 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.938 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -112.3 -121.16 3.9 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.601 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 4' ' ' GLU . 7.5 tp -157.58 44.37 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.376 0.608 . . . . 0.0 109.663 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.862 HD12 ' H ' ' A' ' 7' ' ' VAL . 7.1 mt -40.63 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.041 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 58' ' ' VAL . 20.7 m -131.66 143.96 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.166 0.508 . . . . 0.0 112.317 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 3' ' ' VAL . 61.8 t -108.08 140.31 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.137 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.701 HG13 HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.165 0.507 . . . . 0.0 112.156 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 2' ' ' LEU . 3.9 tt0 -75.42 -39.34 59.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.07 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 1' ' ' ALA . . . 59.6 132.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 112.067 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ALA . 25.4 pt-20 38.87 31.32 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.796 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 81' ' ' ALA . . . 42.8 85.8 0.01 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.842 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.717 HG21 ' HG ' ' A' ' 2' ' ' LEU . 17.3 p -57.43 85.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' GLY . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.138 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.803 0.335 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -51.91 172.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.993 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.758 HG21 ' CG1' ' A' ' 51' ' ' VAL . 4.1 t -140.71 161.82 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.584 ' HB3' HD13 ' A' ' 71' ' ' LEU . 1.6 mp0 -142.73 101.36 3.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.478 HD23 HG23 ' A' ' 73' ' ' VAL . 2.4 mm? -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.093 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' CB ' ' HA2' ' A' ' 69' ' ' GLY . 1.9 mttt -134.16 64.18 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 111.746 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.67 ' H ' HD12 ' A' ' 72' ' ' ILE . 45.4 t 59.83 139.46 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.345 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HD2' HD22 ' A' ' 38' ' ' LEU . 39.4 Cg_endo -72.65 -166.59 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.107 1.871 . . . . 0.0 112.817 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.68 72.24 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.339 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.738 ' CG2' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -65.58 -12.34 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.491 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.553 ' N ' HD12 ' A' ' 10' ' ' ILE . . . 45.35 67.14 1.3 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.897 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.16 -59.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.291 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.3 p80 170.28 171.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.696 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 3.7 pm0 -67.23 177.49 1.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 1.2 p-10 44.49 85.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 66' ' ' ILE . 20.5 m -123.23 159.8 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.877 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -92.68 128.4 38.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.177 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.926 HD13 HG23 ' A' ' 60' ' ' VAL . 6.9 mt -77.84 161.29 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -127.26 -41.66 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.393 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -116.94 157.77 25.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 21' ' ' VAL . 10.4 p -157.24 115.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -135.85 72.32 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.039 HG11 HG11 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -146.49 118.92 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -119.89 18.79 12.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.175 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 56' ' ' LYS . 74.0 t 66.07 -86.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.949 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 60.65 1.41 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.833 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 162.99 25.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -87.6 120.53 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.805 HD13 HG11 ' A' ' 75' ' ' VAL . 1.1 pt -115.5 137.33 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.94 -169.01 1.88 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 31' ' ' VAL . 21.8 t -90.64 43.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.167 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 p30 171.84 68.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.581 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.1 p-10 -147.55 102.09 3.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -48.5 117.62 2.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.477 . . . . 0.0 111.582 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 49' ' ' ALA . 32.6 mt -91.83 -37.79 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.713 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.484 HD13 ' HB ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -155.17 -160.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.963 179.135 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 37' ' ' THR . 94.4 m -161.3 38.13 0.14 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.83 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.878 HD21 HG21 ' A' ' 16' ' ' VAL . 2.7 tp -31.87 152.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.088 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.806 ' CD ' HG22 ' A' ' 44' ' ' THR . 52.8 tt0 -168.95 157.89 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.48 HG22 ' CG1' ' A' ' 16' ' ' VAL . 3.9 p -123.9 -58.01 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' OG1' ' A' ' 40' ' ' THR . 1.3 m-20 174.78 -34.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.699 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.85 -35.24 26.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.63 157.52 35.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.962 0.41 . . . . 0.0 111.426 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.806 HG22 ' CD ' ' A' ' 39' ' ' GLU . 3.1 p -114.97 119.87 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.393 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.471 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -112.86 141.93 46.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.629 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 37' ' ' THR . 15.3 p-10 -126.88 174.97 8.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.648 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 49' ' ' ALA . 63.2 t -141.86 120.17 7.7 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.919 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 82.9 Cg_endo -90.79 31.33 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.978 2.452 . . . . 0.0 112.179 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.67 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 49.4 99.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.071 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.764 ' O ' HG13 ' A' ' 51' ' ' VAL . 1.3 tm-20 -91.89 66.55 5.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 0.0 110.649 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -170.47 151.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.411 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -121.5 76.2 1.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.652 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.45 -124.93 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.106 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.6 t -143.79 138.57 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.496 0.188 . . . . 0.0 111.242 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.847 HG22 HG12 ' A' ' 75' ' ' VAL . 60.1 t -79.64 150.9 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 121.25 0.548 . . . . 0.0 111.211 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.632 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -120.3 -44.97 2.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.344 178.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -108.9 165.99 11.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.6 p -157.78 118.21 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.288 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 6.0 mttt -133.81 71.71 1.46 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.627 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.926 HG23 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -175.22 160.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -164.9 -161.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.811 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.511 HG23 ' CG1' ' A' ' 21' ' ' VAL . 67.7 t -108.45 71.28 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.82 43.43 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.674 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD2' HD12 ' A' ' 18' ' ' ILE . 7.3 p-10 -136.41 172.32 13.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.957 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.686 ' O ' HD12 ' A' ' 66' ' ' ILE . 21.9 mmtt -97.55 131.89 43.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.787 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.91 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -139.14 151.35 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.882 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.9 OUTLIER -140.63 140.22 34.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.328 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.581 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 3.3 mp0 -40.54 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' CB ' ' A' ' 6' ' ' LYS . . . 116.68 57.08 0.31 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.965 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.66 12.79 8.26 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.105 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.813 HD11 ' CG2' ' A' ' 74' ' ' VAL . 6.2 tp 48.51 57.75 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 0.0 110.884 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.852 HG22 HG13 ' A' ' 73' ' ' VAL . 2.8 mt -53.88 -70.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.076 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.039 HG11 HG11 ' A' ' 23' ' ' VAL . 18.3 m -131.65 151.26 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.747 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.813 ' CG2' HD11 ' A' ' 71' ' ' LEU . 20.3 t -122.3 134.54 65.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.959 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 51' ' ' VAL . 27.7 m -123.32 175.6 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HA ' ' HG ' ' A' ' 2' ' ' LEU . 2.1 tt0 -86.6 -40.85 14.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' CG ' ' A' ' 78' ' ' GLU . . . 57.71 125.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.929 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 52' ' ' ALA . 7.8 pt-20 45.81 40.66 6.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.167 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.15 -65.25 2.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.3 p -88.32 158.06 18.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.205 -0.903 . . . . 0.0 111.046 179.963 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.784 0.326 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mt 56.55 175.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.807 ' O ' HG13 ' A' ' 74' ' ' VAL . 4.8 t -152.6 160.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.768 ' HB3' HD13 ' A' ' 71' ' ' LEU . 18.0 mp0 -138.63 108.84 6.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.61 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.791 HD11 HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -68.14 176.55 2.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.754 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.608 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -157.73 162.83 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.306 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.738 ' N ' HD12 ' A' ' 72' ' ' ILE . 86.1 t -51.9 147.97 11.36 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.635 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HD2' HD22 ' A' ' 38' ' ' LEU . 17.0 Cg_exo -66.76 -156.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.084 1.856 . . . . 0.0 112.671 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -120.84 53.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.884 ' HB ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -46.44 -25.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.94 -179.145 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.633 ' H ' HD12 ' A' ' 10' ' ' ILE . . . 87.96 -41.0 3.06 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.882 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.572 ' HA3' HG21 ' A' ' 40' ' ' THR . . . -47.82 -89.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.695 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -169.74 -172.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.61 176.34 2.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.778 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 44.0 78.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.351 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.044 HG21 HD21 ' A' ' 38' ' ' LEU . 33.6 m -122.36 160.5 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.47 118.19 32.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.253 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.048 HD13 HG23 ' A' ' 60' ' ' VAL . 8.9 mt -60.12 162.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.511 HG12 ' HB ' ' A' ' 37' ' ' THR . 0.2 OUTLIER -121.55 -41.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.135 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.8 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -115.53 164.28 14.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG21 ' HB ' ' A' ' 62' ' ' VAL . 27.9 t -145.25 138.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 35' ' ' LEU . 10.0 mt-10 -159.28 41.8 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.991 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.546 HG11 HG11 ' A' ' 73' ' ' VAL . 2.7 m -141.28 116.17 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.02 13.86 3.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.345 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 56' ' ' LYS . 91.5 t 62.72 124.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.44 -23.3 18.37 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.13 138.74 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -73.77 103.58 4.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.791 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.774 HD13 HG21 ' A' ' 75' ' ' VAL . 4.0 pt -76.55 147.95 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.273 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . . . -128.19 -173.24 2.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.71 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.18 39.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.949 0.404 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.35 64.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.669 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.55 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -138.86 101.47 4.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.718 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -47.15 115.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 111.535 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 36' ' ' ILE . 16.7 mt -89.42 -38.07 14.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.678 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -162.06 179.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.634 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 19' ' ' ILE . 62.1 m -144.03 53.82 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.468 0.651 . . . . 0.0 110.207 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.044 HD21 HG21 ' A' ' 16' ' ' VAL . 4.4 tp -38.13 154.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.243 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.843 ' HG3' HG22 ' A' ' 44' ' ' THR . 8.0 tm-20 -160.4 117.88 2.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.743 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.928 HG22 HG11 ' A' ' 16' ' ' VAL . 53.1 p -70.94 -85.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' N ' ' OG1' ' A' ' 40' ' ' THR . 10.5 p30 -153.0 23.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -177.28 -43.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.709 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . -103.85 125.66 50.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.022 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.843 HG22 ' HG3' ' A' ' 39' ' ' GLU . 1.6 p -111.66 118.49 35.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.044 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.443 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -112.9 153.44 27.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 36' ' ' ILE . 7.5 p30 -136.55 165.44 25.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 5' ' ' LEU . 79.0 t -127.54 119.28 21.6 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.7 Cg_endo -90.39 30.6 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.131 2.554 . . . . 0.0 112.466 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.658 ' H ' HG12 ' A' ' 47' ' ' VAL . . . 50.34 99.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.587 ' C ' HG12 ' A' ' 51' ' ' VAL . 2.4 mp0 -91.64 62.27 4.44 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 3' ' ' VAL . 1.3 p 161.75 144.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.381 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -91.28 -173.49 3.63 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.486 ' N ' HG13 ' A' ' 29' ' ' ILE . . . 117.13 -146.94 18.88 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.634 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' O ' ' CE ' ' A' ' 56' ' ' LYS . 63.2 t -143.19 140.42 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.68 HG22 ' CG1' ' A' ' 75' ' ' VAL . 59.0 t -76.13 144.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.229 0.538 . . . . 0.0 111.94 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -114.78 -50.16 2.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.946 178.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 23.5 mt-10 -110.47 173.36 6.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.174 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.944 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.5 p -164.14 123.87 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -132.96 67.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.048 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -170.86 150.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.892 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 21' ' ' VAL . 7.7 mmtt -130.86 -163.85 1.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.492 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.525 ' HB ' HG21 ' A' ' 21' ' ' VAL . 9.0 p -99.63 36.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.046 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.83 65.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.513 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.603 ' CG ' HD12 ' A' ' 18' ' ' ILE . 1.2 p-10 -133.5 161.97 33.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -73.61 113.34 10.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 7' ' ' VAL . 1.1 tp -129.44 166.58 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.253 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.13 137.73 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.271 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 5.1 mp0 -40.23 106.17 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 90.22 69.16 1.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.288 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.97 24.39 4.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.707 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.768 HD13 ' HB3' ' A' ' 4' ' ' GLU . 6.1 tp 48.38 79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.763 ' CG2' HG13 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -73.19 -73.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.161 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.944 HG12 ' HA ' ' A' ' 58' ' ' VAL . 18.4 m -130.28 145.3 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.807 HG13 ' O ' ' A' ' 3' ' ' VAL . 83.5 t -107.02 134.99 47.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.845 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 29' ' ' ILE . 12.6 m -123.63 171.6 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.183 0.515 . . . . 0.0 112.3 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.612 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -79.3 -24.56 42.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 76' ' ' GLU . . . 84.39 -178.43 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -50.01 95.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.397 . . . . 0.0 110.907 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.92 -70.65 1.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.583 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -160.14 -177.53 6.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.854 0.359 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.124 179.944 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.801 0.334 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.12 170.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.758 ' O ' HG13 ' A' ' 74' ' ' VAL . 25.5 t -151.6 159.2 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.55 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -135.37 99.31 4.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.344 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.889 HD12 ' CG2' ' A' ' 73' ' ' VAL . 25.0 mt -62.37 132.23 51.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.589 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -128.12 73.35 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.858 ' H ' HD12 ' A' ' 72' ' ' ILE . 72.0 t 58.55 149.27 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.625 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.75 ' CG ' HD13 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -83.17 -157.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.866 2.377 . . . . 0.0 112.216 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -103.64 99.4 9.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.78 ' HB ' HG22 ' A' ' 40' ' ' THR . 1.2 pp -111.08 68.82 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.28 -7.16 65.0 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.924 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.16 3.89 81.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.94 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.473 ' CE1' ' O ' ' A' ' 10' ' ' ILE . 51.9 p-80 -109.18 177.32 4.79 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.84 0.353 . . . . 0.0 110.97 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -103.4 -172.36 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.165 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 14' ' ' GLU . 8.3 p30 47.93 86.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.615 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.926 HG22 HG22 ' A' ' 66' ' ' ILE . 10.5 m -137.94 -155.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.125 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.46 ' N ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -149.93 138.24 20.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.979 0.418 . . . . 0.0 111.393 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.111 HD13 HG23 ' A' ' 60' ' ' VAL . 7.8 mt -76.99 162.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.847 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.799 HG23 ' C ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -133.52 -9.62 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.887 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB3' ' N ' ' A' ' 37' ' ' THR . . . -149.55 149.06 30.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.473 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.805 ' HA ' HG22 ' A' ' 36' ' ' ILE . 89.6 t -140.71 121.66 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -142.39 28.39 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.755 HG11 HG11 ' A' ' 73' ' ' VAL . 3.7 m -117.76 125.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -137.28 11.56 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 56' ' ' LYS . 89.9 t 62.33 127.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -21.9 22.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -77.67 152.28 33.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 m -84.06 121.3 27.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.509 HD13 HG23 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -108.46 153.54 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.81 -176.1 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.863 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.66 47.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 166.85 74.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.456 ' CG ' ' HB3' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -160.46 117.72 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.97 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -59.44 117.9 5.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 49' ' ' ALA . 63.0 mt -93.1 -44.95 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.805 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -153.13 -179.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.738 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.799 ' C ' HG23 ' A' ' 19' ' ' ILE . 2.7 m -133.05 145.66 51.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.993 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.753 HD23 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -127.11 -172.54 2.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.777 ' CD ' HG22 ' A' ' 44' ' ' THR . 10.0 tt0 -172.19 172.7 4.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.78 HG22 ' HB ' ' A' ' 10' ' ' ILE . 1.2 p -142.25 -157.35 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 -19.69 65.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.864 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -172.79 53.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -173.47 134.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.24 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.777 HG22 ' CD ' ' A' ' 39' ' ' GLU . 71.4 p -107.71 153.86 22.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -172.07 4.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 37' ' ' THR . 1.0 OUTLIER -176.17 174.11 2.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 49' ' ' ALA . 96.9 t -126.38 123.46 24.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.267 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.5 Cg_endo -90.76 29.93 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 0.0 112.23 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . 46.72 93.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.469 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.35 61.74 3.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.45 149.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.142 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 78' ' ' GLU . . . -116.52 75.0 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.9 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 77' ' ' ALA . . . -163.77 -132.22 1.32 Allowed Glycine 0 C--N 1.317 -0.478 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.752 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.8 t -137.26 138.95 44.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.751 -0.225 . . . . 0.0 110.959 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.776 HG22 ' CG1' ' A' ' 75' ' ' VAL . 58.6 t -74.3 146.5 9.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.368 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.45 -46.1 2.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.57 178.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -113.89 173.95 6.17 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.694 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.617 ' HA ' HG12 ' A' ' 73' ' ' VAL . 7.7 p -160.8 116.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -134.14 79.42 1.81 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.111 HG23 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -174.62 152.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.209 0.528 . . . . 0.0 111.029 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.545 ' C ' HG21 ' A' ' 21' ' ' VAL . 1.2 tptt -138.79 173.34 11.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.484 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 62' ' ' VAL . 11.8 p -92.38 52.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.065 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.28 52.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.594 ' OD2' HD12 ' A' ' 18' ' ' ILE . 3.9 p-10 -129.98 -175.66 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.767 0.317 . . . . 0.0 110.973 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.728 ' O ' HD12 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -105.95 149.78 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.926 HG22 HG22 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -138.34 170.84 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.521 ' N ' HG23 ' A' ' 66' ' ' ILE . 1.5 p -154.59 49.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.773 ' HG3' HD11 ' A' ' 10' ' ' ILE . 85.8 mt-10 39.9 63.68 1.01 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.643 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 146.83 68.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.62 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.27 17.61 6.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.747 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.57 HD11 ' CG2' ' A' ' 74' ' ' VAL . 10.2 tp 45.06 50.46 9.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.066 0.46 . . . . 0.0 110.73 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.858 HD12 ' H ' ' A' ' 7' ' ' VAL . 3.8 mt -45.05 -83.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.466 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.889 ' CG2' HD12 ' A' ' 5' ' ' LEU . 24.1 m -120.95 145.07 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.985 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 3' ' ' VAL . 87.8 t -114.38 138.89 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.605 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -131.77 174.32 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.94 -33.31 22.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.572 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.724 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . 54.06 162.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.645 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 52' ' ' ALA . 4.0 mt-10 69.63 -67.95 0.21 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.588 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 80' ' ' THR . . . 127.35 118.19 2.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.632 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 79' ' ' GLY . 60.5 p -159.33 35.3 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.823 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.108 -180.0 . . . . . . . . 0 0 . 1 stop_ save_